{"title": "PDF", "author": "PDF", "url": "https://www.conprueba.es/sites/default/files/informes/2022-08/PS_SESCS_Meditacion_DEF_NIPO.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "id": "PDF", "license": "PDF", "body": "PDF", "comments": "PDF", "commentsbody": "PDF", "raw_text": "PDF", "text": " \n  \nEfectividad y seguridad de \nla meditaci\u00f3n \n \nEffectiveness and safety of \nmeditation  \n \n \n \n \n \n \n \nInforme T\u00e9cnico \nSESCS     \n \n \n \n \n \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N \n \n \n \n Efectividad y seguridad de \nla meditaci\u00f3n \n \nEffectiveness and safety of \nmeditation  \n \n \nInforme T\u00e9cnico \nSESCS \n \n \n \n \n \n \n \n \n \n \n \n \n \n \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N \n \n \n \n \u00c1LVAREZ-P\u00c9REZ, Y. \nEfectividad y seguridad de la meditaci\u00f3n / Y. \u00c1lvar ez-P\u00e9rez, \u2026 [et al.]. \u2013 \nMadrid: Ministerio de Sanidad. Santa Cruz de Teneri fe: Servicio Canario \nde la Salud, - 325 p.; 24 cm. \u2013 (Colecci\u00f3n: Informe s, estudios e \ninvestigaci\u00f3n / Ministerio de Sanidad).  \n \nNIPO: 133-22-007-2 \n \n \nPalabras Clave: \n \n1. Meditaci\u00f3n 2. Revisi\u00f3n Sistem\u00e1tica 3. Efectivida d 4. \nSeguridad \n \nI. Canarias. Servicio Canario de la Salud II. Espa\u00f1 a. Ministerio de \nSanidad \n \n \nEl Servicio de Evaluaci\u00f3n de la Direcci\u00f3n del Servi cio Canario de la \nSalud asume la responsabilidad exclusiva de la forma  y el contenido \nfinal de este informe. Las manifestaciones y conclu siones de este \ninforme son las del Servicio de Evaluaci\u00f3n y no nec esariamente las de \nsus revisores externos. \n \nEste documento puede ser reproducido total o parcia lmente, por \ncualquier medio, siempre que se cite expl\u00edcitamente su procedencia. \n \n \nFecha de publicaci\u00f3n: 2022 \nEdita: Ministerio de Sanidad. Servicio Canario de l a Salud \n \n  \n  \n \n \n \n \n \n \n \n \n \nEste documento ha sido realizado por el Servicio de  Evaluaci\u00f3n del \nServicio Canario de la Salud en el marco de la fina nciaci\u00f3n del Ministerio \nde Sanidad para el desarrollo de las actividades de l Plan anual de \nTrabajo de la Red Espa\u00f1ola de Agencias de Evaluaci\u00f3 n de Tecnolog\u00edas \nSanitarias y Prestaciones del SNS \n \nEste informe se enmarca dentro de los objetivos del  \u201cPlan de Protecci\u00f3n \nde la Salud frente a las pseudoterapias\u201d impulsado por el Ministerio de \nSanidad y el Ministerio de Ciencia e Innovaci\u00f3n \n \n \n \n \n \n \n \n \n \nPara citar este informe: \n\u00c1lvarez-P\u00e9rez Y, Rivero-Santana A, Perestelo-P\u00e9rez L, Duarte-D\u00edaz A, \nRamos-Garc\u00eda V, Toledo-Ch\u00e1varri A, Torres-Casta\u00f1o A , Gonz\u00e1lez-\nHern\u00e1ndez N, Le\u00f3n-Salas B, Esta\u00f1a-Malaret D, Infant e-Ventura I, \nRodr\u00edguez-Rodr\u00edguez L, Serrano-Aguilar P. Efectivid ad y seguridad de la \nmeditaci\u00f3n. Madrid: Ministerio de Sanidad. Santa Cr uz de Tenerife: \nServicio de Evaluaci\u00f3n del Servicio Canario de la S alud; 2022. \n(Colecci\u00f3n: Informes, estudios e investigaci\u00f3n. Min isterio de Sanidad). \n \n \n Agradecimientos \n \nLos autores del presente informe quieren expresar su  agradecimiento a \nCarlos Gonz\u00e1lez Rodr\u00edguez, por su apoyo en las tare as de \ndocumentaci\u00f3n y edici\u00f3n. \n \n  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 7\u00cdndice \nRESUMEN DIRIGIDO A LA CIUDADAN\u00cdA 15  \nSUMMARY ADDRESSED TO CITIZENS 16  \nI. INTRODUCCI\u00d3N 17  \nI.1. Descripci\u00f3n de la meditaci\u00f3n 18  \nI.2. Descripci\u00f3n de las indicaciones cl\u00ednicas 21  \nI.3. Opciones terap\u00e9uticas habituales de referencia  21  \nII. ALCANCE Y OBJETIVO 23  \nIII. METODOLOG\u00cdA 25  \nIII.1. Fuentes de informaci\u00f3n y estrategia de b\u00fasqu eda 25  \nIII.2. Selecci\u00f3n de estudios 26  \nIII.3. Valoraci\u00f3n de la calidad de los estudios 28  \nIII.4. Extracci\u00f3n de datos y s\u00edntesis de la evidenc ia 28  \nIII.5. Participaci\u00f3n de los agentes de inter\u00e9s 30  \nIV. RESULTADOS 33  \nIV.1. Resultado de la b\u00fasqueda bibliogr\u00e1fica 33  \nIV.1.1 Caracter\u00edsticas de los estudios incluidos 35  \nIV.1.2 Calidad metodol\u00f3gica de los estudios incluid os 36  \nIV.2. Descripci\u00f3n y an\u00e1lisis de resultados 38  \nIV.2.1 Seguridad 38  \nIV.2.2 Efectividad 38  \nV. DISCUSI\u00d3N 67  \nV.1. Limitaciones 69  \nVI. CONCLUSIONES 71   \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  8CONTRIBUCI\u00d3N DE LOS AUTORES 73  \nDECLARACI\u00d3N DE INTERESES 75  \nREFERENCIAS BIBLIOGR\u00c1FICAS 76  \nANEXOS 91  \nAnexo 1. Informaci\u00f3n adicional 91  \nAnexo 2. Estrategia de b\u00fasqueda 100  \nAnexo 3. Organizaciones contactadas 107  \nAnexo 4. Estudios excluidos a texto completo 108  \nAnexo 5. Caracter\u00edsticas de los estudios incluidos 124  \nAnexo 6. Calidad metodol\u00f3gica de los estudios inclu idos 143  \nAnexo 7. Resultados de los estudios primarios 299  \nAnexo 8. Figuras adicionales de los meta-an\u00e1lisis r ealizados 312   \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 9\u00cdndice de tablas \nTabla 1. Bases de datos electr\u00f3nicas consultadas .. ........................................... 25  \nTabla 2. Criterios de selecci\u00f3n de los estudios ... ................................................ 26  \nTabla 3. Resultados en las bases de datos electr\u00f3ni cas consultadas ................ 33  \nTabla 4. Caracter\u00edsticas de las Revisiones Sistem\u00e1t icas incluidas ................... 124  \nTabla 5. Caracter\u00edsticas de los estudios primarios incluidos ............................ 126  \nTabla 6. Nivel de calidad de las Revisiones Sistem\u00e1 ticas incluidas. Escala \nAMSTAR-2 .......................................... .............................................. 143  \nTabla 7. Riesgo de sesgo de los estudios primarios incluidos (resumen). \nEscala RoB-2 Cochrane ............................. ...................................... 144  \nTabla 8. Significaci\u00f3n estad\u00edstica de los resultado s de efectividad de los \nestudios primarios incluidos ...................... ....................................... 299  \n \n  \n  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  10 \u00cdndice de figuras \nFigura 1. Proceso de selecci\u00f3n de revisiones sistem \u00e1ticas ................................ 34  \nFigura 2. Proceso de selecci\u00f3n de ensayos controlad os aleatorizados .............. 34  \nFigura 3. Efecto sobre la ansiedad seg\u00fan el tipo de  meditaci\u00f3n (meditaci\u00f3n \nvs. control) ...................................... ................................................... . 46  \nFigura 4. Gr\u00e1fico de embudo de los estudios que eva luaron ansiedad \n(meditaci\u00f3n vs. control) .......................... ............................................ 47  \nFigura 5. Efecto sobre la depresi\u00f3n seg\u00fan el tipo d e meditaci\u00f3n \n(meditaci\u00f3n vs. control) .......................... ............................................ 50  \nFigura 6. Gr\u00e1fico de embudo de los estudios que eva luaron depresi\u00f3n \n(meditaci\u00f3n vs. control) .......................... ............................................ 51  \nFigura 7. Efecto sobre el estr\u00e9s seg\u00fan el tipo de m editaci\u00f3n (meditaci\u00f3n vs. \ncontrol) .......................................... ................................................... .. 52  \nFigura 8. Gr\u00e1fico de embudo de los estudios que eva luaron estr\u00e9s \n(meditaci\u00f3n vs. control) .......................... ............................................ 53  \nFigura 9. Efecto sobre el estr\u00e9s postraum\u00e1tico seg\u00fa n el tipo de meditaci\u00f3n \n(meditaci\u00f3n vs. control) .......................... ............................................ 55  \nFigura 10. Efectividad de OMBM sobre los s\u00edntomas d e TEPT evaluados \npor el cl\u00ednico (CAPS) (meditaci\u00f3n vs. control) .... ................................. 56  \nFigura 11. Efecto sobre la psicopatolog\u00eda general s eg\u00fan el tipo de \nmeditaci\u00f3n (meditaci\u00f3n vs. control) ............... ..................................... 57  \nFigura 12. Efecto sobre la calidad de vida (general  o mental) seg\u00fan el tipo \nde meditaci\u00f3n (meditaci\u00f3n vs. control) ............ ................................... 59  \nFigura 13. Gr\u00e1fico de embudo de los estudios que ev aluaron calidad de \nvida .............................................. ................................................... .... 60  \nFigura 14. Efecto sobre la calidad de vida (f\u00edsica)  seg\u00fan el tipo de \nmeditaci\u00f3n (meditaci\u00f3n vs. control) ............... ..................................... 61  \nFigura 15. Efecto sobre la ansiedad seg\u00fan el tipo d e meditaci\u00f3n \n(meditaci\u00f3n vs. otros tratamientos activos) ....... ................................. 63  \nFigura 16. Efecto sobre la depresi\u00f3n seg\u00fan el tipo de meditaci\u00f3n \n(meditaci\u00f3n vs. otros tratamientos activos) ....... ................................. 64  \n  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 11 Siglas y Acr\u00f3nimos \nACL Adjective Check List scale of anxiety \nAPA American Psychological Association \nAqoL-8D Assessment of Quality of Life 8-dimension \nBAI Beck Anxiety Inventory \nBAM Behavioral Anxiety Measure \nBDI-II Beck Depression Inventory II \nBFI Brief Fatigue Inventory \nBIS Brain Integration Scale \nBPI Brief Pain Inventory \nBSI-18 Brief Symptom Inventory-18 \nCAPS Clinician-Administered Post-traumatic stress d isorder Scale \nCBCT Cognitively based compassion training \nCCG Clinical Global Impression \nCES-D Center for Epidemiologic Studies Depression S cale \nCGI Clinical Global Impression \nCMCL State Anxiety \u2010 Current Mood Checklist \nCPSR Composite Primary IBS Symptom Reduction \nCSAQ-C Cognitive scale of the Cognitive-Somatic Anx iety Questionnaire \nCSI Children Somatisation Inventory \nDASS-21 Depression, Anxiety and Stress Scale \nDAS-SCP Dysfunctional Attitude Scale, self-critical  perfectionism \nDM Diferencia de medias \nDME Diferencia de medias estandarizada \nDSM-III Diagnostic and Statistical Manual of Mental  Disorders, version III \nDST Dementia Screening Test \ndt Desviaciones t\u00edpicas \nECA Ensayo Controlado Aleatorizado \nECNA Ensayo Controlado No Aleatorizado \nETS Evaluaci\u00f3n de tecnolog\u00eda sanitaria \nEVA Escala Visual Anal\u00f3gica \nFACIT Fatigue scale  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  12 FACT-B Functional Assessment of Cancer Therapy-Brea st \nFACT-Cog Functional Assessment of Cancer Therapy-Co gnitive Function \nFAHI Functional Assessment of Human Immunodeficienc y Virus Infection \nFRT Functional Reach Test \nFTSST Five Times Sit to Stand Test \nGAI Geriatric Anxiety Inventory \nGC Grupo control \nGCS Generalized Contentment Scale \nGDS Geriatric Depression Scale \nGHQ General Health Questionnaire \nGI Grupo intervenci\u00f3n \nGRADE Grading of Recommendations, Assessment, Development  and \nEvaluation \nHADS Hospital Anxiety Depression Scale \nHAM-D Hamilton Depression Rating Scale \nHMSE Headache Management Self-Efficay Scale \nHRSD Hamilton Rating Scale for Depression \nHRSRS Holmes-Rahe Social Readjustment Scale \nIC Intervalo de Confianza \nICS Index of Clinical Stress \nIDA Irritability, Depression and Anxiety scale \nIES-R Impact of Events Scale-Revised \nIPAT Institute of Personality and Ability Testing-D epression Scale \nISI Insomnia Severity Index \nKCE Belgian Health Care Knowledge Centre \nLAS Life Adaptation Scale \nLKM Loving-kindness meditation \nLWASQ Lehrer-Woolfolk Trimodal Anxiety Symptom Ques tionnaire \nMA Meta-an\u00e1lisis \nMBCT Mindfulness-based Cognitive Therapy \nMBI Maslach Burnout Inventory \nMBSR Mindfulness-based Stress Reduction \nMHI-5 Mental Health Inventory-5 \nMLWHFQ Minnesota Living with Heart Failure Question naire  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 13 MOS Medical Outcomes Study \nMPQ McGill Pain Questionnaire \nMPSS Modified Post-traumatic stress disorder Sympto m Scale \nMQOL McGill quality of life scale \nMS Mindful selfcompassion \nMSQOL Migraine Specific Quality of Life Scale \nMT Meditaci\u00f3n Trascendental \nMVQOLI Missoula-VITAS Quality of Life Index \nN.I. No informa \nN N\u00famero de participantes \nNICE National Institute of Clinical Excellence \nNPAD Neck Pain and Disability Scale \nPASE Physical Activity Scale for the Elderly \nPCL-5 Post-traumatic stress disorder Checklist for DSM-5\u2013 Specific \nPCL-C Post-traumatic stress disorder Checklist-Civi lian Version \nPCL-M Post-traumatic stress disorder Checklist-Mili tary Version \nPCQ 39-item Dutch Pain Coping Questionnaire \nPHQ-9 Patient Health Questionnaire-9 \nPOMS Profile of Mood States Total Mood Disturbance scale \nPRCS Personal Report of Confidence as a Speaker \nPSQ Psychological Strain Questionnaire \nPSQI Pittsburgh Sleep Quality Index \nPSS Perceived Stress Scale \nPSSS Perceived Social Support Scale \nPSWQ Penn State Worry Questionnaire \nPTQL Pictorial Thai Quality of Life \nPTSD Post-traumatic stress disorder \nQ-LES-Q Quality of Life Enjoyment and Satisfaction Questionnaire \nQ-LES-Q:SF Quality of Life Enjoyment and Satisfacti on Questionnaire-Short Form \nQOLSV Quality of Life Profile Seniors Version \nRCADS-25 Revised Children\u2019s Anxiety and Depression Scale-25 \nRedETS Red Espa\u00f1ola de Agencias de Evaluaci\u00f3n de Tecnolog\u00ed as Sanitarias y \nPrestaciones del Sistema Nacional de Salud \nRMDQ Roland Morris Disability Questionnaire  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  14 RS Revisi\u00f3n sistem\u00e1tica \nS-R Inventory of Anxiousness \nSCL-90 Symptom Checklist-90 \nSDS Symptom Distress Scale \nSF-12 Short Form-12 Health Survey \nSF-36 Short Form-36 Health Survey \nSHQ Social History Questionnaire \nSIDA S\u00edndrome de inmunodeficiencia adquirida \nSIGN Scottish Intercollegiate Guidelines Network \nSRDS Self-Rating Depression Scale \nSTAI State-Trait Anxiety Inventory \nSUSLT Stanford University Stress Level Test \nTEPT Trastorno por estr\u00e9s postraum\u00e1tico \nTFRM Tasa de flujo respiratorio m\u00e1ximo \nTMAS Taylor Manifest Anxiety Scale \nTSC-40 Trauma Symptom Checklist \u2013 40 \nTSES Toronto Side Effects Scale \nTSI Teacher's Stress Inventory \nTUGT Timed up and go test \nVEF1 Volumen espiratorio forzado en 1 segundo \nVIH Virus de la inmunodeficiencia humana \nWHOQOL World Health Organization Quality of Life bri ef form \nOMBM Otras Meditaciones Basadas en Mantras \n6MWT Six-minute walk distance test \n \n \n  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 15 Resumen dirigido a la ciudadan\u00eda \nNombre de la \nt\u00e9cnica con \npretendida \nfinalidad sanitaria Meditaci\u00f3n basada en atenci\u00f3n focalizada; en el amo r, \nbondad y/o la compasi\u00f3n; pr\u00e1cticas mixtas de medita ci\u00f3n \ncon componentes atencionales, emocionales, y/o \nreligioso/espirituales. \nDefinici\u00f3n de la \nt\u00e9cnica e \nindicaciones \ncl\u00ednicas La meditaci\u00f3n se define como una forma de entrenami ento \ncognitivo que tiene como objetivo mejorar la autorr egulaci\u00f3n \natencional y emocional. Las diversas formas de medi tar se \nrelacionan directamente con su prop\u00f3sito, dando lug ar a \ndiferentes tipos de meditaci\u00f3n. Este informe se cen tra en las \nt\u00e9cnicas de meditaci\u00f3n basadas en: 1) atenci\u00f3n foca lizada \n(incluyendo tambi\u00e9n la meditaci\u00f3n trascendental y o tras \nmeditaciones basadas en la repetici\u00f3n de mantras); 2) amor, \nbondad y la compasi\u00f3n; y 3) pr\u00e1cticas mixtas de med itaci\u00f3n \ncon componentes atencionales, emocionales y/o \nreligioso/espirituales. La meditaci\u00f3n estar\u00eda dirig ida a mejorar \nvariables de car\u00e1cter afectivo-emocional (ansiedad,  \ndepresi\u00f3n, estr\u00e9s y otras) en personas con o sin tr astornos \ncl\u00ednicos (f\u00edsicos o psicol\u00f3gicos). \nCalidad de la \nevidencia La calidad de los estudios evaluados sobre la efect ividad de  \nlas t\u00e9cnicas de meditaci\u00f3n evaluadas es baja, es de cir, existe \npoca confianza en los resultados obtenidos. \nResultados claves  Se incluyeron 4 revisiones sistem\u00e1ticas y 87 ensayo s \ncontrolados aleatorizados. La variable de salud m\u00e1s  evaluada \nfue la ansiedad (41 estudios) y el problema de salu d m\u00e1s \nevaluado fue el estr\u00e9s postraum\u00e1tico (10 estudios).  El tipo de \nmeditaci\u00f3n m\u00e1s utilizado fue la meditaci\u00f3n trascend ental (32 \nestudios), seguida de otras meditaciones basadas en  mantras \n(26 estudios), meditaci\u00f3n religiosa/espiritual (4 e studios), \nmeditaci\u00f3n focalizada en la respiraci\u00f3n y/o escaneo  corporal \n(8 estudios), meditaci\u00f3n basada en el amor, bondad y/o la \ncompasi\u00f3n (9 estudios) y meditaciones mixtas (8 est udios). \nConclusi\u00f3n final  Las conclusiones no pueden se r definitivas debido a la baja \ncalidad metodol\u00f3gica de los estudios. Los resultado s \nsugieren que la meditaci\u00f3n basada en mantras podr\u00eda  \nproducir un efecto beneficioso sobre los niveles de  ansiedad, \ndepresi\u00f3n, estr\u00e9s general y postraum\u00e1tico y calidad  de vida \nrelacionada con la salud. Otros tipos de meditaci\u00f3n  tambi\u00e9n \npodr\u00edan producir un efecto positivo sobre estos res ultados de \nsalud mental, aunque el n\u00famero de estudios evaluado s es \nmenor. En el caso de enfermedades f\u00edsicas la eviden cia \ntambi\u00e9n es muy limitada; algunos estudios han encon trado \nresultados estad\u00edsticamente significativos en disti ntos tipos \nde dolor, glaucoma, funcionalidad en personas mayor es, \npsoriasis, s\u00edndrome de intestino irritable o s\u00edndro me \nmetab\u00f3lico, pero como se ha dicho, se trata de evid encia de \nbaja calidad. No se han observado efectos adversos de la \nmeditaci\u00f3n, aunque son muy pocos los estudios que l os han \nevaluado de manera expl\u00edcita.  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  16 Summary addressed to citizens \nName of the \ntechnique with health \npurposes Focused-attention meditation; Loving-kindness and/o r \ncompassion meditacion; mixed meditation practices w ith \nattentional, emotional, and/or religious/spiritual \ncomponents \nDefinition of the \ntechnique and \nclinical indications Meditation is defined as a form of cognitive traini ng tha t \naims to improve attentional and emotional self-regu lation. \nvarious forms of meditation are directly related to  its \npurpose, leading to different types of meditation. This \nreport focuses on: 1) focused-attention meditation (also \nincluding transcendental meditation and other medit ations \nbased on the repetition of mantras); 2) Loving-kind ness and \ncompassion meditacion; and 3) mixed meditation prac tices \nwith attentional, emotional and/or religious/spirit ual \ncomponents. Meditation would be aimed at improving \naffective-emotional variables (anxiety, depression,  stress \nand others) in people with or without clinical diso rders \n(physical or psychological). \nQuality of the \nevidence The quality of the studies evaluated on the effecti veness of \nthe meditation techniques evaluated is low, that is , there is \nlittle confidence in the results obtained. \nKey results  Four systematic reviews and 87 randomized controlle d \ntrials were included. The most evaluated health var iable \nwas anxiety (41 studies) and the most evaluated hea lth \nproblem was post-traumatic stress (10 studies). The  type of \nmeditation more used was transcendental meditation (32 \nstudies), followed by other meditations based on ma ntras \n(26 studies), religious / spiritual meditation (4 s tudies), \nbreath-focused meditation and / or body scanning (8  \nstudies), Loving-kindness and/or compassion meditac ion (9 \nstudies) and mixed meditations (8 studies). \nFinal conclusion  The conclusions can  not be definitive due to the low \nmethodological quality of the studies. The results suggest \nthat mantra-based meditation could have a beneficia l effect \non levels of anxiety, depression, general and post- traumatic \nstress, and health-related quality of life. Other t ypes of \nmeditation could also have a positive effect on the se \nmental health outcomes, although the number of stud ies \nevaluated is fewer. In the case of physical disease s, the \nevidence is also very limited; Some studies have fo und \nstatistically significant results in different type s of pain, \nglaucoma, functionality in the elderly, psoriasis, irritable \nbowel syndrome or metabolic syndrome, but as noted,  this \nis low-quality evidence. No adverse effects of medi tation \nhave been observed, although very few studies have \nexplicitly evaluated them.  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 17 I. Introducci\u00f3n \nEste informe se enmarca en los objetivos del \u201cPlan de Protecci\u00f3n de la \nSalud frente a las pseudoterapias\u201d impulsado por el  Ministerio de \nSanidad y el Ministerio de Ciencia, Innovaci\u00f3n y Un iversidades. Su \nprincipal objetivo es proporcionar a la ciudadan\u00eda informaci\u00f3n veraz para \nque pueda diferenciar las prestaciones y tratamient os cuya eficacia \nterap\u00e9utica o curativa ha sido contrastada cient\u00edfi camente de todos \naquellos productos y pr\u00e1cticas que, en cambio, no l o han hecho. \nEl Plan contempla cuatro l\u00edneas de actuaci\u00f3n y la p rimera de ellas \nes generar, difundir y facilitar informaci\u00f3n, basad a en el conocimiento y \nen la evidencia cient\u00edfica m\u00e1s actualizada y robust a de las \npseudoterapias a trav\u00e9s de la Red Espa\u00f1ola de Agenc ias de Evaluaci\u00f3n \nde Tecnolog\u00edas Sanitarias y Prestaciones del Sistem a Nacional de Salud \n(RedETS). \nCon el fin de avanzar en esta direcci\u00f3n se ha asign ado una l\u00ednea de \nactividad para el apoyo a la evaluaci\u00f3n de la evide ncia cient\u00edfica que se \nrequiere desde el Plan de Protecci\u00f3n de la Salud fr ente a las \npseudoterapias en el marco del Plan de trabajo Anua l de la RedETS.  \nComo punto de partida se elabor\u00f3 un an\u00e1lisis explora torio inicial, \nbasado en una revisi\u00f3n de las publicaciones cient\u00edf icas (revisiones \nsistem\u00e1ticas y ensayos cl\u00ednicos), limitada temporal mente al per\u00edodo \n2012-2018, en una base de datos m\u00e9dica (Pubmed), en  el que se \nregistr\u00f3 un listado de 71 de las 138 t\u00e9cnicas o pro cedimientos \ncontemplados para los que no se han identificado en sayos cl\u00ednicos o \nrevisiones sistem\u00e1ticas publicados durante el perio do 2012-2018 que \nproporcionen evidencia cient\u00edfica. Por tanto, para estas t\u00e9cnicas no se \nlocaliz\u00f3 soporte en el conocimiento cient\u00edfico con metodolog\u00eda lo \nsuficientemente s\u00f3lida (ensayos cl\u00ednicos o revision es sistem\u00e1ticas) que \nsirviera para evaluar su seguridad, eficacia y efec tividad, de manera que \nse clasificaron como pseudoterapias seg\u00fan la defini ci\u00f3n del mencionado \nPlan. Se considera pseudoterapia a la sustancia, pr oducto, actividad o \nservicio con pretendida finalidad sanitaria que no tenga soporte en el \nconocimiento cient\u00edfico ni evidencia cient\u00edfica que  avale su efectividad y \nsu seguridad. \nPara las restantes t\u00e9cnicas en las que se localizar on publicaciones \ncient\u00edficas con la b\u00fasqueda realizada, se ha planif icado un \nprocedimiento de evaluaci\u00f3n progresivo, para analiz arlas en detalle. En  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  18 este marco se incluye la evaluaci\u00f3n de la efectivid ad y seguridad de la \nmeditaci\u00f3n.  \nI.1. I.1. I.1. I.1. Descripci\u00f3n de la Descripci\u00f3n de la Descripci\u00f3n de la Descripci\u00f3n de la meditaci\u00f3n meditaci\u00f3n meditaci\u00f3n meditaci\u00f3n    \nLa meditaci\u00f3n se define como una forma de entrenami ento cognitivo \nque tiene como objetivo mejorar la autorregulaci\u00f3n atencional y \nemocional [1]. Es un t\u00e9rmino general asociado a un conjunto de \npr\u00e1cticas y procedimientos de atenci\u00f3n y concentrac i\u00f3n, cuya finalidad \nes aumentar la conciencia y ejercer control volunta rio sobre los \nprocesos mentales para lograr una mejor comprensi\u00f3n  de la propia \nactividad mental y desarrollar estados \u00f3ptimos de b ienestar psicol\u00f3gico \n[2,3]. Se le atribuyen beneficios para la salud psi cosom\u00e1tica, pudiendo \nutilizarse como estrategia de rehabilitaci\u00f3n y anti estr\u00e9s [4].  \nEn la actualidad, las diversas formas de meditar se  relacionan \ndirectamente con su prop\u00f3sito, sin embargo, dada la  gran variedad de \npr\u00e1cticas y t\u00e9cnicas llamadas meditaci\u00f3n , se acent\u00faa el problema de \nenumerar, diferenciar y definir te\u00f3ricamente los di ferentes tipos de \nmeditaci\u00f3n [5,6]. A ello se le a\u00f1ade la complejidad  asociada a la \ninterpretaci\u00f3n y adaptaci\u00f3n de conceptos y t\u00e9rminos  orientales a la \ncultura occidental, vinculados a los mecanismos cog nitivos subyacentes \nrelacionados con cada una de las modalidades de med itaci\u00f3n.  \nDesde este punto de vista, es importante destacar q ue tambi\u00e9n \nexiste un gran n\u00famero de t\u00e9cnicas que comparten simi litudes en cuanto \na sus elementos y el foco atencional sobre el que r ecae su pr\u00e1ctica, \nencontr\u00e1ndose as\u00ed una gran heterogeneidad en su cla sificaci\u00f3n. No \nobstante, una forma simple de clasificar los tipos de meditaci\u00f3n para \nmanejar esta dificultad es categorizarlos seg\u00fan las  pr\u00e1cticas que se \nrealicen. De esta manera, se pueden identificar t\u00e9c nicas de meditaci\u00f3n \ncon pr\u00e1cticas basadas en [7]:  \n1) Atenci\u00f3n focalizada  (del ingl\u00e9s, focused-attention meditation ): \nconsiste en enfocar la atenci\u00f3n de manera imperturb able en un \nelemento espec\u00edfico, ya sea en la respiraci\u00f3n, en u na emoci\u00f3n, en un \nmantra, en una imagen, en un sonido o en una idea c oncreta [3,8], \nfavoreciendo la concentraci\u00f3n y la metaconciencia [ 9,10]. Algunas \nt\u00e9cnicas de meditaci\u00f3n que se podr\u00edan encajar dentr o de esta categor\u00eda \ncon identidad propia es la meditaci\u00f3n basada en man tras (MBM) y la \nmeditaci\u00f3n trascendental (MT), entre otras (ver Ane xo 1 para m\u00e1s \ninformaci\u00f3n). \n2) Conciencia o monitoreo abierto  (del ingl\u00e9s, open-monitoring \nmeditation ): generalmente comienza enfocando la atenci\u00f3n sobr e el  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 19 momento presente y observando imparcialmente los co ntenidos \nmentales (pensamientos, emociones, sensaciones, etc .) a medida que \nocurren y disminuyen de forma natural [11]. Se cent ra en aumentar la \nconciencia sobre los procesos f\u00edsicos y aurorrefere nciales, pero no \nimplica la selecci\u00f3n de un objeto espec\u00edfico sobre el que orientar la \natenci\u00f3n [12]. Algunas t\u00e9cnicas de meditaci\u00f3n que p odr\u00edan incluirse \ndentro de esta categor\u00eda son la meditaci\u00f3n Zazen (o  Zen), el Shinkataza \n(simplemente sentado) de la Escuela Soto Zen y la m editaci\u00f3n \nVipassana. A partir de esta \u00faltima, en las \u00faltimas d\u00e9cadas se ha \nextendido en occidente la denominada terapia basada en Mindfulness , \ntraducido en castellano como \u201cAtenci\u00f3n Plena\u201d (si b ien este concepto, \ncomo estado psicol\u00f3gico a lograr, no es exclusivo de  esta corriente). En \nlas \u00faltimas d\u00e9cadas, el uso del Mindfulness  para abordar diferentes \nproblemas mentales o para mejorar el bienestar psic ol\u00f3gico desde un \npunto de vista cl\u00ednico ha sido incluido dentro de l as terapias \npsicol\u00f3gicas de tercera generaci\u00f3n, al compartir lo s principios del \nabordaje cognitivo-conductual [13], existiendo en l a actualidad \ndiferentes programas terap\u00e9uticos individuales o gr upales. Dos de ellos, \nla terapia cognitiva basada en Mindfulness ( Mindfulness-based Cognitive \nTherapy , MBCT) y la reducci\u00f3n de estr\u00e9s basada en Mindfuln ess \n(Mindfulness-based Stress Reduction , MBSR), cuentan con evidencia a \nsu favor como para haber sido recomendadas como tra tamiento inicial o \nde mantenimiento frente a la depresi\u00f3n en gu\u00edas de pr\u00e1ctica cl\u00ednica \nelaboradas por el  National Institute of Clinical Excellence  (NICE) del \nReino Unido [14,15], la RedETS [16], la Scottish Intercollegiate \nGuidelines Network  (SIGN) [17], la American Psychological Association  \n(APA) [18], el Belgian Health Care Knowledge Centre  (KCE) [19], as\u00ed \ncomo en otras gu\u00edas elaboradas en Francia [20] o Ca nad\u00e1 [21]. Otros \ninformes de ETS tambi\u00e9n confirman una efectividad t erap\u00e9utica \nequivalente al tratamiento de primera l\u00ednea para al gunas enfermedades \nmentales as\u00ed como en su prevenci\u00f3n [22] y en la mej ora de la salud \npsicol\u00f3gica de personas con afecciones f\u00edsicas [23, 24,33\u201338,25\u201332]. \nRecientemente, en otro informe tambi\u00e9n realizado en  el marco de la \nRedETS, se inform\u00f3 sobre los potenciales beneficios  del Mindfulness en \nel tratamiento del trastorno mental grave, se\u00f1al\u00e1nd ose una reducci\u00f3n de \nla sintomatolog\u00eda general psic\u00f3tica y de la tasa de  rehospitalizaci\u00f3n, as\u00ed \ncomo un aumento de la calidad de vida en pacientes con psicosis, al \nutilizarse como herramienta coadyuvante a la farmac oterapia y a otros \nabordajes integrales rehabilitadores [39] (ver Anexo  1 para m\u00e1s \ninformaci\u00f3n).  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  20 3) Amor, bondad y compasi\u00f3n  (del ingl\u00e9s, Kindness-based \nmeditation ) [3,40,41]: implican principalmente la generaci\u00f3n y el cultivo \nde la compasi\u00f3n de forma que se redirijan los patro nes cognitivos, \nconductuales y afectivos autorreferenciales hacia t endencias y \npensamientos que involucren el bienestar propio y/o  el de los dem\u00e1s \n[9,42]. Algunas t\u00e9cnicas de meditaci\u00f3n que podr\u00edan encajarse dentro de \nesta categor\u00eda son la meditaci\u00f3n  Tonglen , la meditaci\u00f3n basada en la \nbondad y amor (del ingl\u00e9s, Loving-kindness meditation , LKM), la \nmeditaci\u00f3n de compasi\u00f3n (del ingl\u00e9s, Compassion meditation ) y el \nentrenamiento en el cultivo de la compasi\u00f3n (del in gl\u00e9s, Compassion \nCultivation Training ), entre otras (ver Anexo 1 para m\u00e1s informaci\u00f3n). \n4) Movimiento , tambi\u00e9n conocidas como mente-cuerpo (del \ningl\u00e9s, mind-body meditation ): centran su \u00e9nfasis en la armon\u00eda entre el \ncuerpo y la mente, contemplando la meditaci\u00f3n como complemento en \nsus pr\u00e1cticas de ejercicios corporales, como, por e jemplo, el Yoga y el \nTai-chi, entre otras [8,43]. La literatura sobre la s terapias mente-cuerpo \nno es tan abundante y equitativa para todas sus t\u00e9c nicas, ya que \nalgunas han sido m\u00e1s estudiadas que otras, como es el caso del Yoga \nen el manejo de algunas patolog\u00edas, como enfermedad es reum\u00e1ticas \n[44] y el trastorno de estr\u00e9s postraum\u00e1tico [45]. A lgunos estudios sobre \nlas terapias mente-cuerpo informan acerca del poten cial uso y \nbeneficios en el abordaje del insomnio [46], del do lor cr\u00f3nico [47] o de \ns\u00edntomas negativos de la esquizofrenia [48]. No obs tante, esta evidencia \nes a\u00fan limitada [8] y, pese a que estas t\u00e9cnicas ta mbi\u00e9n contienen un \ncomponente meditativo, a menudo es dif\u00edcil determin ar los efectos de la \nmeditaci\u00f3n en s\u00ed misma en comparaci\u00f3n con los efect os fisiol\u00f3gicos del \nejercicio f\u00edsico, dada la cantidad significativa de  movimiento que \nimplican estas t\u00e9cnicas [4]. \nEste informe se centrar\u00e1 en la evaluaci\u00f3n de la efe ctividad y \nseguridad de las t\u00e9cnicas de meditaci\u00f3n basadas en:  1) atenci\u00f3n \nfocalizada (incluyendo la meditaci\u00f3n trascendental y otras meditaciones \nbasadas en la repetici\u00f3n de mantras); 2) amor, bond ad y la compasi\u00f3n; y \n3) pr\u00e1cticas mixtas de meditaci\u00f3n con componentes at encionales, \nemocionales y/o religioso/espirituales; para las qu e existe una mayor \nincertidumbre sobre sus potenciales efectos para la  prevenci\u00f3n y \ntratamiento de varios problemas de salud f\u00edsica y m ental. No se \nincluyen, por tanto, intervenciones terap\u00e9uticas ba sadas en Mindfulness , \ndebido a su efectividad terap\u00e9utica demostrada para  diferentes \ncondiciones de salud. Tampoco se incluyen las t\u00e9cni cas de meditaci\u00f3n \nmente-cuerpo, dada la cantidad significativa de mov imiento que \nimplican y que actualmente se est\u00e1n evaluando expl\u00ed citamente en otros  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 21 informes de ETS dentro del \u201cPlan de Protecci\u00f3n de l a Salud frente a las \npseudoterapias\u201d de la RedETS. \nI.2. Descripci\u00f3n I.2. Descripci\u00f3n I.2. Descripci\u00f3n I.2. Descripci\u00f3n de las indicaciones cl\u00ednicas de las indicaciones cl\u00ednicas de las indicaciones cl\u00ednicas de las indicaciones cl\u00ednicas    \nDe manera general, se atribuyen algunos beneficios a la meditaci\u00f3n, \naunque al parecer este efecto podr\u00eda ser diferente si se comparan \nmedidas de resultado en salud mental, salud f\u00edsica y comportamientos \nsaludables [49]. Este planteamiento parte de que lo s efectos sobre la \nsalud f\u00edsica est\u00e1n determinados por diversos factor es y mediados por \nlos cambios en la salud mental y en el comportamien to saludable de la \npersona [50].  \nDe esta manera, se postula que los mecanismos de la  meditaci\u00f3n \nque influyen sobre la salud (es decir, la autorregu laci\u00f3n atencional y \nemocional) son variables psicol\u00f3gicas que pueden pr oducir efectos \ndirectos sobre la salud mental y el comportamiento saludable de la \npersona, resultando as\u00ed en cambios en su salud f\u00edsi ca [8].  \nExisten algunos estudios sobre los potenciales benef icios en salud \nde los diferentes tipos de meditaci\u00f3n mencionados a nteriormente al \nintervenir sobre el bienestar e interacci\u00f3n social [51], para la prevenci\u00f3n \nde enfermedades cardiovasculares [52] o como tratam iento \ncomplementario para la hipertensi\u00f3n en personas may ores [53]. Sin \nembargo, en la actualidad no se dispone de la sufic iente evidencia \ncient\u00edfica que avale la seguridad y efectividad de este tipo de pr\u00e1cticas \nde meditaci\u00f3n como para establecer su indicaci\u00f3n cl \u00ednica como una \nalternativa a ninguna terapia de la medicina tradic ional [8].  \nI.3. Opciones terap\u00e9uticas habituales de I.3. Opciones terap\u00e9uticas habituales de I.3. Opciones terap\u00e9uticas habituales de I.3. Opciones terap\u00e9uticas habituales de \nreferencia referencia referencia referencia    \nDado que no existen indicaciones espec\u00edficas para la s t\u00e9cnicas de \nmeditaci\u00f3n basadas en la atenci\u00f3n focalizada, el am or, bondad y la \ncompasi\u00f3n y las pr\u00e1cticas mixtas de meditaci\u00f3n con c omponentes \natencionales, emocionales y/o religioso/espirituale s; en el caso de \nenfermedades f\u00edsicas o mentales, no es posible desc ribir las opciones \nhabituales de tratamiento.   \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 23 II. Alcance y objetivo \nEste informe pretende identificar, evaluar cr\u00edticam ente y sintetizar la \nevidencia cient\u00edfica disponible sobre la efectivida d y seguridad de las \nt\u00e9cnicas de meditaci\u00f3n basadas en la atenci\u00f3n focal izada, el amor, \nbondad y la compasi\u00f3n y las pr\u00e1cticas mixtas de medi taci\u00f3n con \ncomponentes atencionales, emocionales y/o religioso /espirituales para \nel abordaje de cualquier indicaci\u00f3n cl\u00ednica o condi ci\u00f3n de salud, en \npersonas de cualquier edad. \nEl informe est\u00e1 dirigido a profesionales y gestores  sanitarios, as\u00ed \ncomo a pacientes, sus familiares y la poblaci\u00f3n en general. \n  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 25 III. Metodolog\u00eda \nEste informe se ha realizado de acuerdo a la Gu\u00eda p ara la elaboraci\u00f3n y \nadaptaci\u00f3n de informes r\u00e1pidos de evaluaci\u00f3n de tec nolog\u00edas sanitarias \n(ETS) desarrollada en la RedETS [54]. \nPara alcanzar el objetivo propuesto, se realiz\u00f3 una  revisi\u00f3n \nsistem\u00e1tica (RS) de la literatura, basada en la met odolog\u00eda Cochrane \n[55], sobre la efectividad y seguridad de las t\u00e9cni cas de meditaci\u00f3n \nbasadas en la atenci\u00f3n focalizada, el amor, bondad y la compasi\u00f3n y las \npr\u00e1cticas mixtas de meditaci\u00f3n con componentes atenc ionales, \nemocionales y/o religioso/espirituales. \nIII.1. Fuentes de informaci\u00f3n III.1. Fuentes de informaci\u00f3n III.1. Fuentes de informaci\u00f3n III.1. Fuentes de informaci\u00f3n    y y y y estrategia de estrategia de estrategia de estrategia de \nb\u00fasqueda b\u00fasqueda b\u00fasqueda b\u00fasqueda     \nEn la Tabla 1 se describen las bases de datos elect r\u00f3nicas consultadas \nhasta septiembre de 2020 y en el Anexo 2 se describe n las estrategias \nde b\u00fasqueda realizadas sin restricciones por idioma . \n \nTabla 1. Bases de datos electr\u00f3nicas consultadas  \nBase de datos Periodo de b\u00fasqueda \nMEDLINE (Ovid) 1946 - septiembre 2020 \nEMBASE (Elsevier) 1974 - septiembre 2020 \nCOCHRANE (Wiley) 1995 - septiembre 2020 \nPsycINFO (Ebsco) 2003 - septiembre 2020 \n \nEl proceso de selecci\u00f3n de los estudios se realiz\u00f3 por dos revisores \nde forma paralela e independiente y, en caso de dud a y/o desacuerdo \nentre ellos, se acudi\u00f3 a un tercer revisor que comp rob\u00f3 los criterios del \nprotocolo e intent\u00f3 llegar a un consenso con los ot ros dos revisores. La \nselecci\u00f3n de los estudios se realiz\u00f3 a partir de lo s res\u00famenes \nrecuperados en las bases de datos seg\u00fan los criteri os de selecci\u00f3n \nantes citados y previa valoraci\u00f3n de la relevancia para esta RS.  \nA continuaci\u00f3n, se recuperaron las publicaciones co mpletas \n(incluyendo todas aquellas en las que su elegibilid ad no se pod\u00eda \ndeterminar por el resumen) y se volvi\u00f3 a comprobar la concordancia con  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  26 los criterios de la revisi\u00f3n. El an\u00e1lisis bibliogr\u00e1 fico se complement\u00f3 con \nla consulta manual de referencias extra\u00eddas de los e studios. \nAdem\u00e1s, se consult\u00f3 a personas expertas en el \u00e1rea p ara identificar \notras posibles publicaciones de inter\u00e9s. Las refere ncias bibliogr\u00e1ficas \nfueron gestionadas a trav\u00e9s del programa Reference Manager 10. \nIII.2. III.2. III.2. III.2. SS SSelecci\u00f3n de estudios elecci\u00f3n de estudios elecci\u00f3n de estudios elecci\u00f3n de estudios    \nLos estudios fueron seleccionados siguiendo los cri terios de selecci\u00f3n \nque se describen en la Tabla 2 y que corresponden a  la siguiente \npregunta de investigaci\u00f3n: \u00bfcu\u00e1l es la efectividad y seguridad de las \nt\u00e9cnicas de meditaci\u00f3n basadas en la atenci\u00f3n focal izada, el amor, \nbondad y la compasi\u00f3n y las pr\u00e1cticas mixtas de medi taci\u00f3n con \ncomponentes atencionales, emocionales y/o religioso /espirituales, \ncomparadas con  las t\u00e9cnicas de intervenci\u00f3n con ev idencia cient\u00edfica \n(p.e., relajaci\u00f3n muscular progresiva, mindfulness ), cuidado habitual o la \nno intervenci\u00f3n, en la mejor\u00eda de sintomatolog\u00eda f\u00ed sica y mental y calidad \nde vida relacionada con la salud, en pacientes con cualquier \nenfermedad y poblaci\u00f3n general? \n \nTabla 2. Criterios de selecci\u00f3n de los estudios \nCriterio Criterios de inclusi\u00f3n Criterios de exclusi\u00f3n \nDise\u00f1o de estudio - Revisiones sistem\u00e1ticas (RS). \n- Ensayos controlados aleatorizados \n(ECA). - Estudios controlados no \naleatorizados. \n- Estudios no controlados/series de \ncasos. \n- Estudios observacionales y/o \ndescriptivos (cuantitativos y/o \ncualitativos). \n- Revisiones narrativas, cartas al \neditor y opiniones de expertos. \n- Res\u00famenes de congresos. \n- Tesis doctorales. \nCaracter\u00edsticas de la \npoblaci\u00f3n - Personas de cualquier edad con \ncualquier patolog\u00eda o condici\u00f3n \ncl\u00ednica. \n- Personas sanas en las que se \npretende prevenir alguna afecci\u00f3n \ncl\u00ednica. - Estudios en personas sanas cuyo \nobjetivo no sea la prevenci\u00f3n de \npatolog\u00edas y/o no se informen de \nmedidas relacionadas con \nvariables cl\u00ednicas (reducci\u00f3n de \ns\u00edntomas, calidad de vida, efectos \nadversos). \nIntervenci\u00f3n Estudios que eval\u00faen las siguientes \nt\u00e9cnicas de meditaci\u00f3n junto con la \natenci\u00f3n convencional en un programa \nde intervenci\u00f3n superior a una semana - Estudios donde la pr\u00e1ctica de \nmeditaci\u00f3n fuera inferior a 1 \nsemana incluyendo la pr\u00e1ctica en \ncasa (p.e., estudios de laboratorio  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 27 Tabla 2. Criterios de selecci\u00f3n de los estudios \nCriterio Criterios de inclusi\u00f3n Criterios de exclusi\u00f3n \nde entrenamiento (salvo en el caso de \nenfermedades/condiciones agudas \ncomo operaciones quir\u00fargicas o parto): \n- Meditaci\u00f3n con pr\u00e1cticas basadas \nen la atenci\u00f3n focalizada \n(incluyendo la meditaci\u00f3n \ntrascendental y otras meditaciones \nbasadas en la repetici\u00f3n de \nmantras). \n- Meditaci\u00f3n con pr\u00e1cticas basadas \nen el amor, bondad y/o la \ncompasi\u00f3n. \n- Meditaci\u00f3n con pr\u00e1cticas mixtas \nde componentes atencionales \n(p.e., sobre la respiraci\u00f3n, \nsensaciones corporales) \nemocionales y/o \nreligioso/espirituales. con medida inmediata de \nresultados). \n- Intervenciones cuyo componente \ncentral no sea la meditaci\u00f3n (p.e., \nself-compassion training ). \n- T\u00e9cnicas desarrolladas original y \nexclusivamente en el \u00e1mbito de la \npsicolog\u00eda cient\u00edfica, no basadas \nen pr\u00e1cticas ancestrales (p.e., \ncompassion-focused therapy ).  \n- Mindfulness , dada la evidencia \ndisponible como indicaci\u00f3n \nterap\u00e9utica en determinadas \npatolog\u00edas. \n- T\u00e9cnicas cuyo elemento central \nsea el componente corporal y de \nmovimiento como las terapias \nmente-cuerpo y t\u00e9cnicas de \nmeditaci\u00f3n tao\u00edstas con \ncomponente central en la energ\u00eda \nvital por su abordaje expl\u00edcito en \notros informes de ETS \nactualmente en desarrollo en el \nmarco del Plan de Protecci\u00f3n de \nla Salud frente a las \npseudoterapias de la RedETS.  \n- Otras terapias \nalternativas/complementarias. \nComparador - T\u00e9cnicas de intervenci\u00f3n con \nevidencia cient\u00edfica (p.e., relajaci\u00f3n \nmuscular progresiva, Mindfulness ).  \n- Cuidado habitual. \n- No intervenci\u00f3n. - Otras terapias \nalternativas/complementarias. \nMedidas de resultado Efectividad:  \n- Reducci\u00f3n de sintomatolog\u00eda mental \n(ansiedad, depresi\u00f3n, estr\u00e9s, \nproblemas conductuales, psicosis) y \nf\u00edsica (dolor y otros s\u00edntomas \nrelacionados con la afecci\u00f3n cl\u00ednica \nde estudio). \n- Calidad de vida relacionada con la \nsalud (general y espec\u00edfica, f\u00edsica y/o \nmental). \nSeguridad:  \n- Efectos adversos graves (i.e., que \nrequieren hospitalizaci\u00f3n o suponen \nuna amenaza para la vida). \n- Efectos adversos leves. - Medidas no relacionadas con \nvariables cl\u00ednicas finales (p.e., \nrendimiento escolar, estilos de \nafrontamiento, autoeficacia, locus \nde control, bienestar espiritual, \nfelicidad). \nIdioma - Ingl\u00e9s, espa\u00f1ol - Otros idiomas \n  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  28 III. III. III. III.33 33. . . . Valoraci\u00f3n de la calidad de los Valoraci\u00f3n de la calidad de los Valoraci\u00f3n de la calidad de los Valoraci\u00f3n de la calidad de los \nestudios estudios estudios estudios        \nEl riesgo de sesgo de los estudios obtenidos fue va lorado cr\u00edticamente \npor dos revisores de forma independiente y las disc repancias fueron \nresueltas por consenso. Los instrumentos utilizados  fueron la escala \nAMSTAR-2 [56] para las RS y la escala RoB-2 de la C ochrane [57] para \nlos ECAs. \nIII. III. III. III.44 44. . . . Extracci\u00f3n de datos y Extracci\u00f3n de datos y Extracci\u00f3n de datos y Extracci\u00f3n de datos y    s\u00edntesis de la s\u00edntesis de la s\u00edntesis de la s\u00edntesis de la \nevidencia evidencia evidencia evidencia    \nUna vez identificados los estudios a incluir en la revisi\u00f3n, se realiz\u00f3 la \nextracci\u00f3n de los datos en un fichero Excel (i.e., id entificaci\u00f3n del \nart\u00edculo, dise\u00f1o, metodolog\u00eda, poblaci\u00f3n de estudio , tipo de meditaci\u00f3n y \nresultados). En primer lugar, se analizaron las RS incluidas y, \nposteriormente, se revisaron los estudios primarios  obtenidos, \nidentificando aquellos que hab\u00edan sido incluidos en  las RS incluidas y los \nque no (por no ser identificados en ellas o por hab er sido publicados \nposteriormente).  \nSe realiz\u00f3 un meta-an\u00e1lisis (MA) para cada medida d e resultado \ncuando hubo datos disponibles. Se extrajo en cada es tudio la diferencia \nestandarizada (g de Hedges ) inter-grupo en el seguimiento. En caso de \nno estar disponible o no poder calcularse a partir de los datos \nreportados, se extrajo la diferencia en el cambio de sde l\u00ednea base hasta \nel seguimiento. En ambos casos se incluyeron las es timaciones \ncalculadas por intenci\u00f3n-de-tratar y/o ajustadas po r confusores si \nestaban disponibles. Dado que combinar diferencias estandarizadas del \ncambio y de las puntuaciones en el seguimiento pued e introducir \nsesgos, pues se basan en desviaciones t\u00edpicas de di stinto tipo, se \nrealizaron an\u00e1lisis de sensibilidad excluyendo los e studios que s\u00f3lo \nreportaron diferencias en el cambio (si eran una mi nor\u00eda) o un an\u00e1lisis de \nsubgrupos (si ambos tipos de estimaciones eran frec uentes). \nAlgunos estudios s\u00f3lo ofrecieron las medias obtenid as en cada \npunto temporal; en esos casos, las desviaciones t\u00edp icas (dt) en el \nseguimiento fueron imputadas (separadamente para lo s grupos de \nintervenci\u00f3n y control), calculando el promedio de la relaci\u00f3n Media \u2013 dt \ndel resto de estudios del mismo tipo de meditaci\u00f3n (o de todos, en caso \nde haber pocos estudios de ese tipo), y aplic\u00e1ndolo  a la media del  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 29 estudio en cuesti\u00f3n. Se realizaron an\u00e1lisis de sens ibilidad excluyendo \nestos estudios. \nEl MA se realiz\u00f3 mediante el m\u00e9todo de la varianza inversa. Se \nconsider\u00f3 la existencia de heterogeneidad con un val or de significaci\u00f3n \np < 0.10 del estad\u00edstico Q de Cochran o con un valo r de I 2 de Higgins \n[58] mayor del 50%. En tal caso, se us\u00f3 un modelo d e efectos \naleatorios, en lugar de efectos fijos. Se realizaro n los siguientes an\u00e1lisis \nde subgrupos a posteriori: \n- Tipo de meditaci\u00f3n: se clasificaron como MT, otras meditaciones \nbasadas en mantras (OMBM), meditaci\u00f3n basada en la \nrespiraci\u00f3n, LKM, meditaci\u00f3n de compasi\u00f3n, meditaci \u00f3n \nreligiosa/espiritual y meditaciones mixtas. No se tr ata de \ncategor\u00edas completamente excluyentes (por ejemplo, e l \nentrenamiento en respiraci\u00f3n puede estar presente e n otras \ncategor\u00edas), pero que definen el elemento central o  exclusivo de \nla meditaci\u00f3n aplicada en el estudio. Dado el ampli o n\u00famero de \nsubgrupos, este an\u00e1lisis dispone de muy poca potenc ia, por lo \nque ha de considerarse de car\u00e1cter meramente descri ptivo y no \ninferencial. \n- Tipo de control: en la comparaci\u00f3n Meditaci\u00f3n versu s Control, \nse clasificaron los tipos de grupo control seg\u00fan su  intensidad. \nSe denominar\u00e1 \"Grupo de intervenci\u00f3n diferida\" al l lamado \ncom\u00fanmente en la literatura \"Lista de espera\" ( \u201cWaiting list\" , \ncomunicar al participante que una vez finalizado el  estudio \npodr\u00e1 acceder a la intervenci\u00f3n, es decir, al progr ama de \nmeditaci\u00f3n en este caso), para evitar confusiones c on listas de \nespera m\u00e9dicas. Este tipo de grupo control  ha most rado un \nefecto nocebo en algunos estudios, por lo que se an aliz\u00f3 \nseparadamente de la no intervenci\u00f3n/tratamiento hab itual. Se \nclasificaron como \u201ccontrol activo\u201d la educaci\u00f3n san itaria, \ninstrucciones inespec\u00edficas de relajaci\u00f3n (p.e., pe rmanecer con \nlos ojos cerrados y en calma), dormir una siesta, e scuchar \nm\u00fasica o un podcast. Finalmente, se agruparon los e studios que \nusaron ejercicio f\u00edsico.  \n- Tipo de poblaci\u00f3n: se agruparon los estudios que in cluyeron \nestudiantes (educaci\u00f3n secundaria o universitarios) , adultos \nsanos y poblaci\u00f3n cl\u00ednica (enfermedades f\u00edsicas o m entales), \nrespectivamente. \n- Tiempo de seguimiento: la mayor\u00eda de estudios ofrec ieron \nresultados entre 1-4 meses tras comenzar la interve nci\u00f3n.  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  30 Cuando un estudio recogi\u00f3 datos en m\u00e1s de un punto temporal, \nen los MA descritos anteriormente se incluy\u00f3 la med ida m\u00e1s \ncercana a los 4 meses, para mantener la homogeneida d. En este \nan\u00e1lisis de subgrupos, sin embargo, se incluy\u00f3 el \u00fa ltimo \nseguimiento de dichos estudios, dado el menor n\u00famer o de \nestudios con seguimientos mayores a 4 meses.  \n- Fecha de publicaci\u00f3n: dado el amplio rango temporal  de los \nestudios obtenidos, se formaron subgrupos intentand o \nmantener un equilibrio en el n\u00famero de estudios en cada uno de \nellos. As\u00ed, se analizaron diferencias entre estudio s publicados \nantes y despu\u00e9s del 2000 (ansiedad) y 2010 (depresi \u00f3n, estr\u00e9s). \nEl sesgo de publicaci\u00f3n se analiz\u00f3 visualmente medi ante el gr\u00e1fico \nde embudo. Los resultados de los estudios que no pu dieron ser \nincluidos en MA se describieron narrativamente, cal culando el efecto \nestandarizado (o la diferencia media en el caso de medidas objetivas) \ncuando este no se report\u00f3 en el art\u00edculo y hubo dat os disponibles. \nIII.5. III.5. III.5. III.5.    Participaci\u00f3n de Participaci\u00f3n de Participaci\u00f3n de Participaci\u00f3n de los los los los agentes agentes agentes agentes    de inter\u00e9s de inter\u00e9s de inter\u00e9s de inter\u00e9s    \nLa implicaci\u00f3n de los agentes con inter\u00e9s en la tec nolog\u00eda a evaluar se \nplante\u00f3 desde el inicio del proceso de evaluaci\u00f3n c on el objetivo de que \npudieran realizar aportaciones sobre los aspectos r elevantes para ellos. \nSe realiz\u00f3 una invitaci\u00f3n activa a trav\u00e9s de correo  electr\u00f3nico a las \norganizaciones profesionales y de usuarios relacion adas con las \nt\u00e9cnicas de meditaci\u00f3n para que aportaran evidencia  cient\u00edfica sobre la \neficacia cl\u00ednica y seguridad de la t\u00e9cnica. Se invi t\u00f3 \u00fanicamente a \naquellas organizaciones que cumpl\u00edan los siguientes  criterios: ser \nentidades acreditadas oficialmente en el estado esp a\u00f1ol, estar \nrelacionadas con las ciencias o el \u00e1mbito de la sal ud, y estar legalmente \nconstituidas (Anexo 3). Se envi\u00f3 el protocolo de tra bajo a estas \norganizaciones junto a un formulario de solicitud d e informaci\u00f3n en la \nque se explic\u00f3 que el objetivo era \u00fanicamente la apo rtaci\u00f3n de evidencia \ncient\u00edfica disponible. Se estableci\u00f3 un plazo de 15  d\u00edas para la recepci\u00f3n \nde aportaciones. Se aceptaron tambi\u00e9n las aportacio nes de \norganizaciones que no fueron invitadas activamente,  siempre y cuando \n\u00e9stas cumplieran los criterios de participaci\u00f3n men cionados y las \naportaciones se recibieran dentro del mismo plazo d e 15 d\u00edas. \nFinalmente se obtuvo respuesta a esta invitaci\u00f3n, p or parte de una \norganizaci\u00f3n (Anexo 3).  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 31 En mes de octubre de 2021 se someti\u00f3 el informe pre liminar a una \nrevisi\u00f3n externa, en la que fueron invitadas a parti cipar organizaciones \nrelacionadas con la t\u00e9cnica, entre las que se encon traban asociaciones \nde pacientes, colegios profesionales y sociedades c ient\u00edficas. Todas \nellas cumpl\u00edan los criterios anteriormente citados (ser entidades en el \nestado espa\u00f1ol, estar relacionadas con las ciencias  o el \u00e1mbito de la \nsalud, y estar legalmente constituidas). Finalmente , participaron en el \nproceso de revisi\u00f3n externa 4 organizaciones, recogi das en el Anexo 3. \n \n \n  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 33 IV. Resultados \nIV.1. IV.1. IV.1. IV.1. Resultado de la b\u00fasqueda bibliogr\u00e1fica Resultado de la b\u00fasqueda bibliogr\u00e1fica Resultado de la b\u00fasqueda bibliogr\u00e1fica Resultado de la b\u00fasqueda bibliogr\u00e1fica        \nEn la b\u00fasqueda electr\u00f3nica se identificaron un tota l de 7147 referencias, \nde las que quedaron 4655 tras eliminar duplicados p ara revisar por t\u00edtulo \ny resumen (Figuras 1 y 2). En la Tabla 3 se describ en los resultados \nobtenidos en cada una de las bases de datos electr\u00f3 nicas consultadas. \n \nTabla 3. Resultados en las bases de datos electr\u00f3ni cas consultadas \nBase de datos (plataforma) N\u00ba de resultados obtenidos \nMEDLINE (Ovid) 1616 \nEMBASE (Elsevier) 1814 \nCOCHRANE (Wiley) 2372 \nPsycINFO (Ebsco) 1345 \nTotal de referencias con duplicados  7147 \nTotal de referencias sin duplicados  4655 \n \nDel total de referencias obtenidas, se seleccionaro n 440 (161 RS + \n279 ECAs) para su lectura a texto completo, tras la cual finalmente se \nincluyeron 4 RS [4,51,59,60] y 84 ECAs publicados e n 86 referencias \n[53,61,70\u201379,62,80\u201389,63,90\u201399,64,100\u2013109,65,110\u201311 9,66,120\u2013\n129,67,130\u2013139,68,140\u2013145,69] (en el Anexo 4 se desc riben las causas \nde exclusi\u00f3n de los estudios no incluidos).   \nVeintitr\u00e9s de esos ECAs estuvieron incluidos en las  RS \nseleccionadas y cumplieron los criterios de inclusi \u00f3n del presente \ninforme \n[67,72,102,108,111,118,120,122,124,125,129,130,73,1 31,138,139,74,76, \n80,83,84,92,93]. \nA partir de la b\u00fasqueda manual de la literatura, se  incluyeron tres \nnuevos ECAs [146\u2013148], quedando un total de 87 ECAs  (publicados en \n89 referencias) incluidos en el presente informe (F igura 2). \n  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  34 1593  referencias identificadas  \n983 referencias excluidas por \nt\u00edtulo/resumen \n157 referencias excluidas \n- 43 por dise\u00f1o/dise\u00f1o de los estudios \n- 89 por intervenci\u00f3n \n- 9 por medidas de resultado \n- 10 no recuperadas/No disponibles \n- 1 duplicada \n- 5 por estar recogidas en otras RS \n 1144 referencias sin duplicados  \n161 referencias seleccionadas \npor t\u00edtulo/resumen 449 referencias duplicadas  \n4 RS  Figura 1. Proceso de selecci\u00f3n de revisiones sistem \u00e1ticas \n \nFigura 2. Proceso de selecci\u00f3n de ensayos controlad os aleatorizados   \n5554 referencias identificadas \n2043  referencias duplicadas  \n3232  referencias excluidas por t\u00edtulo/resumen  3511  referencias sin duplicados  \n279 referencias seleccionadas \npor t\u00edtulo/resumen 193 referencias excluidas \n- 55 por dise\u00f1o \n- 96 por intervenci\u00f3n \n- 27 por medidas de resultado \n- 8 por objetivo \n- 2 idioma \n- 1 duplicado \n- 4 no recuperadas/No disponibles \n  \n87 ECAs (89 referencias) \n- 32 estudios sobre meditaci\u00f3n trascendental (MT) (33 refer encias) \n- 26 estudios sobre otras meditaciones basada en mantras (O MBM) (27 referencias) \n- 4 estudios sobre meditaci\u00f3n religiosa/espiritual \n- 8 estudios sobre meditaci\u00f3n focalizada en la respiraci\u00f3n   \n- 9 estudios sobre meditaci\u00f3n basada en el amor, bondad y compasi\u00f3n (LKM) \n- 8 estudios sobre meditaciones mixtas 3 referencias in cluidas por b\u00fasqueda ma nual   \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 35 IV.1.1 Caracter\u00edsticas de los estudios incluidos  \nA continuaci\u00f3n, se sintetizan las caracter\u00edsticas m \u00e1s relevantes de los \nestudios seleccionados. En el Anexo 5 se muestran do s tablas con las \ncaracter\u00edsticas de las RS y de los estudios primari os incluidos. \n \nRevisiones sistem\u00e1ticas \n \nLa RS de Galante et al. (2014) [51] evalu\u00f3 la efect ividad de la LKM en \npoblaci\u00f3n adulta con cualquier diagn\u00f3stico cl\u00ednico e incluy\u00f3 22 estudios \n(n = 1747) (3 de ellos cumplen con los criterios de l presente informe \n[73,138,139]).  \nLas RS de Gathright et al. (2019) [60] (9 estudios,  n = 851) y Orme-\nJohnson et al. (2014) [59] (14 estudios en 16 art\u00edc ulos, n = 1295) \nevaluaron la efectividad de la MT en poblaci\u00f3n adul ta con hipertensi\u00f3n u \notra enfermedad cardiovascular y ansiedad, respecti vamente; \nincluyendo un total de 23 estudios entre ambas sin duplicados (12 de \nsus estudios incluidos cumplen con los criterios de l presente informe \n[72,80,129,130,83,92,111,118,120,122,124,125]).  \nPor \u00faltimo, la RS de Goyal et al. (2014) [4] evalu\u00f3  la efectividad de \ncualquier programa de meditaci\u00f3n estructurada e inc luy\u00f3 47 estudios (n \n= 3320), de los cuales 11 fueron sobre OMBM (n = 78 2) (10 de sus \nestudios incluidos cumplen con los criterios del pr esente informe \n[67,74,76,84,92,102,108,118,125,131]). \n \nEstudios primarios \n \nLa variable de salud m\u00e1s evaluada fue la ansiedad ( 41 estudios) y el \nproblema de salud m\u00e1s evaluado fue el estr\u00e9s postra um\u00e1tico (10 \nestudios). En relaci\u00f3n al tipo de meditaci\u00f3n m\u00e1s ut ilizado fue la MT (32 \nestudios), seguido de OMBM (26 estudios), meditaci\u00f3 n \nreligiosa/espiritual (4 estudios), meditaci\u00f3n focal izada en la respiraci\u00f3n \ny/o escaneo corporal (8 estudios), LKM (9 estudios)  y meditaciones \nmixtas (8 estudios).  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  36 IV.1.2 Calidad metodol\u00f3gica de los estudios \nincluidos \nRevisi\u00f3n sistem\u00e1tica \n \nLa valoraci\u00f3n de la calidad metodol\u00f3gica de las RS incluidas, evaluadas \nmediante los criterios AMSTAR-2 [56], se muestra en  la Tabla 6 del \nAnexo 6. \nTodas las RS realizaron MA, pero ninguna aport\u00f3 inf ormaci\u00f3n sobre \nla evaluaci\u00f3n del impacto potencial del riesgo de s esgo en estudios \nindividuales sobre los resultados del MA, ni inform aron acerca de las \nfuentes de financiaci\u00f3n de los estudios incluidos e n la revisi\u00f3n. Orme-\nJohnson et al. (2014) [59] no realizaron la selecci \u00f3n y extracci\u00f3n de \ndatos por pares y s\u00f3lo la RS de Galante et al. (201 4) [51] incluy\u00f3 el \nlistado de estudios excluidos. El resto de criterios  de calidad fueron \ncumplidos por las cuatro RS. \n \nECAs \n \nLa valoraci\u00f3n completa de la calidad metodol\u00f3gica d e los estudios \nincluidos, evaluados mediante la escala RoB-2 de la  Cochrane [57], se \ndescribe en el Anexo 6. La Tabla 7 del Anexo 6 muestr a un resumen de \nla valoraci\u00f3n del riesgo de sesgo. \nLa calificaci\u00f3n de alto riesgo de sesgo en alguno d e los dominios \nevaluados o la calificaci\u00f3n de riesgo de sesgo inci erto en tres o m\u00e1s \ndominios lleva a calificar el estudio con un alto r iesgo de sesgo general, \npor lo que ninguno de los estudios incluidos fue ev aluado con un bajo \nriesgo de sesgo [57]. \nAtendiendo al tipo de meditaci\u00f3n evaluada, se obtuv o un alto \nriesgo de sesgo en alguna de las medidas de resulta do evaluadas en el \n87% de los estudios en MT, en el 81% de los estudio s en OMBM y en el \n100% de los estudios basados en el resto de meditac iones. \nDe manera general, un 26% de los estudios evaluados  \nproporcionan informaci\u00f3n acerca del proceso de alea torizaci\u00f3n y \nocultaci\u00f3n de la secuencia y varios de esos estudio s no ofrecen \ninformaci\u00f3n sobre los procedimientos de cegamiento llevados a cabo. \nDadas las caracter\u00edsticas de las intervenciones, lo s instructores de \nmeditaci\u00f3n no pudieron estar cegados a las condicio nes de los grupos, \npor lo que ning\u00fan estudio fue evaluado como bajo ri esgo de sesgo en el \nDominio 2 (i.e., efecto de la asignaci\u00f3n a la inter venci\u00f3n).   \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 37 En 26 estudios se llev\u00f3 a cabo un an\u00e1lisis por inte nci\u00f3n de tratar \n[68,69,97,99,100,103,106,107,114,115,121,124,71,125 ,128,133,139,142, \n143,76,78,83,85,92,94,95] y en 9 los an\u00e1lisis se re alizaron con todos los \nparticipantes elegibles despu\u00e9s de la aleatorizaci\u00f3 n \n[65,77,80,101,116,130,138,145,146], por lo que la e valuaci\u00f3n del \nDominio 2 (i.e., efecto de la asignaci\u00f3n a la inter venci\u00f3n) no se consider\u00f3 \nafectada por alto riesgo de sesgo. \nVeintitr\u00e9s estudios incluidos evaluaron tanto medid as auto-\nreportadas (p.e., cuestionarios de ansiedad, depres i\u00f3n, calidad de vida, \netc.), hetero-reportadas (p.e., sintomatolog\u00eda obse rvada por el cl\u00ednico), \ncomo medidas objetivas (p.e., presi\u00f3n sangu\u00ednea, pr esi\u00f3n intraocular, \netc.) que son de inter\u00e9s para este informe, por lo que en estos casos se \nllev\u00f3 a cabo una doble evaluaci\u00f3n de riesgo de sesg o del estudio \natendiendo a cada tipo de medida de resultado. S\u00f3lo  en cuatro de ellos \nse observa una diferencia en la valoraci\u00f3n general del estudio cuando se \natiende a medidas auto-reportadas (alto riesgo de s esgo general) en \ncomparaci\u00f3n a medidas objetivas (riesgo de sesgo in cierto general) \n[65,68,85,107]. El resto de estudios permanece con una valoraci\u00f3n de \nalto riesgo de sesgo o riesgo incierto de sesgo, in dependientemente de \nla medida de resultado evaluada. \nDel resto de estudios con un \u00fanico tipo de medida d e resultado, \ns\u00f3lo 7 fueron calificados con un riesgo de sesgo in cierto, la mayor\u00eda \ndebido a la falta de informaci\u00f3n sobre si los parti cipantes fueron \nconscientes del grupo al que hab\u00edan sido asignados,  cuando se \ncomparaban con un grupo control activo con protocol o similar al del \ngrupo de intervenci\u00f3n [74,83,94,100,106,132,149].  \nEstuvieron disponibles los protocolos de 15 estudio s para \ndeterminar si los resultados se analizaron siguiend o un plan de an\u00e1lisis \npreviamente establecido, por lo que en el Dominio 5  (i.e., selecci\u00f3n del \nresultado reportado) la evaluaci\u00f3n se corresponde c on un nivel bajo de \nriesgo de sesgo [66,68,100,106,107,134,135,69,75,81 ,82,85,86,94,95]. \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  38 IV. IV. IV. IV.22 22....    Descripci\u00f3n y an\u00e1lisis de resultados Descripci\u00f3n y an\u00e1lisis de resultados Descripci\u00f3n y an\u00e1lisis de resultados Descripci\u00f3n y an\u00e1lisis de resultados    \nIV.2.1 Seguridad \nS\u00f3lo seis estudios reportaron expl\u00edcitamente informa ci\u00f3n sobre la \nseguridad de la meditaci\u00f3n: un estudio sobre la LKM  [118], 2 sobre la \nMT [92,138] y 3 sobre OMBM [96,106,134]. En ninguno  de ellos se \nobservaron eventos adversos que se pudieran relacio nar con la \naplicaci\u00f3n de las t\u00e9cnicas de meditaci\u00f3n.  \nIV.2.2 Efectividad \nRevisiones sistem\u00e1ticas \nDe los 22 estudios que se incluyeron en la RS de Ga lante et al. (2014) \n[51] (n = 1747), nueve se incluyeron en diferentes MA con an\u00e1lisis por \nsubgrupos en funci\u00f3n del comparador (n = 861). Se o bserv\u00f3 que la LKM \nmostr\u00f3 una efectividad moderada para disminuir la d epresi\u00f3n \nautoinformada (diferencia de medias estandarizada ( DME) = - 0.61, \nIC95%: 1.08, 0.14; I 2 = 0%; 2 estudios) frente al grupo de no \nintervenci\u00f3n. Sin embargo, no se encontraron difere ncias significativas \nen la comparaci\u00f3n con la relajaci\u00f3n progresiva, Mindfulness , un grupo \nde discusi\u00f3n sobre salud y t\u00e9cnicas de visualizaci\u00f3 n. Tampoco hubo \ndiferencias significativas para las medidas de ansi edad, calidad de vida \ny satisfacci\u00f3n vital. La calidad metodol\u00f3gica de lo s estudios incluidos en \nla RS fue de baja a moderada.  \nEn la RS con MA de Gatrhright et al. (2019) [60] (9  estudios) con \n851 adultos con hipertensi\u00f3n o enfermedad cardiovas cular se observ\u00f3 \nuna reducci\u00f3n en la presi\u00f3n arterial sist\u00f3lica (d+ = 0.31) y diast\u00f3lica (d+ \n= 0.53) en el grupo intervenido con MT. Sin embargo , estas diferencias \nno fueron significativas respecto al grupo control y tampoco encontraron \ncambios en los s\u00edntomas depresivos de los participa ntes tras la \nintervenci\u00f3n. La calidad metodol\u00f3gica de los estudi os incluidos en la RS \nfue baja.  \nPor su parte, la RS con MA de Orme-Johnson et al. ( 2014) [59] (14 \nestudios en 16 art\u00edculos) con 1295 participantes en  la que se evalu\u00f3 el \nefecto de la MT sobre el rasgo de ansiedad en compa raci\u00f3n con los \ngrupos de control activo (10 estudios) encontraron que la MT redujo de \nforma significativa el rasgo de ansiedad, con un ta ma\u00f1o del efecto \nmoderado (d = -0.50, IC95%: -0.70, -0.30; I 2 = 2.8%). En comparaci\u00f3n  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 39 con el tratamiento habitual (grupo de intervenci\u00f3n diferida o controles de \natenci\u00f3n) (14 estudios) se observ\u00f3 un efecto signif icativo favorable a la \nMT con un tama\u00f1o del efecto tambi\u00e9n moderado (d = -  0.62, IC95%: -\n0.82, 0.43; I 2 = 50.5%). Las poblaciones con niveles elevados de \nansiedad inicial mostraron tama\u00f1os del efecto mayor es (-0.74 a -1.2). \nLos estudios que utilizaron medidas repetidas mostr aron reducciones \nsustanciales en las primeras 2 semanas y efectos so stenidos a los 3 \na\u00f1os. La intersecci\u00f3n de la regresi\u00f3n de Egger no f ue estad\u00edsticamente \nsignificativa, indicando una ausencia de sesgo de p ublicaci\u00f3n. \nOnce de los 47 estudios que se incluyeron en la RS con MA de \nGoyal et al. (2014) [4] evaluaron el efecto de la m editaci\u00f3n basada en \nmantras (MT y OMBM) sobre resultados de estr\u00e9s psic ol\u00f3gico y \nbienestar, no encontrando resultados significativos  para este tipo de \nmeditaci\u00f3n en diferentes condiciones de salud sobre  ansiedad (-0.22, \nIC95%: -0.49, 0.04), depresi\u00f3n (-0.27, IC95%: -0.61 , 0.06), ni estr\u00e9s (-\n0.26, IC95%: -0.55, 0.04). La calidad metodol\u00f3gica de los estudios \nincluidos en la RS fue baja a moderada. \n \nEstudios primarios \nEn la Tabla 8 del Anexo 7 se muestran los resultados  de efectividad de \nlos estudios incluidos. \nMEDITACI\u00d3N VS. CONTROL  \nSignos, s\u00edntomas f\u00edsicos y calidad de vida espec\u00edfi ca \n \nAsma \n \nWilson et al. (1975) [140] (n = 21) compararon la M T frente a un grupo \ncontrol (lectura). Tras 3 meses de intervenci\u00f3n se evalu\u00f3 el volumen \nespiratorio forzado en 1 segundo, la tasa de flujo respiratorio m\u00e1ximo y \nla resistencia de las v\u00edas respiratorias. S\u00f3lo se r ealizaron contrastes \nintra-grupo. La diferencia entre valores post-inter venci\u00f3n (c\u00e1lculo propio, \nintervenci\u00f3n menos control) no fue significativa pa ra ninguna de las tres \nvariables (0.19 L, p = 0.56; 74.00 L/min, p = 0.08;  -0.85 cmH 2O/L/s, p = \n0.28, respectivamente).  \n \nC\u00e1ncer de mama  \n \nCuatro estudios evaluaron el efecto de la meditaci\u00f3 n sobre los s\u00edntomas \ny efectos adversos del tratamiento en pacientes con  c\u00e1ncer de mama. \nNidich et al. (2009a)[110] (n = 130) evaluaron MT v s. tratamiento habitual  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  40 en mujeres mayores de 55 a\u00f1os. Milbury et al. (2013 ) [107] (n = 46) \naplicaron meditaci\u00f3n tibetana (mezcla de ejercicios  de respiraci\u00f3n, \nmantra sonoro y actividades cognitivas) frente al g rupo de intervenci\u00f3n \ndiferida. Wren et al. (2019) [142] (n = 138) y Dion  et al. (2016) [81] (n = 38) \nusaron LKM; el primero compar\u00f3 con tratamiento habi tual, mientras que \nDion et al. [81] compararon meditaci\u00f3n m\u00e1s terapia de masaje frente a \ns\u00f3lo masaje.  \n \n- Fatiga: Ninguno de los tres estudios que la evaluar on obtuvo \nbeneficios significativos, con efectos similares en  Milbury et al. [107] \n(Brief Fatigue Inventory (BFI) , p = 0.53) y Wren et al. [142] (subescala \nde fatiga del cuestionario Functional Assessment of Chronic Illness \nTherapy (FACIT), p = 0.61). Dion et al. [81] no reporta las  \ndesviaciones t\u00edpicas (Escala Visual Anal\u00f3gica (EVA)  0-10).  \n \n- Dolor: Wren et al. [142] observaron diferencias sig nificativamente \nfavorables a la meditaci\u00f3n en dolor corporal (\u00edtems  extra\u00eddos del \nBrief Pain Inventory (BPI), p = 0.02 para la comparaci\u00f3n con \ntratamiento habitual). No hubo diferencias signific ativas en dolor en \nla mama (p = 0.77 para la interacci\u00f3n). Dion et al.  [81] obtuvieron \nreducciones significativas en ambos grupos, sin dif erencias entre \nellos (EVA 0-10).  \n \n- Calidad de vida en c\u00e1ncer: Nidich et al. (2009a) [1 10] encontraron \nun beneficio significativo de la MT a los 18 meses en la puntuaci\u00f3n \ntotal del Functional Assessment of Cancer Therapy\u2013Breast  (FACT-B) \n(g = 0.38, IC95%: 0.03, 0.72, c\u00e1lculo propio). Milb ury et al. [107], un \nmes tras comenzar la intervenci\u00f3n, no encontr\u00f3 dife rencias \nsignificativas en cuatro subescalas de deterioro co gnitivo del FACIT. \n \nDolor osteomuscular cr\u00f3nico \n \nTres estudios, todos con seguimientos de 2 meses, e valuaron la \nefectividad de la meditaci\u00f3n en el dolor osteomuscu lar mediante una \nEVA (0-100). Michalsen et al. [106] (n = 68) y Jeit ler et al. [94] (n = 89) \nevaluaron el mismo programa de meditaci\u00f3n Jyoti (OMBM) frente a \nejercicio f\u00edsico, en dolor cr\u00f3nico de espalda y cer vical, respectivamente. \nEl primero no obtuvo diferencias significativas en la reducci\u00f3n de dolor \n(p = 0.78) ni en la afectaci\u00f3n a la funcionalidad ( Roland Morris Disability \nQuestionnaire (RMDQ), p = 0.15). Jeitler et al. [94] obtuvieron u n efecto \nsignificativo sobre el dolor en reposo (diferencia de medias (DM) = -13.2, \nIC95%: -24.4, 2.1) y la molestia causada por el dol or (DM = -11.0,  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 41 IC95%: -21.0, 1.0), pero no sobre el dolor en movim iento (p = 0.133) ni \nla funcionalidad ( Neck Pain and Disability Scale (NPAD), p = 0.96).   \nCarson et al. (2005) [73] (n = 43) compararon la me ditaci\u00f3n LKM \nfrente al tratamiento habitual en pacientes con dol or cr\u00f3nico de espalda. \nEl estudio no realiza contrastes inter-grupo, por l o que se realizaron \ncomparaciones con los resultados post-intervenci\u00f3n reportados (prueba \nz). No hubo diferencias significativas en la puntua ci\u00f3n total del McGill \nPain Questionnaire (MPQ)  (p = 0.34) ni en las dos subescalas de dolor \nhabitual (p = 0.64) y peor dolor (p = 0.65) del BPI . \n \nEnfermedad coronaria \n \nTres estudios evaluaron la MT en personas con enfer medad coronaria (n \n= 372 en total). Se encontraron reducciones signifi cativas en la presi\u00f3n \narterial sist\u00f3lica en el grupo de meditaci\u00f3n frente  al control tanto en el \nestudio de Paul-Labrador et al. (2006) [118] (\u22123.4 \u00b1 2,0 frente a 2.8 \u00b1 2.1 \nmmHg; p = 0.04) como en el de Schneider et al. (201 2) [125] (IC 95%: \n\u22128.3 a \u22121.5 mmHg; p = 0.01). En este \u00faltimo, tras u n periodo de \nseguimiento de 5.4 a\u00f1os de seguimiento, hubo una re ducci\u00f3n \nsignificativa del riesgo de mortalidad, sufrir un i nfarto de miocardio y/o \nictus del 48% tras la MT (p = 0.025) y no se observ aron resultados \nsignificativos sobre el n\u00famero de hospitalizaciones . Por su parte, en el \nestudio de Bokhari et al. (2019) [66] se encontr\u00f3 u na mejora significativa \nen la reserva de flujo mioc\u00e1rdico tanto en el grupo  de meditaci\u00f3n solo \n(112.8%; tama\u00f1o del efecto = 0.36) como en el grupo  de meditaci\u00f3n + \nrehabilitaci\u00f3n cardiaca est\u00e1ndar con ejercicio f\u00edsi co (120.7%; tama\u00f1o del \nefecto = 0.64) en comparaci\u00f3n con los grupos de sol o rehabilitaci\u00f3n \ncardiaca est\u00e1ndar con ejercicio f\u00edsico y de atenci\u00f3 n habitual. \nUn estudio evalu\u00f3 la MT en estudiantes sanos [63] y  observ\u00f3 una \nmayor disminuci\u00f3n en el \u00edndice de masa del ventr\u00edcu lo izquierdo a los 4 \nmeses de seguimiento en comparaci\u00f3n con el grupo co ntrol (p <0.04). \n \nFuncionalidad f\u00edsica en personas mayores  \n \nJanyacharoen et al. (2018) [91] (n = 42) compararon  los efectos de la \nmeditaci\u00f3n focalizada en la respiraci\u00f3n frente a ed ucaci\u00f3n en salud. Tras \nocho semanas de intervenci\u00f3n, el grupo de meditaci\u00f3 n obtuvo \nresultados significativamente mejores en el Timed up and go test  (TUGT) \n(6.4 vs. 8.6 seg, p < 0.01) y el Functional reach test (FRT) (26 vs. 21 cm, \np < 0.01). No hubo diferencias significativas en el  Six-minute walk \ndistance test (6-MWT) (p = 0.93) y el Five times sit to stand test (FTSST) \n(p = 0.16). Jayadevappa et al. (2007) [92] (n = 23) , obtuvo una mejora  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  42 significativa en el 6-MWT  de la MT frente a la educaci\u00f3n en la salud (p = \n0.034) despu\u00e9s de tres y seis meses. Las diferencia s en \nhospitalizaciones y eventos cardiacos no fueron sig nificativas (p > 0.05).  \n \nFunci\u00f3n cognitiva en personas mayores \n \nEn el estudio de Alexander et al. (1989) [61] se enc ontr\u00f3 a los 3 meses \nun mejor rendimiento del grupo de MT en la escala d e aprendizaje \nasociativo (t = 2.32, p < 0.025) y en la tarea de s obreaprendizaje verbal (t \n= 2.50, p < 0.01). No hubo diferencias significativ as entre ninguno de los \ngrupos en el Dementia Screening Test (DST), test de fluencia verbal y \ntest de Stroop (p > 0.05). \n \nGlaucoma \n \nGagrani et al. (2018) [85] (n = 60 pacientes con gl aucoma primario de \n\u00e1ngulo abierto) compararon la meditaci\u00f3n centrada e n la respiraci\u00f3n \nfrente al tratamiento habitual durante 6 semanas. L a diferencia en la \nreducci\u00f3n de la presi\u00f3n intraocular fue significati vamente favorable a la \nintervenci\u00f3n (-1.5 mm Hg, IC95%: -2.30, -0.70, c\u00e1lc ulo propio).  \n \nInsuficiencia cardiaca congestiva \n \nCuriati et al. (2005) [79] (n = 19), con una combin aci\u00f3n de ejercicios de \nrespiraci\u00f3n, atenci\u00f3n dirigida a las sensaciones co rporales (escaneo \ncorporal) y mantra, encontraron tras 14 semanas mej or\u00edas intra-grupo \nsignificativas s\u00f3lo en el grupo de intervenci\u00f3n, en  el nivel de \nnorepinefrina, el cociente ventilaci\u00f3n por minuto/p roducci\u00f3n de di\u00f3xido \nde carbono, y en la puntuaci\u00f3n en el Minnesota Living with Heart Failure \nQuestionnaire (MLWHFQ), pero no se realizaron contrastes inter-gr upo.  \n \nParto por ces\u00e1rea  \n \nBeiranvand et al. (2014) [65] (n = 160) evaluaron e l efecto de la \nmeditaci\u00f3n basada en la oraci\u00f3n religiosa (islam) a  los 30 minutos, 1, 3 y \n6 horas despu\u00e9s de la intervenci\u00f3n quir\u00fargica en co mparaci\u00f3n con un \ngrupo control que no recibi\u00f3 la intervenci\u00f3n. Se en contr\u00f3 una mejora \nestad\u00edsticamente significativa en el dolor postoper atorio a las 3 horas \n(EVA 0-10: 1.5 \u00b1 0.3 frente a 3.0 \u00b1 1.3, p = 0.030)  y a las 6 horas (1.3 \u00b1 \n0.8 frente a 3.0 \u00b1 1.1, p = 0.003), adem\u00e1s de menos  n\u00e1useas y v\u00f3mitos \n(p = 0.001). No hubo diferencias significativas en presi\u00f3n sangu\u00ednea  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 43 sist\u00f3lica (p = 0.473) y diast\u00f3lica (p = 0.585), tas a cardiaca (p = 0.585) y \nrespiratoria (p = 0.569). \n \nPresi\u00f3n sangu\u00ednea \n \nLa RS de Gathright et al. (2019) [60] realiz\u00f3 un MA  con 9 estudios (n = \n851) sobre la efectividad de la MT en poblaci\u00f3n adu lta con hipertensi\u00f3n \nu otra enfermedad cardiovascular. Incluyeron dos te sis doctorales no \nincluidas en esta revisi\u00f3n. Los resultados no fuero n significativos para la \npresi\u00f3n sist\u00f3lica (6 estudios; d = 0.27, IC95%: \u22120. 04, 0.57) y diast\u00f3lica (6 \nestudios; d = 0.28, IC95%: \u22120.02, 0.59). Los efecto s fueron aun menores \ncuando se incluyeron dos estudios con intervencione s adicionales a la \nMT.  \nEn este informe se han identificado tres estudios q ue eval\u00faan \npresi\u00f3n sangu\u00ednea en poblaci\u00f3n cl\u00ednica, publicados posteriormente a la \nfecha de b\u00fasqueda de Gathright et al. (2019) [60]. Bokhari et al. (2019) \n[66] (n = 56), en pacientes con enfermedad coronari a, no obtuvo \ndiferencias a los 3 meses entre MT (con o sin rehab ilitaci\u00f3n cardiaca) \nfrente a tratamiento habitual (con o sin rehabilita ci\u00f3n cardiaca) en \npresi\u00f3n sist\u00f3lica y diast\u00f3lica (p > 0.05). Chandler  et al. (2020) [75] (n = \n30), con personas adultas pre-hipertensas, obtuvo u n efecto significativo \nde la meditaci\u00f3n basada en la respiraci\u00f3n a los 12 meses (sist\u00f3lica: -\n11.6 vs. -0.4 mmHg, p < 0.04; diast\u00f3lica: p < 0.01,  no se reporta el \ncambio en cada grupo). Por su parte, Wren et al. (2 019) [142] (n = 138) \nen mujeres con c\u00e1ncer de mama no encontraron efecto s significativos \nentre grupos. Se incluyeron tambi\u00e9n otros cuatro es tudios con muestras \npeque\u00f1as [88,117,126,133], no contemplados en Gathr ight et al. (2019) \n[60], donde s\u00f3lo uno de ellos [117] encontr\u00f3 mejor\u00ed as significativas de la \npresi\u00f3n sangu\u00ednea en el grupo de meditaci\u00f3n en comp araci\u00f3n con los \ngrupos control. \nEn relaci\u00f3n a la poblaci\u00f3n sana, se incluyeron cuat ro estudios \n[53,63,111,129] donde no se observaron diferencias significativas. \n \nPsoriasis \n \nGaston et al. (1988) [87] (n = 24) compararon la me ditaci\u00f3n (escaneo de \nsensaciones corporales) con meditaci\u00f3n m\u00e1s imaginer \u00eda (i.e., producci\u00f3n \nde una imagen mental de los s\u00edntomas de la psoriasi s y su \ntransformaci\u00f3n hasta la sanaci\u00f3n) y un grupo de int ervenci\u00f3n diferida. \nTras 12 semanas, se observ\u00f3 una diferencia signific ativa en la \nevaluaci\u00f3n cl\u00ednica de la gravedad de la psoriasis e ntre los grupos de \ntratamiento y de control (r parcial = 0.30, p < 0.0 1). No se asoci\u00f3 ning\u00fan  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  44 impacto adicional con el uso de la imaginer\u00eda (r pa rcial = - 0.06, p > \n0.05).  \n \nS\u00edndrome de Intestino Irritable  \n \nKeefer y Blanchard (2001) [96] (n = 16) evaluaron l a efectividad de la \nRespuesta de Relajaci\u00f3n de Benson (OMBM) frente al grupo de \nintervenci\u00f3n diferida con monitoreo de s\u00edntomas. Tr as seis semanas de \nintervenci\u00f3n, se observ\u00f3 una reducci\u00f3n estad\u00edsticam ente significativa de \nla severidad de los s\u00edntomas gastrointestinales ( Composite Primary IBS \nSymptom Reduction , CPSR) favorable al grupo de meditaci\u00f3n (t = -1.97 , \np = 0.04). Entre los s\u00edntomas individuales, el efec to solo fue significativo \nen las flatulencias (F = 5.603, p = 0.039). \n \nS\u00edndrome metab\u00f3lico \n \nVaccarino et al., (2013) [133] (n = 68) no encontra ron diferencias \nsignificativas, al a\u00f1o de comenzar la intervenci\u00f3n,  entre OMBM y \neducaci\u00f3n en salud en el cambio en la vasodilataci\u00f3 n mediada por flujo \ndependiente del endotelio (2.1% vs. 1.4%, respectiv amente, p=0.51). La \ndiferencia en la reducci\u00f3n de la puntuaci\u00f3n total d e factores de riesgo \nfue significativamente favorable a la intervenci\u00f3n (g = -0.48, IC95%: -\n0.97, -0.00; p = 0.04, c\u00e1lculo propio). \n \nS\u00edndrome de Inmunodeficiencia Adquirida (SIDA) por Virus de \nInmunodeficiencia Humana (VIH) \n \nTres estudios incluyeron pacientes con SIDA por VIH . Chhatre  et al. \n(2013) [76] (n = 22), con MT, obtuvo una mejor\u00eda si gnificativa a los 6 \nmeses en el Functional Assessment of HIV Infection (FAHI) (g = -0.97, \nIC95%: -1.92, -0.03, c\u00e1lculo propio), mientras que Bormann et al. (2006) \n[67] (n = 93), en un periodo similar, no encontraro n diferencias \nsignificativas en la frecuencia de pensamientos int rusivos relacionados \ncon el SIDA (p = 0.92). Williams et al. (2005) [139 ] (n = 58), tampoco \nobtuvieron un efecto significativo en el Missoula-VITAS Quality of Life \nIndex (MVQOLI) a los 2 y 17 meses (p > 0.05). \n \nS\u00edntomas y trastornos psicol\u00f3gicos \n \nAnsiedad \n \nSe incluyeron en el MA de meditaci\u00f3n frente a contr ol 36 estudios (n = \n2450) que evaluaron ansiedad auto-reportada (18 con  el cuestionario  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 45 State-Trait Anxiety Inventory (STAI), subescala rasgo; 2 con el Profile of \nMood States Total Mood Disturbance scale (POMS),  subescala \nansiedad; 2 con el Beck Anxiety Inventory (BAI); 2 con el Depression, \nAnxiety and Stress Scale (DASS-21), subescala ansiedad;  y el resto con \notros instrumentos). Quince estudios incluyeron est udiantes y 12 \nincluyeron personas adultas de la poblaci\u00f3n general , mientras que 8 \nincluyeron poblaci\u00f3n con una afecci\u00f3n cl\u00ednica (2 co n c\u00e1ncer de mama, 2 \ncon dolor cr\u00f3nico, 1 con SIDA, 1 con ansiedad, 1 co n estr\u00e9s \npostraum\u00e1tico y 1 con alcoholismo). Finalmente, un estudio incluy\u00f3 \nvarones internos de prisi\u00f3n [112] y aunque no ten\u00eda n diagn\u00f3stico cl\u00ednico \nse ha incluido en el subgrupo de poblaci\u00f3n cl\u00ednica al evaluar estr\u00e9s \npostraum\u00e1tico como medida principal. La mayor\u00eda de estudios evalu\u00f3 \nMT o OMBM y s\u00f3lo hubo un estudio en los grupos de m editaci\u00f3n \nreligiosa y mixta, respectivamente. Dos estudios ll aman al grupo control \n\u201crelajaci\u00f3n\u201d [80,136], aunque no se trat\u00f3 de una t\u00e9 cnica de relajaci\u00f3n \nestandarizada, sino que simplemente se dieron instr ucciones de \nsentarse c\u00f3modamente con los ojos cerrados en un lu gar tranquilo ( \u201csin \npensar en nada\u201d  en un estudio y \u201cevitando pensamientos estresantes\u201d  en \nel otro), por lo que se incluyeron en la categor\u00eda de \u201ccontrol activo\u201d. \nSe introdujeron en el MA las diferencias en el segu imiento \n(ajustadas por l\u00ednea base cuando fue posible), salv o para 4 estudios: dos \nporque s\u00f3lo ofrec\u00edan datos de cambio [111,132] y en  otros dos porque \nlos grupos estaban significativamente desbalanceado s en l\u00ednea base y \nno se report\u00f3 la diferencia ajustada en el seguimie nto [80,99]. En otros \nseis estudios que no ofrec\u00edan dt de ning\u00fan tipo [61 ,81,102,117,119,145], \n\u00e9stas se imputaron, tal y como se coment\u00f3 en la sec ci\u00f3n de an\u00e1lisis \nestad\u00edstico. La exclusi\u00f3n de todos estos estudios, i ndividual o \nconjuntamente, no modific\u00f3 sustancialmente los resu ltados. \nEl resultado global fue significativamente favorabl e a la intervenci\u00f3n \n(g = -0.45, IC95%: -0.56, -0.34; I 2 = 42%) (Figura 3).   \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  46 Figura 3. Efecto sobre la ansiedad seg\u00fan el tipo de  meditaci\u00f3n (meditaci\u00f3n \nvs. control) \n \n \n  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 47 El an\u00e1lisis de subgrupos por tipo de control no res ult\u00f3 significativo \n(p = 0.10) (Figura A2, ver en Anexo 8). El efecto de  la intervenci\u00f3n fue \nsignificativo en todos los subgrupos excepto en los 3 estudios que \ncompararon con ejercicio f\u00edsico (g = -0.19, IC95%: -0.41, 0.04; I 2 = 0%).  \nEl an\u00e1lisis de subgrupos por poblaci\u00f3n result\u00f3 sign ificativo (p = \n0.03). En poblaci\u00f3n cl\u00ednica el efecto fue significa tivo, aunque de menor \nintensidad (g = -0.24, IC95%: -0.41, -0.07) que en estudiantes (-0.49, \nIC95%: -0.62, -0.36) y adultos sanos (g = -0.54, IC 95%: -0.79, -0.30).  \nNo hubo diferencias significativas entre estudios p ublicados antes \no despu\u00e9s del a\u00f1o 2000 (p = 0.52, Figura A4, ver en  Anexo 8), ni entre \nlos distintos periodos de seguimiento (p = 0.41, Fi gura A5, ver en Anexo \n8). \nEl efecto de la intervenci\u00f3n tambi\u00e9n fue significat ivo, aunque de \nmenor intensidad, en el subgrupo con seguimientos m \u00e1s largos (entre 6-\n36 meses, g = -0.35, IC95%: -0.57, -0.12; I 2 = 31%). \nEl gr\u00e1fico de embudo muestra una distribuci\u00f3n sim\u00e9t rica de los \nestudios, sin evidencia de sesgo de publicaci\u00f3n (Fi gura 4). \n \n \nFigura 4. Gr\u00e1fico de embudo de los estudios que eva luaron ansiedad \n(meditaci\u00f3n vs. control)  \n \n \n  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  48  \nOtros 5 estudios no reportaron datos num\u00e9ricos que pudieran ser \nincluidos en el MA, 2 con MT [70,82], 2 con OMBM [1 03,134] y 1 con \nLKM [73]. Vasudev et al. [134], en personas mayores  con depresi\u00f3n (n = \n51), obtuvo un efecto significativo de la intervenc i\u00f3n frente al tratamiento \nhabitual a los 3 meses (F = 2.95, p < 0.05). Dunne et al. [82] (n = 58) y \nCarson et al. [73] (n = 43), en personal de emergen cias y personas con \ndolor de espalda, respectivamente, reportan una red ucci\u00f3n significativa \nen el grupo de meditaci\u00f3n, pero no realizan un cont raste inter-grupo. \nLos dos estudios restantes no obtuvieron resultados  significativos.   \n \nConsumo de sustancias \n \nTres estudios evaluaron la efectividad de la medita ci\u00f3n sobre el \nconsumo de alcohol [108,131] y tabaco [116]. En Tua b et al. (1994) [131] \n(n = 66 hombres con alcoholismo), el grupo de MT mo str\u00f3 un n\u00famero de \nd\u00edas sin beber significativamente menor que el trat amiento habitual a los \n6, 12 y 18 meses (76.3% vs. 45.7% en el periodo 13- 18 meses, p < \n0.05). Murphy et al. (1986) [108] (n = 60) evaluaro n el efecto de la \nmeditaci\u00f3n cl\u00ednicamente estandarizada (un tipo de O MBM), frente a un \nprograma de ejercicio f\u00edsico (correr) y un grupo de  no tratamiento, en \nestudiantes universitarios con elevado consumo soci al de alcohol. La \nreducci\u00f3n en el consumo en el grupo de MT no fue si gnificativamente \ndiferente a la de los otros dos grupos al final del  tratamiento ni tras 6 \nsemanas de seguimiento (p > 0.05). \nTambi\u00e9n con estudiantes universitarios, Ottens (197 5) [116] (n = 36) \nevalu\u00f3 la efectividad de la MT frente a un grupo de  discusi\u00f3n \n(denominado \u201cauto-control\u201d) y no tratamiento. Tras diez semanas de \nintervenci\u00f3n, los dos primeros grupos redujeron su consumo \nsignificativamente en comparaci\u00f3n con el control (F  = 4.84, p < 0.01 \npara la interacci\u00f3n), sin diferencias significativa s entre ellos. \n \nDepresi\u00f3n \n \nSe incluyeron en el MA 26 estudios (n = 1897) con d atos de depresi\u00f3n \nauto-reportada (el instrumento m\u00e1s usado fue el Center for \nEpidemiologic Studies Depression Scale (CES-D), en 7 estudios). Doce \nestudios incluyeron adultos de la poblaci\u00f3n general  y 14 de poblaci\u00f3n \ncl\u00ednica (3 con enfermedad cardiaca, 3 con c\u00e1ncer, 2  con SIDA por VIH, 2 \ncon dolor cr\u00f3nico, 2 con estr\u00e9s postraum\u00e1tico, 1 co n depresi\u00f3n y 1 con \nansiedad). Diez estudios ofrecieron datos de cambio  en las \npuntuaciones, mientras que el resto report\u00f3 los res ultados en el  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 49 seguimiento (solo en 5 casos se pudieron introducir  en el MA datos \najustados por l\u00ednea base). Se imputaron las desviac iones t\u00edpicas en el \nseguimiento en tres estudios [81,102,123]; su poste rior exclusi\u00f3n no \nmodific\u00f3 sustancialmente los resultados. \nSe obtuvo un efecto significativo y homog\u00e9neo a fav or de la \nmeditaci\u00f3n, de peque\u00f1a intensidad (g = -0.32, IC95% : -0.41, -0.22; I 2 = \n15%) (Figura 5). El efecto fue significativo en tod os los subgrupos de \nmeditaci\u00f3n excepto en LKM (3 estudios; g = -0.15, IC 95%: -0.42, 0.12; I 2 \n= 46%) y en el \u00fanico estudio que aplic\u00f3 meditaci\u00f3n religiosa/espiritual \n[78]. La exclusi\u00f3n de estos dos subgrupos no modific \u00f3 el resultado \nglobal de forma significativa (g = -0.33, IC95%: -0 .43, -0.24; I 2 = 11%). \n  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  50  \nFigura 5. Efecto sobre la depresi\u00f3n seg\u00fan el tipo d e meditaci\u00f3n (meditaci\u00f3n \nvs. control)  \n \n \nLos estudios que reportaron datos de cambio obtuvie ron un efecto \nsignificativamente mayor (g = -0.44, IC95%: -0.58, -0.29; I 2 = 23%) que \nlos que ofrecieron diferencias en el seguimiento (g  = -0.24, IC95%: -\n0.35, -0.12; I 2 = 0%, p = 0.03 para la diferencia entre grupos) (Fi gura D2, \nver en Anexo 8). El an\u00e1lisis de subgrupos seg\u00fan el t ipo de control no \nresult\u00f3 significativo (p = 0.12) (Figura D3, ver en  Anexo 8). Tampoco la  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 51 comparaci\u00f3n con ejercicio f\u00edsico fue significativa (g = -0.10, IC95%: -\n0.33, 0.1).  No hubo diferencias significativas seg \u00fan el tipo de poblaci\u00f3n \n(p = 0.46) (Figura D4, ver en Anexo 8), ni entre est udios publicados antes \no despu\u00e9s del 2010 (p = 0.48) (Figura D5, ver en An exo 8). El an\u00e1lisis \nseg\u00fan el tiempo de seguimiento (m\u00e1s o menos de 4 me ses) tampoco fue \nsignificativo (p = 0.14, Figura D6, ver en Anexo 8),  aunque los estudios \ncon m\u00e1s de 4 meses obtuvieron un efecto menor, al l \u00edmite de la \nsignificaci\u00f3n (g = -0.19, IC95%: -0.38, 0.00) (Figu ra D6, ver en Anexo 8). \nEl gr\u00e1fico de embudo muestra simetr\u00eda salvo por un estudio con \nalto error est\u00e1ndar relativo y efecto fuerte [92] ( Figura 6). \n \n \nFigura 6. Gr\u00e1fico de embudo de los estudios que eva luaron depresi\u00f3n \n(meditaci\u00f3n vs. control)  \n \n \n \nUn estudio no pudo ser incluido en el MA al reporta r medianas (n = 178) \n[103]. Se observ\u00f3 una diferencia significativa a fa vor de la meditaci\u00f3n \n(combinaci\u00f3n de t\u00e9cnicas de respiraci\u00f3n y ejercicio s de atenci\u00f3n \nfocalizada) frente al grupo de intervenci\u00f3n diferid a, a los 2 meses de \ncomenzar la intervenci\u00f3n, en la subescala de depres i\u00f3n del POMS (-3.0 \nvs. 0, p = 0.019).   \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  52  \nEstr\u00e9s \n \nSe incluyeron 20 estudios (n = 1661) que evaluaron estr\u00e9s, 11 de ellos \ncon la Perceived Stress Scale  (PSS). Se excluyeron medidas que son \ndenominadas como psychological distress , pero que eval\u00faan \npsicopatolog\u00eda general (p.e., General Health Questionnaire (GHQ) , Brief \nSymtoms Inventory-18 (BSI-18)) (ver apartado de Psicopatolog\u00eda \ngeneral). Catorce estudios incluyeron adultos de la  poblaci\u00f3n general y 6 \npoblaci\u00f3n cl\u00ednica (2 con SIDA por VIH, 2 con dolor cr\u00f3nico, 1 con \nenfermedad cardiaca y 1 con c\u00e1ncer). En tres estudi os [84,100,111] se \nintrodujo en el MA la diferencia en el cambio en la s puntuaciones; su \nexclusi\u00f3n no modific\u00f3 sustancialmente los resultados . \nEl MA obtuvo un resultado significativamente favora ble a la \nintervenci\u00f3n (g = -0.37, IC95%: -0.53, -0.21; I 2 = 58%) (Figura 7). El \ngrupo de LKM (3 estudios) y compasi\u00f3n (2 estudios c on efectos nulo y \nfuerte respectivamente) fueron los \u00fanicos que no ob tuvieron un \nresultado significativo. Al excluir estos subgrupos,  el resultado global se \nincrement\u00f3 hasta -0.44 (IC95%: -0.59, -0.27; I 2 = 45%). \n \nFigura 7. Efecto sobre el estr\u00e9s seg\u00fan el tipo de m editaci\u00f3n (meditaci\u00f3n vs. \ncontrol) \n  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 53 El an\u00e1lisis de subgrupos por tipo de control result \u00f3 significativo (p = \n0.003). S\u00f3lo la comparaci\u00f3n con el grupo de interve nci\u00f3n diferida obtuvo \nun resultado significativo (g = 0.59, IC95%: -0.81,  0.36; I 2 = 45%) (Figura \nE2, ver en Anexo 8). En cuanto a la poblaci\u00f3n, el ef ecto fue significativo \nen adultos sanos (g = -0.46, IC95%: -0.65, -0.27; I2 = 62%), pero no en \npoblaci\u00f3n cl\u00ednica (g = -0.13, IC95%: -0.40, 0.13; I2 = 27%, p = 0.05 para \nla diferencia entre grupos) (Figura E3, ver en Anex o 8). Los an\u00e1lisis \nseg\u00fan la fecha de publicaci\u00f3n (antes o despu\u00e9s de 2 010, p = 0.68) \n(Figura E4, ver en Anexo 8) y el tiempo de seguimien to (p = 0.12, Figura \nE5, ver en Anexo 8) no fueron significativos, si bie n en este \u00faltimo caso \nel efecto en los estudios de m\u00e1s de 4 meses fue muy  peque\u00f1o y no \nsignificativo (g = -0.19, IC95%: -0.46, 0.08; I 2 = 45%). \nEl gr\u00e1fico de embudo muestra cierta asimetr\u00eda, pero  no en el \nsentido de \u201c small-study effects \u201d (Figura 8).  \n \n \nFigura 8. Gr\u00e1fico de embudo de los estudios que eva luaron estr\u00e9s (meditaci\u00f3n \nvs. control)  \n \n \n \nCuatro estudios no pudieron ser incluidos en el MA.  Severtsen et al. \n[127] (OMBM) incluyeron s\u00f3lo 5 participantes por gr upo, que mostraban \nuna diferencia intensa en las puntuaciones de l\u00ednea  base. En este \nestudio, el grupo de meditaci\u00f3n empez\u00f3 y termin\u00f3 (6  semanas) con  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  54 menores puntuaciones de estr\u00e9s, aunque la reducci\u00f3n  fue mayor en el \ngrupo de ejercicio aer\u00f3bico. Dunne et al. [82] (n =  58, personal de \nemergencias) observaron un menor nivel de estr\u00e9s en  el grupo de MT \nuna semana tras la intervenci\u00f3n (d = -0.64), pero n o a los dos meses, en \ncomparaci\u00f3n con no intervenci\u00f3n. Manocha et al. [10 3] informaron de \nuna reducci\u00f3n significativa del estr\u00e9s en el grupo de MT en comparaci\u00f3n \ncon el grupo control a los 2 meses (cambio mediano -37.0 vs. -17.5, p = \n0.026). Chandler et al. [75] (n = 84, personas con pre-hipertensi\u00f3n) \nreporta el n\u00famero de participantes con alto estr\u00e9s,  sin diferencias \nsignificativas entre la meditaci\u00f3n (respiraci\u00f3n) y educaci\u00f3n sanitaria, a \nlos 1, 3, 6 y 12 meses. \n \nEstr\u00e9s laboral (burnout) \n \nCinco estudios, todos con muestras peque\u00f1as, evalua ron el efecto de la \nMT [84], OMBS [62,82,115] y meditaci\u00f3n religiosa/es piritual [77] con el \nMaslach Burnout Inventory (MBI), sobre el estr\u00e9s laboral de profesorado \ny personal de emergencias sanitarias. No ha sido po sible realizar MA \ndebido a la heterogeneidad o no disponibilidad de l os resultados. Elder \net al. (2014) [84] (n = 40) obtuvo un efecto signif icativamente favorable a \nla intervenci\u00f3n a los 3 meses (Delta de Glass = 0.4 0, p = 0.018). \nAnderson et al. (1999) [62] (n = 91) y Chirico et a l. (2020) [77] (n = 50) \ntambi\u00e9n obtuvieron un efecto significativo, a las 9  y 12 semanas, \nrespectivamente, en las subescalas de agotamiento e mocional (F = 31.4, \np < 0.001; Delta de Glass = 1.78, p < 0.001) y desp ersonalizaci\u00f3n (F = \n7.9, p = 0.008; Delta de Glass = 1.90, p < 0.001). Oman et al. (2006) \n[115] (n = 61) no obtuvieron efectos significativos  a las 19 semanas en \nninguna de las subescalas del MBI (p-valores > 0.16 ). Por \u00faltimo, Dunne \net al. [82] (n = 51) observaron una reducci\u00f3n signi ficativa en el grupo de \nmeditaci\u00f3n en la subescala de agotamiento emocional , pero no ofrece el \ncontraste inter-grupo. \n \nEstr\u00e9s postraum\u00e1tico \n \nSe incluyeron 7 estudios (n = 573) que evaluaron s\u00ed ntomas de estr\u00e9s \npostraum\u00e1tico (5 con el Post-traumatic stress disorder Checklist (PCL), \nversi\u00f3n civil o militar). Cuatro estudios usaron MT  (2 con personas \ninternas en prisi\u00f3n [112,113], 1 con militares vete ranos [114], otro con \npersonas refugiadas [121]), dos estudios con vetera nos aplicaron OMBM \n[68,146] y uno aplic\u00f3 una combinaci\u00f3n de respiraci\u00f3 n y LKM-compasi\u00f3n \nen mujeres que hab\u00edan sufrido violencia interperson al [101]. El estudio \ncon personas refugiadas de Rees et al. [121] no se ha incluido en el MA  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 55 por mostrar un alto riesgo de sesgo de selecci\u00f3n (u n 59% de los \nparticipantes asignados al grupo de meditaci\u00f3n no c omenz\u00f3 el \nprograma, realiz\u00e1ndose posteriormente un dise\u00f1o de muestras \nemparejadas). Este estudio mostr\u00f3 un efecto muy int enso en la \nreducci\u00f3n de los s\u00edntomas de estr\u00e9s postraum\u00e1tico a uto-reportados (g = \n-8.75, IC95%: -10.81, -6.70). El MA de los 6 estudi os restantes fue \nsignificativamente favorable a la intervenci\u00f3n (g =  -0.60, IC95%: -0.78, -\n0.43; I 2 = 0%). El efecto fue significativo en los 3 tipos de meditaci\u00f3n \n(Figura 9).  \n \n \nFigura 9. Efecto sobre el estr\u00e9s postraum\u00e1tico seg\u00fa n el tipo de meditaci\u00f3n \n(meditaci\u00f3n vs.   control) \n \n \n \n \nTres estudios realizaron una evaluaci\u00f3n cl\u00ednica med iante la escala \nClinically Administered PTSD Scale  (CAPS) (Figura 10). En los dos \nestudios de OMBM el efecto global no alcanz\u00f3 la sig nificaci\u00f3n (g = -\n0.27, IC95%: -0.57, 0.03). Nidich et al. (2018) [11 4], con MT, obtuvo un \nresultado significativamente favorable a la interve nci\u00f3n (g = -0.57, \nIC95%: -0.91, -0.22), al igual que el resultado glo bal de los tres estudios \n(g = -0.40, IC95%: -0.62, -0.17; I 2 = 0%). \n \n \n \n  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  56 Figura 10. Efectividad de OMBM sobre los s\u00edntomas d e TEPT evaluados por el \ncl\u00ednico (CAPS) (meditaci\u00f3n vs. control) \n \n \n \n \nPsicopatolog\u00eda general \n \nSe incluyeron 7 estudios (n = 336) que aplicaron di ferentes tipos de \nmeditaci\u00f3n (todos en poblaci\u00f3n cl\u00ednica salvo uno [7 7]) y evaluaron \npsicopatolog\u00eda general medida a trav\u00e9s de las escal as BSI-18, GHQ, \nSCL-90 y SDS. El estudio de Lehrer et al. (1983) [1 02] no se incluy\u00f3 en el \nMA porque no report\u00f3 ninguna desviaci\u00f3n t\u00edpica y se  descart\u00f3 hacer \nimputaciones dado el bajo n\u00famero de estudios y de p articipantes. El \nresultado global fue de g = -0.84 (IC95%: -1.43, -0 .25, I 2 =84%). Chirico \net al. (2020) [77] fue el responsable de toda la he terogeneidad, por lo \nque se excluy\u00f3 del an\u00e1lisis. El resultado tras su exc lusi\u00f3n fue \nsignificativamente favorable para el grupo de medit aci\u00f3n (g = -0.50, \nIC95%: -0.74, -0.27) (Figura 11). \n \n  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 57  \nFigura 11. Efecto sobre la psicopatolog\u00eda general s eg\u00fan el tipo de meditaci\u00f3n \n(meditaci\u00f3n vs. control) \n \n \n \n \nInsomnio  \n \nCinco estudios (tres con meditaciones mixtas [64,107 ,109], uno con MT \n[112] y otro con OMBM [69]) evaluaron problemas de sue\u00f1o, tres de \nellos con el Pittsburgh Sleep Quality Index (PSQI). No ha sido posible \nrealizar MA para esta variable informe debido a la alta heterogeneidad. \nNanthakwang et al. (2020) [109] (n = 51) obtuvieron  un efecto fuerte tras \n2 meses de intervenci\u00f3n en personas mayores con pob re calidad del \nsue\u00f1o (g = -1.67, IC95%: -2.26, -1.07). Nidich et a l. (2016) [112] (n = \n181), con hombres encarcelados, tambi\u00e9n obtuvieron un resultado \nsignificativo a los 4 meses (g = -0.67, IC95%: -1.0 1, -0.34). Milbury et al. \n(2013) [107] (n = 46), en mujeres con c\u00e1ncer de mam a, no observaron \ndiferencias significativas tras 10 semanas (p = 0.2 9). Bormann et al. \n(2018) [69] (n = 173), en personas con trastorno de  estr\u00e9s postraum\u00e1tico, \ntambi\u00e9n obtuvieron resultados significativos a los 2 meses (g = -0.36, \nIC95%: -0.66, -0.06). Por \u00faltimo, Basso et al. (201 9) [64] (n = 42) \nobtuvieron un resultado significativamente peor par a la meditaci\u00f3n (g = \n0.70, IC95%: 0.07, 1.32). \n  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  58 Calidad de vida relacionada con la salud \n \nSe incluyeron en el MA un total de 15 estudios (n =  792) con diferentes \ntipos de meditaci\u00f3n e instrumentos. No se incluyero n los estudios que \nusaron el cuestionario Quality of Life Enjoyment and Satisfaction \nQuestionnaire (Q-LES-Q), al tratarse de un instrumento que incluy e \ndimensiones de calidad de vida no relacionadas con la salud. Cinco \nestudios reportaron calidad de vida global [53,85,9 1,109,139] y 10 el \ncomponente mental de la calidad de vida (en su defe cto se incluy\u00f3 la \nsubescala de salud mental del Short Form-36 Health Survey (SF-36)). \nTres estudios incluyeron adultos sanos [91,100,115]  y el resto poblaci\u00f3n \ncl\u00ednica. En tres estudios [92,115,139] se introdujo  la diferencia en el \ncambio desde l\u00ednea base; su exclusi\u00f3n no modific\u00f3 el  resultado. \nEl resultado global fue significativamente favorabl e a la meditaci\u00f3n \n(g = 0.51, IC95%: 0.23, 0.80; I 2 = 73%). El estudio de Nanthakwang et al. \n[109], que obtuvo un efecto muy fuerte en personas mayores con pobre \ncalidad del sue\u00f1o, fue el responsable de toda la he terogeneidad, por lo \nque se excluy\u00f3 de todos los an\u00e1lisis. El resultado t ras su exclusi\u00f3n fue \nde g = 0.38 (IC95%: 0.24, 0.52) (Figura 12). Los re sultados fueron \nsignificativos para todos los tipos de meditaci\u00f3n e xcepto para la \nmeditaci\u00f3n religiosa/espiritual (2 estudios) y el \u00fa nico estudio de LKM \n[139], todos con muestras peque\u00f1as. \n  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 59  \nFigura 12. Efecto sobre la calidad de vida (general  o mental) seg\u00fan el tipo de \nmeditaci\u00f3n (meditaci\u00f3n vs. control)  \n \n \nLos estudios que evaluaron calidad de vida general obtuvieron un mayor \nefecto (g = 0.61, IC95%: 0.31, 0.91; I 2 = 22%) que los que evaluaron el \ncomponente mental (o la subescala de salud mental) (g = 0.31, IC95%: \n0.15, 0.47; I 2 = 0%, p = 0.09 para la diferencia inter-grupos) (F igura CV2, \nver en Anexo 8). No hubo diferencias significativas seg\u00fan el tipo de \ncontrol. La comparaci\u00f3n con control activo (3 estud ios; g = 0.35, IC95%: \n-0.10, 0.51; I 2 = 0%) y ejercicio (2 estudios; g = 0.15, IC95%: -0 .16, 0.47; \nI2 = 0%) no fue significativa (Figura CV3, ver en Ane xo 8). No hubo \ndiferencias significativas entre los 3 estudios que  incluyeron adultos \nsanos y los que incluyeron poblaci\u00f3n cl\u00ednica (p = 0 .76) (Figura CV4, ver \nen Anexo 8), ni entre distintos periodos de seguimie nto (p = 0.80) (Figura \nCV5, ver en Anexo 8). \nVasudev et al. [134] (n = 51), en personas mayores con depresi\u00f3n, \nno ofrecieron datos num\u00e9ricos v\u00e1lidos para el MA. N o obstante, \ntampoco se observaron diferencias significativas a los 3 meses entre  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  60 meditaci\u00f3n (OMBM) y tratamiento habitual, en el cue stionario Quality of \nLife Profile Seniors Version  (QOLSV). \nEl gr\u00e1fico de embudo no muestra evidencia de sesgo de \npublicaci\u00f3n (Figura 13).  \n \n \nFigura 13. Gr\u00e1fico de embudo de los estudios que ev aluaron calidad de vida  \n \n \n \nOcho estudios (n = 324) ofrecieron datos sobre el c omponente \nf\u00edsico de la calidad de vida o la subescala de salu d general del SF-36. En \nel caso de Williams et al. [139] (pacientes con SID A por VIH en fase \nterminal) se introdujo en el MA la puntuaci\u00f3n de la  subescala de \nfuncionalidad del cuestionario aplicado ( Missoula-VITAS Quality of Life \nIndex , MVQOLI). Todos los estudios excepto Leach et al. [ 100] \nincluyeron poblaciones cl\u00ednicas. De nuevo, el estud io de Nanthakwang et \nal. [109] aport\u00f3 toda la heterogeneidad. Al excluirl o, se obtuvo un \nresultado no significativo (g = 0.18, IC95%: -0.07,  0.42) (Figura 14).  \n \n \n \n \n  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 61 Figura 14. Efecto sobre la calidad de vida (f\u00edsica)  seg\u00fan el tipo de meditaci\u00f3n \n(meditaci\u00f3n vs. control) \n \n \n \n \n  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  62 MEDITACI\u00d3N VS. OTROS TRATAMIENTOS ACTIVOS  \nSignos, s\u00edntomas y calidad de vida espec\u00edfica \n \nCefaleas y migra\u00f1as \n \nEn el estudio de Jong et al. (2019) [95] (n = 131 n i\u00f1os) se encontr\u00f3 una \nreducci\u00f3n significativa (p < 0.001) en la frecuenci a de cefaleas en el \ngrupo de meditaci\u00f3n y los dos de control, sin difer encias significativas \nentre los grupos. En el estudio de Wachholtz et al.  (2008) [137] (n = 92) \nse evalu\u00f3 la efectividad de la meditaci\u00f3n con mantr a espiritual frente a \nun mantra secular interno, externo y un grupo de rel ajaci\u00f3n muscular \nprogresiva, con un mes de seguimiento. El grupo expe rimental mostr\u00f3 \nuna reducci\u00f3n significativamente superior a los otr os tres grupos en la \nfrecuencia del dolor un mes tras comenzar el progra ma (mantra secular \ninterno: \u03b72 = 0.22, p < 0.001; mantra secular externo: \u03b72 = 0.82, p < \n0.001; relajaci\u00f3n: \u03b72 = 0.37, p < 0.001), pero no hubo diferencias \nsignificativas en la severidad (EVA 0-10, p >0.05).  No se observaron \ndiferencias significativas frente a la relajaci\u00f3n m uscular en la Migraine \nSpecific Quality of Life Scale (MSQOL)  tras 4 semanas de seguimiento (p \n< 0.05).  \n \nConsumo de sustancias  \n \nTuab et al. (1994) [131] (n = 118) compararon la MT  frente al biofeedback \ny la estimulaci\u00f3n transcraneal con corriente direct a (denominada en el \nestudio como neuroterapia). En el seguimiento a los  6, 12 y 18 meses, \nno hubo diferencias significativas entre MT y biofe edback. La diferencia \ncon la neuroterapia s\u00f3lo fue significativamente fav orable a la MT en el \nperiodo 13-18 meses (76.3% vs. 60.5% d\u00edas sin beber  a los 13-18 \nmeses, p < 0.05). \n \nPresi\u00f3n sangu\u00ednea \n \nHager et al. (1978) [89] (n = 30), no obtuvieron di ferencias significativas \ntras 4 semanas entre OMBM y biofeedback en la reduc ci\u00f3n de la \npresi\u00f3n sist\u00f3lica o diast\u00f3lica en pacientes con hip ertensi\u00f3n (p > 0.05). Lo \nmismo ocurri\u00f3 en Hafner et al. (1982) [88] (n = 21) , que adem\u00e1s incluy\u00f3 la \ncombinaci\u00f3n de ambos tratamientos. \n \n  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 63 S\u00edntomas psicol\u00f3gicos \n \nAnsiedad \n \nDiez estudios (n = 213) incluyeron un grupo de rela jaci\u00f3n muscular como \ncomparaci\u00f3n [70,95,98,102,105,117,120,137,145,148].  Solo uno de ellos \n[145] obtuvo una diferencia significativa, a favor de la meditaci\u00f3n (p < \n0.02 para la interacci\u00f3n). Se realiz\u00f3 un MA con 5 e studios, pues el resto \nno report\u00f3 ninguna dt y se descart\u00f3 hacer imputacio nes dado el bajo \nn\u00famero de estudios y de participantes. El resultado  no fue significativo \n(g = -0.17, IC95%: -0.44, 0.10; I 2 = 0%) (Figura 15). \n \n \nFigura 15. Efecto sobre la ansiedad seg\u00fan el tipo d e meditaci\u00f3n (meditaci\u00f3n \nvs. otros tratamientos activos)  \n \n \n \n \nDos estudios compararon la meditaci\u00f3n con tratamien tos psicol\u00f3gicos. \nBrooks et al. (1986) [72], en veteranos de la guerr a de Vietnam, \nobtuvieron un efecto fuerte a favor de la MT en la Taylor Anxiety Scale \n(TMAS), frente a distintos tipos de psicoterapia co njuntamente (g = -\n1.75, IC95%: -2.88, -0.62). Jong et al. (2019) [95] , en ni\u00f1os y ni\u00f1as con \ncefalea, no obtuvieron diferencias significativas f rente a la hipnoterapia \nen la subescala de ansiedad del Revised Children\u2019s Anxiety and \nDepression Scale-short version  (RCADS-25 , p = 0.15).  \n \n \n \n  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  64 Depresi\u00f3n \n \nTres estudios compararon la MT [95] y OMBM [102,137 ] frente a la \nrelajaci\u00f3n muscular progresiva. Jong et al. [95] no  obtuvieron diferencias \nsignificativas a los 3 (p = 0.16) y 9 meses (p = 0. 15) en la subescala de \ndepresi\u00f3n del RCADS-25. Wachholtz et al. (2008) [13 7], en estudiantes \ncon migra\u00f1a, tampoco encontraron diferencias signif icativas a las 4 \nsemanas en el CES-D (p > 0.05). Finalmente, Lehrer et al. (1983) [102], \nen personas con ansiedad, observaron un mejor resul tado para el grupo \nde relajaci\u00f3n a las 5 semanas (p < 0.04) pero no a los 9 meses (p > 0.05), \nen la subescala del Symptom Checklist-90 (SCL-90).  \nCuatro estudios compararon la meditaci\u00f3n con tratam ientos \npsicol\u00f3gicos [69,72,95,114]. Salvo Brooks et al. (1 986) [72], que \nobtuvieron un efecto fuerte a favor de la MT en el BDI , ninguno obtuvo \nun efecto significativo. Sin embargo, el MA de esto s tres estudios result\u00f3 \nsignificativo (g = -0.25, IC95%: -0.45, -0.05; I 2 = 0%).  \n \nEstr\u00e9s postraum\u00e1tico \n \nCuatro estudios (5 muestras, n = 431), todos ellos con militares \nveteranos, compararon la meditaci\u00f3n frente a terapi a centrada en el \npresente [69,147], exposici\u00f3n prolongada [114]y vari os tipos de \npsicoterapia conjuntamente [72]. El MA mostr\u00f3 un ef ecto peque\u00f1o pero \nsignificativo de la meditaci\u00f3n (g = -0.31, IC95%: - 0.50, -0.11; I 2 = 27%) \n(Figura 16). Al excluir el estudio con mayor efecto [72], causante de toda \nla heterogeneidad, el resultado se mantiene signifi cativo (g = -0.27, \nIC95%: -0.47, -0.07). \n \n \nFigura 16. Efecto sobre la depresi\u00f3n seg\u00fan el tipo de meditaci\u00f3n (meditaci\u00f3n \nvs. otros tratamientos activos)  \n \n \n \n  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 65 Calidad de vida relacionada con la salud \n \nBormann et al. (2018) [69] (n = 173), con militares  veteranos, no \nobtuvieron diferencias dos meses tras comenzar el e studio entre OMBM \ne intervenci\u00f3n psicol\u00f3gica con Terapia Centrada en el Presente en el \ncuestionario WHOQOL-5 (p = 0.45). \n  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 67 V. Discusi\u00f3n \nEsta RS ha evaluado la efectividad y seguridad de l a meditaci\u00f3n, \nexcluyendo las t\u00e9cnicas de Mindfulness  y la meditaci\u00f3n que implica \nmovimiento corporal (p.e., yoga, tai-chi). Se ha id entificado un alto \nn\u00famero de estudios que evaluaron la efectividad de la meditaci\u00f3n sobre \nvariables psicol\u00f3gicas: ansiedad, depresi\u00f3n; y en m enor medida estr\u00e9s y \ncalidad de vida relacionada con la salud. Sin embar go, esta evidencia \nmuestra una serie de limitaciones importantes: se t rata de estudios con \nriesgo de sesgo alto o incierto, debido a los peque \u00f1os tama\u00f1os \nmuestrales en general, la imposibilidad de cegar a los participantes, la \nfalta de informaci\u00f3n general sobre el ocultamiento de la asignaci\u00f3n y el \nalto porcentaje de p\u00e9rdidas en muchos estudios. La informaci\u00f3n \ndisponible se refiere mayoritariamente a la meditac i\u00f3n basada en \nmantras (MT u otro tipo), con pocos estudios sobre el resto de t\u00e9cnicas. \nAdem\u00e1s, las poblaciones cl\u00ednicas incluidas son hete rog\u00e9neas y en su \nmayor parte presentan enfermedades f\u00edsicas, con muy  pocos estudios \nque incluyan muestras diagnosticadas de trastornos psiqui\u00e1tricos. \nComo aspectos positivos sobre los aspectos evaluado s puede se\u00f1alarse \nuna consistencia de los resultados moderada-alta a trav\u00e9s de los \nestudios; intervalos de confianza relativamente est rechos; resultados en \ngeneral te\u00f3ricamente esperables en los an\u00e1lisis de subgrupos (i.e., \nmenor efecto con controles m\u00e1s activos, en poblacio nes cl\u00ednicas y en \nseguimientos m\u00e1s largos); y se ve reforzada por la ausencia de \ndiferencias o incluso superioridad frente a otros t ratamientos \nestablecidos como la relajaci\u00f3n muscular progresiva  o la psicoterapia \n(aunque en estos casos el n\u00famero de estudios es bas tante menor y \npr\u00e1cticamente restringidos al estr\u00e9s postraum\u00e1tico en el caso de la \npsicoterapia).  \nGlobalmente, la meditaci\u00f3n muestra efectos estandar izados \nsignificativos de intensidad entre peque\u00f1a y modera da sobre los niveles \nde ansiedad, depresi\u00f3n, estr\u00e9s (incluido estr\u00e9s pos traum\u00e1tico en \nmilitares) y calidad de vida. El efecto sobre la an siedad (g = 0.45) es \nsimilar al obtenido para la MT en la revisi\u00f3n de Or me-Johnson (2014) \n[59] (g = -0.50), que meta-analiz\u00f3 10 estudios. En el caso de la \ndepresi\u00f3n, Gathright et al. (2019) [60], tambi\u00e9n pa ra MT, obtuvieron un \nefecto menor y no significativo (g = -0.27), aunque  s\u00f3lo incluyen 5 \nestudios.  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  68 La significaci\u00f3n cl\u00ednica de estos resultados es inc ierta, y a\u00fan m\u00e1s \nteniendo en cuenta que en general el efecto fue men or en poblaciones \ncl\u00ednicas (en su mayor\u00eda con enfermedades f\u00edsicas). En el \u00e1mbito de la \ncalidad de vida relacionada con la salud, existe evi dencia de que la \ndiferencia m\u00ednimamente importante para el paciente se sit\u00faa \naproximadamente en media desviaci\u00f3n t\u00edpica (g = 0.50 ) [150]. En ese \ncaso, las mejor\u00edas observadas se situar\u00edan alrededo r de ese l\u00edmite, seg\u00fan \nlos instrumentos usados. En cualquier caso, esta re gla no puede \ngeneralizarse al resto de medidas. \nAunque no sea posible establecer una clasificaci\u00f3n exhaustiva e \ninequ\u00edvoca de los diferentes tipos de meditaci\u00f3n (p .e., el entrenamiento \nde la respiraci\u00f3n es com\u00fan a todos o muchos de ello s) existen \nelementos bien diferenciados que se proponen como o bjetos de \nfocalizaci\u00f3n de la atenci\u00f3n: mantras, sensaciones c orporales, deseo de \nbienestar propio y para el resto de personas (LKM),  benevolencia y \nempat\u00eda con el sufrimiento propio y para el resto d e personas \n(compasi\u00f3n), espiritualidad/trascendencia o relaci\u00f3 n con lo divino. Como \nse ha comentado, la mayor\u00eda de estudios incluidos h an aplicado \nmeditaci\u00f3n basada en mantras, dado el desarrollo m\u00e1 s antiguo en \noccidente de estas t\u00e9cnicas, con la introducci\u00f3n de  la MT en los a\u00f1os \nsesenta. En el caso de la LKM, los estudios incluid os han sido pocos y \nheterog\u00e9neos, con resultados globales no significat ivos. La RS de \nGalante et al. (2014) [51] sobre meditaci\u00f3n basada en amabilidad y \ncompasi\u00f3n obtuvo efectos significativos sobre el es tr\u00e9s y la depresi\u00f3n, \npero incluy\u00f3 solamente 3 y 2 estudios respectivamen te para estas \nvariables y con muestras peque\u00f1as. Con respecto a l os efectos de esta \nmeditaci\u00f3n sobre la ansiedad, con un mayor n\u00famero d e estudios, no \nencontr\u00f3 resultados significativos.  \nDe esta argumentaci\u00f3n, se deduce que contin\u00faa existi endo \nincertidumbre sobre este tipo de meditaci\u00f3n, as\u00ed co mo sobre la \nmeditaci\u00f3n basada en la compasi\u00f3n o la meditaci\u00f3n r eligiosa. Es posible \nque la efectividad de los distintos tipos de medita ci\u00f3n est\u00e9 modulada \npor las diferentes creencias, preferencias y expecta tivas de las personas \nrespecto a los distintos componentes de las t\u00e9cnica s o el objeto de \natenci\u00f3n [151,152]. \nEn cuanto a la efectividad de la meditaci\u00f3n sobre l os signos y \ns\u00edntomas f\u00edsicos, as\u00ed como sobre la calidad de vida  espec\u00edfica de cada \nenfermedad, hay muy pocos estudios para cada una de  ellas, salvo para \npersonas con hipertensi\u00f3n, donde los resultados no han sido en general \nsignificativos. La evaluaci\u00f3n de la calidad de los resultados muestra las \nmismas limitaciones metodol\u00f3gicas comentadas anteri ormente. En este  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 69 contexto de alta incertidumbre, se han observado dif erencias \nsignificativas en distintos tipos de dolor, glaucom a, funcionalidad en \npersonas mayores, psoriasis, s\u00edndrome de intestino irritable o s\u00edndrome \nmetab\u00f3lico. \nEn relaci\u00f3n a la seguridad, s\u00f3lo seis estudios de l os incluidos en \neste informe evaluaron los posibles efectos adverso s derivados de la \nLKM, MT y OMBM, no encontrando ninguno. Este hecho posiblemente \nrefleja la asunci\u00f3n impl\u00edcita de la seguridad de es tas t\u00e9cnicas. Sin \nembargo, algunos estudios recientes apuntan a que e n determinadas \npr\u00e1cticas de meditaci\u00f3n, como el Mindfulness  (no evaluada en este \ninforme) o la atenci\u00f3n focalizada, pueden aparecer algunos efectos no \ndeseados, como s\u00edntomas de ansiedad y despersonaliz aci\u00f3n o \ndesrealizaci\u00f3n, durante sesiones de meditaci\u00f3n, sie ndo m\u00e1s frecuentes \nen las sesiones individuales y de mayor duraci\u00f3n [1 53\u2013155]. Por otra \nparte, cabe la posibilidad de que pr\u00e1cticas que pod r\u00edan ser beneficiosas \no inocuas en algunas personas, como la atenci\u00f3n foc alizada, resultasen \nperjudiciales en caso de determinados trastornos me ntales (e.g., \nobsesivo-compulsivo). Por tanto, si bien no parece probable la aparici\u00f3n \nde efectos adversos graves o que permanezcan tras a bandonar la \npr\u00e1ctica, la investigaci\u00f3n futura deber\u00eda evaluar d e forma sistem\u00e1tica la \naparici\u00f3n de estos eventos. \nV.1. Limitaciones V.1. Limitaciones V.1. Limitaciones V.1. Limitaciones    \nLa principal limitaci\u00f3n de esta revisi\u00f3n se refiere  a la posibilidad de sesgo \nde publicaci\u00f3n. La inspecci\u00f3n visual de los gr\u00e1fico s de embudo no \nmuestra evidencia de tal sesgo, pero aun as\u00ed la exi stencia de sesgo no \npuede descartarse. La b\u00fasqueda en las diferentes ba ses de datos \nelectr\u00f3nicas se complement\u00f3 con la b\u00fasqueda manual de referencias a \npartir de los estudios incluidos en el informe, as\u00ed  como mediante la \nconsulta a los agentes implicados; no obstante, no se realiz\u00f3 una \nb\u00fasqueda formal en bases de datos de literatura gri s. Adem\u00e1s, existe la \nposibilidad de que no se hayan incluido estudios re levantes como \nresultado de su no publicaci\u00f3n, porque lo est\u00e9n en una lengua distinta \ndel ingl\u00e9s o castellano, o por haberse publicado en  revistas no \nindexadas. \nPor otra parte, no se ha realizado una valoraci\u00f3n s istem\u00e1tica de la \ncalidad de la evidencia mediante el sistema Grading of \nRecommendations, Assessment, Development and Evalua tion  (GRADE), \naunque se han comentado los aspectos relevantes en la discusi\u00f3n \n(consistencia y precisi\u00f3n de los resultados, riesgo  de sesgo de los  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  70 estudios, bajo n\u00famero de estudios de meditaci\u00f3n no basada en mantras \ny de poblaciones con trastornos mentales).  \n  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 71 VI. Conclusiones \n\u2022 La meditaci\u00f3n basada en mantras es la que dispone de mayor \ncantidad de evidencia, aunque el riesgo de sesgo de  los estudios es \nalto o incierto, al igual que en otros tipos de med itaci\u00f3n. Los \nresultados indican que este tipo de meditaci\u00f3n podr \u00eda producir un \nefecto beneficioso sobre los niveles de ansiedad, d epresi\u00f3n, estr\u00e9s \ngeneral y postraum\u00e1tico y calidad de vida relaciona da con la salud. \nSin embargo, no est\u00e1 clara la relevancia cl\u00ednica de  los efectos \nobtenidos.  \n\u2022 Otros tipos de meditaci\u00f3n disponen de un n\u00famero co nsiderablemente \nmenor de estudios, con las mismas limitaciones meto dol\u00f3gicas. La \nmeditaci\u00f3n basada exclusivamente en la respiraci\u00f3n y/o sensaciones \ncorporales, la basada en la compasi\u00f3n o la combinac i\u00f3n de diferentes \npr\u00e1cticas podr\u00edan producir un efecto beneficioso so bre los resultados \nde salud mental comentados anteriormente. En el cas o de la \nmeditaci\u00f3n LKM y la meditaci\u00f3n religiosa/espiritual , los resultados \nobtenidos no han sido significativos, pero como se ha comentado, el \nbajo n\u00famero de estudios no permite extraer conclusi ones definitivas.  \n\u2022 En el caso de los s\u00edntomas f\u00edsicos, la evidencia s ugiere una ausencia \nde efecto sobre la hipertensi\u00f3n arterial, la condic i\u00f3n m\u00e1s evaluada. \nPara el resto de enfermedades la evidencia es muy l imitada y tambi\u00e9n \nde baja calidad, observ\u00e1ndose resultados significat ivos en distintos \ntipos de dolor, glaucoma, funcionalidad en personas  mayores, \npsoriasis, s\u00edndrome de intestino irritable o s\u00edndro me metab\u00f3lico. \n\u2022 Existen muy pocos estudios con personas con diagn\u00f3 stico confirmado \nde trastornos mentales. \n\u2022 Muy pocos estudios evaluaron la aparici\u00f3n de efect os adversos, sin \nperjuicios observables, por lo que es necesario seg uir evaluando la \nseguridad de estas t\u00e9cnicas. \n  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 73 Contribuci\u00f3n de los autores  \n\u2022 Yolanda \u00c1lvarez-P\u00e9rez. Fundaci\u00f3n Canaria Instituto de Investigaci\u00f3n \nSanitaria de Canarias (FIISC) \u2013 Planificaci\u00f3n, dire cci\u00f3n y revisi\u00f3n del \nestudio, selecci\u00f3n de estudios, extracci\u00f3n de datos,  lectura cr\u00edtica de \nlos estudios incluidos, s\u00edntesis cuantitativa de re sultados y redacci\u00f3n \nparcial del presente informe. \n\u2022 Amado Rivero-Santana. Fundaci\u00f3n Canaria Instituto de Investigaci\u00f3n \nSanitaria de Canarias (FIISC). Red de Investigaci\u00f3n  en Servicios de \nSalud en Enfermedades Cr\u00f3nicas (REDISSEC) \u2013 Selecci \u00f3n de \nestudios, extracci\u00f3n de datos, lectura cr\u00edtica de lo s estudios \nincluidos, s\u00edntesis cuantitativa de resultados y re dacci\u00f3n parcial del \npresente informe. \n\u2022 Lilisbeth Perestelo-P\u00e9rez. Servicio de Evaluaci\u00f3n del Servicio Canario \nde la Salud (SESCS). Red de Investigaci\u00f3n en Servic ios de Salud en \nEnfermedades Cr\u00f3nicas (REDISSEC) \u2013 Supervisi\u00f3n del estudio, \nselecci\u00f3n de estudios, revisi\u00f3n interna del borrado r del informe y de \nla versi\u00f3n final del informe. \n\u2022 Andrea Duarte-D\u00edaz. Fundaci\u00f3n Canaria Instituto de Investigaci\u00f3n \nSanitaria de Canarias (FIISC) \u2013 Selecci\u00f3n de estudi os, extracci\u00f3n de \ndatos, lectura cr\u00edtica de los estudios incluidos, s \u00edntesis cuantitativa de \nresultados y redacci\u00f3n parcial del presente informe .  \n\u2022 Vanesa Ramos-Garc\u00eda . Fundaci\u00f3n Canaria Instituto de Investigaci\u00f3n \nSanitaria de Canarias (FIISC) \u2013 Selecci\u00f3n de estudi os, extracci\u00f3n de \ndatos, lectura cr\u00edtica de los estudios incluidos y revisi\u00f3n interna del \ninforme. \n\u2022 Ana Toledo-Ch\u00e1varri. Fundaci\u00f3n Canaria Instituto de Investigaci\u00f3n \nSanitaria de Canarias (FIISC). Red de Investigaci\u00f3n  en Servicios de \nSalud en Enfermedades Cr\u00f3nicas (REDISSEC) \u2013 Selecci \u00f3n de \nestudios, extracci\u00f3n de datos, lectura cr\u00edtica de lo s estudios incluidos \ny revisi\u00f3n interna del informe. \n\u2022 Alezandra Torres-Casta\u00f1o . Fundaci\u00f3n Canaria Instituto de \nInvestigaci\u00f3n Sanitaria de Canarias (FIISC) \u2013 Selec ci\u00f3n de estudios, \nextracci\u00f3n de datos, lectura cr\u00edtica de los estudios  incluidos y \nrevisi\u00f3n interna del informe.  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  74 \u2022 Nerea Gonz\u00e1lez-Hern\u00e1ndez . Instituto de Investigaci\u00f3n en Servicios de \nSalud-Kronikgune. Osakidetza, Unidad de investigaci \u00f3n Hospital \nGaldakao-Usansolo. Red de Investigaci\u00f3n en Servicio s de Salud en \nEnfermedades Cr\u00f3nicas (REDISSEC) \u2013 Extracci\u00f3n de dat os, lectura \ncr\u00edtica de los estudios incluidos y revisi\u00f3n intern a del informe. \n\u2022 Beatriz Le\u00f3n-Salas . Fundaci\u00f3n Canaria Instituto de Investigaci\u00f3n \nSanitaria de Canarias (FIISC). Red de Investigaci\u00f3n  en Servicios de \nSalud en Enfermedades Cr\u00f3nicas (REDISSEC) \u2013 Extracci \u00f3n de datos, \nlectura cr\u00edtica de los estudios incluidos y revisi\u00f3 n interna del informe. \n\u2022 Daniel Esta\u00f1a-Malaret . Fundaci\u00f3n Canaria Instituto de Investigaci\u00f3n \nSanitaria de Canarias (FIISC) \u2013Extracci\u00f3n de datos, lectura cr\u00edtica de \nlos estudios incluidos y revisi\u00f3n interna del infor me. \n\u2022 Diego Infante-Ventura . Fundaci\u00f3n Canaria Instituto de Investigaci\u00f3n \nSanitaria de Canarias (FIISC) \u2013Extracci\u00f3n de datos, lectura cr\u00edtica de \nlos estudios incluidos y revisi\u00f3n interna del infor me. \n\u2022 Leticia Rodr\u00edguez-Rodr\u00edguez. Fundaci\u00f3n Canaria Instituto de \nInvestigaci\u00f3n Sanitaria de Canarias (FIISC) \u2013 Desar rollo de la \nestrategia de b\u00fasqueda, consulta en bases de datos y revisi\u00f3n \ninterna del informe. \n\u2022 Pedro Serrano-Aguilar. Servicio de Evaluaci\u00f3n del Servicio Canario de \nla Salud (SESCS). Red de Investigaci\u00f3n en Servicios  de Salud en \nEnfermedades Cr\u00f3nicas (REDISSEC) \u2013 Supervisi\u00f3n del estudio, \nrevisi\u00f3n del borrador del informe y de la versi\u00f3n f inal del informe.   \n \n \n consultas@sescs.es \n \n \n  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 75 Declaraci\u00f3n de intereses \nLos autores del presente informe declaran no tener conflictos de \nintereses en relaci\u00f3n con la tecnolog\u00eda evaluada y los comparadores \nconsiderados.  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  76 Referencias bibliogr\u00e1ficas \n1.  Tang Y-Y, H\u00f6lzel BK, Posner MI. Erratum: The ne uroscience of \nmindfulness meditation. Nat. Rev. Neurosci. 2015 Ma y;16(5):312\u2013\n312.  \n2.  Cahn BR, Polich J. Meditation (Vipassana) and t he P3a event-\nrelated brain potential. Int. J. Psychophysiol. 200 9 Apr;72(1):51\u2013\n60.  \n3.  Walsh R. Meditaci\u00f3n. Nat. Medicat. 1996;43:16\u20132 2.  \n4.  Goyal M, Singh S, Sibinga EMS, Gould NF, Rowlan d-Seymour A, \nSharma R, et al. Meditation Programs for Psychologi cal Stress \nand Well-being: A Systematic Review and Meta-analys is. JAMA \nIntern. Med. 2014 Mar;174(3):357.  \n5.  Shapiro DJ. Overview: clinical and physiologica l comparison of \nmeditation with other self-control strategies. Am. J. Psychiatry. \n1982 Mar;139(3):267\u201374.  \n6.  Thomas JW, Cohen M. A Methodological Review of Meditation \nResearch. Front. Psychiatry. 2014 Jul;5.  \n7.  Brandmeyer T, Delorme A, Wahbeh H. The neurosci ence of \nmeditation: classification, phenomenology, correlat es, and \nmechanisms. Prog. Brain Res. 2019;244:1\u201329.  \n8.  Rose S, Zell E, Strickhouser JE. The Effect of Meditation on \nHealth: a Metasynthesis of Randomized Controlled Tr ials. \nMindfulness (N. Y). 2020 Feb;11(2):507\u201316.  \n9.  Dahl CJ, Lutz A, Davidson RJ. Reconstructing an d \ndeconstructing the self: cognitive mechanisms in me ditation \npractice. Trends Cogn. Sci. 2015 Sep;19(9):515\u201323.  \n10.  Lutz A, Slagter HA, Dunne JD, Davidson RJ. Att ention regulation \nand monitoring in meditation. Trends Cogn. Sci. 200 8 \nApr;12(4):163\u20139.  \n11.  Fox KCR, Dixon ML, Nijeboer S, Girn M, Floman JL , Lifshitz M, et \nal. Functional neuroanatomy of meditation: A review  and meta-\nanalysis of 78 functional neuroimaging investigatio ns. Neurosci. \nBiobehav. Rev. 2016 Jun;65:208\u201328.  \n12.  Flavell JH. Metacognition and cognitive monito ring: A new area of \ncognitive-developmental inquiry. Am. Psychol. 1979; 34(10):906\u2013\n11.  \n13.  Chambers R, Gullone E, Allen NB. Mindful emoti on regulation: An \nintegrative review. Clin. Psychol. Rev. 2009 Aug;29 (6):560\u201372.   \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 77 14.  National Institute for Health and Care Excellen ce (NICE). \nDepression in adults: recognition and management. C linical \nguideline [CG90]; 2009.  \n15.  National Institute for Health and Care Excellen ce (NICE). \nCommon mental health problems: identification and p athways to \ncare. Clinical guideline [CG123]; 2011.  \n16.  Grupo de trabajo de la Gu\u00eda de Pr\u00e1ctica Cl\u00ednic a sobre el Manejo \nde la Depresi\u00f3n en el Adulto. Gu\u00eda de Pr\u00e1ctica Cl\u00edn ica sobre el \nManejo de la Depresi\u00f3n en el Adulto. Ministerio de Sanidad, \nServicios Sociales e Igualdad. Agencia de Evaluaci\u00f3 n de \nTecnolog\u00edas Sanitarias de Galicia (avalia-t). Gu\u00edas  de Pr\u00e1ctica \nCl\u00ednica en el SNS: Avalia-t 2013/06.; 2014.  \n17.  Intercollegiate Guidelines Network S. Scottish  Intercollegiate \nGuidelines Network Part of NHS Quality Improvement Scotland \nSIGN Non-pharmaceutical management of depression in  adults \nHelp us to improve SIGN guidelines-click here to co mplete our \nsurvey [Internet]. 2010. Disponible en: \nwww.sign.ac.uk/pdf/sign50eqia.pdf \n18.  American Psychological Association. Clinical P ractice Guideline \nfor the Treatment of Depression Across Three Age Co horts. 2019.  \n19.  Karyotaki E, Smit Y, Cuijpers P , Debauche Plat e-forme \nScientifique Psychotropes M, Sant\u00e9 Publique \u2013 FOD \nVolksgezondheid S, De Keyser T, et al. The long-ter m efficacy of \npsychotherapy, alone or in combination with antidep ressants, in \nthe treatment of adult major depression [Internet].  2014 [Accedido  \n17-05-2021]. Disponible en: www.kce.fgov.be \n20.  Bennabi D, Charpeaud T, Yrondi A, Genty J-B, D estouches S, \nLancrenon S, et al. Clinical guidelines for the man agement of \ntreatment-resistant depression: French recommendati ons from \nexperts, the French Association for Biological Psych iatry and \nNeuropsychopharmacology and the fondation FondaMent al. \nBMC Psychiatry. 2019 Dec 28;19(1):262.  \n21.  Parikh S V., Quilty LC, Ravitz P , Rosenbluth M , Pavlova B, \nGrigoriadis S, et al. Canadian Network for Mood and  Anxiety \nTreatments (CANMAT) 2016 Clinical Guidelines for th e \nManagement of Adults with Major Depressive Disorder . Can. J. \nPsychiatry. 2016 Sep 11;61(9):524\u201339.  \n22.  Centre for Alcohol and Other Drugs. Drug and A lcohol \nPsychosocial Interventions Professional Practice Gu idelines. \n2008.  \n23.  Ghahari S, Mohammadi-Hasel K, Malakouti S, Ros hanpajouh M. \nMindfulness-based Cognitive Therapy for Generalised  Anxiety  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  78 Disorder: a Systematic Review and Meta-analysis. Ea st Asian \nArch. Psychiatry. 2020 Jun;30(2):52\u20136.  \n24.  Goldin PR, Morrison A, Jazaieri H, Brozovich F , Heimberg R, \nGross JJ. Group CBT versus MBSR for social anxiety disorder: A \nrandomized controlled trial. J. Consult. Clin. Psyc hol. 2016 \nMay;84(5):427\u201337.  \n25.  Blanck P , Perleth S, Heidenreich T, Kr\u00f6ger P , Ditzen B, Bents H, et \nal. Effects of mindfulness exercises as stand-alone intervention \non symptoms of anxiety and depression: Systematic r eview and \nmeta-analysis. Behav. Res. Ther. 2018 Mar;102:25\u201335 .  \n26.  Perestelo-Perez L, Barraca J, Pe\u00f1ate W, Rivero -Santana A, \nAlvarez-Perez Y. Mindfulness-based interventions fo r the \ntreatment of depressive rumination: Systematic revi ew and meta-\nanalysis. Int. J. Clin. Heal. Psychol. 2017 Sep;17( 3):282\u201395.  \n27.  Khoury B, Sharma M, Rush SE, Fournier C. Mindf ulness-based \nstress reduction for healthy individuals: A meta-an alysis. J. \nPsychosom. Res. 2015 Jun;78(6):519\u201328.  \n28.  Sharma M, Rush SE. Mindfulness-Based Stress Re duction as a \nStress Management Intervention for Healthy Individu als. J. Evid. \nBased. Complementary Altern. Med. 2014 Oct;19(4):27 1\u201386.  \n29.  Cillessen L, Johannsen M, Speckens AEM, Zachar iae R. \nMindfulness \u2010based interventions for psychological and physical \nhealth outcomes in cancer patients and survivors: A  systematic \nreview and meta \u2010analysis of randomized controlled trials. \nPsychooncology. 2019 Dec;28(12):2257\u201369.  \n30.  Toivonen KI, Zernicke K, Carlson LE. Web-Based  Mindfulness \nInterventions for People With Physical Health Condi tions: \nSystematic Review. J. Med. Internet Res. 2017 Aug;1 9(8):e303.  \n31.  Xunlin N, Lau Y, Klainin-Yobas P . The effectiv eness of \nmindfulness-based interventions among cancer patien ts and \nsurvivors: a systematic review and meta-analysis. S upport. Care \nCancer. 2020 Apr;28(4):1563\u201378.  \n32.  Scott-Sheldon LAJ, Gathright EC, Donahue ML, B alletto B, \nFeulner MM, DeCosta J, et al. Mindfulness-Based Int erventions \nfor Adults with Cardiovascular Disease: A Systemati c Review and \nMeta-Analysis. Ann. Behav. Med. 2020 Jan;54(1):67\u20137 3.  \n33.  Goldberg SB, Tucker RP , Greene PA, Davidson RJ , Wampold BE, \nKearney DJ, et al. Mindfulness-based interventions for psychiatric \ndisorders: A systematic review and meta-analysis. C lin. Psychol. \nRev. 2018 Feb;59:52\u201360.  \n34.  Hilton L, Hempel S, Ewing BA, Apaydin E, Xenak is L, Newberry S, \net al. Mindfulness Meditation for Chronic Pain: Sys tematic Review  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 79 and Meta-analysis. Ann. Behav. Med. 2017 Apr;51(2): 199\u2013213.  \n35.  Carletto S, Cavalera C, Sadowski I, Rovaris M,  Borghi M, Khoury \nB, et al. Mindfulness-Based Interventions for the I mprovement of \nWell-Being in People With Multiple Sclerosis: A Sys tematic \nReview and Meta-Analysis. Psychosom. Med. 2020 \nJul;82(6):600\u201313.  \n36.  Simpson R, Simpson S, Ramparsad N, Lawrence M,  Booth J, \nMercer SW. Effects of Mindfulness-based interventio ns on \nphysical symptoms in people with multiple sclerosis  \u2013 a \nsystematic review and meta-analysis. Mult. Scler. R elat. Disord. \n2020 Feb;38:101493.  \n37.  Canadian Journal of Health Technologies (CADTH ). Mindfulness \nTraining for Chronic Pain Management: A Review of t he Clinical \nEvidence and Guidelines. Report RC0318-000; 2012.  \n38.  Canadian Journal of Health Technologies (CADTH ). Mindfulness \nTraining for Chronic Non-malignant Pain Management:  A Review \nof the Clinical Effectiveness, Cost-effectiveness a nd Guidelines. \nReport RC1138-000; 2019.  \n39.  Luengo Gonz\u00e1lez R, Rapado Castro M, Fraguas He rr\u00e1ez D. \nEficacia de las terapias de tercera generaci\u00f3n en p ersonas con \ntrastorno mental grave. Madrid. Ministerio de Sanid ad, Consumo \ny Bienestar Social. Unidad de Evaluaci\u00f3n de Tecnolo g\u00edas \nSanitarias de la Comunidad de Madrid. Informes de E valuaci\u00f3n \nde Tecnolog\u00edas Sanitarias; 2016.  \n40.  Lippelt DP, Hommel B, Colzato LS. Focused atte ntion, open \nmonitoring and loving kindness meditation: effects on attention, \nconflict monitoring, and creativity \u00e2\u20ac\u201c A review. F ront. Psychol. \n2014 Sep;5.  \n41.  Matko K, Sedlmeier P . What Is Meditation? Prop osing an \nEmpirically Derived Classification System. Front. P sychol. 2019 \nOct;10.  \n42.  Kang Y, Gray JR, Dovidio JF. The nondiscrimina ting heart: \nLovingkindness meditation training decreases implic it intergroup \nbias. J. Exp. Psychol. Gen. 2014 Jun;143(3):1306\u201313 .  \n43.  Lee C, Crawford C, Hickey A. Mind\u2013Body Therapi es for the Self-\nManagement of Chronic Pain Symptoms. Pain Med. 2014  \nApr;15(S1):S21\u201339.  \n44.  Sieczkowska SM, Casagrande P de O, Coimbra DR,  Vilarino GT, \nAndreato LV, Andrade A. Effect of yoga on the quali ty of life of \npatients with rheumatic diseases: Systematic review  with meta-\nanalysis. Complement. Ther. Med. 2019 Oct;46:9\u201318.   \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  80 45.  Cramer H, Anheyer D, Saha FJ, Dobos G. Yoga fo r posttraumatic \nstress disorder \u2013 a systematic review and meta-anal ysis. BMC \nPsychiatry. 2018 Dec;18(1):72.  \n46.  Wang X, Li P , Pan C, Dai L, Wu Y, Deng Y. The Effect of Mind-\nBody Therapies on Insomnia: A Systematic Review and  Meta-\nAnalysis. Evidence-Based Complement. Altern. Med. 2 019 \nFeb;2019:1\u201317.  \n47.  Nduwimana I, Nindorera F, Thonnard JL, Kossi O . Effectiveness of \nwalking versus mind-body therapies in chronic low b ack pain. \nMedicine (Baltimore). 2020 Aug;99(35):e21969.  \n48.  Sabe M, Sentissi O, Kaiser S. Meditation-based  mind-body \ntherapies for negative symptoms of schizophrenia: S ystematic \nreview of randomized controlled trials and meta-ana lysis. \nSchizophr. Res. 2019 Oct;212:15\u201325.  \n49.  Strickhouser JE, Zell E, Krizan Z. Does person ality predict health \nand well-being? A metasynthesis. Heal. Psychol. 201 7 \nAug;36(8):797\u2013810.  \n50.  Hodes GE, Pfau ML, Leboeuf M, Golden SA, Chris toffel DJ, \nBregman D, et al. Individual differences in the per ipheral immune \nsystem promote resilience versus susceptibility to social stress. \nProc. Natl. Acad. Sci. 2014 Nov;111(45):16136\u201341.  \n51.  Galante J, Galante I, Bekkers M-J, Gallacher J . Effect of \nkindness-based meditation on health and well-being:  A \nsystematic review and meta-analysis. J. Consult. Cl in. Psychol. \n2014 Dec;82(6):1101\u201314.  \n52.  Hartley L, Mavrodaris A, Flowers N, Ernst E, R ees K. \nTranscendental meditation for the primary preventio n of \ncardiovascular disease. Cochrane Database Syst. Rev . 2017 Nov; \n53.  de F\u00e1tima Rosas Marchiori M, Kozasa EH, Mirand a RD, Monezi \nAndrade AL, Perrotti TC, Leite JR. Decrease in bloo d pressure \nand improved psychological aspects through meditati on training \nin hypertensive older adults: A randomized control study. Geriatr. \nGerontol. Int. 2014 Oct;15(10):1158\u201364.  \n54.  Pu\u00f1al-Riob\u00f3o J, Ba\u00f1os \u00c1lvarez E, Varela Lema L , Castillo Mu\u00f1oz \nM, Atienza Merino G, Ubago P\u00e9rez R, et al. Gu\u00eda par a la \nelaboraci\u00f3n y adaptaci\u00f3n de informes r\u00e1pidos de eva luaci\u00f3n de \ntecnolog\u00edas sanitarias. Red Espa\u00f1ola de Agencias de  Evaluaci\u00f3n \nde Tecnolog\u00edas y Prestaciones del SNS. Agencia Gall ega para la \nGesti\u00f3n del Conocimiento en Salud. Unidad de Asesor amiento \nCient\u00edfico-T\u00e9cnico, avalia-t. Madrid: Ministerio de  Sanidad, \nServicios Sociales e Igualdad; 2016.  \n55.  Higgins J, Green S, editors. Cochrane Handbook  for Systematic  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 81 Reviews of Interventions. Version 5.1.0 [updated Ma rch 2011]. \nThe Cochrane Collaboration; 2011.  \n56.  Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C,  Moran J, et al. \nAMSTAR 2: a critical appraisal tool for systematic reviews that \ninclude randomised or non-randomised studies of hea lthcare \ninterventions, or both. BMJ. 2017 Sep;358:j4008.  \n57.  Sterne J, Savovi \u0107 J, Page M, Elbers R, Blencowe N, Boutron I, et \nal. RoB 2: a revised tool for assessing risk of bia s in randomised \ntrials. BMJ. 2019; \n58.  Deeks JJ, Altman DG, Bradburn MJ. Statistical Methods for \nExamining Heterogeneity and Combining Results from S everal \nStudies in Meta-Analysis. In: Systematic Reviews in  Health Care. \nLondon, UK: BMJ Publishing Group; 2001. p. 285\u2013312.  \n59.  Orme-Johnson DW, Barnes VA. Effects of the Tra nscendental \nMeditation Technique on Trait Anxiety: A Meta-Analys is of \nRandomized Controlled Trials. J. Altern. Complement . Med. 2014 \nMay;20(5):330\u201341.  \n60.  Gathright EC, Salmoirago-Blotcher E, DeCosta J , Balletto BL, \nDonahue ML, Feulner MM, et al. The impact of transc endental \nmeditation on depressive symptoms and blood pressur e in adults \nwith cardiovascular disease: A systematic review an d meta-\nanalysis. Complement. Ther. Med. 2019 Oct;46:172\u20139.   \n61.  Alexander CN, Langer EJ, Newman RI, Chandler HM , Davies JL. \nTranscendental Meditation, mindfulness, and longevi ty: An \nexperimental study with the elderly. J. Pers. Soc. P sychol. \n1989;57(6):950\u201364.  \n62.  Anderson VL, Levinson EM, Barker W, Kiewra KR.  The effects of \nmeditation on teacher perceived occupational stress , state and \ntrait anxiety, and burnout. Sch. Psychol. Q. 1999;14 (1):3\u201325.  \n63.  Barnes VA, Kapuku GK, Treiber FA. Impact of Tr anscendental \nMeditation on Left Ventricular Mass in African Amer ican \nAdolescents. Evidence-Based Complement. Altern. Med . \n2012;2012:1\u20136.  \n64.  Basso JC, McHale A, Ende V, Oberlin DJ, Suzuki  WA. Brief, daily \nmeditation enhances attention, memory, mood, and em otional \nregulation in non-experienced meditators. Behav. Br ain Res. 2019 \nJan;356:208\u201320.  \n65.  Beiranvand S, Noparast M, Eslamizade N, Saeedi kia S. The \neffects of religion and spirituality on postoperati ve pain, \nhemodynamic functioning and anxiety after cesarean s ection. \nActa Med. Iran. 2014;52(12):909\u201315.   \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  82 66.  Bokhari S, Schneider RH, Salerno JW, Rainforth  M V., Gaylord-\nKing C, Nidich SI. Effects of cardiac rehabilitatio n with and \nwithout meditation on myocardial blood flow using q uantitative \npositron emission tomography: A pilot study. J. Nuc l. Cardiol. \n2019 Sep; \n67.  Bormann JE, Gifford AL, Shively M, Smith TL, R edwine L, Kelly A, \net al. Effects of Spiritual Mantram Repetition on H IV Outcomes: A \nRandomized Controlled Trial. J. Behav. Med. 2006 Au g;29(4):359\u2013\n76.  \n68.  Bormann JE, Thorp SR, Wetherell JL, Golshan S,  Lang AJ. \nMeditation-based mantram intervention for veterans with \nposttraumatic stress disorder: A randomized trial. Psychol. \nTrauma Theory, Res. Pract. Policy. 2013 May;5(3):25 9\u201367.  \n69.  Bormann JE, Thorp SR, Smith E, Glickman M, Bec k D, Plumb D, \net al. Individual Treatment of Posttraumatic Stress  Disorder Using \nMantram Repetition: A Randomized Clinical Trial. Am . J. \nPsychiatry. 2018 Oct;175(10):979\u201388.  \n70.  Boswell PC, Murray EJ. Effects of meditation o n psychological \nand physiological measures of anxiety. J. Consult. C lin. Psychol. \n1979;47(3):606\u20137.  \n71.  Brito-Pons G, Campos D, Cebolla A. Implicit or  Explicit \nCompassion? Effects of Compassion Cultivation Train ing and \nComparison with Mindfulness-based Stress Reduction.  \nMindfulness (N. Y). 2018 Oct;9(5):1494\u2013508.  \n72.  Brooks JS, Scarano T. Transcendental Meditatio n in the \nTreatment of Post-Vietnam Adjustment. J. Couns. Dev . 1985 \nNov;64(3):212\u20135.  \n73.  Carson JW, Keefe FJ, Lynch TR, Carson KM, Goli  V, Fras AM, et \nal. Loving-Kindness Meditation for Chronic Low Back  Pain. J. \nHolist. Nurs. 2005 Sep;23(3):287\u2013304.  \n74.  Castillo-Richmond A, Schneider RH, Alexander CN , Cook R, \nMyers H, Nidich S, et al. Effects of Stress Reducti on on Carotid \nAtherosclerosis in Hypertensive African Americans. Stroke. 2000 \nMar;31(3):568\u201373.  \n75.  Chandler J, Sox L, Diaz V, Kellam K, Neely A, N emeth L, et al. \nImpact of 12-Month Smartphone Breathing Meditation Program \nupon Systolic Blood Pressure among Non-Medicated St age 1 \nHypertensive Adults. Int. J. Environ. Res. Public H ealth. 2020 \nMar;17(6):1955.  \n76.  Chhatre S, Metzger DS, Frank I, Boyer J, Thomp son E, Nidich S, \net al. Effects of behavioral stress reduction Trans cendental \nMeditation intervention in persons with HIV. AIDS C are. 2013  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 83 Oct;25(10):1291\u20137.  \n77.  Chirico F, Sharma M, Zaffina S, Magnavita N. S pirituality and \nPrayer on Teacher Stress and Burnout in an Italian Cohort: A \nPilot, Before-After Controlled Study. Front. Psycho l. 2020 Jan;10.  \n78.  Cole BS, Hopkins CM, Spiegel J, Tisak J, Agarw ala S, Kirkwood \nJM. A randomised clinical trial of the effects of s piritually focused \nmeditation for people with metastatic melanoma. Men t. Health. \nRelig. Cult. 2012 Feb;15(2):161\u201374.  \n79.  Curiati JA, Bocchi E, Freire JO, Arantes AC, B raga M, Garcia Y, et \nal. Meditation Reduces Sympathetic Activation and I mproves the \nQuality of Life in Elderly Patients with Optimally Treated Heart \nFailure: A Prospective Randomized Study. J. Altern.  Complement. \nMed. 2005 Jun;11(3):465\u201372.  \n80.  Dillbeck MC. The effect of the transcendental meditation \ntechnique on anxiety level. J. Clin. Psychol. 1977 O ct;33(4):1076\u2013\n8.  \n81.  Dion LJ, Engen DJ, Lemaine V, Lawson DK, Brock  CG, Thomley \nBS, et al. Massage therapy alone and in combination  with \nmeditation for breast cancer patients undergoing au tologous \ntissue reconstruction: A randomized pilot study. Co mplement. \nTher. Clin. Pract. 2016 May;23:82\u20137.  \n82.  Dunne PJ, Lynch J, Prihodova L, O\u2019Leary C, Gho reyshi A, Basdeo \nSA, et al. Burnout in the emergency department: Ran domized \ncontrolled trial of an attention-based training pro gram. J. Integr. \nMed. 2019 May;17(3):173\u201380.  \n83.  Duraimani S, Schneider RH, Randall OS, Nidich SI, Xu S, Ketete \nM, et al. Effects of Lifestyle Modification on Telo merase Gene \nExpression in Hypertensive Patients: A Pilot Trial o f Stress \nReduction and Health Education Programs in African Americans. \nPLoS One. 2015 Nov;10(11):e0142689.  \n84.  Elder C. Effect of Transcendental Meditation o n Employee Stress, \nDepression, and Burnout: A Randomized Controlled St udy. Perm. \nJ. 2014 Mar;19\u201323.  \n85.  Gagrani M, Faiq MA, Sidhu T, Dada R, Yadav RK,  Sihota R, et al. \nMeditation enhances brain oxygenation, upregulates B DNF and \nimproves quality of life in patients with primary o pen angle \nglaucoma: A randomized controlled trial. Restor. Ne urol. \nNeurosci. 2018 Nov;36(6):741\u201353.  \n86.  Galante J, Bekkers M-J, Mitchell C, Gallacher J. Loving-Kindness \nMeditation Effects on Well-Being and Altruism: A Mi xed-Methods \nOnline RCT. Appl. Psychol. Heal. Well-Being. 2016 N ov;8(3):322\u2013\n50.   \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  84 87.  Gaston L, Crombez J-C, Joly J, Hodgins S, Dumo nt M. Efficacy \nof Imagery and Meditation Techniques in Treating Ps oriasis. \nImagin. Cogn. Pers. 1989 Sep;8(1):25\u201338.  \n88.  Hafner RJ. Psychological treatment of essentia l hypertension: A \ncontrolled comparison of meditation and meditation plus \nbiofeedback. Biofeedback Self. Regul. 1982 Sep;7(3) :305\u201316.  \n89.  Hager JL, Surwit RS. Hypertension self-control  with a portable \nfeedback unit or meditation-relaxation. Biofeedback Self. Regul. \n1978 Sep;3(3):269\u201376.  \n90.  Heide FJ, Wadlington WL, Lundy RM. Hypnotic re sponsivity as a \npredictor of outcome in meditation. Int. J. Clin. E xp. Hypn. 1980 \nOct;28(4):358\u201366.  \n91.  Janyacharoen T, Sirijariyawat K, Nithiatthawan on T, Pamorn P . \nThe effects of meditation on physical performances and quality of \nlife in healthy elderly subjects. J. Clin. Gerontol . Geriatr. 2018 \nJun;9(2):67\u201371.  \n92.  Jayadevappa R, Johnson JC, Bloom BS, Nidich S,  Desai S, \nChhatre S, et al. Effectiveness of transcendental m editation on \nfunctional capacity and quality of life of African Americans with \ncongestive heart failure: a randomized control stud y. Ethn. Dis. \n2007;17(1):72\u20137.  \n93.  Jazaieri H, McGonigal K, Jinpa T, Doty JR, Gro ss JJ, Goldin PR. A \nrandomized controlled trial of compassion cultivati on training: \nEffects on mindfulness, affect, and emotion regulat ion. Motiv. \nEmot. 2013 Feb;38(1):23\u201335.  \n94.  Jeitler M, Brunnhuber S, Meier L, L\u00fcdtke R, B\u00fc ssing A, Kessler C, \net al. Effectiveness of Jyoti Meditation for Patien ts With Chronic \nNeck Pain and Psychological Distress\u2014A Randomized C ontrolled \nClinical Trial. J. Pain. 2015 Jan;16(1):77\u201386.  \n95.  Jong MC, Boers I, van Wietmarschen HA, Tromp E , Busari JO, \nWennekes R, et al. Hypnotherapy or transcendental m editation \nversus progressive muscle relaxation exercises in the  treatment of \nchildren with primary headaches: a multi-centre, pr agmatic, \nrandomised clinical study. Eur. J. Pediatr. 2019 Fe b;178(2):147\u2013\n54.  \n96.  Keefer L, Blanchard EB. The effects of relaxati on response \nmeditation on the symptoms of irritable bowel syndr ome: results \nof a controlled treatment study. Behav. Res. Ther. 2001 \nJul;39(7):801\u201311.  \n97.  Kindlon DJ. Comparison of Use of Meditation an d Rest in \nTreatment of Test Anxiety. Psychol. Rep. 1983 Dec;53 (3):931\u20138.  \n98.  Kirsch I, Henry D. Self-desensitization and me ditation in the  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 85 reduction of public speaking anxiety. J. Consult. Cl in. Psychol. \n1979;47(3):536\u201341.  \n99.  Knabb JJ, Vazquez VE, Garzon FL, Ford KM, Wang  KT, Conner \nKW, et al. Christian meditation for repetitive nega tive thinking: A \nmultisite randomized trial examining the effects of a 4-week \npreventative program. Spiritual. Clin. Pract. 2020 Mar;7(1):34\u201350.  \n100.  Leach MJ, Francis A, Ziaian T. Transcendental  Meditation for the \nimprovement of health and wellbeing in community-dw elling \ndementia caregivers [TRANSCENDENT]: a randomised wa it-list \ncontrolled trial. BMC Complement. Altern. Med. 2015  \nDec;15(1):145.  \n101.  Lee MY, Zaharlick A, Akers D. Impact of Medit ation on Mental \nHealth Outcomes of Female Trauma Survivors of Inter personal \nViolence With Co-Occurring Disorders: A Randomized Controlled \nTrial. J. Interpers. Violence. 2015 Jul;32(14):2139 \u201365.  \n102.  Lehrer PM, Schoicket S, Carrington P , Woolfol k RL. \nPsychophysiological and cognitive responses to stre ssful stimuli \nin subjects practicing progressive relaxation and cl inically \nstandardized meditation. Behav. Res. Ther. 1980;18( 4):293\u2013303.  \n103.  Manocha R, Black D, Sarris J, Stough C. A Ran domized, \nControlled Trial of Meditation for Work Stress, Anxi ety and \nDepressed Mood in Full-Time Workers. Evidence-Based  \nComplement. Altern. Med. 2011;2011:1\u20138.  \n104.  Menezes CB, de Paula Couto MC, Buratto LG, Er thal F, Pereira \nMG, Bizarro L. The Improvement of Emotion and Atten tion \nRegulation after a 6-Week Training of Focused Medit ation: A \nRandomized Controlled Trial. Evidence-Based Complem ent. \nAltern. Med. 2013;2013:1\u201311.  \n105.  Menezes CB, Bizarro L. Effects of a Brief Med itation Training on \nNegative Affect, Trait Anxiety and Concentrated Att ention. Paid. \n(Ribeir\u00e3o Preto). 2015 Dec;25(62):393\u2013401.  \n106.  Michalsen A, Kunz N, Jeitler M, Brunnhuber S,  Meier L, L\u00fcdtke R, \net al. Effectiveness of focused meditation for pati ents with \nchronic low back pain\u2014A randomized controlled clini cal trial. \nComplement. Ther. Med. 2016 Jun;26:79\u201384.  \n107.  Milbury K, Chaoul A, Biegler K, Wangyal T, Sp elman A, Meyers \nCA, et al. Tibetan sound meditation for cognitive d ysfunction: \nresults of a randomized controlled pilot trial. Psy chooncology. \n2013 Oct;22(10):2354\u201363.  \n108.  Murphy TJ, Pagano RR, Marlatt GA. Lifestyle m odification with \nheavy alcohol drinkers: Effects of aerobic exercise and \nmeditation. Addict. Behav. 1986 Jan;11(2):175\u201386.   \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  86 109.  Nanthakwang N, Siviroj P, Matanasarawoot A, S apbamrer R, \nLerttrakarnnon P , Awiphan R. Effectiveness of Deep Breathing \nand Body Scan Meditation Combined with Music to Imp rove \nSleep Quality and Quality of Life in Older Adults. Open Public \nHealth J. 2020 Jun;13(1):232\u20139.  \n110.  Nidich SI, Fields JZ, Rainforth M V., Pomeran tz R, Cella D, \nKristeller J, et al. A Randomized Controlled Trial of the Effects of \nTranscendental Meditation on Quality of Life in Old er Breast \nCancer Patients. Integr. Cancer Ther. 2009 Sep;8(3) :228\u201334.  \n111.  Nidich SI, Rainforth M V., Haaga DAF, Hagelin  J, Salerno JW, \nTravis F, et al. A Randomized Controlled Trial on E ffects of the \nTranscendental Meditation Program on Blood Pressure , \nPsychological Distress, and Coping in Young Adults.  Am. J. \nHypertens. 2009 Dec;22(12):1326\u201331.  \n112.  Nidich S. Reduced Trauma Symptoms and Perceiv ed Stress in \nMale Prison Inmates through the Transcendental Medi tation \nProgram: A Randomized Controlled Trial. Perm. J. 20 16;20(4).  \n113.  Nidich S. Transcendental Meditation and Reduc ed Trauma \nSymptoms in Female Inmates: A Randomized Controlled  Study. \nPerm. J. 2017;21(16).  \n114.  Nidich S, Mills PJ, Rainforth M, Heppner P , S chneider RH, \nRosenthal NE, et al. Non-trauma-focused meditation versus \nexposure therapy in veterans with post-traumatic str ess disorder: \na randomised controlled trial. The Lancet Psychiatr y. 2018 \nDec;5(12):975\u201386.  \n115.  Oman D, Hedberg J, Thoresen CE. Passage medit ation reduces \nperceived stress in health professionals: A randomi zed, controlled \ntrial. J. Consult. Clin. Psychol. 2006;74(4):714\u20139.   \n116.  Ottens AJ. The effect of transcendental medit ation upon \nmodifying the cigarette smoking habit. J. Sch. Heal th. 1975 \nDec;45(10):577\u201383.  \n117.  Parker JC, Gilbert GS, Thoreson RW. Reduction  of autonomic \narousal in alcoholics: A comparison of relaxation an d meditation \ntechniques. J. Consult. Clin. Psychol. 1978;46(5):8 79\u201386.  \n118.  Paul-Labrador M, Polk D, Dwyer JH, Velasquez I, Nidich S, \nRainforth M, et al. Effects of a Randomized Control led Trial of \nTranscendental Meditation on Components of the Meta bolic \nSyndrome in Subjects With Coronary Heart Disease. A rch. Intern. \nMed. 2006 Jun;166(11):1218.  \n119.  Puryear HB, Cayce CT, Thurston MA. Anxiety Re duction \nAssociated with Meditation: Home Study. Percept. Mo t. Skills. \n1976 Oct;43(2):527\u201331.   \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 87 120.  Raskin M. Muscle Biofeedback and Transcendent al Meditation. A \ncontrolled evaluation of efficacy in the treatment of chronic \nanxiety. Arch. Gen. Psychiatry. 1980 Jan;37(1):93.  \n121.  Rees B, Travis F, Shapiro D, Chant R. Reducti on in Posttraumatic \nStress Symptoms in Congolese Refugees Practicing \nTranscendental Meditation. J. Trauma. Stress. 2013 \nApr;26(2):295\u20138.  \n122.  Schneider RH, Staggers F, Alexander CN, Sheppa rd W, Rainforth \nM, Kondwani K, et al. A Randomized Controlled Trial  of Stress \nReduction for Hypertension in Older African America ns. \nHypertension. 1995 Nov;26(5):820\u20137.  \n123.  Alexander CN, Schneider RH, Staggers F, Sheppa rd W, \nClayborne BM, Rainforth M, et al. Trial of Stress R eduction for \nHypertension in Older African Americans. Hypertensi on. 1996 \nAug;28(2):228\u201337.  \n124.  Schneider R, Alexander C, Staggers F, Orme-Joh nson D, \nRainforth M, Salerno, J, et al. A randomized contro lled trial of \nstress reduction in African Americans treated for h ypertension for \nover one year. Am. J. Hypertens. 2005 Jan;18(1):88\u2013 98.  \n125.  Schneider RH, Grim CE, Rainforth M V., Kotche n T, Nidich SI, \nGaylord-King C, et al. Stress Reduction in the Seco ndary \nPrevention of Cardiovascular Disease. Circ. Cardiov asc. Qual. \nOutcomes. 2012 Nov;5(6):750\u20138.  \n126.  Seer P , Raeburn JM. Meditation training and e ssential \nhypertension: A methodological study. J. Behav. Med . 1980 \nMar;3(1):59\u201371.  \n127.  Severtsen B, Bruya MA. Effects of Meditation and Aerobic \nExercise on EEG Patterns. J. Neurosci. Nurs. 1986 \nAug;18(4):206\u201310.  \n128.  Shahar B, Szepsenwol O, Zilcha-Mano S, Haim N , Zamir O, Levi-\nYeshuvi S, et al. A Wait-List Randomized Controlled  Trial of \nLoving-Kindness Meditation Programme for Self-Criti cism. Clin. \nPsychol. Psychother. 2014 Jul;22(4):346\u201356.  \n129.  Sheppard WD, Staggers FJ, John L. The effects  of a stress \nmanagement program in a high security government ag ency. \nAnxiety, Stress. Coping. 1997 Jan;10(4):341\u201350.  \n130.  So K, Orme-Johnson DW. Three randomized experi ments on the \nlongitudinal effects of the Transcendental Meditati on technique \non cognition. Intelligence. 2001 Oct;29(5):419\u201340.  \n131.  Tuab E, Steiner SS, Weingarten E, Walton KG. Effectiveness of \nBroad Spectrum Approaches to Relapse Prevention in Severe  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  88 Alcoholism: Alcohol. Treat. Q. 1994 Oct;11(1\u20132):187 \u2013220.  \n132.  Travis F, Valosek L, Konrad A, Link J, Salern o J, Scheller R, et al. \nEffect of meditation on psychological distress and brain \nfunctioning: A randomized controlled study. Brain C ogn. 2018 \nAug;125:100\u20135.  \n133.  Vaccarino V, Kondwani KA, Kelley ME, Murrah N  V., Boyd L, \nAhmed Y, et al. Effect of Meditation on Endothelial  Function in \nBlack Americans With Metabolic Syndrome. Psychosom.  Med. \n2013 Jul;75(6):591\u20139.  \n134.  Vasudev A, Arena A, Burhan AM, Ionson E, Hirj ee H, Maldeniya P , \net al. A training programme involving automatic sel f-transcending \nmeditation in late-life depression: preliminary ana lysis of an \nongoing randomised controlled trial. BJPsych Open. 2016 \nMar;2(2):195\u20138.  \n135.  Ionson E, Limbachia J, Rej S, Puka K, Newman RI, Wetmore S, et \nal. Effects of Sahaj Samadhi meditation on heart ra te variability \nand depressive symptoms in patients with late-life depression. Br. \nJ. Psychiatry. 2019 Apr;214(4):218\u201324.  \n136.  Wachholtz AB, Pargament KI. Is Spirituality a  Critical Ingredient of \nMeditation? Comparing the Effects of Spiritual Medi tation, \nSecular Meditation, and Relaxation on Spiritual, Psy chological, \nCardiac, and Pain Outcomes. J. Behav. Med. 2005 \nAug;28(4):369\u201384.  \n137.  Wachholtz AB, Pargament KI. Migraines and med itation: does \nspirituality matter? J. Behav. Med. 2008 Aug;31(4): 351\u201366.  \n138.  Weibel DT, McClintock AS, Anderson T. Does Lo ving-Kindness \nMeditation Reduce Anxiety? Results from a Randomize d \nControlled Trial. Mindfulness (N. Y). 2016 Jun;8(3) :565\u201371.  \n139.  Williams A-L, Selwyn PA, Liberti L, Molde S, Njike VY, McCorkle \nR, et al. A Randomized Controlled Trial of Meditati on and \nMassage Effects on Quality of Life in People with L ate-Stage \nDisease: A Pilot Study. J. Palliat. Med. 2005 Oct;8 (5):939\u201352.  \n140.  Wilson AF, Honsberger R, Chiu JT, Novey HS. T ranscendental \nMeditation and Asthma. Respiration. 1975;32(1):74\u20138 0.  \n141.  Wolf DB, Abell N. Examining the Effects of Med itation Techniques \non Psychosocial Functioning. Res. Soc. Work Pract. 2003 \nJan;13(1):27\u201342.  \n142.  Wren AA, Shelby RA, Soo MS, Huysmans Z, Jaros z JA, Keefe FJ. \nPreliminary efficacy of a lovingkindness meditation  intervention \nfor patients undergoing biopsy and breast cancer su rgery: A \nrandomized controlled pilot study. Support. Care Ca ncer. 2019 \nSep;27(9):3583\u201392.   \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 89 143.  Wu BWY, Gao J, Leung HK, Sik HH. A Randomized  Controlled \nTrial of Awareness Training Program (ATP), a Group- Based \nMahayana Buddhist Intervention. Mindfulness (N. Y).  2019 \nJul;10(7):1280\u201393.  \n144.  Yang K-P , Su W-M, Huang C-K. The Effect of Me ditation on \nPhysical and Mental Health in Junior College Studen ts. J. Nurs. \nRes. 2009 Dec;17(4):261\u20139.  \n145.  Zuroff DC, Schwarz JC. Effects of transcenden tal meditation and \nmuscle relaxation on trait anxiety, maladjustment, l ocus of \ncontrol, and drug use. J. Consult. Clin. Psychol. 1 978;46(2):264\u2013\n71.  \n146.  Bormann JE, Thorp S, Wetherell JL, Golshan S.  A Spiritually \nBased Group Intervention for Combat Veterans With \nPosttraumatic Stress Disorder. J. Holist. Nurs. 200 8 \nJun;26(2):109\u201316.  \n147.  Heffner KL, Crean HF, Kemp JE. Meditation pro grams for \nveterans with posttraumatic stress disorder: Aggreg ate findings \nfrom a multi-site evaluation. Psychol. Trauma Theor y, Res. Pract. \nPolicy. 2016 May;8(3):365\u201374.  \n148.  Kirkland K, Hollandsworth JG. Effective test taking: Skills-\nacquisition versus anxiety-reduction techniques. J. Consult. Clin. \nPsychol. 1980;48(4):431\u20139.  \n149.  Lutz A, Jha AP , Dunne JD, Saron CD. Investiga ting the \nphenomenological matrix of mindfulness-related pract ices from a \nneurocognitive perspective. Am. Psychol. 2015 Oct;7 0(7):632\u201358.  \n150.  Norman GR, Sloan JA, Wyrwich KW. Interpretati on of Changes in \nHealth-related Quality of Life. Med. Care. 2003 May ;41(5):582\u201392.  \n151.  Burke A, Lam CN, Stussman B, Yang H. Prevalen ce and patterns \nof use of mantra, mindfulness and spiritual meditat ion among \nadults in the United States. BMC Complement. Altern . Med. 2017 \nDec;17(1):316.  \n152.  Burke A. Comparing Individual Preferences for  Four Meditation \nTechniques: Zen, Vipassana (Mindfulness), Qigong, a nd Mantra. \nEXPLORE. 2012 Jul;8(4):237\u201342.  \n153.  Cebolla A, Demarzo M, Martins P , Soler J, Gar cia-Campayo J. \nUnwanted effects: Is there a negative side of medit ation? A \nmulticentre survey. PLoS One. 2017 Sep;12(9):e01831 37.  \n154.  Britton WB. Can mindfulness be too much of a good thing? The \nvalue of a middle way. Curr. Opin. Psychol. 2019 Au g;28:159\u201365.  \n155.  Schlosser M, Sparby T, V\u00f6r\u00f6s S, Jones R, Marc hant NL. \nUnpleasant meditation-related experiences in regula r meditators:  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  90 Prevalence, predictors, and conceptual consideratio ns. PLoS \nOne. 2019 May;14(5):e0216643.   \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 91 Anexos \nAnexo Anexo Anexo Anexo 11 11. Informaci\u00f3n . Informaci\u00f3n . Informaci\u00f3n . Informaci\u00f3n adicional adicional adicional adicional     \n1. Meditaci\u00f3n basada en la atenci\u00f3n focalizada \n \nLas pr\u00e1cticas de atenci\u00f3n focalizada tienen como ob jetivo desarrollar \nespecialmente la habilidad de enfocar la atenci\u00f3n d e manera \nimperturbable en un elemento espec\u00edfico, ya sea en la respiraci\u00f3n, en \nuna emoci\u00f3n, en un mantra, en una imagen, en un son ido o en una idea \nconcreta [1,2], favoreciendo la concentraci\u00f3n y la metaconciencia [3,4].  \nAlgunos ejemplos de meditaci\u00f3n de atenci\u00f3n focaliza da es la \nmeditaci\u00f3n con observaci\u00f3n de la llamas de velas (d el ingl\u00e9s, Jyoti \nmeditation ) o las meditaciones centradas en la respiraci\u00f3n, e ntendiendo \nla meditaci\u00f3n en este \u00faltimo caso como la pr\u00e1ctica de mantener la \natenci\u00f3n focalizada en la inspiraci\u00f3n y espiraci\u00f3n [5] y no como un \nelemento espec\u00edfico de otras t\u00e9cnicas que han demos trado cierta \nefectividad para tratar diversas afecciones como el  m\u00e9todo Buteyko \npara el asma [6] o la respiraci\u00f3n diafragm\u00e1tica par a el control de la \nansiedad [7]. \nAlgunas t\u00e9cnicas de meditaci\u00f3n cl\u00e1sicamente incluid as en alguna \nde esas categor\u00edas anteriormente mencionadas han ad quirido entidad \npropia, como es el caso de la meditaci\u00f3n basada en mantras (del ingl\u00e9s, \nmantra-based meditation ), que a menudo se clasifica como un estilo de \natenci\u00f3n focalizada, pero que presenta algunas cara cter\u00edsticas \ndiferenciales que han llevado a algunos autores a c onsiderarla un tipo de \nmeditaci\u00f3n en s\u00ed misma [8]. \nEn este sentido, la meditaci\u00f3n basada en la repetic i\u00f3n de mantras \nse diferencia de la atenci\u00f3n focalizada en que el o bjeto de atenci\u00f3n es \nuna producci\u00f3n verbal-motora voluntaria, en lugar d e sensaciones \ncorporales que surgen de manera natural (como la re spiraci\u00f3n) u objetos \nf\u00edsicos externos (como un objeto o un punto en el es pacio sobre el que \nse enfoca la mirada) [8]. Teniendo en cuenta estas diferencias, la \nmeditaci\u00f3n basada en la repetici\u00f3n de mantras podr\u00ed a considerarse \ncomo un tipo \u00fanico de meditaci\u00f3n [9]. \n \n  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  92 2. Meditaci\u00f3n basada en la repetici\u00f3n de mantras \n \nLa meditaci\u00f3n basada en mantras generalmente implic a la repetici\u00f3n \ncontinua de una palabra, frase o conjunto de s\u00edlaba s (en silencio o en \nvoz alta) con contenido religioso-espiritual o no. Se ha planteado que el \nsonido o mantra en la meditaci\u00f3n act\u00faa como un veh\u00ed culo eficaz para \nanular el habla mental (que es la forma predominant e de pensamiento \nconsciente para la mayor\u00eda de las personas), rediri giendo continuamente \nlos pensamientos autom\u00e1ticos negativos o intrusivos  que perpet\u00faan la \nangustia [10].   \nSi bien la meditaci\u00f3n basada en mantras generalment e se ha \ncategorizado como un tipo de meditaci\u00f3n de atenci\u00f3n  focalizada, hay \nautores que sugieren que la repetici\u00f3n de un sonido , una palabra o una \noraci\u00f3n hace que la meditaci\u00f3n basada en mantras se a \u00fanica al existir \nuna producci\u00f3n ling\u00fc\u00edstica (verbal-motora voluntari a), en lugar de la \nproducci\u00f3n corporal natural de sensaciones (como la  respiraci\u00f3n) o el \nenfoque hacia objetos f\u00edsicos externos [8]. \nExisten varios subtipos de meditaci\u00f3n con mantras, c omo la \nmeditaci\u00f3n con Sri Yantra (focalizaci\u00f3n en un mantr a visual con forma \ngeom\u00e9trica), la meditaci\u00f3n ACEM, la Meditaci\u00f3n Cl\u00edn icamente \nEstandarizada y la Meditaci\u00f3n Trascendental, entre otras [10\u201312]: \n\u2022 Meditaci\u00f3n Trascendental (MT) : repetici\u00f3n de mantras sin \nsignificado religioso que busca asentar la mente en  niveles m\u00e1s \ntranquilos de pensamiento hasta alcanzar un estado silencioso de \nconciencia trascendental [13]. Algunos autores defi enden la \nnecesidad de diferenciar la Meditaci\u00f3n Trascendenta l del resto de \nmeditaciones basadas en mantras puesto que, a pesar  de hacer uso \nde ellos, permite al individuo alcanzar un estado s uperior de \nautoconciencia en el que poco a poco el mantra se v uelve una \nexperiencia secundaria hasta su desaparici\u00f3n [8,14\u20131 6]. Sin \nembargo, tanto las pr\u00e1cticas basadas en mantras com o la MT se \nbasan, en definitiva, en el mismo principio fundame ntal de repetici\u00f3n \nde una palabra o frase para provocar una respuesta de relajaci\u00f3n, por \nlo que podr\u00edan abordarse de forma conjunta [10]. \n\u2022 Meditaci\u00f3n ACEM : repetici\u00f3n mental de un mantra, que se \ndenomina \"sonido de meditaci\u00f3n\". Es una meditaci\u00f3n r\u00edtmica y sin \nconexi\u00f3n con la respiraci\u00f3n, que requiere s\u00f3lo un es fuerzo m\u00ednimo \npara mantener un enfoque relajado de atenci\u00f3n en el  sonido de la \nmeditaci\u00f3n, induciendo una actitud mental libre en la que los \npensamientos y sensaciones espont\u00e1neos pueden apare cer y \ndesaparecer sin ning\u00fan control o participaci\u00f3n espe cial de la persona  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 93 [17]. \n\u2022 Meditaci\u00f3n Cl\u00ednicamente Estandarizada : es una versi\u00f3n \noccidentalizada de una t\u00e9cnica de meditaci\u00f3n concen trativa basada \nen mantra, similar a la meditaci\u00f3n trascendental, d onde la atenci\u00f3n \nes dirigida a un mantra s\u00e1nscrito u otro elegido in dividualmente por la \npersona [18]. \n \n3. Meditaci\u00f3n basada en la conciencia o monitoreo a bierto \n \nLa pr\u00e1ctica de monitoreo abierto generalmente comie nza enfocando la \natenci\u00f3n sobre el momento presente y observando imp arcialmente los \ncontenidos mentales (pensamientos, emociones, sensa ciones, etc.) a \nmedida que ocurren y disminuyen de forma natural [9 ]. En este tipo de \nmeditaci\u00f3n, las habilidades de monitoreo se transfo rman en un estado \nde conciencia reflexiva con un amplio alcance de ate nci\u00f3n, pero sin \nenfocarse en un objeto espec\u00edfico [4,19]. La medita ci\u00f3n de monitoreo \nabierto tambi\u00e9n se centra en el cultivo de la metac onciencia, esto es, el \nproceso de aumentar la conciencia sobre los proceso s f\u00edsicos y \naurorreferenciales, pero no implica la selecci\u00f3n de  un objeto espec\u00edfico \nsobre el que orientar la atenci\u00f3n [20]. En estas pr \u00e1cticas de meditaci\u00f3n \nse busca que las personas que la practican intenten  expandir su alcance \natencional para incorporar a la conciencia el flujo  de percepciones, \npensamientos, emociones y/o conciencia subjetiva [3 ,4,21]. La \nmeditaci\u00f3n Vipassana, tambi\u00e9n conocida como Mindfulness  [5], as\u00ed \ncomo los elementos introspectivos de la meditaci\u00f3n Zazen (o meditaci\u00f3n \nZen) y el Shinkataza (simplemente sentado) de la Es cuela Soto Zen [5], \nson ejemplos de meditaci\u00f3n de monitorio abierto.  \nEl uso del Mindfulness  ha demostrado una efectividad terap\u00e9utica \nequivalente al tratamiento de primera l\u00ednea para al gunas enfermedades \nmentales, como el trastorno de ansiedad generalizad a [22], la ansiedad \nsocial [23] y la depresi\u00f3n [24,25], as\u00ed como en su prevenci\u00f3n [26,27]. \nSeg\u00fan la gu\u00eda de pr\u00e1ctica cl\u00ednica del NICE para el tratamiento de la \ndepresi\u00f3n, la terapia cognitiva basada en Mindfulness  (MBCT) est\u00e1 \nindicada en el tratamiento de personas con antecede ntes de depresi\u00f3n \nque actualmente se encuentren sin s\u00edntomas pero que  se consideran en \nriesgo de reca\u00edda a pesar de tomar medicamentos ant idepresivos, o \naquellos que no pueden continuar o eligen no contin uar con la \nmedicaci\u00f3n antidepresiva, as\u00ed como para las persona s que han tenido \nun tratamiento previo para la depresi\u00f3n pero que co ntin\u00faan teniendo \ns\u00edntomas depresivos residuales. El objetivo de la M BCT consiste en \npermitir que las personas aprendan a ser m\u00e1s consci entes de las  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  94 sensaciones corporales y los pensamientos y sentimi entos asociados \ncon la reca\u00edda depresiva. Est\u00e1 estructurada en un p rograma de \nentrenamiento (normalmente de 8 sesiones semanales de 2 horas y 4 \nsesiones de seguimiento en los 12 meses posteriores  al final del \ntratamiento) que utiliza t\u00e9cnicas extra\u00eddas de la me ditaci\u00f3n Vipassana y \nla terapia cognitiva dise\u00f1adas espec\u00edficamente para  prevenir la reca\u00edda o \nla recurrencia de la depresi\u00f3n [28, 29]. En el plan o de las enfermedades \nf\u00edsicas tambi\u00e9n se encuentra literatura cient\u00edfica v\u00e1lida que avala la \nefectividad del Mindfulness  en la mejora de la salud psicol\u00f3gica de \npersonas con afecciones como el c\u00e1ncer [30\u201332], enf ermedades \ncardiovasculares [33], dolor cr\u00f3nico [34,35] y escl erosis m\u00faltiple [36,37], \nentre otras. Este resultado beneficioso del Mindfulness  sobre la salud \nvendr\u00eda dado por el efecto de variables psicol\u00f3gica s como la \nreevaluaci\u00f3n positiva de eventos estresantes y otro s est\u00edmulos negativos \n[38]. Las intervenciones de la tercera generaci\u00f3n p resentan algunos \nefectos beneficiosos en pacientes con trastornos ps ic\u00f3ticos, pudiendo \nser un tratamiento \u00fatil y seguro como coadyuvante a  la farmacoterapia, \naunque su evidencia es limitada. Un reciente inform e de ETS realizado \nbajo el marco de la RedETS sobre la eficacia de las  terapias de tercera \ngeneraci\u00f3n en personas con trastorno mental grave c oncluy\u00f3 que la \nevidencia disponible respalda el uso de psicoeducac i\u00f3n basada en \nMindfulness en pacientes con trastornos psic\u00f3ticos, mejorando l a salud \npsicosocial y el funcionamiento a corto y medio pla zo (postratamiento y \n6-12 meses tras la intervenci\u00f3n); sin embargo, la e videncia a largo plazo \n(m\u00e1s all\u00e1 de 12 meses) es insuficiente para recomen dar su uso \ngeneralizado en pacientes con psicosis espec\u00edficame nte en Espa\u00f1a [39]. \nPor otra parte, la investigaci\u00f3n en el campo de la neuroimagen ha \nmostrado que el Mindfulness  produce cambios significativos en los \npatrones de actividad cerebral, aunque a\u00fan se est\u00e1 lejos de lograr una \nintegraci\u00f3n te\u00f3rica que explique estos efectos [5,3 9\u201341].  \n \n4. Meditaci\u00f3n basada en el amor, bondad y la compas i\u00f3n \n \nLas pr\u00e1cticas de meditaci\u00f3n basada en la bondad (de l ingl\u00e9s, Kindness-\nbased meditation ) implican principalmente la generaci\u00f3n y el cultiv o de \nla compasi\u00f3n de forma que se redirijan los patrones  cognitivos, \nconductuales y afectivos autorreferenciales hacia t endencias y \npensamientos que involucren el bienestar propio y/o  el de los dem\u00e1s \n[3,42].  \nA diferencia de los tipos de meditaci\u00f3n anteriores,  en los que la \natenci\u00f3n se dirig\u00eda, sin juicio ni intervenci\u00f3n, a objetos, mantras o el \npropio flujo de pensamientos, emociones y sensacion es, en las  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 95 pr\u00e1cticas basadas en el amor, la bondad y la compas i\u00f3n los esfuerzos \nse dirigen a manipular directamente el contenido de  los pensamientos y \nlas emociones [3,43]. En cierto modo, las pr\u00e1cticas  basadas en el amor y \nla compasi\u00f3n tambi\u00e9n podr\u00edan considerarse una forma  de atenci\u00f3n \nfocalizada, ya que las personas que la practican a menudo se enfocan \nen un solo objeto, la persona objetivo de la bondad  amorosa, para \ncultivar un tono emocional consistente. Sin embargo , dado el fuerte \n\u00e9nfasis en el cultivo deliberado de emociones alegr es, altruistas y \nemp\u00e1ticas, bastante exclusivo de estas pr\u00e1cticas ant eriores, parece \nexistir suficiente justificaci\u00f3n para considerarlas como un tipo de \nmeditaci\u00f3n en s\u00ed misma [9].  \nAlgunos ejemplos son la Meditaci\u00f3n Tonglen (centrad a en conectar \ncon el sufrimiento interior para poder superarlo), la Meditaci\u00f3n basada \nen la bondad y amor (LKM- del ingl\u00e9s, Loving-kindness meditation ) y la \nMeditaci\u00f3n de Compasi\u00f3n (del ingl\u00e9s, Compassion meditation ) [44]. \nEstas dos \u00faltimas han sido com\u00fanmente incluidas en programas \ndestinados a mejorar la salud y el bienestar [44,45 ]. \n\u2022 Meditaci\u00f3n de la bondad y amor (LKM) : tiene como objetivo \nprofundizar los sentimientos de alegr\u00eda, bienestar y felicidad para \ntodos los seres vivos, as\u00ed como promover comportami entos \naltruistas [9]. Est\u00e1 estrechamente relacionada con la Meditaci\u00f3n \nde la Compasi\u00f3n, pero no son id\u00e9nticas, ya que esta  \u00faltima \nimplica t\u00e9cnicas para cultivar la compasi\u00f3n por qui enes est\u00e1n \nafectados por una desgracia y se enfoca en el alivi o de ese \nsufrimiento; es decir, la meditaci\u00f3n de la compasi\u00f3 n es una forma \nespecial de meditaci\u00f3n de la bondad amorosa en la q ue la \nbondad se dirige hacia quienes sufren [46,47]. Los ejercicios de la \nLKM consisten en involucrar un aspecto particular d e uno mismo, \npero de una manera consciente en lugar de anal\u00edtica  o cr\u00edtica [48]. \nTanto la meditaci\u00f3n basada en la bondad y amor como  la \nMeditaci\u00f3n de Compasi\u00f3n difieren sustancialmente de l \nMindfulness , ya que \u00e9ste implica fomentar la conciencia sin \nprejuicios de las experiencias en el momento present e al \nenfocarse en experiencias corporales o sensoriales, estados \nafectivos, pensamientos o im\u00e1genes, mientras que es tos tipos de \nmeditaci\u00f3n basados en el amor y la compasi\u00f3n enfoca n la \nconciencia en el alivio del sufrimiento propio y aj eno [45,49]. \n\u2022 El entrenamiento en el cultivo de la compasi\u00f3n  (del ingl\u00e9s, \nCompassion Cultivation Training ) se trata de un programa \nestructurado con pr\u00e1cticas diarias de meditaci\u00f3n ce ntradas en la \nmeditaci\u00f3n de compasi\u00f3n y la meditaci\u00f3n basada en l a bondad y \namor. desarrollado por un equipo de la Universidad de Stanford  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  96 [51]. \n \nReferencias: \n \n1.  Rose S, Zell E, Strickhouser JE. The Effect of Medi tation on Health: \na Metasynthesis of Randomized Controlled Trials. Mi ndfulness (N. \nY). 2020 Feb 10;11(2):507\u201316.  \n2.  Walsh R. Meditaci\u00f3n. Nat. Medicat. 1996;43:16\u201322.  \n3.  Dahl CJ, Lutz A, Davidson RJ. Reconstructing and de constructing \nthe self: cognitive mechanisms in meditation practi ce. Trends Cogn. \nSci. 2015 Sep;19(9):515\u201323.  \n4.  Lutz A, Slagter HA, Dunne JD, Davidson RJ. Attentio n regulation \nand monitoring in meditation. Trends Cogn. Sci. 200 8 \nApr;12(4):163\u20139.  \n5.  Brandmeyer T, Delorme A, Wahbeh H. The neuroscience  of \nmeditation: classification, phenomenology, correlat es, and \nmechanisms. Prog. Brain Res. 2019;244:1\u201329.  \n6.  Santino TA, Chaves GS, Freitas DA, Fregonezi GA, Me ndon\u00e7a KM. \nBreathing exercises for adults with asthma. Cochrane  Database \nSyst. Rev. 2020 Mar 25;3(3):CD001277.  \n7.  Hopper SI, Murray SL, Ferrara LR, Singleton JK. Eff ectiveness of \ndiaphragmatic breathing for reducing physiological and \npsychological stress in adults. JBI Database Syst. Rev. Implement. \nReports. 2019 Sep;17(9):1855\u201376.  \n8.  Travis F. Transcendental experiences during meditati on practice. \nAnn. N. Y. Acad. Sci. 2014 Jan;1307(1):1\u20138.  \n9.  Fox KCR, Dixon ML, Nijeboer S, Girn M, Floman JL, Lif shitz M, et al. \nFunctional neuroanatomy of meditation: A review and  meta-analysis \nof 78 functional neuroimaging investigations. Neuro sci. Biobehav. \nRev. 2016 Jun;65:208\u201328.  \n10.  Lynch J, Prihodova L, Dunne PJ, Carroll \u00c1, Walsh C,  McMahon G, et \nal. Mantra meditation for mental health in the gene ral population: A \nsystematic review. Eur. J. Integr. Med. 2018 Oct;23 :101\u20138.  \n11.  Ospina MB, Bond K, Karkhaneh M, Buscemi N, Dryden D M, Barnes \nV, et al. Clinical Trials of Meditation Practices i n Health Care: \nCharacteristics and Quality. J. Altern. Complement.  Med. 2008 \nDec;14(10):1199\u2013213.  \n12.  Xu J, Vik A, Groote IR, Lagopoulos J, Holen A, Elli ngsen \u00d8, et al. \nNondirective meditation activates default mode netw ork and areas \nassociated with memory retrieval and emotional proc essing. Front. \nHum. Neurosci. 2014;8.  \n13.  Forem J. Transcedental Meditation: The Essential Te achings of \nMaharishi Mahesh Yogi. New York: Hay House; 2012.  \n14.  Travis F, Shear J. Focused attention, open monitori ng and automatic \nself-transcending: Categories to organize meditatio ns from Vedic,  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 97 Buddhist and Chinese traditions. Conscious. Cogn. 2 010 \nDec;19(4):1110\u20138.  \n15.  Yogi M, Tompkins M. The Science of Being and Art of  Living. \nLondon: International SRM Publications; 1966.  \n16.  Yogi M. Celebrating perfection in education. Mahari shi Vedic; 1997.  \n17.  Davanger S, Ellingsen \u00d8, Holen A, Hugdahl K. Medita tion-Specific \nPrefrontal Cortical Activation during Acem Meditati on: An FMRI \nStudy. Percept. Mot. Skills. 2010 Aug;111(1):291\u201330 6.  \n18.  Lehrer PM, Schoicket S, Carrington P , Woolfolk RL. \nPsychophysiological and cognitive responses to stre ssful stimuli in \nsubjects practicing progressive relaxation and clini cally \nstandardized meditation. Behav. Res. Ther. 1980;18( 4):293\u2013303.  \n19.  Lutz A, Jha AP , Dunne JD, Saron CD. Investigating t he \nphenomenological matrix of mindfulness-related pract ices from a \nneurocognitive perspective. Am. Psychol. 2015 Oct;7 0(7):632\u201358.  \n20.  Flavell JH. Metacognition and cognitive monitoring:  A new area of \ncognitive-developmental inquiry. Am. Psychol. 1979; 34(10):906\u201311.  \n21.  Manna A, Raffone A, Perrucci MG, Nardo D, Ferretti A, Tartaro A, et \nal. Neural correlates of focused attention and cogn itive monitoring \nin meditation. Brain Res. Bull. 2010 Apr;82(1\u20132):46 \u201356.  \n22.  Ghahari S, Mohammadi-Hasel K, Malakouti S, Roshanpa jouh M. \nMindfulness-based Cognitive Therapy for Generalised  Anxiety \nDisorder: a Systematic Review and Meta-analysis. Ea st Asian Arch. \nPsychiatry. 2020 Jun 30;30(2):52\u20136.  \n23.  Goldin PR, Morrison A, Jazaieri H, Brozovich F, Hei mberg R, Gross \nJJ. Group CBT versus MBSR for social anxiety disorde r: A \nrandomized controlled trial. J. Consult. Clin. Psyc hol. 2016 \nMay;84(5):427\u201337.  \n24.  Blanck P, Perleth S, Heidenreich T, Kr\u00f6ger P , Ditze n B, Bents H, et \nal. Effects of mindfulness exercises as stand-alone intervention on \nsymptoms of anxiety and depression: Systematic revie w and meta-\nanalysis. Behav. Res. Ther. 2018 Mar;102:25\u201335.  \n25.  Perestelo-Perez L, Barraca J, Pe\u00f1ate W, Rivero-Sant ana A, Alvarez-\nPerez Y. Mindfulness-based interventions for the tr eatment of \ndepressive rumination: Systematic review and meta-a nalysis. Int. J. \nClin. Heal. Psychol. 2017 Sep;17(3):282\u201395.  \n26.  Khoury B, Sharma M, Rush SE, Fournier C. Mindfulnes s-based \nstress reduction for healthy individuals: A meta-an alysis. J. \nPsychosom. Res. 2015 Jun;78(6):519\u201328.  \n27.  Sharma M, Rush SE. Mindfulness-Based Stress Reducti on as a \nStress Management Intervention for Healthy Individu als. J. Evid. \nBased. Complementary Altern. Med. 2014 Oct 22;19(4) :271\u201386. \n28.  National Institute for Health and Care Excellence (N ICE). Depression \nin adults: recognition and management. Clinical gui deline [CG90];  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  98 2009.  \n29.  National Institute for Health and Care Excellence (N ICE). Common \nmental health problems: identification and pathways  to care. Clinical \nguideline [CG123]; 2011.  \n30.  Xunlin N, Lau Y, Klainin-Yobas P . The effectiveness  of mindfulness-\nbased interventions among cancer patients and survi vors: a \nsystematic review and meta-analysis. Support. Care Cancer. 2020 \nApr 13;28(4):1563\u201378.  \n31.  Cillessen L, Johannsen M, Speckens AEM, Zachariae R . \nMindfulness \u2010based interventions for psychological and physical \nhealth outcomes in cancer patients and survivors: A  systematic \nreview and meta \u2010analysis of randomized controlled trials. \nPsychooncology. 2019 Dec 11;28(12):2257\u201369.  \n32.  Toivonen KI, Zernicke K, Carlson LE. Web-Based Mind fulness \nInterventions for People With Physical Health Condi tions: \nSystematic Review. J. Med. Internet Res. 2017 Aug 3 1;19(8):e303.  \n33.  Scott-Sheldon LAJ, Gathright EC, Donahue ML, Ballet to B, Feulner \nMM, DeCosta J, et al. Mindfulness-Based Interventio ns for Adults \nwith Cardiovascular Disease: A Systematic Review an d Meta-\nAnalysis. Ann. Behav. Med. 2020 Jan 1;54(1):67\u201373.  \n34.  Hilton L, Hempel S, Ewing BA, Apaydin E, Xenakis L,  Newberry S, et \nal. Mindfulness Meditation for Chronic Pain: System atic Review and \nMeta-analysis. Ann. Behav. Med. 2017 Apr 22;51(2):1 99\u2013213.  \n35.  Goldberg SB, Tucker RP , Greene PA, Davidson RJ, Wam pold BE, \nKearney DJ, et al. Mindfulness-based interventions for psychiatric \ndisorders: A systematic review and meta-analysis. C lin. Psychol. \nRev. 2018 Feb;59:52\u201360.  \n36.  Carletto S, Cavalera C, Sadowski I, Rovaris M, Borg hi M, Khoury B, \net al. Mindfulness-Based Interventions for the Impr ovement of Well-\nBeing in People With Multiple Sclerosis: A Systemat ic Review and \nMeta-Analysis. Psychosom. Med. 2020 Jul;82(6):600\u20131 3.  \n37.  Simpson R, Simpson S, Ramparsad N, Lawrence M, Boot h J, \nMercer SW. Effects of Mindfulness-based interventio ns on physical \nsymptoms in people with multiple sclerosis \u2013 a syst ematic review \nand meta-analysis. Mult. Scler. Relat. Disord. 2020  Feb;38:101493.  \n38.  Garland EL, Farb NA, R. Goldin P, Fredrickson BL. M indfulness \nBroadens Awareness and Builds Eudaimonic Meaning: A  Process \nModel of Mindful Positive Emotion Regulation. Psych ol. Inq. 2015 \nOct 2;26(4):293\u2013314.  \n39.  Luengo Gonz\u00e1lez R, Rapado Castro M, Fraguas Herr\u00e1ez  D. Eficacia \nde las terapias de tercera generaci\u00f3n en personas c on trastorno \nmental grave. Madrid. Ministerio de Sanidad, Consum o y Bienestar \nSocial. Unidad de Evaluaci\u00f3n de Tecnolog\u00edas Sanitar ias de la \nComunidad de Madrid. Informes de Evaluaci\u00f3n de Tecn olog\u00edas  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 99 Sanitarias; 2016.  \n40.  Cahn BR, Polich J. Meditation (Vipassana) and the P 3a event-\nrelated brain potential. Int. J. Psychophysiol. 200 9 Apr;72(1):51\u201360.  \n41.  Magalhaes AA, Oliveira L, Pereira MG, Menezes CB. D oes \nMeditation Alter Brain Responses to Negative Stimul i? A Systematic \nReview. Front. Hum. Neurosci. 2018 Nov 13;12.  \n42.  Vignaud P , Donde C, Sadki T, Poulet E, Brunelin J. Neural effects of \nmindfulness-based interventions on patients with ma jor depressive \ndisorder: A systematic review. Neurosci. Biobehav. Rev. 2018 \nMay;88:98\u2013105.  \n43.  Kang Y, Gray JR, Dovidio JF. The nondiscriminating heart: \nLovingkindness meditation training decreases implic it intergroup \nbias. J. Exp. Psychol. Gen. 2014 Jun;143(3):1306\u201313 .  \n44.  Salzberg S. Mindfulness and loving-kindness. Contem p. Buddhism. \n2011 May 1;12(1):177\u201382.  \n45.  Galante J, Galante I, Bekkers M-J, Gallacher J. Eff ect of kindness-\nbased meditation on health and well-being: A system atic review and \nmeta-analysis. J. Consult. Clin. Psychol. 2014 Dec; 82(6):1101\u201314.  \n46.  Hofmann SG, Grossman P , Hinton DE. Loving-kindness and \ncompassion meditation: Potential for psychological interventions. \nClin. Psychol. Rev. 2011 Nov;31(7):1126\u201332.  \n47.  Grossman P , Van Dam NT. Mindfulness, by any other n ame\u2026: trials \nand tribulations of sati in western psychology and science. \nContemp. Buddhism. 2011 May 1;12(1):219\u201339.  \n48.  Graser J, Stangier U. Compassion and Loving-Kindnes s Meditation. \nHarv. Rev. Psychiatry. 2018;26(4):201\u201315.  \n49.  Kristeller, Jean & Johnson, Thomas. (2005). Cultiva ting Loving-\nKindness: A Two-Stage Model for the Effects of Medi tation on \nCompassion, Altruism and Spirituality. \n50.  Jazaieri H, McGonigal K, Jinpa T, Doty JR, Gross JJ , Goldin PR. A \nrandomized controlled trial of compassion cultivati on training: \nEffects on mindfulness, affect, and emotion regulat ion. Motiv. Emot. \n2014 Feb 13;38(1):23\u201335.  \n51.  Salzberg S. Lovingkindness: The revolutionary art o f happiness. \nBoston, MA: Shambhala; 1995.  \n  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  100 Anexo Anexo Anexo Anexo 22 22. Estrategia . Estrategia . Estrategia . Estrategia de b\u00fasqueda de b\u00fasqueda de b\u00fasqueda de b\u00fasqueda     \nMedline (Ovid)  \n1 Meditation/mt [Methods]  776  \n2 meditation*.ti,kw.  2794  \n3 (Kindness -based or Kindness based or Kindnessbased or KBM or \nLoving-kindness or Loving kindness or Lovingkindnes s or \ncompassion* or mind-training* or mind training*).ti . 3621 \n4 ((Kindness -based or Kindness based or Kindnessbased or KBM or \nLoving-kindness or Loving kindness or Lovingkindnes s or \ncompassion* or mind-training* or mind training*) ad j2 (meditation* or \ntherap* or treatment* or intervention* or training* )).ti,ab. 633 \n5 compassion.kw.  526  \n6 (meditation* adj2 (training* or program*)).ti,ab.  525  \n7 ((Focused attention or Mantra or Yantra or Breath o r Transcendental \nor Zazen or Tonglen or Dzogchen or Metta) adj2 (med itation* or \ntherap* or treatment* or intervention* or training* )).ti,ab. 805 \n8 1 or 2 or 3 or 4 or 5 or 6 or 7  7548  \n9 Randomized Controlled Trials as Topic/  136472  \n10  randomized controlled trial/  513797  \n11  Random Allocation/  103651  \n12  Double Blind Method/  159959  \n13  Single Blind Method/  29074  \n14  clinical trial/  524945  \n15  clinical trial, phase i.pt.  20836  \n16  clinical trial, phase ii.pt.  33477  \n17  clinical trial, phase iii.pt.  17255  \n18  clinical trial, phase iv.pt.  1958  \n19  controlled clinical trial.pt.  93856  \n20  randomized controlled trial.pt.  51 3797  \n21  multicenter study.pt.  279680  \n22  clinical trial.pt.  524945  \n23  exp Clinical Trials as topic/  346280  \n24  or/9 -23  1382741  \n25  (clinical adj trial$).tw.  375108  \n26  ((singl$ or doubl$ or treb$ or tripl$) adj (blind$3  or mask$3)).tw.  174589  \n27  PLACEBO S/  35100  \n28  placebo$.tw.  218028  \n29  randomly allocated.tw.  29277  \n30  (allocated adj2 random$).tw.  32606  \n31  or/25 -30  646822  \n32  24 or 31  1656637  \n33  case report.tw.  317230  \n34  letter/  1100384  \n35  historical article/  360289  \n36  or/33 -35  1761749  \n37  32 not 36  1619035  \n38  8 and 37  1207  \n39  systematic$ review$.ti,ab.  184952  \n40  meta -analysis as topic/  18373   \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 101 41  meta -analytic$.ti,ab.  7437  \n42  meta -analysis.ti,ab,pt.  182497  \n43  metanalysis.ti,ab.  265  \n44  metaanalysis.ti,ab.  1623  \n45  meta analysis.ti,ab.  155231  \n46  meta -synthesis.ti,ab.  926  \n47  metasynthesis.ti,ab.  339  \n48  meta synthesis.ti,ab.  926  \n49  meta -regression.ti,ab.  8168  \n50  metaregression.ti,ab.  700  \n51  meta regression.ti,ab.  8168  \n52  (synthes$ adj3 literature).ti,ab.  3719  \n53  (synthes$ adj3 evidence).ti ,ab.  11215  \n54  integrative review.ti,ab.  3192  \n55  data synthesis.ti,ab.  11552  \n56  (research synthesis or narrative synthesis).ti,ab.  3532  \n57  (systematic study or systematic studies).ti,ab.  12372  \n58  (systematic comparison$ or systematic overview$).ti ,ab.  3482  \n59  evidence based review.ti,ab.  2087  \n60  comprehensive review.ti,ab.  15909  \n61  critical review.ti,ab.  16041  \n62  quantitative review.ti,ab.  686  \n63  structured review.ti,ab.  849  \n64  realist review.ti,ab.  328  \n65  realist synthesis.ti,ab.  220  \n66  or/39 -65 364256  \n67  review.pt.  2697398  \n68  medline.ab.  120605  \n69  pubmed.ab.  124240  \n70  cochrane.ab.  87415  \n71  embase.ab.  96429  \n72  cinahl.ab.  28905  \n73  psyc?lit.ab.  917  \n74  psyc?info.ab.  37632  \n75  (literature adj3 search$).ab.  63667  \n76  (database$ adj3 search$). ab.  64119  \n77  (bibliographic adj3 search$).ab.  2716  \n78  (electronic adj3 search$).ab.  23314  \n79  (electronic adj3 database$).ab.  31185  \n80  (computeri?ed adj3 search$).ab.  3607  \n81  (internet adj3 search$).ab.  3389  \n82  included studies.ab.  25735  \n83  (inclusio n adj3 studies).ab.  17335  \n84  inclusion criteria.ab.  90273  \n85  selection criteria.ab.  30827  \n86  predefined criteria.ab.  2012  \n87  predetermined criteria.ab.  1081  \n88  (assess$ adj3 (quality or validity)).ab.  83264  \n89  (select$ adj3 (study or studies)).ab.  69 264  \n90  (data adj3 extract$).ab.  66624  \n91  extracted data.ab.  15038   \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  102 92  (data adj2 abstracted).ab.  5457  \n93  (data adj3 abstraction).ab.  1778  \n94  published intervention$.ab.  188  \n95  ((study or studies) adj2 evaluat$).ab.  192710  \n96  (intervention$ adj2 evalu at$).ab.  11799  \n97  confidence interval$.ab.  429060  \n98  heterogeneity.ab.  171919  \n99  pooled.ab.  93513  \n100  pooling.ab.  12750  \n101  odds ratio$.ab.  279544  \n102  (Jadad or coding).ab.  187567  \n103  or/68 -102  1507948  \n104  67 and 103  250794  \n105  review.ti.  492347  \n106  105 and 103  157864  \n107 (review$ adj4 (papers or trials or studies or evide nce or intervention$ \nor evaluation$)).ti,ab. 194416 \n108  66 or 104 or 106 or 107  601514  \n109  letter.pt.  1100384  \n110  editorial.pt.  542283  \n111  comment.pt.  869662  \n112  109 or 110  or 111  1886585  \n113  108 not 112  587176  \n114  exp animals/ not humans/  4737515  \n115  113 not 114  573168  \n116  8 and 115  409  \n \nEmbase (Elsevier) \n139  #8  AND  #137  567  \n138  #8  AND  #38  1247  \n137  #135  NOT  #136  849177  \n136  'conference abstract':it  3186763  \n135  #133  NOT  #134  816233  \n134 'cochrane database of systematic reviews*':jt OR  'the cochrane \ndatabase of systematic reviews':jt 19732 \n133  #131  NOT  #132  833568  \n132  ('animal'  OR  'nonhuman') NOT  'human'/exp  6061693  \n131  #127  NOT  #130  867037  \n130  #128  OR  #129  160359 4 \n129  'editorial':it  574059  \n128  letter:it  1029535  \n127  #82  OR  #122  OR  #124  OR  #125  OR  #126  883917  \n126 (retriev*  NEAR/10 \n(papers OR trials OR studies OR evidence OR interve ntion* OR eval \nuation* OR outcome* OR findings)):ti,ab 24977 \n125 (review*  NEAR/10 (papers  OR  trials  OR  'trial \ndata' OR studies OR evidence OR intervention* OR ev aluation* OR \noutcome* OR findings)):ti,ab 471317 \n124  #120  AND  #123  134545  \n123  review:ti  470629  \n122  #120  AND  #121  212231   \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 103 121  review:it  2406018  \n120 #83  OR  #84  OR  #85  OR  #86  OR #87  OR  #88  OR  #89  OR  #90  OR  #9 \n1 OR #92 OR #93 OR #94 OR #95 OR #96 OR #97 OR #98 OR #99 \nOR #100 OR #101 OR #102 OR #103 OR #104 OR #105 OR #106 O\nR #107 OR #108 OR #109 OR #110 OR #111 OR #112 OR # 113 OR \n#114 OR #115 OR #116 OR #117 OR #118 OR #119 1711144 \n119  'evidence -based':ti,ab  12133  \n118  jadad:ab OR  coding:ab  191297  \n117  'odds ratio*':ab  286543  \n116  pooling:ab  14084  \n115  pooled:ab  103902  \n114  heterogeneity:ab  179084  \n113  'confidence interval*':ab  420556  \n112  (intervention*  NEAR/2  evaluat*):ab  13426  \n111  ((study  OR  studies) NEAR/2  evaluat*):ab  228343  \n110  'published intervention*':ab  186  \n109  (data  NEAR/2  abstraction):ab  1913  \n108  (data  NEAR/2  abstracted):ab  7688  \n107  'extracted data':ab  15268  \n106  (data  NEAR/3  extract*):ab  69351  \n105  ('select*'  NEAR/ 3 (study  OR  studies)):ab  75318  \n104  ('assess*'  NEAR/3 (quality  OR  validity)):ab  8816  \n103  'predetermined criteria':ab  1189  \n102  'predefined criteria':ab  2281  \n101  'selection criteria':ab  32413  \n100  'inclusion criteria':ab  118072  \n99  ('inclusion'  NEAR/3  'st udies'):ab  15994  \n98  'included studies':ab  22012  \n97  (internet  NEAR/3  search*):ab  3725  \n96  (computeri*ed  NEAR/3  search*):ab  397  \n95  ('electronic'  NEAR/3  'database*'):ab  30557  \n94  ('electronic'  NEAR/3  'search*'):ab  21355  \n93  ('bibliographic'  NEAR/3  'search* '):ab  2483  \n92  ('database*'  NEAR/3  'search*'):ab  59334  \n91  ('literature'  NEAR/3  'search*'):ab  62004  \n90  lilacs:ab  6467  \n89  psyc*info:ab  22035  \n88  psyc*lit:ab  981  \n87  cinahl:ab  24103  \n86  embase:ab  85375  \n85  cochrane:ab  81877  \n84  pubmed:ab  10739  \n83  medline: ab  117904  \n82 #39  OR  #40  OR  #41  OR  #42  OR  #43  OR  #44  OR  #45  OR  #46  OR  #4 \n7 OR #48 OR #49 OR #50 OR #51 OR #52 OR #53 OR #54 OR #55 \nOR #56 OR #57 OR #58 OR #59 OR #60 OR #61 OR #62 OR  #63 O\nR #64 OR #65 OR #66 OR #67 OR #68 OR #69 OR #70 OR #71 OR \n#72 OR #73 OR #74 OR #75 OR #76 OR #77 OR #78 OR #7 9 OR #8 \n0 OR #81 457479 \n81  ('search'  NEAR/1 (strateg*  OR  term*)):ti,ab  32282  \n80  'medline':ti,ab AND (('inclusion'  NEAR/3  'criteria'):ti,ab)  21167  \n79  ('pooled data'  NEAR/6 (studies  OR  trials)):ti,ab  2574  \n78  ('poole d'  NEAR/2  'analysis'):ti,ab  16721   \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  104 77  'realist synthesis':ti,ab  153  \n76  'realist review':ti,ab  226  \n75  'structured review':ti,ab  943  \n74  'quantitative review':ti,ab  693  \n73  'critical analysis':ti,ab  8011  \n72  'critical review':ti,ab  16112  \n71  'comprehensive  review':ti,ab  13949  \n70  ('evidence -based'  NEAR/2  'review'):ti,ab  3289  \n69  ('literature review'  NEAR/2  'adverse event*'):ti,ab  13  \n68  ('literature review'  NEAR/2  'adverse effect*'):ti,ab  3 \n67  ('literature review'  NEAR/2  'side effect*'):ti,ab  16  \n66  (revie w NEAR/3  'scientific literature'):ti,ab  1594  \n65  'systematic* literature research*':ti,ab  267  \n64  (systematic  NEAR/2  search*):ti,ab  25055  \n63  'systematic comparison*':ti,ab OR  'systematic overview*':ti,ab  3155  \n62  'systematic study':ti,ab OR  'systematic st udies':ti,ab  11476  \n61  'research synthesis':ti,ab OR  'narrative synthesis':ti,ab  2367  \n60  'data synthesis':ti,ab  11899  \n59  'integrative review':ti,ab  2021  \n58  (synthes*  NEAR/2  qualitative):ti,ab  2081  \n57  (synthes*  NEAR/3  evidence):ti,ab  9063  \n56  (synthes*  NEAR/3  literature):ti,ab  3131  \n55  'meta regression':ti,ab  7133  \n54  'metaregression':ti,ab  869  \n53  'meta -regression':ti,ab  7133  \n52  'meta synthesis':ti,ab  674  \n51  'metasynthesis':ti,ab  288  \n50  'meta -synthesis':ti,ab  674  \n49  'meta analysis':ti,ab  147324  \n48  'metaanalysis':ti,ab  6956  \n47  'metanalysis':ti,ab  470  \n46  'meta -analysis':ti,ab  147324  \n45  'meta -analityc*':ti,ab  0 \n44  'meta analysis (topic)'  38062  \n43  'meta analysis'  226151  \n42  'systematic review (topic)'  22481  \n41  'systematic review'  235143  \n40  'syste matic* literature review*':ti,ab  11845  \n39  'systematic review':ti,ab  140378  \n38  #28  NOT  #37  1719004  \n37  #29  OR  #30  OR  #31  OR  #32  OR  #33  OR  #34  OR  #35  OR  #36  6787956  \n36  'note'/it  737118  \n35  'editorial'/it  589513  \n34  'conference proceeding'/it  0 \n33  'confer ence abstract'/it  3293251  \n32  'conference paper'/it  749308  \n31  'abstract report'/de OR  'letter'/de  1084800  \n30  'case report':ti,ab  388379  \n29  'case study'/de  58795  \n28 #9  OR  #10  OR  #11  OR  #12  OR  #13  OR  #14  OR  #15  OR  #16  OR  #17 \n OR #18 OR #19 OR #20 OR #21 OR #22 OR #23 OR #24 O R #25 O\nR #26 OR #27 2100849 \n27  'prospective study'/de  500308   \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 105 26  placebo*:ti,ab  284931  \n25  ((treble  OR  triple) NEAR/1  blind*):ti,ab  1015  \n24  'double blind*':ti,ab  196554  \n23  'single blind*':ti,ab  22356  \n22  (random*  NEAR/2  allocat*):ti ,ab  38813  \n21  rct:ti,ab  31466  \n20  'randomi*ed controlled trial*':ti,ab  194912  \n19  'placebo'/de  336229  \n18  'crossover procedure'/de  58081  \n17  'double blind procedure'/de  157909  \n16  'single blind procedure'/de  34003  \n15  'randomization'/exp  81184  \n14  'phase 4  clinical trial'/de  3304  \n13  'phase 3 clinical trial'/de  38105  \n12  'multicenter study'/de  206417  \n11  'controlled clinical trial'/de  426215  \n10  'randomized controlled trial'/de  536242  \n9 'clinical trial'/de  963806  \n8 #1  OR  #2  OR  #3  OR  #4  OR  #5  OR  #6  OR  #7  7141  \n7 (('focused \nattention' OR mantra OR yantra OR breath OR transce ndental OR z\nazen OR tonglen OR dzogchen OR metta) NEAR/2 \n(meditation* OR therap* OR treatment* OR interventi on* OR training* \n)):ti,ab 1134 \n6 (meditation*  NEAR/2 (training*  OR  program*)):t i,ab  649  \n5 compassion:kw  1456  \n4 (('kindness -based'  OR  'kindness \nbased' OR kindnessbased OR kbm OR 'loving-kindness'  OR 'loving \nkindness' OR lovingkindness OR compassion* OR 'mind -\ntraining*' OR 'mind training*') NEAR/2 \n(meditation* OR therap* OR treatment* OR interventi on* OR training* \n)):ti,ab 936 \n3 ('kindness -based':ti OR  'kindness based':ti OR  'kindnessbased':ti \nOR kbm:ti OR 'loving-kindness':ti OR 'loving kindne ss':ti \nOR lovingkindness:ti OR compassion*:ti OR 'mind tra ining*':ti \nOR mind:ti) AND training*:ti 261 \n2 'meditation':ti,kw  359  \n1 'meditation'/mj  2666  \n \n \nCochrane Library - Wiley  \n1 MeSH descriptor: [Meditation] this term only  596  \n2 meditation:ti  1138  \n3 (Kindness -based or Kindness based or Kindnessbased or KBM or \nLoving-kindness or Loving kindness or Lovingkindnes s or \ncompassion* or mind-training* or mind training*):ti  457 \n4 ((\"Kindness -based\" or \"Kindness based\" or Kindnessbased or KBM or \n\"Loving-kindness\" or \"Loving kindness\" or Lovingkin dness or \ncompassion* or \"mind-training*\" or \"mind training*\" ) near/2 \n(meditation* or therap* or treatment* or interventi on* or training*)):ti,ab 322 \n5 compassion*:kw  254  \n6 (meditation* near/2 (training* or program*)):ti,ab  387   \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  106 7 ((\"Focused attention\" or Mantra or Yantra or Breath  or Transcendental \nor Zazen or Tonglen or Dzogchen or Metta) near/2 (m editation* or \ntherap* or treatment* or intervention* or training* )):ti,ab 353 \n8 #1 or #2 or #3 or #4 or #5 or #6 or #7  2373  \n \n \nPsicINFO (Ebsco)   \n9 S7 AND S8  740  \n8 MM \"Clinical trials\" OR MR (\"Treatment Effectiv eness Evaluation\") OR TI \n((randomi?ed n7 trial*) or ((single or doubl* or tr ipl* or treb*) and (blind* or \nmask*)) or (controlled n3 trial*) or (clinical n2 t rial*)) OR AB ((randomi?ed \nn7 trial*) or ((single or doubl* or tripl* or treb* ) and (blind* or mask*)) or \n(controlled n3 trial*) or (clinical n2 trial*)) OR KW ((randomi?ed n7 trial*) or \n((single or doubl* or tripl* or treb*) and (blind* or mask*)) or (controlled n3 \ntrial*) or (clinical n2 trial*)) 104391 \n7 S1 OR S2 OR S3 OR S4 OR S5 OR S6  17386  \n6 TI ( ((Focused attention or Mantra or Yantra or Breath  or Transcendental \nor Zazen or Tonglen or Dzogchen or Metta) N2 (medit ation* or therap* or \ntreatment* or intervention* or training*)) ) OR AB ( ((Focused attention or \nMantra or Yantra or Breath or Transcendental or Zaz en or Tonglen or \nDzogchen or Metta) N2 (meditation* or therap* or tr eatment* or \nintervention* or training*)) ) 73 \n5 TI (meditation* N2 (training* or program*)) OR AB ( meditation* N2 \n(training* or program*)) 830 \n4 KW compassion*  3822  \n3 DE \"M editation\" or TI meditation* or KW meditation*  582  \n2 TI ( ((Kindness -based or Kindness based or Kindnessbased or KBM or \nLoving-kindness or Loving kindness or Lovingkindnes s or compassion* \nOR mind-training* or mind training*) N2 (meditation * or therap* or \ntreatment* or intervention* or training*)) ) OR AB ( ((Kindness-based or \nKindness based or Kindnessbased or KBM or Loving-ki ndness or Loving \nkindness or Lovingkindness or compassion* OR mind-t raining* or mind \ntraining*) N2 (meditation* or therap* or treatment*  or intervention* or \ntraining*)) ) 1485 \n1 TI ( Kindness -based or Kindness based or Kindnessbased or KBM or \nLoving-kindness or Loving kindness or Lovingkindnes s or compassion* \nOR mind-training* or mind training* ) OR AB ( Kindn ess-based or \nKindness based or Kindnessbased or KBM or Loving-ki ndness or Loving \nkindness or Lovingkindness or compassion* OR mind-t raining* or mind \ntraining* ) OR KW ( Kindness-based or Kindness base d or \nKindnessbased or KBM or Loving-kindness or Loving k indness or \nLovingkindness or compassion* OR mind-training* or mind training* ) 11,93 \n  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 107 Anexo Anexo Anexo Anexo 33 33. Organizaciones contactadas . Organizaciones contactadas . Organizaciones contactadas . Organizaciones contactadas    \nOrganizaciones participantes en la revisi\u00f3n del pro tocolo  \nOrganizaci\u00f3n Contacto Papel Env\u00eda \nrevisi\u00f3n \nACEM Espa\u00f1a Xaqueline \nRobert Gate Representante de \nAsociaci\u00f3n S\u00ed \nAssociaci\u00f3 per a la investigaci\u00f3, desenvolupament \ni difusi\u00f3 de t\u00e8cniques de meditaci\u00f3 terap\u00e8utiques \nINTRO-MENT Junta \nDirectiva Representante de \nAsociaci\u00f3n No \nAsociaci\u00f3n Centro de Yoga y Meditaci\u00f3n Santiago \nGuerra Junta \nDirectiva Representante de \nAsociaci\u00f3n No \nAsociaci\u00f3n Meditaci\u00f3n Advaita Viveka Junta \nDirectiva Representante de \nAsociaci\u00f3n No \nOrganizaciones contactadas que mostraron declinaci\u00f3 n \nexpl\u00edcita a participar en la revisi\u00f3n del protocolo  \nOrganizaci\u00f3n \nFundaci\u00f3n Privada Vipassana \n\u00darsula Calvo Center \nOrganizaciones contactadas sin respuesta en la revi si\u00f3n del \nprotocolo \nOrganizaci\u00f3n \nFundaci\u00f3n IFSU (International Foundation for Spirit ual Unfoldment)   \nSociedad Espa\u00f1ola de Meditaci\u00f3n \nAsociaci\u00f3n Espa\u00f1ola de Instructores de Meditaci\u00f3n y Mi ndfulness \nAsociaci\u00f3n Espa\u00f1ola de Mindfulness y Compasi\u00f3n (AEMIND)  \nAsociaci\u00f3n Espa\u00f1ola de Meditaci\u00f3n Vipassana \nAsociaci\u00f3 Amics de la Meditaci\u00f3 i les ter\u00e0pies alternat ives (ATMA) \nAEMS Atenci\u00f3n Escucha Meditaci\u00f3n Sanaci\u00f3n \nAsociaci\u00f3n AMA: Arte y Meditaci\u00f3n en Acci\u00f3n \nAsociaci\u00f3n Aragonesa de Yoga, Meditaci\u00f3n, Psicolog\u00eda y Mindfulness \nAsociaci\u00f3n Mediterr\u00e1nea de Terapias Hol\u00edsticas, AMTH \nAssociaci\u00f3 Akasha. Espai Obert per a la Meditaci\u00f3, la I nvestigaci\u00f3, l'Art i la Ter\u00e0pia \nAssociaci\u00f3 d'estudis budistes i meditaci\u00f3 karma tx\u00f6pel \nAssociaci\u00f3 Dansame (Dansa, Salut i Meditaci\u00f3) \nAsociaci\u00f3n Brahma Kumaris en Espa\u00f1a \nAsociaci\u00f3n de Yoga Tradicional Espa\u00f1a \nAsociaci\u00f3n Rigpa Espa\u00f1a \nAsociaci\u00f3n Jard\u00edn de la Meditaci\u00f3n \nOrganizaciones participantes en la revisi\u00f3n externa del informe  \nOrganizaci\u00f3n \nFundaci\u00f3n IFSU (International Foundation for Spirit ual Unfoldment)   \nACEM Espa\u00f1a \nAsociaci\u00f3n Nacional de Profesionales y Aut\u00f3nomos de las T erapias Naturales (COFENAT) \nConsejo General de Colegios Oficiales de Psic\u00f3logos \n  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  108 Anexo 4. Estudios excluidos Anexo 4. Estudios excluidos Anexo 4. Estudios excluidos Anexo 4. Estudios excluidos    a texto a texto a texto a texto \ncompleto completo completo completo    \nRevisiones sistem\u00e1ticas \nDISE\u00d1O/DISE\u00d1O DE LOS ESTUDIOS INCLUIDOS \n\u2022 Alexander C;Robinson P;Orme-Johnson DW;Schneider RH; The effects of transcendental meditation \ncompared to other methods of relaxation and meditati on in reducing risk factors, morbidity, and \nmortalityHomeostasis in Health and Disease1994 \n\u2022 Arthur HM;Patterson C;Stone JA;The role of compleme ntary and alternative therapies in cardiac \nrehabilitation: a systematic evaluation. [Review]Europe an Journal of Cardiovascular Prevention & \nRehabilitation 13(1):3-9,2006 \n\u2022 Bormann JE;Weinrich S;Allard CB;Beck D;Johnson BD;Ho lt LC;Chapter 5 mantram repetition: an \nevidence-based complementary practice for military per sonnel and veterans in the 21st \ncenturyAnnual review of nursing research2014 \n\u2022 Bowen S;Witkiewitz K;Chawla N;Grow J;Integrating mi ndfulness meditation and cognitive behavioral \ntraditions for the long-term treatment of addictive b ehaviorsJournal of Clinical Outcomes \nManagement2011 \n\u2022 Carpenter JJ;Hines SH;Lan VM;Guided Imagery for Pain  Management in Postoperative Orthopedic \nPatients: An Integrative Literature Review. [Review]Jou rnal of Holistic Nursing 35(4):342-351,2016 \n\u2022 Cearley SM;Immaneni S;Shankar P;Irritable Bowel Syndr ome: The effect of FODMAPs and meditation \non pain managementEuropean Journal of Integrative Me dicine2017 \n\u2022 Chan RR;Larson JL;Meditation Interventions for Chroni c Disease Populations: A Systematic Review. \n[Review]Journal of Holistic Nursing 33(4):351-65,2015  \n\u2022 Cheng FK;Tse S;Applying the Buddhist four immeasurabl es to mental health care: A critical \nreviewJournal of Religion & Spirituality in Social Wo rk: Social Thought2015 \n\u2022 Cheng FK;Tse S;The use of Chinese Buddhist theories in  counselling, psychotherapy, psychology, \nand mental health research: An integrative reviewInter national Journal for the Advancement of \nCounselling2014 \n\u2022 Chida Y;Steptoe A;Powell LH;Religiosity/spirituality an d mortality: A systematic quantitative \nreviewPsychotherapy and Psychosomatics2009 \n\u2022 Chiesa A;Serretti A;Mindfulness based cognitive therap y for psychiatric disorders: A systematic \nreview and meta-analysis2017 \n\u2022 Chiesa A;Zen meditation: an integration of current e vidence. [Review] Journal of Alternative & \nComplementary Medicine 15(5):585-92,2009 \n\u2022 Delmonte MM;Mantras and meditation: A literature revi ewPerceptual and Motor Skills1983 \n\u2022 Edwards MK;Loprinzi PD;Comparative effects of meditat ion and exercise on physical and \npsychosocial health outcomes: a review of randomized co ntrolled trials. [Review]Postgraduate \nMedicine 130(2):222-228,2018 \n\u2022 Eppley KR;Abrams AI;Shear J;Differential effects of r elaxation techniques on trait anxiety: a meta-\nanalysisJournal of Clinical Psychology 45(6):957-74,198 9 \n\u2022 Goldstein KM;Shepherd-Banigan M;Coeytaux RR;McDuffie  JR;Adam S;Befus D;Goode AP;Kosinski \nAS;Masilamani V;Williams JW;Use of mindfulness, meditati on and relaxation to treat vasomotor \nsymptoms. [Review]Climacteric2020 \n\u2022 Greenlee H;DuPont-Reyes MJ;Balneaves LG;Carlson LE;Cohe n MR;Deng G;Johnson JA;Mumber \nM;Seely D;Zick SM;Boyce LM;Tripathy D;Clinical practi ce guidelines on the evidence-based use of \nintegrative therapies during and after breast cancer treatmentCA Cancer Journal for Clinicians2017 \n\u2022 Househam AM;Peterson CT;Mills PJ;Chopra D;The Effect s of Stress and Meditation on the Immune \nSystem, Human Microbiota, and Epigenetics. [Review]Advan ces in Mind-Body Medicine 31(4):10-\n25,2017 \n\u2022 Khalsa SS;Rudrauf D;Hassanpour MS;Davidson RJ;Tranel D; The practice of meditation is not \nassociated with improved interoceptive awareness of the h eartbeatPsychophysiology  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 109 57(2):e13479,2020 \n\u2022 Kozasa EH;Tanaka LH;Monson C;Little S;Leao FC;Peres M P;The effects of meditation-based \ninterventions on the treatment of fibromyalgia. [Review ]Current Pain & Headache Reports 16(5):383-\n7,2012 \n\u2022 Kuijpers HJ;van der Heijden FM;Tuinier S;Verhoeven WM; Meditation-induced psychosis. [Review] \nPsychopathology 40(6):461-4,2007 \n\u2022 Marciniak R;Sheardova K;Cermakova P;Hudecek D;Sumec R;Hort J;Effect of meditation on cognitive \nfunctions in context of aging and neurodegenerative d iseases. [Review]Frontiers in Behavioral \nNeuroscience 8:17,2014 \n\u2022 Morone NE;Greco CM;Mind-body interventions for chroni c pain in older adults: A structured \nreviewPain Medicine2007 \n\u2022 Ooi SL;Giovino M;Pak SC;Transcendental meditation for  lowering blood pressure: An overview of \nsystematic reviews and meta-analyses. [Review]Complementary  Therapies in Medicine 34:26-\n34,2017 \n\u2022 Ospina MB;Bond K;Karkhaneh M;Buscemi N;Dryden DM;Barn es V;Carlson LE;Dusek JA;Shannahoff-\nKhalsa D;Clinical trials of meditation practices in he alth care: characteristics and quality. [Review] \nJournal of Alternative & Complementary Medicine 14(10 ):1199-213,2008 \n\u2022 Rees B;Overview of outcome data of potential meditatio n training for soldier resilience. \n[Review]Military Medicine 176(11):1232-42,2011 \n\u2022 Reiner K;Tibi L;Lipsitz JD;Do Mindfulness-Based Interv entions Reduce Pain Intensity? A Critical \nReview of the LiteraturePain Medicine (United States) 2013 \n\u2022 Robert S;Lamontagne Y;Transcendental meditation: A c ritical reviewInformation Psychiatrique1979 \n\u2022 Rubia K;The neurobiology of Meditation and its clini cal effectiveness in psychiatric disorders. \n[Review] Biological Psychology 82(1):1-11,2009 \n\u2022 Salhofer I;Will A;Monsef I;Skoetz N;Meditation for a dults with haematological malignancies. \n[Review]Cochrane Database of Systematic Reviews 2:CD011 157,2016 \n\u2022 Samarasekara K;Effects of mindfulness meditation on pa tients with cancer: A review of \nliteratureAnnals of Oncology2017 \n\u2022 Schneider RH;Alexander CN;Staggers F;Rainforth M;Sal erno JW;Hartz A;Arndt S;Barnes VA;Nidich \nSI;Long-term effects of stress reduction on mortality in persons > or = 55 years of age with systemic \nhypertensionAmerican Journal of Cardiology 95(9):1060- 4,2005 \n\u2022 Schneider RH;Carr T;Transcendental Meditation in th e prevention and treatment of cardiovascular \ndisease and pathophysiological mechanisms: An evidence-ba sed reviewAdvances in Integrative \nMedicine2014 \n\u2022 Seekis V;Bradley GL;Duffy AL;Self-compassion intervention s in body image: A review of the \nliterature2019 \n\u2022 Sharma P;Mahapatra A;Gupta R;Meditation-induced psych osis: a narrative review and individual \npatient data analysisIrish Journal of Psychological Medi cine :1-7,2019 \n\u2022 Shonin E;Van Gordon W;Compare A;Zangeneh M;Griffith s MD;Buddhist-derived loving-kindness and \ncompassion meditation for the treatment of psychopathol ogy: A systematic reviewMindfulness2015 \n\u2022 Shonin E;Van Gordon W;Griffiths MD;Buddhist philosop hy for the treatment of problem \ngamblingJournal of Behavioral Addictions2013 \n\u2022 Suyin L;Klainin-Yobas P;Hui-Chen C;The effectiveness of  stress and anxiety management \ninterventions for adults diagnosed with cardiovascular disease in healthcare facilities: A systematic \nreviewJBI Database of Systematic Reviews and Implementati on Reports2010 \n\u2022 Swinyard CA;Chaube S;Sutton DB;Neurological and beha vioral aspects pf transcendental meditation \nrelevant to alcoholism: A reviewAnnals of the New Yor k Academy of Sciences1974 \n\u2022 Teixeira ME;Meditation as an intervention for chronic  pain: an integrative review. [Review] Holistic \nNursing Practice 22(4):225-34,2008 \n\u2022 Thomas JW;Cohen M;A methodological review of meditati on researchFrontiers in Psychiatry2014 \n\u2022 Walsh RN;Meditation research: An introduction and re viewJournal of Transpersonal Psychology1979 \n\u2022 Walton KG;Schneider RH;Nidich SI;Salerno JW;Nordstr om CK;Bairey Merz CN;Psychosocial stress \nand cardiovascular disease part 2: Effectiveness of the T ranscendental Meditation program in \ntreatment and preventionBehavioral Medicine2002 \nINTERVENCI\u00d3N \n\u2022 Agoha BC;Ogiri SO;Akindele ZA;Ogiri SO;Effectiveness o f behavioural therapy on the blood pressure  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  110 of adults with hypertension: A systematic review in non-a frican populationsNigerian Postgraduate \nMedical Journal 27(2):76-82,2020 \n\u2022 Alexander CN;Robinson P;Rainforth M;Treating and pre venting alcohol, nicotine, and drug abuse \nthrough transcendental meditation: A review and statis tical meta-analysisAlcoholism Treatment \nQuarterly1994 \n\u2022 Annells S;Kho K;Bridge P;Meditate don't medicate: Ho w medical imaging evidence supports the role \nof meditation in the treatment of depressionRadiograp hy2016 \n\u2022 Araujo RV;Fernandes AFC;Nery IS;Andrade EMLR;Nogueira  LT;Azevedo FHC;Meditation effect on \npsychological stress level in women with breast cancer: a  systematic review. [Portuguese, \nEnglish]Revista Da Escola de Enfermagem Da Usp 53:e03529 ,2019 \n\u2022 Arias AJ;Steinberg K;Banga A;Trestman RL;Systematic r eview of the efficacy of meditation \ntechniques as treatments for medical illness. [Review]Jo urnal of Alternative & Complementary \nMedicine 12(8):817-32,2006 \n\u2022 Austin J;Drossaert CHC;Schroevers MJ;Sanderman R;Kirb y JN;Bohlmeijer ET;Compassion-based \ninterventions for people with long-term physical condi tions: a mixed methods systematic \nreviewPsychology & Health :1-27,2020 \n\u2022 Beddoe AE;Lee KA;Mind-body interventions during pregna ncyJournal of Obstetric, Gynecologic, & \nNeonatal Nursing: Clinical Scholarship for the Care of Women, Childbearing Families, & \nNewborns2008 \n\u2022 Black DS;Milam J;Sussman S;Sitting-meditation interv entions among youth: a review of treatment \nefficacy. [Review] Pediatrics 124(3):e532-41,2009 \n\u2022 Boellinghaus I;Jones FW;Hutton J;The role of mindfuln ess and loving-kindness meditation in \ncultivating self-compassion and other-focused concern in health care professionalsMindfulness2014 \n\u2022 Breedvelt JJF;Amanvermez Y;Harrer M;Karyotaki E;Gilb ody S;Bockting CLH;Cuijpers P;Ebert DD;The \nEffects of Meditation, Yoga, and Mindfulness on Depr ession, Anxiety, and Stress in Tertiary \nEducation Students: A Meta-AnalysisFrontiers in psychiat ry Frontiers Research Foundation \n10:193,2019 \n\u2022 Candy B;Jones L;Varagunam M;Speck P;Tookman A;King M; Spiritual and religious interventions for \nwellG\u00c7\u00c9being of adults in the terminal phase of disea seCochrane Database of Systematic \nReviews2012 \n\u2022 Carim-Todd L;Mitchell SH;Oken BS;Mind-body practices:  an alternative, drug-free treatment for \nsmoking cessation? A systematic review of the literature.  [Review]Drug & Alcohol Dependence \n132(3):399-410,2013 \n\u2022 Chan JSY;Deng K;Wu J;Yan JH;Effects of Meditation a nd Mind-Body Exercises on Older Adults' \nCognitive Performance: A Meta-analysisGerontologist 59(6 ):e782-e790,2019 \n\u2022 Chen KW;Berger CC;Manheimer E;Forde D;Magidson J;Dac hman L;Lejuez CW;Meditative therapies \nfor reducing anxiety: a systematic review and meta-anal ysis of randomized controlled trials. \n[Review]Depression & Anxiety 29(7):545-62,2012 \n\u2022 Cheng FK;Is meditation conducive to mental well-being  for adolescents? An integrative review for \nmental health nursingInternational Journal of Africa  Nursing Sciences2016 \n\u2022 Chiesa A;Calati R;Serretti A;Does mindfulness training  improve cognitive abilities? A systematic \nreview of neuropsychological findingsClinical Psycholog y Review2011 \n\u2022 Dharmawardene M;Givens J;Wachholtz A;Makowski S;Tjia J ;A systematic review and meta-analysis \nof meditative interventions for informal caregivers and health professionalsBMJ supportive & palliative \ncare2016 \n\u2022 Evans S;Ling M;Hill B;Rinehart N;Austin D;Sciberras E;S ystematic review of meditation-based \ninterventions for children with ADHDEuropean Child an d Adolescent Psychiatry2018 \n\u2022 Farias M;Maraldi E;Wallenkampf KC;Lucchetti G;Advers e events in meditation practices and \nmeditation-based therapies: a systematic reviewActa Psyc hiatrica Scandinavica2020 \n\u2022 Gallegos AM;Crean HF;Pigeon WR;Heffner KL;Meditation  and yoga for posttraumatic stress disorder: \nA meta-analytic review of randomized controlled trial s. [Review]Clinical Psychology Review 58:115-\n124,2017 \n\u2022 Gard T;Holzel BK;Lazar SW;The potential effects of meditation on age-related cognitive decline: a \nsystematic review. [Review]Annals of the New York Academ y of Sciences 1307:89-103,2014 \n\u2022 Gill LN;Renault R;Campbell E;Rainville P;Khoury B;Min dfulness induction and cognition: A systematic \nreview and meta-analysisConsciousness and Cognition2020 \n\u2022 Gon+\u00baalves JP;Lucchetti G;Menezes PR;Vallada H;Religio us and spiritual interventions in mental  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 111 health care: a systematic review and meta-analysis of rand omized controlled clinical \ntrialsPsychological medicine2015 \n\u2022 Gu Q;Hou JC;Fang XM;Mindfulness Meditation for Prima ry Headache Pain: A Meta-AnalysisChinese \nMedical Journal 131(7):829-838,2018 \n\u2022 He B;Zhang L;Zhuang JH;Xu J;Li P;Peng H;The effects of different meditation exercises on sleep \nquality in older people: a network meta-analysisEurope an Geriatric Medicine2019 \n\u2022 Hilton L;Maher AR;Colaiaco B;Apaydin E;Sorbero ME;B ooth M;Shanman RM;Hempel S;Meditation \nfor posttraumatic stress: Systematic review and meta-anal ysis. [Review]Psychological \nTrauma:Theory, Pesearch, Practice and Policy 9(4):45 3-460,2017 \n\u2022 Hunot V;Moore TH;Caldwell DM;Furukawa TA;Davies P;Jon es H;Honyashiki M;Chen P;Lewis \nG;Churchill R;'Third wave' cognitive and behavioural t herapies versus other psychological therapies \nfor depression. [Review]Cochrane Database of Systematic R eviews (10):CD008704,2013 \n\u2022 Hurley RV;Patterson TG;Cooley SJ;Meditation-based in terventions for family caregivers of people \nwith dementia: a review of the empirical literature.  [Review]Aging & Mental Health 18(3):281-8,2014 \n\u2022 Innes KE;Selfe TK;Vishnu A;Mind-body therapies for me nopausal symptoms: a systematic review. \n[Review] Maturitas 66(2):135-49,2010 \n\u2022 Jain FA;Walsh RN;Eisendrath SJ;Christensen S;Rael CB; Critical analysis of the efficacy of meditation \ntherapies for acute and subacute phase treatment of depressive disorders: a systematic review. \n[Review]Psychosomatics 56(2):140-52,2015 \n\u2022 Jorm AF;Christensen H;Griffiths KM;Parslow RA;Rodgers B ;Blewitt KA;Effectiveness of \ncomplementary and self-help treatments for anxiety diso rders. [Review] Medical Journal of Australia \n181(S7):S29-46,2004 \n\u2022 Khoury B;Knauper B;Schlosser M;Carriere K;Chiesa A;Ef fectiveness of traditional meditation retreats: \nA systematic review and meta-analysis. [Review]Journal of Psychosomatic Research 92:16-25,2017 \n\u2022 Khoury B;Lecomte T;Gaudiano BA;Paquin K;Mindfulness in terventions for psychosis: a meta-\nanalysis. [Review]Schizophrenia Research 150(1):176-84 ,2013 \n\u2022 Kili\u00e7 A;Hudson J;McCracken LM;Ruparelia R;Fawson S;H ughes LD;A Systematic Review of the \nEffectiveness of Self-Compassion-Related Interventions for Individuals With Chronic Physical Health \nConditionsBehavior Therapy2020 \n\u2022 Koncz A;Demetrovics Z;Takacs ZK;Meditation interventio ns efficiently reduce cortisol levels of at-risk \nsamples: a meta-analysisHealth Psychology Review :1-29,2020  \n\u2022 Kreplin U;Farias M;Brazil IA;The limited prosocial ef fects of meditation: A systematic review and \nmeta-analysis. [Review]Scientific Reports 8(1):2403,2018  \n\u2022 Krisanaprakornkit T;Ngamjarus C;Witoonchart C;Piyavhat kul N;Meditation therapies for attention-\ndeficit/hyperactivity disorder (ADHD). [Review] Cochrane  Database of Systematic Reviews \n(6):CD006507,2010 \n\u2022 Kwekkeboom KL;Bratzke LC;A Systematic Review of Relax ation, Meditation, and Guided Imagery \nStrategies for Symptom Management in Heart Failure. [Review]Journal of Cardiovascular Nursing \n31(5):457-68,2016 \n\u2022 Kwon CY;Lee B;Chung SY;Kim JW;Do Cochrane reviews ref lect the latest evidence on meditation \nand mindfulness-based interventions? A snapshot of the cu rrent evidenceExplore: The Journal of \nScience & Healing2020 \n\u2022 Lafferty WE;Downey L;McCarty RL;Standish LJ;Patrick D L;Evaluating CAM treatment at the end of \nlife: a review of clinical trials for massage and medit ation. [Review] Complementary Therapies in \nMedicine 14(2):100-12,2006 \n\u2022 Langhorst J;Klose P;Dobos GJ;Bernardy K;H+\u00f1user W;Effi cacy and safety of meditative movement \ntherapies in fibromyalgia syndrome: A systematic review an d meta-analysis of randomized controlled \ntrials  Rheumatology International2013 \n\u2022 Levin AB;Hadgkiss EJ;Weiland TJ;Jelinek GA;Meditation  as an adjunct to the management of multiple \nsclerosis. [Review]Neurology Research International2014 \n\u2022 Luberto CM;Shinday N;Song R;Philpotts LL;Park ER;Fric chione GL;Yeh GY;A Systematic Review and \nMeta-analysis of the Effects of Meditation on Empathy, C ompassion, and Prosocial \nBehaviorsMindfulness 9(3):708-724,2018 \n\u2022 Lv J;Liu Q;Zeng X;Oei TPS;Liu Y;Xu K;Sun W;Hou H;Liu  J;The effect of four Immeasurables \nmeditations on depressive symptoms: A systematic review and me ta-analysis. [Review]Clinical \nPsychology Review 76:101814,2020 \n\u2022 Lynch J;Prihodova L;Dunne PJ;Carroll +;Walsh C;McMahon  G;White B;Mantra meditation for mental  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  112 health in the general population: A systematic reviewE uropean Journal of Integrative Medicine2018 \n\u2022 Matthews E;Carter P;Page M;Dean G;Berger A;Sleep-Wak e Disturbance: A Systematic Review of \nEvidence-Based Interventions for Management in Patients With CancerClinical Journal of Oncology \nNursing 22(1):37-52,2018 \n\u2022 Matvienko-Sikar K;Lee L;Murphy G;Murphy L;The effects o f mindfulness interventions on prenatal \nwell-being: A systematic reviewPsychology & health2016 \n\u2022 Mavranezouli I;Megnin-Viggars O;Daly C;Dias S;Stockton S;Meiser-Stedman R;Trickey D;Pilling \nS;Research Review: Psychological and psychosocial treatmen ts for children and young people with \npost-traumatic stress disorder: a network meta-analysis . [Review]Journal of Child Psychology & \nPsychiatry & Allied Disciplines 61(1):18-29,2020 \n\u2022 Metcalf O;Varker T;Forbes D;Phelps A;Dell L;DiBattist a A;Ralph N;O'Donnell M;Efficacy of Fifteen \nEmerging Interventions for the Treatment of Posttraum atic Stress Disorder: A Systematic Review. \n[Review]Journal of Traumatic Stress 29(1):88-92,2016 \n\u2022 Montero-Marin J;Garcia-Campayo J;Perez-Yus MC;Zabale ta-Del-Olmo E;Cuijpers P;Meditation \ntechniques v. relaxation therapies when treating anxi ety: a meta-analytic reviewPsychological \nMedicine 49(13):2118-2133,2019 \n\u2022 Morgan N;Irwin MR;Chung M;Wang C;The effects of mind -body therapies on the immune system: \nMeta-analysisPLoS ONE2014 \n\u2022 Nascimento SS;Oliveira LR;DeSantana JM;Correlations be tween brain changes and pain \nmanagement after cognitive and meditative therapies: A systematic review of neuroimaging studies. \n[Review]Complementary Therapies in Medicine 39:137-1 45,2018 \n\u2022 Park SH;Han KS;Blood Pressure Response to Meditation an d Yoga: A Systematic Review and Meta-\nAnalysis. [Review]Journal of Alternative & Complementar y Medicine 23(9):685-695,2017 \n\u2022 Paudyal P;Jones C;Grindey C;Dawood R;Smith H;Meditati on for asthma: Systematic review and \nmeta-analysisJournal of Asthma 55(7):771-778,2018 \n\u2022 Rahimi-Ardabili H;Reynolds R;Vartanian LR;McLeod LVD ;Zwar N;A systematic review of the efficacy \nof interventions that aim to increase self-compassion on nutrition habits, eating behaviours, body \nweight and body imageMindfulness2018 \n\u2022 Rainforth MV;Schneider RH;Nidich SI;Gaylord-King C;S alerno JW;Anderson JW;Stress reduction \nprograms in patients with elevated blood pressure: a syst ematic review and meta-analysis. [Review] \nCurrent Hypertension Reports 9(6):520-8,2007 \n\u2022 Rao A;DiGiacomo M;Newton PJ;Phillips JL;Hickman LD;M editation and secondary prevention of \ndepression and anxiety in heart disease: A systematic re viewMindfulness2019 \n\u2022 Ravalier JM;Wegrzynek P;Lawton S;Systematic review: co mplementary therapies and employee well-\nbeing. [Review]Occupational Medicine (Oxford) 66(6): 428-36,2016 \n\u2022 Reangsing C;Rittiwong T;Schneider JK;Effects of mindf ulness meditation interventions on depression \nin older adults: A meta-analysisAging & Mental Health :1-10,2020 \n\u2022 Rohlf VI;Interventions for occupational stress and com passion fatigue in animal care \nprofessionalsG\u00c7\u00f6A systematic reviewTraumatology2018 \n\u2022 Ruiz-Fern+\u00edndez MD;Ort+\u00a1z-Amo R;Ortega-Gal+\u00edn +;Ib+ \u00ed+\u00a6ez-Masero O;Rodr+\u00a1guez-Salvador \nMDM;Ramos-Pichardo JD;Mindfulness therapies on health  professionalsInternational journal of \nmental health nursing2020 \n\u2022 Ruotsalainen JH;Verbeek JH;Marin+\u00ae A;Serra C;Prevent ing occupational stress in healthcare \nworkersCochrane Database of Systematic Reviews2015 \n\u2022 Russell-Williams J;Jaroudi W;Perich T;Hoscheidt S;El Ha j M;Moustafa AA;Mindfulness and \nmeditation: treating cognitive impairment and reduci ng stress in dementia. [Review]Reviews in the \nNeurosciences 29(7):791-804,2018 \n\u2022 Schumer MC;Lindsay EK;Creswell JD;Brief mindfulness tr aining for negative affectivity: A systematic \nreview and meta-analysisJournal of Consulting & Clinical  Psychology 86(7):569-583,2018 \n\u2022 Sedlmeier P;Eberth J;Schwarz M;Zimmermann D;Haarig F;Jaeger S;Kunze S;The psychological \neffects of meditation: a meta-analysisPsychological Bull etin 138(6):1139-71,2012 \n\u2022 Shah K;Ramos-Garcia M;Bhavsar J;Lehrer P;Mind-body tr eatments of irritable bowel syndrome \nsymptoms: An updated meta-analysisBehaviour Research & T herapy 128:103462,2020 \n\u2022 Shi L;Zhang D;Wang L;Zhuang J;Cook R;Chen L;Meditat ion and blood pressure: a meta-analysis of \nrandomized clinical trials. [Review]Journal of Hypert ension 35(4):696-706,2017 \n\u2022 Shires A;Sharpe L;Davies JN;Newton-John TRO;The effica cy of mindfulness-based interventions in \nacute pain: A systematic review and meta-analysisPain2020   \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 113 \u2022 Shiyko MP;Hallinan S;Naito T;Effects of mindfulness tr aining on posttraumatic growth: A systematic \nreview and meta-analysisMindfulness2017 \n\u2022 Shonin E;Van Gordon W;Slade K;Griffiths MD;Mindfulne ss and other Buddhist-derived interventions \nin correctional settings: A systematic reviewAggression and  Violent Behavior2013 \n\u2022 Sinclair S;Kondejewski J;Raffin-Bouchal S;King-Shier  KM;Singh P;Can Self-Compassion Promote \nHealthcare Provider Well-Being and Compassionate Care to Others? Results of a Systematic Review. \n[Review]Applied Psychology Health and Well-being 9(2): 168-206,2017 \n\u2022 Slemp GR;Jach HK;Chia A;Loton DJ;Kern ML;Contemplat ive interventions and employee distress: A \nmeta-analysis. [Review]Stress & Health 35(3):227-255,2019  \n\u2022 Spinelli C;Wisener M;Khoury B;Mindfulness training for healthcare professionals and trainees: A \nmeta-analysis of randomized controlled trials. [Review]J ournal of Psychosomatic Research 120:29-\n38,2019 \n\u2022 Stillwell SB;Vermeesch AL;Scott JG;Interventions to Re duce Perceived Stress Among Graduate \nStudents: A Systematic Review With Implications for Evid ence-Based Practice. [Review]Worldviews \non Evidence-Based Nursing 14(6):507-513,2017 \n\u2022 Treanor CJ;McMenamin UC;O'Neill RF;Cardwell CR;Clar ke MJ;Cantwell M;Donnelly M;Non-\npharmacological interventions for cognitive impairment  due to systemic cancer treatment. \n[Review]Cochrane Database of Systematic Reviews (8):CD0 11325,2016 \n\u2022 Tsitsi T;Raftopoulos V;Papastavrou E;Charalambous A;Comp lementary and alternative medical \ninterventions for the management of anxiety in parents of children who are hospitalized and suffer \nfrom a malignancy: A systematic review of RCTsEuropean Journal of Integrative Medicine2014 \n\u2022 Turk F;Waller G;Is self-compassion relevant to the patho logy and treatment of eating and body image \nconcerns? A systematic review and meta-analysis. [Review]Cli nical Psychology Review \n79:101856,2020 \n\u2022 Viveiros J;Chamberlain B;O'Hare A;Sethares KA;Meditati on interventions among heart failure \npatients: An integrative review. [Review]European Jour nal of Cardiovascular Nursing 18(8):720-\n728,2019 \n\u2022 Wahbeh H;Sagher A;Back W;Pundhir P;Travis F;A Systemati c Review of Transcendent States Across \nMeditation and Contemplative Traditions. [Review]Expl ore: The Journal of Science & Healing \n14(1):19-35,2018 \n\u2022 Wasson RS;Barratt C;O'Brien WH;Effects of Mindfulness- Based Interventions on Self-compassion in \nHealth Care Professionals: a Meta-analysisMindfulness :1-21 ,2020 \n\u2022 Waters L;Barsky A;Ridd A;Allen K;Contemplative educat ion: A systematic, evidence-based review of \nthe effect of meditation interventions in schoolsEduca tional Psychology Review2015 \n\u2022 Wentzel D;Brysiewicz P;Integrative Review of Facility Interventions to Manage Compassion Fatigue in \nOncology Nurses. [Review]Oncology Nursing Forum 44(3):E12 4-E140,2017 \n\u2022 Xia T;Hu H;Seritan AL;Eisendrath S;The Many Roads to M indfulness: A Review of Nonmindfulness-\nBased Interventions that Increase Mindfulness. [Review]Jo urnal of Alternative & Complementary \nMedicine 25(9):874-889,2019 \n\u2022 Yang H;Wu X;Wang M;The Effect of Three Different Me ditation Exercises on Hypertension: A Network \nMeta-AnalysisEvidence-Based Complementary & Alternative M edicine: eCAM2017 \n\u2022 Zeng X;Chio FH;Oei TP;Leung FY;Liu X;A Systematic Revi ew of Associations between Amount of \nMeditation Practice and Outcomes in Interventions Using  the Four Immeasurables Meditations. \n[Review]Frontiers in Psychology 8:141,2017 \n\u2022 Zeng X;Chiu CP;Wang R;Oei TP;Leung FY;The effect of  loving-kindness meditation on positive \nemotions: a meta-analytic review. [Review]Frontiers in P sychology 6:1693,2015 \n\u2022 Zeng Y;Dong J;Huang M;Zhang JE;Zhang X;Xie M;Wefel JS;Nonpharmacological interventions for \ncancer-related cognitive impairment in adult cancer patients: A network meta-analysisInternational \nJournal of Nursing Studies 104:103514,2020 \n\u2022 Zhang J;Diaz-Roman A;Cortese S;Meditation-based thera pies for attention-deficit/hyperactivity \ndisorder in children, adolescents and adults: a systematic  review and meta-analysisEvidence-Based \nMental Health 21(3):87-94,2018 \n\u2022 Zhang Q;Gao X;Liu S;Yu L;Zhu J;Qiu S;Therapies for c ognitive impairment in breast cancer survivors \ntreated with chemotherapy: A protocol for systematic re viewMedicine2020 \n\u2022 Zhang Y;Luo Y;Zeng Y;Meta-analysis of meditative/rela xation-based interventions for cognitive \nimpairment in cancer patient. [Review]International Journal of Nursing Sciences 4(3):322-327,2017  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  114 MEDIDAS DE RESULTADO  \n\u2022 Canter PH;Ernst E;The cumulative effects of Transcenden tal Meditation on cognitive function--a \nsystematic review of randomised controlled trials. [Review ] Wiener Klinische Wochenschrift 115(21-\n22):758-66,2003 \n\u2022 Chiesa A;Serretti A;A systematic review of neurobiologi cal and clinical features of mindfulness \nmeditations. [Review]Psychological Medicine 40(8):1239 -52,2010 \n\u2022 Kaur A;Singh M;A systemic review of meditation and psyc hophysiologyIndian Journal of Public \nHealth Research and Development2018 \n\u2022 Lee DJ;Kulubya E;Goldin P;Goodarzi A;Girgis F;Review  of the Neural Oscillations Underlying \nMeditation. [Review]Frontiers in Neuroscience 12:178, 2018 \n\u2022 Pascoe MC;Thompson DR;Jenkins ZM;Ski CF;Mindfulness medi ates the physiological markers of \nstress: Systematic review and meta-analysis. [Review]Journa l of Psychiatric Research 95:156-\n178,2017 \n\u2022 Tomasino B;Chiesa A;Fabbro F;Disentangling the neural  mechanisms involved in Hinduism- and \nBuddhism-related meditationsBrain & Cognition 90:32- 40,2014 \n\u2022 Tomasino B;Fregona S;Skrap M;Fabbro F;Meditation-rel ated activations are modulated by the \npractices needed to obtain it and by the expertise: An  ALE meta-analysis studyFrontiers in Human \nNeuroscience2013 \nRECOGIDAS EN OTRAS REVISIONES \n\u2022 Anderson JW;Liu C;Kryscio RJ;Blood pressure response to  transcendental meditation: a meta-\nanalysisAmerican Journal of Hypertension 21(3):310-6,20 08 \n\u2022 Bai Z;Chang J;Chen C;Li P;Yang K;Chi I;Investigating  the effect of transcendental meditation on \nblood pressure: a systematic review and meta-analysis. [Re view]Journal of Human Hypertension \n29(11):653-62,2015 \n\u2022 Canter PH;Ernst E;Insufficient evidence to conclude w hether or not Transcendental Meditation \ndecreases blood pressure: results of a systematic review of  randomized clinical trials. [Review] \nJournal of Hypertension 22(11):2049-54,2004 \n\u2022 Hartley L;Mavrodaris A;Flowers N;Ernst E;Rees K;Transcen dental meditation for the primary \nprevention of cardiovascular disease. [Review]Cochrane D atabase of Systematic Reviews \n(12):CD010359,2014 \n\u2022 Krisanaprakornkit T;Krisanaprakornkit W;Piyavhatkul N; Laopaiboon M;Meditation therapy for anxiety \ndisorders. [Review] Cochrane Database of Systematic Revie ws (1):CD004998,2006 \nDUPLICADOS \n\u2022 Goyal M;Singh S;Sibinga EMS;Gould NF;Rowland-Seymour A;Sharma R;Berger Z;Sleicher D;Maron \nDD;Shihab HM;Ranasinghe PD;Linn S;Saha S;Bass EB;Hayth ornthwaite JA. Meditation Programs for \nPsychological Stress and Well-BeingAgency for Healthcar e Research and Quality (US) AHRQ \nComparative Effectiveness Reviews, Report No : 13(14)-EH C116-EF2014 \nEstudios primarios \nDISE\u00d1O \n\u2022 Arch JJ;Brown KW;Dean DJ;Landy LN;Brown KD;Laudenslag er ML;Self-compassion training \nmodulates alpha-amylase, heart rate variability, and s ubjective responses to social evaluative threat \nin womenPsychoneuroendocrinology 42:49-58,2014 \n\u2022 Aspy DJ;Proeve M;Mindfulness and Loving-Kindness Meditation Psychological Reports 120(1):102-\n117,2017 \n\u2022 Beaumont E;Durkin M;McAndrew S;Martin CR;Using compa ssion focused therapy as an adjunct to \ntrauma-focused CBT for fire service personnel suffering with trauma-related symptomsthe Cognitive \nBehaviour Therapist2016 \n\u2022 Borchardt AR;Zoccola PM;Recovery from stress: an exper imental examination of focused attention \nmeditation in novicesJournal of Behavioral Medicine 4 1(6):836-849,2018 \n\u2022 Boxleitner G;Jolie S;Shaffer D;Pasacreta N;Bai M;McC orkle R;Comparison of Two Types of \nMeditation on Patients' Psychosocial Responses During Ra diation Therapy for Head and Neck \nCancerJournal of Alternative & Complementary Medicine  23(5):355-361,2017  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 115 \u2022 Calderon R;Jr;Effects of nonpharmacological approac hes on cholesterol levels in mild hypertensive \nAfrican Americans: a pilot study of the Transcendental Meditation program and a health education \nprogram2000 \n\u2022 Chapin HL;Darnall BD;Seppala EM;Doty JR;Hah JM;Macke y SC;Pilot study of a compassion \nmeditation intervention in chronic pain2014 \n\u2022 Cutshall SM;Wentworth LJ;Wahner-Roedler DL;Vincent A;Schmidt JE;Loehrer LL;Cha SS;Bauer \nBA;Evaluation of a biofeedback-assisted meditation pro gram as a stress management tool for \nhospital nurses: a pilot study2011 \n\u2022 Delmonte MM;Physiological responses during meditation and restBIOFEEDBACK SELF-REGUL1984 \n\u2022 Devi LM;Mangaiyarkkarasi K;A Comparative Study to Assess the  Effectiveness of Laughter Therapy \nVersus Meditation on Stress and Anxiety among Nursing St udents at Selected College, \nBangaloreInternational journal of nursing education2 019 \n\u2022 Gaylord C;Orme-Johnson D;Travis F;The effects of the tr anscendental mediation technique and \nprogressive muscle relaxation on EEG coherence, stress r eactivity, and mental health in black \nadults1989 \n\u2022 Gilbert GS;Parker JC;Claiborn CD;Differential mood changes in alcoholics as a function of anxiety \nmanagement strategiesJ Clin Psychol1978 \n\u2022 Goldman BL;Domitor PJ;Murray EJ;Effects of Zen medit ation on anxiety reduction and perceptual \nfunctioningJ Consult Clin Psychol1979 \n\u2022 Goldstein L;Nidich SI;Goodman R;Goodman D;The effec t of transcendental meditation on self-\nefficacy, perceived stress, and quality of life in mother s in Uganda2018 \n\u2022 HenneghanImproving Cognitive and Psychosocial Symptoms a nd Social Functioning in Breast \nCancer SurvivorsArch Phys Med Rehabil2019 \n\u2022 Hirshberg MJ;Goldberg SB;Schaefer SM;Flook L;Findley  D;Davidson RJ;Divergent effects of brief \ncontemplative practices in response to an acute stresso r: A randomized controlled trial of brief breath \nawareness, loving-kindness, gratitude or an attention co ntrol practice2018 \n\u2022 Johnson DP;Penn DL;Fredrickson BL;Kring AM;Meyer PS;Ca talino LI;Brantley M;A pilot study of \nloving-kindness meditation for the negative symptoms of s chizophrenia2011 \n\u2022 Kearney DJ;Malte CA;McManus C;Martinez ME;Felleman B; Simpson TL;Loving-kindness meditation \nfor posttraumatic stress disorder: a pilot study2013 \n\u2022 Keng SL;Tan JX;Effects of brief mindful breathing an d loving-kindness meditation on shame and \nsocial problem solving abilities among individuals with h igh borderline personality traits2017 \n\u2022 Khalsa DS;Bowles H;Huysmans Z;Kandati S;Montgomery C;Sel fe TK;Innes K;Effects of meditation \nand musiclistening on blood biomarkers of cellular ag ing and Alzheimer's disease in adults with \npreclinical memory loss: an exploratory randomized con trolled trialGlobal Adv Health Med2018 \n\u2022 Kirby J;Laczko D;A Randomized Micro-Trial of a Loving -Kindness Meditation for Young Adults Living \nat Home with their ParentsJournal of child and famil y studies2017 \n\u2022 Kratter;Jonathan;Hogan;John D;The Use of Meditation in the Treatment of Attention Deficit Disorder \nwith Hyperactivity1982 \n\u2022 Krucoff M;Crater S;Green C;Maas A;Seskevitch J;Loeffle r K;Raju S;Novel applications of ECG \nmonitoring for the quantification of noetic phenome naJournal of electrocardiology1999 \n\u2022 Landry JM;Physiological and psychological effects of a Himalayan singing bowl in meditation \npractice: a quantitative analysis2014 \n\u2022 Lane JD;Seskevich JE;Pieper CF;Brief meditation train ing can improve perceived stress and negative \nmood2007 \n\u2022 Law RW;An analogue study of loving-kindness meditation a s a buffer against social \nstressDissertation abstracts international: section b: the  sciences and engineering2012 \n\u2022 Lehrer PM;Schoicket S;Carrington P;Woolfolk RL;Psycho physiological and cognitive responses to \nstressful stimuli in subjects practicing progressive rela xation and clinically standardized \nmeditation1980 \n\u2022 Loiselle ME;Academic physician burnout and transcenden tal meditation: A mixed methods \nrandomized controlled trial2018 \n\u2022 Lopez G;Chaoul A;Powers-James C;Spelman A;Wei Q;Engl e R;Hashmi Y;Bruera E;Cohen L;A \nPragmatic Evaluation of Symptom Distress After Group Me ditation for Cancer Patients and \nCaregivers: a Preliminary ReportJ Pain Symptom Manage20 18 \n\u2022 Manikonda JP;St+\u00c2rk S;T+\u00c2gel S;Lobm++ller A;Gr++nbe rg I;Bedel S;Schardt F;Angermann \nCE;Jahns R;Voelker W;Contemplative meditation reduces  ambulatory blood pressure and stress- \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  116 induced hypertension: A randomized pilot trialJ Hum Hypertens2008 \n\u2022 Manikonda JP;Stoerk S;Toegel S;Schardt F;Angermann C;Jahns R;Ertl G;Faller H;Voelker W;Influence \nof a spiritual-holistic therapy with contemplative me ditation in combination with breathing techniques \n(CMBT) on stress-induced hypertoniaMedizinische klini k2007 \n\u2022 Manocha R;A randomised trial of mental silence orient ated meditation for work-related stress, anxiety \nand depressive feelings.Asian journal of psychiatry.2011  \n\u2022 Moretti-Altuna G;The effects of meditation versus med ication in the treatment of Attention Deficit \nDisorder with Hyperactivity1987 \n\u2022 Oman D;Bormann JE;Mantram repetition fosters self-eff icacy in veterans for managing PTSD: A \nrandomized trialPsycholog Relig Spiritual2015 \n\u2022 Orme-Johnson D;8.1 THREE RANDOMIZED EXPERIMENTS ON THE LONGITUDINAL EFFECTS OF \nTHE TRANSCENDENTAL MEDITATION TECHNIQUE ON COGNITIO N2019 \n\u2022 Orme-Johnson DW;Schneider RH;Son YD;Nidich S;Cho ZH ;Neuroimaging of meditation's effect on \nbrain reactivity to pain2006 \n\u2022 Patel C;Carruthers M;Coronary risk factor reduction th rough biofeedback-aided relaxation and \nmeditationJournal of the royal college of general pr actitioners1977 \n\u2022 Plumb D;Bormann J;Beck D;Glickman M;Zhao S;Osei-Bonsu  P;Johnston J;Elwy R;Meditation-based \nmantram repetition program for veterans with PTSD: a  randomized controlled trial in the va healthcare \nsystemJ Altern Complement Med2014 \n\u2022 Psychophysiological effects of pregressive relaxation and mantra meditationBiol Psychol1980 \n\u2022 Ratcliff CG;Prinsloo S;Chaoul A;Zepeda SG;Cannon R;S pelman A;Yang WT;Cohen L;A Randomized \nControlled Trial of Brief Mindfulness Meditation for  Women Undergoing Stereotactic Breast \nBiopsy2019 \n\u2022 SaundersMEDITATIVE INTERVENTIONS IN CHILD AND ADOLES CENT PSYCHIATRYJ Am Acad \nChild Adolesc Psychiatry2019 \n\u2022 Schneider RH;Castillo-Richmond A;Alexander CN;Myers H; Kaushik V;Aranguri C;Norris K;Haney \nC;Rainforth M;Calderon R;Nidich S;Behavioral treatme nt of hypertensive heart disease in African \nAmericans: rationale and design of a randomized contr olled trial2001 \n\u2022 Schneider RH;Myers HF;Marwaha K;Rainforth MA;Salerno JW;Nidich SI;Gaylord-King C;Alexander \nCN;Norris KC;Stress Reduction in the Prevention of Left  Ventricular Hypertrophy: A Randomized \nControlled Trial of Transcendental Meditation and He alth Education in Hypertensive African \nAmericans2019 \n\u2022 Sinha, S.S. & Jain, A.K. & Tyagi, S. & Mahajan, A.S. .Effect of meditation on heart rate, blood pressure \nand exercise performance in coronary artery disease pa tientsIndian J Physiol Pharmacol2018 \n\u2022 Smith JC;Psychotherapeutic effects of transcendental m editation with controls for expectation of \nrelief and daily sittingJ Consult Clin Psychol1976 \n\u2022 Soo MS;Jarosz JA;Wren AA;Soo AE;Mowery YM;Johnson KS; Yoon SC;Kim C;Hwang ES;Keefe \nFJ;Shelby RA;Imaging-Guided Core-Needle Breast Biopsy: Impact of Meditation and Music \nInterventions on Patient Anxiety, Pain, and Fatigue20 16 \n\u2022 Srikanth N Jois, R Moulya, Lancy D\u2019SouzaMitigation o f perceived stress and enhancement of quality \nof life among female adolescents using meditation on twin heartsIndian journal of public health \nresearch and development2017 \n\u2022 Surwit RS;Shapiro D;Good MI;Comparison of cardiovascul ar biofeedback, neuromuscular \nbiofeedback, and meditation in the treatment of bor derline essential hypertension1978 \n\u2022 Thomas D;Abbas KA;Comparison of transcendental meditati on and progressive relaxation in \nreducing anxietyBR MED J1978 \n\u2022 Torkamani F;Aghayousefi A;Alipour A;Nami M;Effects of Single-Session Group Mantra-meditation on \nSalivary Immunoglobulin A and Affective State: A Psych oneuroimmunology Viewpoint2018 \n\u2022 Wachholtz A;Vohra R;Metzger A;A reanalysis of a random ized trial on meditation for migraine \nheadaches: Distraction is not enough but meditation ta kes time2019 \n\u2022 WeinsteinIsometric squeeze relaxation (progressive rel axation) vs meditation: absorption and \nfocusing as predictors of state effectsPercept Mot Skil ls1992 \n\u2022 Yunati M;Deshpande V;Yuwanate A;Dynamics of heart ra te induced by sahaja yoga meditation in \nhealthy normal subjects above 40 yearsNatl J Physiol Pharm Pharmacol2014 \n\u2022 Yunesian M;Aslani A;Vash JH;Yazdi AB;Effects of Transce ndental Meditation on mental health: a \nbefore-after study2008  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 117 \u2022 Zamarra JW;Schneider RH;Besseghini I;Robinson DK;Saler no JW;Usefulness of the transcendental \nmeditation program in the treatment of patients with  coronary artery disease1996 \nINTERVENCI\u00d3N \n\u2022 Ascone L;Sundag J;Schlier B;Lincoln TM;Feasibility and  Effects of a Brief Compassion-Focused \nImagery Intervention in Psychotic Patients with Paranoi d Ideation: A Randomized Experimental Pilot \nStudyClinical Psychology & Psychotherapy 24(2):348-358,20 16 \n\u2022 Barnes VA;Davis HC;Murzynowski JB;Treiber FA;Impact of m editation on resting and ambulatory \nblood pressure and heart rate in youthPsychosomatic Medic ine 66(6):909-14,2004 \n\u2022 Barnes VA;Gregoski MJ;Tingen MS;Treiber FA;Influences of family environment and meditation \nefficacy on hemodynamic function among African Ameri can adolescentsJournal of complementary & \nintegrative medicine2010 \n\u2022 Braehler C;Gumley A;Harper J;Wallace S;Norrie J;Gilb ert P;Exploring change processes in \ncompassion focused therapy in psychosis: results of a feasib ility randomized controlled trialBritish \nJournal of Clinical Psychology 52(2):199-214,2013 \n\u2022 Brazier A;Mulkins A;Verhoef M;Evaluating a yogic breat hing and meditation intervention for \nindividuals living with HIV/AIDSAmerican Journal of He alth Promotion2020 \n\u2022 Brown P;Waite F;Rovira A;Nickless A;Freeman D;Virtual  reality clinical-experimental tests of \ncompassion treatment techniques to reduce paranoiaScie ntific reports2020 \n\u2022 Buijze GA;De Jong HMY;Kox M;van de Sande MG;Van Scha ardenburg D;Van Vugt RM;Popa \nCD;Pickkers P;Baeten DLP;An add-on training program involving breathing exercises, cold exposure, \nand meditation attenuates inflammation and disease act ivity in axial spondyloarthritis - A proof of \nconcept trialPLoS ONE [Electronic Resource] 14(12): e0225749,2019 \n\u2022 Butler LD;Waelde LC;Hastings TA;Chen XH;Symons B;Marsha ll J;Kaufman A;Nagy TF;Blasey \nCM;Seibert EO;Spiegel D;Meditation with yoga, group  therapy with hypnosis, and psychoeducation \nfor long-term depressed mood: a randomized pilot tria lJournal of Clinical Psychology 64(7):806-\n20,2008 \n\u2022 Campbell IN;Gallagher M;McLeod HJ;O'Neill B;McMilla n TM;Brief compassion focused imagery for \ntreatment of severe head injuryNeuropsychological Rehabi litation 29(6):917-927,2017 \n\u2022 Canter PH;Meditation in chronic heart failure: Sign ificance of results not clearFocus on Alternative \nand Complementary Therapies2005 \n\u2022 Carlyle M;Rockliff H;Edwards R;Ene C;Karl A;Marsh B;Ha rtley L;Morgan CJ;Investigating the \nFeasibility of Brief Compassion Focused Therapy in Indivi duals in Treatment for Opioid Use \nDisorderSubstance Abuse 13:1178221819836726,2019 \n\u2022 Cheong MJ;Son SE;Kang HW;Lee Y;Bae KH;Kang Y;Lee EM ;Lee GE;Seo JH;Weon HW;Lee JY;Lyu \nYS;Meditation-based clinical study to determine the c orrelation of quantitative electroencephalogram \n(qEEG) and 24-hour EEG activityMedicine 97(43):e12557 ,2018 \n\u2022 Colgary CD;Dong S;Fisher PH;One-Session Mindfulness versu s Concentrative Meditation: the Effects \nof Stress AnticipationAmerican journal of health educ ation2020 \n\u2022 Crane C;Jandric D;Barnhofer T;Williams JM;Dispositiona l mindfulness, meditation, and conditional \ngoal setting: ErratumMindfulness (N Y)2011 \n\u2022 Crane C;Jandric D;Barnhofer T;Williams JMG;Dispositio nal mindfulness, meditation, and conditional \ngoal settingMindfulness (N Y)2010 \n\u2022 Daneshvar S;Shafiei M;Basharpoor S;Group-based Compassio n-focused Therapy on Experiential \nAvoidance, Meaning-in-life, and Sense of Coherence in  Female Survivors of Intimate Partner Violence \nwith PTSD: A Randomized Controlled TrialJ Interpers Violence2020 \n\u2022 DeBerry S;The effects of mediation-relaxation on anx iety and depression in a geriatric \npopulationPsychotherapy (Chic)1982 \n\u2022 Dhokia M;Elander J;Clements K;Gilbert P;A Randomized -Controlled Pilot Trial of an Online \nCompassionate Mind Training Intervention to Help Peo ple With Chronic Pain Avoid Analgesic \nMisusePsychol Addict Behav2020 \n\u2022 Downey L;Diehr P;Standish LJ;Patrick DL;Kozak L;Fishe r D;Congdon S;Lafferty WE;Might massage \nor guided meditation provide 'means to a better end'?  Primary outcomes from an efficacy trial with \npatients at the end of life2009 \n\u2022 Feldman G;Greeson J;Senville J;Differential effects of mindful breathing, progressive muscle \nrelaxation, and loving-kindness meditation on decente ring and negative reactions to repetitive \nthoughts2010  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  118 \u2022 Feliu-Soler A;Pascual JC;Elices M;Martin-Blanco A;Ca rmona C;Cebolla A;Simon V;Soler J;Fostering \nSelf-Compassion and Loving-Kindness in Patients With Bo rderline Personality Disorder: A \nRandomized Pilot Study2016 \n\u2022 Gharraee B;Tajrishi KZ;Farani AR;Bolhari J;Farahani H;A randomized controlled trial of compassion \nfocused therapy for social anxiety disorderIran J Psyc hiatr Behav Sci2018 \n\u2022 Grepmair L;Mitterlehner F;Loew T;Bachler E;Rother W ;Nickel M;Promoting mindfulness in \npsychotherapists in training influences the treatment results of their patients: a randomized, double-\nblind, controlled study2007 \n\u2022 Grepmair L;Mitterlehner F;Loew T;Nickel M;Promotion  of mindfulness in psychotherapists in training: \npreliminary study2007 \n\u2022 Halamov\u00e1Psychological and physiological effects of emoti on focused training for self-compassion \nand self-protectionResearch in Psychotherapy: Psychopath ology, Process and Outcome2019 \n\u2022 Haukaas RB;Gjerde IB;Varting G;Hallan HE;Solem S;A r andomized controlled trial comparing the \nattention training technique and mindful self-compassi on for students with symptoms of depression \nand anxietyFront Psychol2018 \n\u2022 Hidderley M;Holt M;A pilot randomized trial assessing t he effects of autogenic training in early stage \ncancer patients in relation to psychological status an d immune system responsesEur J Oncol \nNurs2004 \n\u2022 Hooff Madelon LM;Baas M;Recovering by means of meditati on: the role of recovery experiences and \nintrinsic motivationPsychologie appliquee [Applied psycho logy]2012 \n\u2022 Hudson MP;Thompson AR;Emerson LM;Compassion-focused se lf-help for psychological distress \nassociated with skin conditions: a randomized feasibilit y trialPsychol Health2020 \n\u2022 Huerin M;Ju+\u00edrez WM;Lobo M;Rodr+\u00a1guez J;Lago N;Rost an M;Liprandi +;Impact of a meditation \nprogram on pulse-wave velocity, C-reactive protein and quality of lifeRev Argent Cardiol2015 \n\u2022 Johnson M;A randomized study of a novel Zen dialogue m ethod for producing spiritual and well-\nbeing enhancement: implications for end-of-life care 2010 \n\u2022 Kaplan KH;Goldenberg DL;Galvin-Nadeau M;The impact o f a meditation-based stress reduction \nprogram on fibromyalgia1993 \n\u2022 Kelly AC;Carter JC;Self-compassion training for binge eating disorder: a pilot randomized controlled \ntrial2014 \n\u2022 Kelly AC;Waring SV;A feasibility study of a 2-week self-c ompassionate letter-writing intervention for \nnontreatment seeking individuals with typical and atyp ical anorexia nervosaInt J Eating Disord2018 \n\u2022 Kelly AC;Wisniewski L;Martin-Wagar C;Hoffman E;Group-B ased Compassion-Focused Therapy as an \nAdjunct to Outpatient Treatment for Eating Disorders:  A Pilot Randomized Controlled Trial2016 \n\u2022 Kelly AC;Zuroff DC;Foa CL;Gilbert P;Who benefits from  training in self-compassionate self-\nregulation? A study of smoking reductionJournal of soc ial and clinical psychology2010 \n\u2022 Kelman AR;Evare BS;Barrera AZ;Mu+\u00a6oz RF;Gilbert P;A proofG\u00c7\u00c9ofG\u00c7\u00c9concept pilot randomized \ncomparative trial of brief internetG\u00c7\u00c9based compassiona te mind training and \ncognitiveG\u00c7\u00c9behavioral therapy for perinatal and int ending to become pregnant womenClin Psychol \nPsychother2018 \n\u2022 Kirby JN;Baldwin S;A Randomized Micro-trial of a Lovi ng-Kindness Meditation to Help Parents \nRespond to Difficult Child Behavior VignettesJournal o f child and family studies2018 \n\u2022 Kurdi MS;Gasti V;Intraoperative Meditation Music as an  Adjunct to Subarachnoid Block for the \nImprovement of Postoperative Outcomes Following Cesare an Section: A Randomized Placebo-\ncontrolled Comparative Study2018 \n\u2022 Latifi Z;Soltani M;Mousavi S;Evaluation of the effect iveness of self-healing training on self-\ncompassion, body image concern, and recovery process in p atients with skin cancerComplement \nTher Clin Pract2020 \n\u2022 Lavender A;Startup H;Naumann U;Samarawickrema N;DeJo ng H;Kenyon M;van den EF;Schmidt \nU;Emotional and social mind training: a randomised c ontrolled trial of a new group-based treatment \nfor bulimia nervosa2012 \n\u2022 Lee SH;Ahn SC;Lee YJ;Choi TK;Yook KH;Suh SY;Effecti veness of a meditation-based stress \nmanagement program as an adjunct to pharmacotherapy i n patients with anxiety disorder2007 \n\u2022 Lee SH;Hwang SM;Kang DH;Yang HJ;Brain education-bas ed meditation for patients with \nhypertension and/or type 2 diabetes: A pilot randomized  controlled trial2019 \n\u2022 Lee SY;Kang J;Effect of virtual reality meditation on  sleep quality of intensive care unit patients: A \nrandomised controlled trial2020  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 119 \u2022 Leite JR;Ornellas FL;Amemiya TM;de Almeida AA;Dias AA ;Afonso R;Little S;Kozasa EH;Effect of \nprogressive self-focus meditation on attention, anxiety,  and depression scores2010 \n\u2022 Lincoln TM;Hohenhaus F;Hartmann M;Can paranoid thoug hts be reduced by targeting negative \nemotions and self-esteem? An experimental investigation  of a brief compassion-focused \ninterventionCogn Ther Res2013 \n\u2022 Lindsay EK;Chin B;Greco CM;Young S;Brown KW;Wright AG C;Smyth JM;Burkett D;Creswell JD;How \nmindfulness training promotes positive emotions: dismant ling acceptance skills training in two \nrandomized controlled trialsJ Pers Soc Psychol2018 \n\u2022 Lindsay EK;Young S;Brown KW;Smyth JM;Creswell JD;Mindfu lness training reduces loneliness and \nincreases social contact in a randomized controlled t rialProceedings of the national academy of \nsciences of the united states of america2019 \n\u2022 Lindsay EK;Young S;Smyth JM;Brown KW;Creswell JD;Accept ance lowers stress reactivity: \ndismantling mindfulness training in a randomized contr olled trial2018 \n\u2022 Logie K;Frewen P;Self/other referential processing fo llowing mindfulness and loving-kindness \nmeditationMindfulness (N Y)2014 \n\u2022 Lucre KM;Corten N;An exploration of group compassion- focused therapy for personality \ndisorderPsychol Psychother2013 \n\u2022 Magill M;Colby SM;Orchowski L;Murphy JG;Hoadley A;Braz il LA;Barnett NP;How does brief \nmotivational intervention change heavy drinking and h arm among underage young adult drinkers?J \nConsult Clin Psychol2017 \n\u2022 Mak WW;Tong AC;Yip SY;Lui WW;Chio FH;Chan AT;Wong C C;Efficacy and Moderation of Mobile \nApp-Based Programs for Mindfulness-Based Training, Self -Compassion Training, and Cognitive \nBehavioral Psychoeducation on Mental Health: Randomize d Controlled Noninferiority Trial2018 \n\u2022 Millstine DM;Bhagra A;Jenkins SM;Croghan IT;Stan DL; Boughey JC;Nguyen MT;Pruthi S;Use of a \nWearable EEG Headband as a Meditation Device for Wom en With Newly Diagnosed Breast Cancer: A \nRandomized Controlled Trial2019 \n\u2022 Mishra S;Sailesh KS;Bashetti S;Ashok S;Archana R;Mukkad an JK;Reddy UK;Beneficial effects of \nheart fullness meditation on depression, anxiety, stress and cognition in school children of rural area \nof TelanganaJournal of chemical and pharmaceutical sciences2017 \n\u2022 Miyahara M;Wilson R;Pocock T;Kano T;Fukuhara H;How d oes brief guided mindfulness meditation \nenhance empathic concern in novice meditators?: A pil ot test of the suggestion hypothesis vs The \nmindfulness hypothesisCurr Psychol2020 \n\u2022 Moffitt RL;Neumann DL;Williamson SP;Comparing the e fficacy of a brief self-esteem and self-\ncompassion intervention for state body dissatisfaction an d self-improvement motivation2018 \n\u2022 Moritz S;Quan H;Rickhi B;Liu M;Angen M;Vintila R;Sa wa R;Soriano J;Toews J;A home study-based \nspirituality education program decreases emotional dist ress and increases quality of life--a \nrandomized, controlled trialAltern Ther Health Med2 006 \n\u2022 Noorbala F;Borjali A;Ahmadian-Attari MM;Noorbala AA ;Effectiveness of Compassionate Mind \nTraining on Depression, Anxiety, and Self-Criticism in  a Group of Iranian Depressed PatientsIranian \njournal of psychiatry2013 \n\u2022 Obasi CN;Brown R;Ewers T;Barlow S;Gassman M;Zgierska A; Coe CL;Barrett B;Advantage of \nmeditation over exercise in reducing cold and flu il lness is related to improved function and quality of \nlife2013 \n\u2022 Ong JC;Manber R;Segal Z;Xia Y;Shapiro S;Wyatt J;A ra ndomized controlled trial of mindfulness \nmeditation for chronic insomnia: long-term outcomes 2014 \n\u2022 Ong JC;Xia Y;Smith-Mason CE;Manber R;A randomized co ntrolled trial of mindfulness meditation for \nchronic insomnia: Effects on daytime symptoms and cog nitive-emotional arousalMindfulness (N \nY)2018 \n\u2022 Palmeira L;Pinto-Gouveia J;Cunha M;Exploring the eff icacy of an acceptance, mindfulness & \ncompassionate-based group intervention for women strugg ling with their weight (Kg-Free): A \nrandomized controlled trial2017 \n\u2022 Pandya SP;Meditation for treating adults with bipola r disorder II: A multi-city study2019 \n\u2022 Pandya SP;Older Adults Who Meditate Regularly Perform  Better on Neuropsychological Functioning \nand Visual Working Memory Tests: A Three-month Waitlist  Control Design Study with a Cohort of \nSeniors in Assisted Living FacilitiesExp Aging Res2020 \n\u2022 Patel CH;Biofeedback aided relaxation and meditatio n in the management of \nhypertensionBIOFEEDBACK SELF-REGUL1977  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  120 \u2022 Patra S;Telles S;Positive impact of cyclic meditation on subsequent sleep2009 \n\u2022 Philips KH;Brintz CE;Moss K;Gaylord SA;Didgeridoo Soun d Meditation for Stress Reduction and \nMood Enhancement in Undergraduates: A Randomized Con trolled TrialGlobal Adv Health Med2019 \n\u2022 Polich G;Gray S;Tran D;Morales-Quezada L;Glenn M;Com paring focused attention meditation to \nmeditation with mobile neurofeedback for persistent sy mptoms after mild-moderate traumatic brain \ninjury: a pilot study2020 \n\u2022 Pomykala KL;Silverman DH;Geist CL;Voege P;Siddarth P; Nazarian N;Cyr NMS;Khalsa DS;Lavretsky \nH;A pilot study of the effects of meditation on region al brain metabolism in distressed dementia \ncaregivers2012 \n\u2022 Prakhinkit S;Suppapitiporn S;Tanaka H;Suksom D;Effec ts of Buddhism walking meditation on \ndepression, functional fitness, and endothelium-depend ent vasodilation in depressed elderly2020 \n\u2022 Reis NA;Kowalski KC;Ferguson LJ;Sabiston CM;Sedgwick WA ;Crocker PRE;Self-compassion and \nwomen athletes' responses to emotionally difficult spor t situations: an evaluation of a brief \ninductionPsychology of sport and exercise2015 \n\u2022 Renner KA;Valentiner DP;Holzman JB;Focus-of-attenti on behavioral experiment: an examination of a \ntherapeutic procedure to reduce social anxiety2017 \n\u2022 Rodgers RF;Donovan E;Cousineau T;Yates K;McGowan K;Coo k E;Lowy AS;Franko DL;BodiMojo: \nEfficacy of a Mobile-Based Intervention in Improving Body Image and Self-Compassion among \nAdolescents2018 \n\u2022 Rohsenow DJ;Monti PM;Martin RA;Colby SM;Myers MG;Gullive r SB;Brown RA;Mueller TI;Gordon \nA;Abrams DB;Motivational enhancement and coping skil ls training for cocaine abusers: effects on \nsubstance use outcomes2004 \n\u2022 Sadeghi ZH;Yazdi-Ravandi S;Pirnia B;Compassion-focused  therapy on levels of anxiety and \ndepression among women with breast cancer: A randomiz ed pilot trialInternat Jour of Canc \nManagt2018 \n\u2022 Sampaio C;Magnavita G;Ladeia AM;Effect of Healing Me ditation on Weight Loss and Waist \nCircumference of Overweight and Obese Women: Randomiz ed Blinded Clinical Trial2019 \n\u2022 Sampaio CV;Lima MG;Ladeia AM;Efficacy of Healing med itation in reducing anxiety of individuals at \nthe phase of weight loss maintenance: A randomized bli nded clinical trial2016 \n\u2022 Seppala EM;Nitschke JB;Tudorascu DL;Hayes A;Goldstei n MR;Nguyen DT;Perlman D;Davidson \nRJ;Breathing-based meditation decreases posttraumatic stress disorder symptoms in U.S. military \nveterans: a randomized controlled longitudinal study20 14 \n\u2022 Shaltout HA;Tooze JA;Rosenberger E;Kemper KJ;Time, touch, and compassion: effects on \nautonomic nervous system and well-being2012 \n\u2022 Sharma A;Barrett MS;Cucchiara AJ;Gooneratne NS;Thase  ME;A Breathing-Based Meditation \nIntervention for Patients With Major Depressive Disorder Following Inadequate Response to \nAntidepressants: A Randomized Pilot Study2017 \n\u2022 Sommers-Spijkerman MPJ;Trompetter HR;Schreurs KMG;Bo hlmeijer ET;Compassion-focused \ntherapy as guided self-help for enhancing public men tal health: A randomized controlled trial2018 \n\u2022 Sonnex C;Roe CA;Roxburgh EC;Testing the Pagan Prescr iption: using a Randomized Controlled Trial \nto Investigate Pagan Spell-Casting as a Form of Noncon tact HealingJ Altern Complement Med2020 \n\u2022 Sood A;Sharma V;Schroeder DR;Gorman B;Stress Managem ent and Resiliency Training (SMART) \nprogram among Department of Radiology faculty: a pilo t randomized clinical trialExplore (New York, \nN Y )2014 \n\u2022 Stevenson J;Mattiske JK;Nixon RDV;The effect of a bri ef online self-compassion versus cognitive \nrestructuring intervention on trait social anxietyBeha v Res Ther2019 \n\u2022 Tloczynski J;A preliminary study of opening-up meditati on college adjustment, and self-\nactualization1994 \n\u2022 Toole AM;Craighead LW;Brief self-compassion meditation  training for body image distress in young \nadult women2016 \n\u2022 Tsai SL;Crockett MS;Effects of relaxation training, c ombining imagery, and meditation on the stress \nlevel of Chinese nurses working in modern hospitals in  Taiwan1993 \n\u2022 Turan B;Foltz C;Cavanagh JF;Wallace BA;Cullen M;Rosen berg EL;Jennings PA;Ekman P;Kemeny \nME;Anticipatory sensitization to repeated stressors: the  role of initial cortisol reactivity and \nmeditation/emotion skills training2015 \n\u2022 Vandana B;Vaidyanathan K;Saraswathy LA;Sundaram KR;Kum ar H;Impact of integrated amrita \nmeditation technique on adrenaline and cortisol level s in healthy volunteersEvid -Based Complement  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 121 Altern Med2011 \n\u2022 Venturelli M;Ce E;Limonta E;Schena F;Caimi B;Carugo  S;Veicsteinas A;Esposito F;Effects of \nendurance, circuit, and relaxing training on cardio vascular risk factors in hypertensive elderly \npatients2015 \n\u2022 Venuturupalli RS;Chu T;Vicari M;Kumar A;Fortune N;S pielberg B;Virtual Reality+\u00f3G\u00e9\u00bcG\u00c7\u00a3Based \nBiofeedback and Guided Meditation in Rheumatology: a  Pilot StudyACR open rheumatology2019 \n\u2022 Vimalakanthan K;Kelly AC;Trac S;From competition to compassion: A caregiving approach to \nintervening with appearance comparisonsBody Image 25: 148-162,2018 \n\u2022 Wallmark E;Safarzadeh K;Daukantaite D;Maddux Rachel  E;Promoting altruism through meditation: an \n8-week randomized controlled pilot studyMindfulness201 3 \n\u2022 Wells RE;Collier J;Posey G;Morgan A;Auman T;Strittmat ter B;Magalhaes R;Adler-Neal A;McHaffie \nJG;Zeidan F;Attention to breath sensations does not eng age endogenous opioids to reduce \npainPain2020 \nMEDIDAS DE RESULTADO \n\u2022 Bach Jennifer M;Guse T;The effect of contemplation a nd meditation on 'great compassion' on the \npsychological well-being of adolescentsJournal of positi ve psychology2015 \n\u2022 Barnes VA;Bauza LB;Treiber FA;Impact of stress reductio n on negative school behavior in \nadolescents2003 \n\u2022 Beblo T;Pelster S;Schilling C;Kleinke K;Iffland B;D riessen M;Fernando S;Breath Versus Emotions: The \nImpact of Different Foci of Attention During Mindfu lness Meditation on the Experience of Negative \nand Positive Emotions2018 \n\u2022 Bormann JE;Carrico AW;Increases in positive reappraisal coping during a group-based mantram \nintervention mediate sustained reductions in anger in H IV-positive personsInt J Behav Med2009 \n\u2022 Brandon JE;Poppen R;A comparison of behavioral, medit ation, and placebo control relaxation \ntraining procedures1985 \n\u2022 Crawford JN;Talkovsky AM;Bormann JE;Lang AJ;Targeting  hyperarousal: Mantram Repetition \nProgram for PTSD in US veteransEur J Psychotraumatol20 19 \n\u2022 Credidio SG;Comparative effectiveness of patterned bi ofeedback vs meditation training on EMG and \nskin temperature changesBehav Res Ther1982 \n\u2022 Fredrickson BL;Cohn MA;Coffey KA;Pek J;Finkel SM;Open  hearts build lives: positive emotions, \ninduced through loving-kindness meditation, build conse quential personal resources2008 \n\u2022 Haaga DAF;Grosswald S;Gaylord-King C;Rainforth M;Tanne r M;Travis F;Effects of the transcendental \nmeditation program on substance use among university stud entsCardiology research and \npractice2011 \n\u2022 Hunsinger M;Livingston R;Isbell L;The impact of loving-k indness meditation on affective learning and \ncognitive controlMindfulness2013 \n\u2022 Isgett SF;Algoe SB;Boulton AJ;Way BM;Fredrickson BL;C ommon variant in OXTR predicts growth in \npositive emotions from loving-kindness trainingPsychoneuro endocrinology2016 \n\u2022 Jazaieri H;Jinpa GT;McGonigal K;Rosenberg EL;Finkels tein J;Simon-Thomas E;Cullen M;Doty \nJR;Gross JJ;Goldin PR;Enhancing compassion: A randomize d controlled trial of a compassion \ncultivation training programJournal of Happiness Stud ies: An Interdisciplinary Forum on Subjective \nWell-Being2013 \n\u2022 Lagopoulos J;Xu J;Rasmussen I;Vik A;Malhi GS;Eliassen CF;Arntsen IE;Saether JG;Hollup S;Holen \nA;Davanger S;Ellingsen O;Increased theta and alpha EE G activity during nondirective \nmeditationJournal of Alternative & Complementary Med icine 15(11):1187-92,2009 \n\u2022 Linden W;Practicing of meditation by school children  and their levels of field dependence-\nindependence, test anxiety, and reading achievementJ ournal of Consulting & Clinical Psychology \n41(1):139-43,1973 \n\u2022 Lutz A;Slagter HA;Rawlings NB;Francis AD;Greischar L L;Davidson RJ;Mental training enhances \nattentional stability: neural and behavioral evidenceJ ournal of Neuroscience 29(42):13418-27,2009 \n\u2022 MacLean CR;Walton KG;Wenneberg SR;Levitsky DK;Mandarin o JP;Waziri R;Hillis SL;Schneider \nRH;Effects of the Transcendental Meditation program o n adaptive mechanisms: changes in hormone \nlevels and responses to stress after 4 months of practiceP sychoneuroendocrinology 22(4):277-\n95,1997 \n\u2022 Mishra J;Sagar R;Parveen S;Kumaran S;Modi K;Maric V; Ziegler D;Gazzaley A;Closed-loop digital \nmeditation for neurocognitive and behavioral developm ent in adolescents with childhood  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  122 neglectTransl Psychiatry Psychiatry 10(1):153,2020 \n\u2022 Mohan A;Sharma R;Bijlani RL;Effect of meditation on  stress-induced changes in cognitive \nfunctionsJournal of Alternative & Complementary Medici ne 17(3):207-12,2011 \n\u2022 \u00d8ktedalen O;Solberg EE;Hauger AH;Opstad PK;The influ ence of physical and mental training on \nplasma beta-endorphin level and pain perception afte r intensive physical exerciseStress and \nHealth2001 \n\u2022 Puente AE;Beiman I;The effects of behavior therapy, se lf-relaxation, and transcendental meditation \non cardiovascular stress responseJournal of Clinical Psyc hology 36(1):291-5,1980 \n\u2022 Puente AE;Psychophysiological investigations on transcend ental meditationBiofeedback & Self \nRegulation 6(3):327-42,1981 \n\u2022 Ramsburg Jared T;Youmans Robert J;Meditation in the higher-education classroom: meditation \ntraining improves student knowledge retention during lecturesMindfulness2014 \n\u2022 Rosenberg EL;Zanesco AP;King BG;Aichele SR;Jacobs TL;B ridwell DA;MacLean KA;Shaver \nPR;Ferrer E;Sahdra BK;Lavy S;Wallace BA;Saron CD;Inte nsive meditation training influences \nemotional responses to sufferingEmotion 15(6):775-90, 2015 \n\u2022 Wachholtz AB;Malone CD;Pargament KI;Effect of Diffe rent Meditation Types on Migraine Headache \nMedication UseBehavioral Medicine 43(1):1-8,2017 \n\u2022 Wenk-Sormaz H;Meditation can reduce habitual respon dingAlternative Therapies in Health & \nMedicine 11(2):42-58,2005 \n\u2022 Wenneberg SR;Schneider RH;Walton KG;MacLean CR;Levit sky DK;Salerno JW;Wallace \nRK;Mandarino JV;Rainforth MV;Waziri R;A controlled study of the effects of the Transcendental \nMeditation program on cardiovascular reactivity and a mbulatory blood pressureInternational Journal \nof Neuroscience 89(1-2):15-28,1997 \n\u2022 Ziegler DA;Simon AJ;Gallen CL;Skinner S;Janowich JR ;Volponi JJ;Rolle CE;Mishra J;Kornfield \nJ;Anguera JA;Gazzaley A;Closed-loop digital meditatio n improves sustained attention in young \nadultsNature Human Behaviour 3(7):746-757,2019 \nOBJETIVO \n\u2022 Baldwin S;Bandarian-Balooch S;Adams R;Attachment and  compassion-threat: Influence of a secure \nattachment-primePsychology and psychotherapy2019 \n\u2022 Bormann JE;Oman D;Walter KH;Johnson BD;Mindful atte ntion increases and mediates psychological \noutcomes following mantram repetition practice in ve terans with posttraumatic stress \ndisorderMedical Care2014 \n\u2022 Lee WL;Sung HC;Liu SH;Chang SM;Meditative music listen ing to reduce state anxiety in patients \nduring the uptake phase before positron emission tomogr aphy (PET) scansBritish Journal of \nRadiology 90(1070):20160466,2017 \n\u2022 Pagliaro G;Pandolfi P;Collina N;Frezza G;Brandes A;G alli M;Avventuroso FM;De Lisio S;Musti \nMA;Franceschi E;Esposti RD;Lombardo L;Cavallo G;Di B attista M;Rimondini S;Poggi R;Susini \nC;Renzi R;Marconi L;A Randomized Controlled Trial o f Tong Len Meditation Practice in Cancer \nPatients: Evaluation of a Distant Psychological Healing  EffectExplore: The Journal of Science & \nHealing 12(1):42-9,2016 \n\u2022 Rieck TM;Lee JR;Ferguson JA;Peterson LA;Martin Lilli e CM;Clark MM;Limburg PJ;Bauer BA;A \nRandomized Controlled Trial in the Evaluation of a N ovel Stress Management Tool: A Lounge Chair \nExperienceGlobal Advances In Health and Medicine2019 \n\u2022 Schneider RH;Alexander CN;Staggers F;Rainforth M;Sal erno JW;Hartz A;Arndt S;Barnes VA;Nidich \nSI;Long-term effects of stress reduction on mortality in persons > or = 55 years of age with systemic \nhypertensionAmerican Journal of Cardiology 95(9):1060- 4,2005 \n\u2022 Smith JC;Personality correlates of continuation and ou tcome in meditation and erect sitting control \ntreatmentsJournal of Consulting and Clinical Psycholog y1978 \n\u2022 Sollgruber A;Bornemann-Cimenti H;Szilagyi IS;Sandner -Kiesling A;Spirituality in pain medicine: A \nrandomized experiment of pain perception, heart rat e and religious spiritual well-being by using a \nsingle session meditation methodologyPLoS ONE [Electron ic Resource] 13(9):e0203336,2018 \nIDIOMA \n\u2022 Lu CF;Liao JC;Liu CY;Liu HY;Chang YH;Meditation the rapy in the treatment of anxiety \ndisordersTaiwanese journal of psychiatry1998 \n\u2022 Shim JY;Analysis of Stress Hormone Reaction According t o DoIn Exercise and Meditation \nProgramKorea sport research2004  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 123 DUPLICADOS \n\u2022 Oman D;Richards TA;Hedberg J;Thoresen CE;Passage medit ation improves caregiving self-efficacy \namong health professionals: a randomized trial and qua litative assessmentJournal of Health \nPsychology 13(8):1119-35,2008  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  124 Anexo 5. Caracter\u00edsticas de los estudios inc Anexo 5. Caracter\u00edsticas de los estudios inc Anexo 5. Caracter\u00edsticas de los estudios inc Anexo 5. Caracter\u00edsticas de los estudios incluidos luidos luidos luidos    \nTabla 4. Caracter\u00edsticas de las Revisiones Sistem\u00e1t icas incluidas \n1er  autor \n(a\u00f1o) Bases de datos \nconsultadas y fecha \nde b\u00fasqueda Tipo de \nmeditaci\u00f3n Criterios de selecci\u00f3n N\u00ba estudios \nincluidos  Evaluaci\u00f3n \ndel riesgo de \nsesgo Medidas de \nresultado incluidas \nGalante \n(2014) \n[51] Central, Medline, \nEmbase, AMED, \nPsycINFO, CINAHL \nPlus, ASSIA y Google \nScholar. \n \nB\u00fasqueda hasta marzo \nde 2013 Meditaci\u00f3n \nbasada en la \nbondad o \ncompasi\u00f3n 1)  Poblaci\u00f3n adulta \n2)  Dise\u00f1o: ECA  \n3)  Art\u00edculos publicados en revistas revisadas por pares, tesis \no actas de congresos \n4)  Presentar medidas de resultados relacionados con la \nsalud y/o el bienestar \n5)  Intervenciones principalmente basadas en cualquier tipo  \nde meditaci\u00f3n basada en la bondad. Las intervenciones \nse consideraron principalmente como una forma de \nmeditaci\u00f3n basada en la bondad si: A) el objetivo prin cipal \nexpl\u00edcito de la intervenci\u00f3n era generar intencional mente \nbondad/compasi\u00f3n en algunas de sus formas; B) los \nejercicios de meditaci\u00f3n basada en la bondad/compasi\u00f3n  \neran predominantes (> del 50% de los ejercicios) 22 estudios \n(ECAs) \n \n18 sobre LKM, \nmeditaci\u00f3n Tonglen y \nentrenamiento en \ncompasi\u00f3n \n \n4 sobre CBCT/MS/ \nmanejo del estr\u00e9s a \ntrav\u00e9s del perd\u00f3n  Criterios \nCochrane - Bienestar \n- Calidad de vida \n- Dolor \n- Depresi\u00f3n \n- Ansiedad \n- Estr\u00e9s \n- Altruismo \n- Empat\u00eda \n- Compasi\u00f3n \n- Mindfulness  \n- Efectos adversos \nGathright \n(2019) \n[60] PubMed, PsycINFO, \nCINAHL, Cochrane \nLibrary, Web of \nScience, secciones de \nreferencia de art\u00edculos \nincluidos, tablas de \ncontenido de revistas y \nbases de datos de \ninvestigaci\u00f3n (NIH \nRePORTer y \nClinicalTrials.gov) \n \nB\u00fasqueda hasta junio \nde 2019 Meditaci\u00f3n \nTrascendental 1)  Poblaci\u00f3n adulta con hipertensi\u00f3n u otra enfermedad  \ncardiovascular \n2)  Dise\u00f1o: ECA o cuasi-experimental \n3)  Presentar datos de evaluaci\u00f3n de un estado psicol\u00f3gico \n(p.e. depresi\u00f3n) y/o resultado fisiol\u00f3gico (p.e., presi \u00f3n \nsangu\u00ednea) \n4)  Presentar datos para calcular los tama\u00f1os del efecto \n5)  No restricciones por idioma ni ubicaci\u00f3n geogr\u00e1fica 9 estudios \n(8 ECAs 1 \nECNA) \n \nTodos sobre  \nmeditaci\u00f3n \nTrascendental  Escala \nJadad - Presi\u00f3n sangu\u00ednea \n- Depresi\u00f3n \nGoyal \n(2014) [4] MEDLINE, PsycINFO, \nEMBASE, SCOPUS, \nCINAHL, AMED, Distintos tipos de \nmeditaci\u00f3n 1)  Poblaci\u00f3n adulta con diagn\u00f3stico cl\u00ednico (m\u00e9dico o \npsiqui\u00e1trico), definido como cualquier afecci\u00f3n (p.e ., \npresi\u00f3n arterial alta, ansiedad), incluido un factor 47 estudios \n(ECAs) Criterios \nCochrane y \nGu\u00eda - Ansiedad \n- Depresi\u00f3n \n- Estr\u00e9s   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 125 Tabla 4. Caracter\u00edsticas de las Revisiones Sistem\u00e1t icas incluidas \n1er  autor \n(a\u00f1o) Bases de datos \nconsultadas y fecha \nde b\u00fasqueda Tipo de \nmeditaci\u00f3n Criterios de selecci\u00f3n N\u00ba estudios \nincluidos  Evaluaci\u00f3n \ndel riesgo de \nsesgo Medidas de \nresultado incluidas \nPsycArticles y \nCochrane Library \n \nB\u00fasqueda hasta junio \nde 2013  estresante (se excluyeron los estudios con personas \nsanas) \n2)  Cualquier programa de meditaci\u00f3n estructurada que \ncontenga al menos 4 horas de entrenamiento con \ninstrucciones para practicar fuera de la sesi\u00f3n de \nentrenamiento; incluido: 1) Basada en Mindfulness; 2) \nBasada en mantras; 3) Otra meditaci\u00f3n \n3)  Se excluyeron los programas de meditaci\u00f3n en los que la  \nmeditaci\u00f3n no era la base y la mayor\u00eda de la intervenci \u00f3n \n4)  Dise\u00f1o: ECA con control activo y estudios longitudinale s \nque ocurriesen en entornos generales y cl\u00ednicos \n5)  El control activo para los estudios se defini\u00f3 como un \nprograma que se adaptaba en tiempo y atenci\u00f3n al grup o \nde intervenci\u00f3n con el prop\u00f3sito de igualar las \nexpectativas de beneficio. Pod\u00edan ser: A) un control a ctivo \nno espec\u00edfico s\u00f3lo coincide con el tiempo y la atenci\u00f3 n, y \nno es una terapia conocida; B) un control activo \nespec\u00edfico compara la intervenci\u00f3n con otra terapia \nconocida, como la relajaci\u00f3n muscular progresiva  \n36 sobre \nMindfulness \n \n11 sobre mantras \n Evidence-\nbased \nPractice \nCenter \nMethods   \n - Afecto positivo y \nnegativo \n- Calidad de vida \n- Atenci\u00f3n \n- Calidad de sue\u00f1o \n- Uso de sustancias \n- Dolor \n- Peso \nOrme-\nJohnson \n(2014) \n[59] PubMed, Cochrane \nCollaboration, \nDissertation Abstracts \nInternational, bibli \nograf\u00edas de meditaci\u00f3n, \nart\u00edculos de revisi\u00f3n y \nantolog\u00edas de \ninvestigaci\u00f3n \nB\u00fasqueda desde 1970 \nhasta 2012 Meditaci\u00f3n \nTrascendental 1)  Presentar datos de los resultados de la t\u00e9cnica est\u00e1ndar \nde meditaci\u00f3n trascendental como tratamiento \n2)  Inclusi\u00f3n de uno o m\u00e1s grupos de control o de \ncomparaci\u00f3n \n3)  Participantes asignados al azar a grupos experimentales \ny de control \n4)  Presentar datos sobre el cambio longitudinal a lo larg o \ndel tiempo \n5)  Presentar medidas de resultado en ansiedad 14 estudios \n(ECAs) \n \nTodos sobre  \nmeditaci\u00f3n \nTrascendental  CLEAR score \nchecklist - Ansiedad \nCBCT: Entrenamiento en compasi\u00f3n de base cognitiva (Cognitively based compassion training) ; ECAs: Ensayos Controlados Aleatorizados; ECNA: Ensayos Cont rolados No Aleatorizados; MS:  \nAutocompasi\u00f3n consciente (Mindful selfcompassion);  LKM: meditaci\u00f3n basada en la bondad y amor ( Loving-kindness meditation ) \n  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  126 Tabla 5. Caracter\u00edsticas de los estudios primarios incluidos \nMEDITACI\u00d3N TRASCENDENTAL (MT) \nPoblaci\u00f3n cl\u00ednica \n1er  autor  (a\u00f1o), \npa\u00eds  Poblaci\u00f3n Muestra  Caracter\u00edsticas de las sesiones de \nintervenci\u00f3n  Comparador (GC) Duraci\u00f3n \nintervenci\u00f3n y \nseguimiento Medidas de resultado \nde inter\u00e9s (instrumentos \nutilizados) \nBokhari \n(2019)[66], \nEE.UU.  Enfermedad \ncoronaria  N = 56 aleatorizados \nEdad media: 63 a\u00f1os \nMujeres: 35%  Sesiones individuales y grupales de 60-\n90 min durante 6 d\u00edas + 5 sesiones de \nseguimiento  \u2022 Rehabilitaci\u00f3n cardiaca \nest\u00e1ndar con ejercicio \nf\u00edsico \n\u2022 Rehabilitaci\u00f3n cardiaca \nest\u00e1ndar con ejercicio \nf\u00edsico + Meditaci\u00f3n \ntrascendental \n\u2022 Atenci\u00f3n habitual 12 semanas \nNo seguimiento  \u2022 Reserva de flujo \nmioc\u00e1rdico \n\u2022 Presi\u00f3n sangu\u00ednea \n\u2022 Factores de riesgo: \no Depresi\u00f3n (BDI-II) \no Sintomatolog\u00eda \ngeneral (GHQ) \nBrooks \n(1985)[72], \nEE.UU. 1 Veteranos de \nguerra con \nTEPT  N =18 aleatorizados \nEdad media: 33.3 a\u00f1os \nMujeres: 0%  Sesiones diarias de 90 min, una al d\u00eda \ndurante 4 d\u00edas y sesiones semanales de \nseguimiento durante 3 meses + \nindicaci\u00f3n de meditar dos veces al d\u00eda \ndurante 20 min  \u2022 Psicoterapia grupal de \ntipo ecl\u00e9ctico 12 semanas \nNo seguimiento  \u2022 Gravedad del TEPT \n(entrevista DSM-III) \n\u2022 Ansiedad (TMAS) \n\u2022 Depresi\u00f3n (BDI-II) \nCastillo-\nRichmond \n(2000)[74], \nEE.UU. 2 Hipertensi\u00f3n N = 138 aleatorizados \nEdad media: 53.85 a\u00f1os  \nMujeres: 68.5% Sesiones individuales y grupales \ndurante una semana + 8 sesiones de \nrefuerzo + pr\u00e1ctica diaria de 20 min dos \nveces al d\u00eda \u2022 Educaci\u00f3n para la \nsalud 9 semanas \nNo seguimiento \n \u2022 Presi\u00f3n sangu\u00ednea  \n\u2022 Medida de \naterosclerosis (espesor \n\u00edntima-media \ncarot\u00eddeo) \nChhatre \n(2013)[76], \nEE.UU. 2 VIH-SIDA N = 22 aleatorizados \nEdad media: 49.,9 a\u00f1os \nMujeres: 14%  5 sesiones de 120 min durante 5 d\u00edas + \n9 sesiones de refuerzo + pr\u00e1ctica diaria \nde 20 min dos veces al d\u00eda \u2022 Educaci\u00f3n para la \nsalud 24 semanas \nNo seguimiento \u2022 Calidad de vida (FAHI; \nSF-36) \n\u2022 Depresi\u00f3n (CES-D) \n\u2022 Estr\u00e9s percibido (PSS) \nDuraimani Hipertensi\u00f3n N = 152 aleatorizados 6 sesiones individuales y grupales de \u2022 Educaci\u00f3n para la 16 semanas \u2022 Presi\u00f3n sangu\u00ednea   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 127 (2015)[83], \nEE.UU. 3 Edad media: 58.05 a\u00f1os  \nMujeres: 54.2% 90-120 min durante 6 d\u00edas + 2 sesiones \nde refuerzo de 60min + pr\u00e1ctica diaria \nde 20 min dos veces al d\u00eda salud No seguimiento \nHeffner \n(2016)[147], \nEE.UU. Veteranos de \nguerra con \nTEPT N = 79 aleatorizados \nEdad media: N.I. \nMujeres: 10% M. Trascendental: Sesiones individuales \ny grupales de 15-30min, dos veces al \nd\u00eda durante 5 d\u00edas + 10 sesiones de \nrefuerzo opcionales \nM. basada en mantras: Sesiones \ngrupales de 90 min, una vez a la \nsemana \u2022 Terapia de grupo \ncentrada en el presente 4 y 8 semanas \n \nSeguimiento 1 \ny 2 semanas \ndesde \nfinalizaci\u00f3n \nintervenci\u00f3n \u2022 Sintomatolog\u00eda TEPT \n(CAPS; PCL-S) \nJayadevappa \n(2007)[92],  \nEEUU 2,3  Insuficiencia \ncard\u00edaca \ncongestiva N = 23 aleatorizados \nEdad media: 64.1 a\u00f1os \nMujeres: 61% 7 sesiones individuales y grupales de 90 \nmin durante 7 d\u00edas + pr\u00e1ctica individual \ndiaria de 15-20 min, dos veces al d\u00eda + \n9 sesiones de refuerzo \u2022 Educaci\u00f3n para la \nsalud 24 semanas \nNo seguimiento \u2022 Calidad de vida (SF-\n36) \n\u2022 Depresi\u00f3n (CES-D) \n\u2022 Estr\u00e9s percibido (PSS) \n\u2022 Funcionalidad f\u00edsica \n(Six-minute-walk test ) \nJong \n(2019)[95], \nSuecia y \nPa\u00edses bajos Ni\u00f1os con \ncefalea  N = 131 aleatorizados \nEdad media: 13 a\u00f1os \nMujeres: 77% 5 sesiones individuales de 60-90 min + \npr\u00e1ctica diaria de 10 min dos veces al \nd\u00eda \u2022 Hipnoterapia \n\u2022 Relajaci\u00f3n muscular \nprogresiva 12 semanas \nSeguimiento a \nlos 9 meses \u2022 Frecuencia dolor de \ncabeza \n\u2022 Depresi\u00f3n y ansiedad \n(RCADS-25) \n\u2022 Afrontamiento del \ndolor (PCQ) \n\u2022 Somatizaci\u00f3n (CSI) \nNidich \n(2009a)[110], \nEE.UU. C\u00e1ncer de \nmama N =130 aleatorizados \nEdad media: 63.84 a\u00f1os  \nMujeres: 100% 7 sesiones individuales y grupales de \n60-90 min durante 7 d\u00edas + sesiones de \nrefuerzo mensuales (opcionales) + \npr\u00e1ctica diaria regular \u2022 Atenci\u00f3n habitual 72 semanas \nNo seguimiento \n \u2022 Calidad de vida (FACT-\nB; SF-36) \n\u2022 Mortalidad \nNidich \n(2016)[112], \nEE.UU. Internos de \nprisi\u00f3n con \nsintomatolog\u00eda \nTEPT N = 181 aleatorizados \nEdad media: 29 a\u00f1os \nMujeres: 0% 5 sesiones de 60 min + pr\u00e1ctica \nindividual de 20 min dos veces al d\u00eda + \nsesiones de refuerzo opcionales durante \nlas 16 semanas \u2022 Atenci\u00f3n habitual 16 semanas \nNo seguimiento \u2022 Sintomatolog\u00eda TETP \n(TSC-40 subescalas \ndepresi\u00f3n, ansiedad, \nproblemas de sue\u00f1o) \n\u2022 Estr\u00e9s percibido (PSS)  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  128 Nidich \n(2017)[113], \nEE.UU. Internas de \nprisi\u00f3n con \nsintomatolog\u00eda \nTEPT N = 22 aleatorizados \nEdad media: 45 a\u00f1os \nMujeres: 100% 2 sesiones individuales de 20 min dos \nveces al d\u00eda + sesiones grupales \nopcionales de 30-40 min dos veces por \nsemana durante las 16 semanas \u2022 Grupo de intervenci\u00f3n \ndiferida 16 semanas \nNo seguimiento \u2022 Sintomatolog\u00eda TETP \n(PCL-C) \nNidich \n(2018)[114], \nEE.UU. Veteranos de \nguerra con \nTEPT N = 203 aleatorizados \nEdad media:47 a\u00f1os \nMujeres:17% 12 sesiones grupales de 90 min \n(sesiones m\u00faltiples en la primera \nsemana, seguidas de sesiones \nposteriores espaciadas gradualmente \ndurante 12 semanas) + 40min diarios de \ntrabajo aut\u00f3nomo \u2022 Terapia de prolongada \n\u2022 Educaci\u00f3n para la \nsalud 12 semanas \nNo seguimiento \u2022 Sintomatolog\u00eda TEPT \n(CAPS; PCL-M) \n\u2022 Depresi\u00f3n (PHQ-9)  \n\u2022 Calidad de vida (Q-\nLES-Q) \n\u2022 Estado de \u00e1nimo \n(POMS) \nPaul-Labrador \n(2006)[118], \nEE.UU. 1,2,3  Enfermedad \ncoronaria N = 103 aleatorizados \nEdad media: 67.4 a\u00f1os \nMujeres: 18% 2 sesiones individuales de 60 min + 3 \nsesiones grupales de 90 min durante 6 \nd\u00edas + 2 sesiones grupales semanales \nde refuerzo durante 4 semanas y \nsesiones semanales hasta el final de la \nintervenci\u00f3n \u2022 Educaci\u00f3n para la \nsalud 16 semanas \nNo seguimiento \u2022 Presi\u00f3n sangu\u00ednea \nRaskin \n(1980)[120], \nEE.UU. 1 Estudiantes \ncon \nansiedad N = 37 aleatorizados \nEdad media: 34 a\u00f1os \nMujeres: 74.2% 4 d\u00edas consecutivos + sesiones \nsemanales de refuerzo + pr\u00e1ctica diaria \nde 20 min dos veces al d\u00eda \u2022 Retroalimentaci\u00f3n \nelectromiogr\u00e1fica \n\u2022 Relajaci\u00f3n 6 semanas de \nl\u00ednea base \n6 semanas \ntratamiento \nSeguimientos a \nlos 3, 6, 12 y 18 \nmeses \u2022 Ansiedad (TMAS; \nCMCL) \nRees \n(2013)[121], \nRep\u00fablica \nDemocr\u00e1tica \ndel Congo Refugiados \nde guerra \ncon TEPT N = 42 aleatorizados \nEdad media: 32 a\u00f1os \nMujeres: 62% 2 sesiones individuales de 60 y 90 min + \n3 sesiones grupales de 120min + \nsesiones semanales de refuerzo de \n60min opcionales \u2022 Grupo de intervenci\u00f3n \ndiferida 4 semanas \nSeguimiento a \nlas 19 semanas \u2022 Sintomatolog\u00eda TEPT \n(PCL-C) \n \nSchneider \n(1995)[122] & \nAlexander \n(1996)[123] Hipertensi\u00f3n N = 127 aleatorizados \nEdad media: 66 a\u00f1os \nMujeres: 58.3% 2 sesiones individuales y 3 sesiones \ngrupales de 90 min, durante 1 semana + \npr\u00e1ctica individual de 20 min dos veces \nal d\u00eda + 3 sesiones grupales de 90 min \nde refuerzo al mes \u2022 Relajaci\u00f3n Muscular \nProgresiva \n\u2022 Educaci\u00f3n en \nhipertensi\u00f3n 12 semanas \nNo seguimiento \u2022 Presi\u00f3n sangu\u00ednea   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 129 EE.UU. 3 \nSchneider \n(2005)[124], \nEE.UU. 3 Hipertensi\u00f3n N =197 aleatorizados \nEdad media: 48.5 a\u00f1os \nMujeres: 52.7%  \n 3 sesiones individuales y grupales + 3 \nsesiones de refuerzo de 90 min + \npr\u00e1ctica diaria de 20 min dos veces al \nd\u00eda \u2022 Educaci\u00f3n para la \nsalud \n\u2022 Relajaci\u00f3n muscular \nprogresiva 12 meses \nNo seguimiento \u2022 Presi\u00f3n sangu\u00ednea \nSchneider \n(2012)[125], \nEE.UU. 2,3  Enfermedad \ncoronaria N = 213 aleatorizados \nEdad media: 59 a\u00f1os \nMujeres: 42% 6 sesiones individuales y grupales de 90 \na 120 min + sesiones de seguimiento y \nmantenimiento hasta un promedio de \n5,4 a\u00f1os + pr\u00e1ctica diaria de 20 min dos \nveces al d\u00eda \u2022 Educaci\u00f3n para la \nsalud 5,4 a\u00f1os de \nmedia \nNo seguimiento \u2022 Presi\u00f3n sangu\u00ednea \n\u2022 Depresi\u00f3n (CES-D) \n\u2022 Riesgo de mortalidad  \n\u2022 Hospitalizaci\u00f3n \nSeer \n(1980)[126], \nNueva Zelanda Hipertensi\u00f3n N = 41 aleatorizados \nEdad media: 43.2 a\u00f1os \nMujeres: 44% Sesiones individuales de 15-20 min 2 \nveces al d\u00eda durante 25 semanas \u2022 Placebo \n\u2022 No tratamiento 25 semanas \nNo seguimiento \u2022 Presi\u00f3n sangu\u00ednea \nTuab \n(1994)[131], \nEE.UU. 2 Adultos con \nalcoholismo N =118 aleatorizados  \nEdad media: 44.3 a\u00f1os \nMujeres: 0% 20 sesiones de 60-90 min + indicaci\u00f3n \nde meditar dos veces al d\u00eda durante 15-\n20 min \u2022 Atenci\u00f3n \nhabitual+Biofeedback \n\u2022 Atenci\u00f3n \nhabitual+Neuroterapia  \n\u2022 Atenci\u00f3n habitual 3 semanas \nSeguimiento a \nlos 6, 12 y 18 \nmeses \u2022 Consumo de alcohol \n(SHQ) \n\u2022 Estado de \u00e1nimo \n(POMS) \nWilson \n(1975)[140], \nEE.UU. \n(Estudio \ncruzado) Asma \nbronquial N =25 aleatorizados \nRango: 14-57 a\u00f1os \nMujeres: 43% 2 sesiones introductorias de 120 min + \nSesiones de 20-30 min dos veces al d\u00eda \ndurante 12 semanas \u2022 Lectura en periodo de \ntiempo en el que no se \npracticaba meditaci\u00f3n 24 semanas \n(cruce a las 12 \nsemanas) \nSeguimiento a \nlos 6 meses \u2022 Gravedad y duraci\u00f3n \nsintomatolog\u00eda \nautorreportadas \n\u2022 Funci\u00f3n pulmonar \nPoblaci\u00f3n no cl\u00ednica  \nAlexander \n(1989)[61], \nEE.UU. Personas \nmayores en \nresidencia N: 77 aleatorizados \nEdad media: 81 a\u00f1os \nMujeres: 82% Sesiones individuales de 20 min dos \nveces al d\u00eda \u2022 Mindfulness \n\u2022 Relajaci\u00f3n \n\u2022 Grupo de intervenci\u00f3n \ndiferida 13 semanas \nNo seguimiento \u2022 Funci\u00f3n cognitiva (DST \ny bater\u00eda pruebas) \n\u2022 Ansiedad (STAI) \n\u2022 Depresi\u00f3n (SDS)  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  130 Barnes \n(2012)[63], \nEE.UU. Estudiantes \nde instituto N = 156 aleatorizados  \nEdad media: 16.2 a\u00f1os \nMujeres: 27% 1 sesi\u00f3n individual de 15 min + 1 sesi\u00f3n \ngrupal de 15 min cinco d\u00edas a la \nsemana + 15 min de pr\u00e1ctica individual \ndos veces al d\u00eda los fines de semana \ndurante 4 meses + pr\u00e1ctica diaria \nindividual de 15 min despu\u00e9s de \ncompletar intervenci\u00f3n (durante \nseguimiento) \u2022 Educaci\u00f3n en salud 16 semanas \nSeguimiento a \nlos 4 meses \u2022 Masa del ventr\u00edculo \nizquierdo del coraz\u00f3n  \n\u2022 Presi\u00f3n sangu\u00ednea \nDillbeck \n(1977)[80], \nSuiza 1 Estudiantes \nuniversitarios N = 33 aleatorizados \nEdad media: 21.7 a\u00f1os \nMujeres: 21% 4 sesiones de 90 min, durante 4 d\u00edas + \npr\u00e1ctica individual de 15-20 min dos \nveces al d\u00eda \u2022 Relajaci\u00f3n 2 semanas \nNo seguimiento \u2022 Ansiedad (STAI) \nElder \n(2014)[84], \nEE.UU. 2 Trabajadores \nen residencia \nestudiantes \ncon \nproblemas \nde conducta N = 40 aleatorizados \nEdad media: 36 a\u00f1os \nMujeres: 52% 2 sesiones individuales + 3 sesiones \ngrupales + pr\u00e1ctica individual de 15-20 \nmin diaria \u2022 Grupo de intervenci\u00f3n \ndiferida 12 semanas \nNo seguimiento \u2022 Estr\u00e9s percibido (PSS) \n\u2022 Depresi\u00f3n (MHI-5) \n\u2022 Burnout (MBI) \nLeach \n(2015)[100], \nAustralia Cuidadores \nde personas \ncon \ndemencia N =17 aleatorizados \nEdad media: 66 a\u00f1os \nMujeres: 88% 12 sesiones (14 horas en total) \u2022 Grupo de intervenci\u00f3n \ndiferida 12 semanas \nSeguimiento a \nlos 4 meses \u2022 Calidad de vida (AqoL-\n8D) \n\u2022 Ansiedad, depresi\u00f3n y \nestr\u00e9s ( WebNeuro \nstress ) \nNidich \n(2009b)[111], \nEE.UU. 1 Estudiantes \nuniversitarios N =298 aleatorizados \nEdad media: 25.5 a\u00f1os \nMujeres: 60% Curso de 7 pasos con sesiones \nindividuales y grupales + sesiones \nindividuales de refuerzo + pr\u00e1ctica \ndiaria de 20 min dos veces al d\u00eda \u2022 Grupo de intervenci\u00f3n \ndiferida 12 semanas \nNo seguimiento \u2022 Presi\u00f3n sangu\u00ednea \n\u2022 Estado de \u00e1nimo \n(POMS subescalas \nansiedad, depresi\u00f3n y \nestr\u00e9s) \nOttens \n(1975)[116], \nEE.UU. Estudiantes \nuniversitarios N = 54 aleatorizados \nEdad media: 21.7 a\u00f1os \nMujeres: 42.6% 10 semanas de intervenci\u00f3n + \nindicaci\u00f3n de meditar dos veces al d\u00eda \ndurante ese periodo de tiempo \u2022 Auto-control  \n\u2022 No tratamiento 10 semanas \nNo seguimiento \n \u2022 Consumo de cigarrillos \n(auto-registro) \nSheppard \n(1997)[129], \nEE.UU. 1 Trabajadores N = 44 aleatorizados \nEdad media: 50.5 a\u00f1os \nRatio hombre/mujer 0.85  2 sesiones semanales de 60 min \ndurante 12 semanas + indicaci\u00f3n de \nmeditar dos veces al d\u00eda durante 20 min \u2022 Programa de manejo \ndel estr\u00e9s 12 semanas \nSeguimiento a \nlos 3 a\u00f1os \u2022 Ansiedad (STAI) \n\u2022 Depresi\u00f3n (IPAT)   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 131  \u2022 Presi\u00f3n sangu\u00ednea \nSo (2001)[130], \nEE.UU. 1 Estudiantes \nde \nsecundaria Estudio 1 \nN = 154 aleatorizados \nEdad media: 16.6 a\u00f1os \nMujeres: 49.35 a\u00f1os Estudio 1 \nPr\u00e1ctica de 15-20 min, dos veces al d\u00eda Estudio 1 \n\u2022 Siesta \n\u2022 No intervenci\u00f3n Estudio 1 \n24 semanas \nNo seguimiento Estudio 1 \n\u2022 Ansiedad (STAI) \nEstudio 2 \nN = 118 aleatorizados \nEdad media: 14.6 a\u00f1os \nMujeres: 100% Estudio 2 \nPr\u00e1ctica de 15-20 min, dos veces al d\u00eda Estudio 2 \n\u2022 No tratamiento \n\u2022 Meditaci\u00f3n \ncontemplativa Estudio 2 \n24 semanas \nNo seguimiento Estudio 2 \n\u2022 Ansiedad (STAI) \nEstudio 3 \nN = 99 aleatorizados \nEdad media: 17.8 a\u00f1os \nMujeres: 0%  Estudio 3 \nPr\u00e1ctica de 15-20 min, dos veces al d\u00eda Estudio 3 \n\u2022 No tratamiento Estudio 3 \n48 semanas \nNo seguimiento Estudio 3 \n\u2022 Ansiedad (STAI) \nTravis \n(2018)[132], \nEE.UU. \n Personal de \nla oficina del \nDistrito \nEscolar \nUnificado de \nSan \nFrancisco \n N = 96 aleatorizados \nEdad media: 45.8 a\u00f1os \nMujeres: 80% 5 sesiones individuales y grupales de \n90 min durante 5 d\u00edas consecutivos + \nreuniones semanales grupales de \nrefuerzo para la comentar experiencias \ndurante la meditaci\u00f3n, aplicaci\u00f3n de la \nmeditaci\u00f3n a diferentes \u00e1reas de la vida \no investigaci\u00f3n sobre los efectos de la \nmeditaci\u00f3n \u2022 Grupo de intervenci\u00f3n \ndiferida 5 d\u00edas \nSeguimiento a \nlos 4 meses \u2022 Estado de \u00e1nimo \n(POMS subescalas \nansiedad y depresi\u00f3n) \nZuroff \n(1978)[145], \nEE.UU. Estudiantes N = 60 aleatorizados \nEdad media: N.I. \nMujeres: 50% 5 sesiones grupales de 60 min + 1 \nsesi\u00f3n individual de 60 min \u2022 Relajaci\u00f3n muscular \n\u2022 No tratamiento 9 semanas \nSeguimiento a \nlas 2 semanas \u2022 Ansiedad (ACL; S-R; \nBAM) \nOTRAS MEDITACIONES BASADAS EN MANTRAS (OMBM)  \nPoblaci\u00f3n cl\u00ednica \nBormann \n(2006)[67], \nEE.UU. 2 VIH-SIDA N = 93 aleatorizados \nEdad media: 42.9 a\u00f1os \nMujeres: 19.4% 5 sesiones de 90 min durante 5 \nsemanas + contactos telef\u00f3nicos \nsemanales durante 4 semanas + 1 \u2022 Sesiones educativas \ngrupales 10 semanas \nSeguimiento a \nlos 3 meses  \u2022 Estr\u00e9s percibido (PSS) \n\u2022 Ansiedad (STAI) \n\u2022 Depresi\u00f3n (CES-D)  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  132 sesi\u00f3n grupal final en la 10\u00aa semana \u2022 Calidad de vida (Q-\nLES-Q) \nBormann \n(2008)[146], \nEE.UU. Veteranos de \nguerra con \nTEPT N =29 aleatorizados \nEdad media: 56 a\u00f1os \nMujeres: 0% Una sesi\u00f3n semanal de 90 min en \nformato grupal, durante 6 semanas + \ntratamiento habitual \u2022 Atenci\u00f3n habitual 6 semanas \nNo seguimiento \u2022 Sintomatolog\u00eda TEPT \n(CAPS; PTSD \nChecklist)  \n\u2022 Distr\u00e9s (BSI-18) \n\u2022 Calidad de vida (Q-\nLES-Q:SF) \nBormann \n(2013)[68], \nEE.UU. Veteranos de \nguerra con \nTEPT N = 146 aleatorizados \nEdad media: 57 a\u00f1os \nMujeres: 2.73% Una sesi\u00f3n semanal de 90 min en \nformato grupal, durante 6 semanas + \ntratamiento habitual \u2022 Atenci\u00f3n habitual 12 semanas \nSeguimiento a \nlas 6 semanas \u2022 Sintomatolog\u00eda TEPT \n(CAPS; PCL) \n\u2022 Ansiedad y depresi\u00f3n \n(BSI-18) \n\u2022 Calidad de vida (SF-\n12) \nBormann \n(2018)[69], \nEE.UU. Veteranos de \nguerra con \nTEPT N = 173 aleatorizados \nEdad media: 48.9 a\u00f1os \nMujeres: 15% 8 sesiones individuales de 60 min, una \na la semana \u2022 Terapia centrada en el \npresente 9 semanas \nSeguimiento a \nlos 2 meses \u2022 Sintomatolog\u00eda TETP \n(CAPS; PCLM) \n\u2022 Insomnio (ISI) \n\u2022 Depresi\u00f3n (PHQ-9) \n\u2022 Calidad de vida \n(WHOQOL) \nHager \n(1978)[89], \nEE.UU. Adultos con \npresi\u00f3n \narterial \nlim\u00edtrofe N = 30 aleatorizados \nEdad media: N.I. \nMujeres: 50% Sesiones individuales de 20 min 2 \nveces 5 d\u00edas a la semana durante 4 \nsemanas \u2022 Biofeedback 4 semanas \nNo seguimiento \u2022 Presi\u00f3n sangu\u00ednea \nKeefer \n(2001)[96], \nEE.UU. S\u00edndrome de \nIntestino \nIrritable N = 16 aleatorizados \nEdad media: 51 a\u00f1os \nMujeres: 69.23% 6 sesiones de 30 min, una a la semana, \ndurante seis semanas + indicaci\u00f3n de \nmeditar dos veces al d\u00eda durante 15 min \u2022 Monitoreo de s\u00edntomas \ngastrointestinales 6 semanas \nSeguimiento a \nlos 3 meses \u2022 S\u00edntomas \ngastrointestinales \n(CPSR) \n\u2022 Efectos adversos   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 133 Kirsch \n(1979)[98], \nEE.UU.  Estudiantes \ncon \nansiedad a \nhablar en \np\u00fablico N = 38 aleatorizados \nEdad media: N.I. \nMujeres: N.I. Sesi\u00f3n inicial de exploraci\u00f3n de la \nhistoria del problema + descripci\u00f3n del \ntratamiento + manual de aplicaci\u00f3n de \nla t\u00e9cnica de respuesta de relajaci\u00f3n de \nBenson (t\u00e9cnica basada en mantra) \u2022 Desensibilizaci\u00f3n \nsistem\u00e1tica \n\u2022 Desensibilizaci\u00f3n \nsistem\u00e1tica + \nmeditaci\u00f3n como \nreemplazo de la \nrelajaci\u00f3n progresiva 5 semanas \u2022 Ansiedad (PRCS) \nJeitler \n(2015)[94], \nAlemania y \nAustria Dolor de \ncuello \ncr\u00f3nico N = 89 aleatorizados \nEdad media: 50 a\u00f1os \nMujeres: 82% Sesiones grupales semanales de 15-30 \nmin + 45 min de meditaci\u00f3n individual + \npr\u00e1ctica en casa de 15 a 30 min diarios \u2022 Realizaci\u00f3n de ejercicio \nenfocado a estirar, \nfortalecer y movilizar \nlos m\u00fasculos 8 semanas \nNo seguimiento \u2022 Dolor (EVA; NPAD) \n\u2022 Calidad de vida (SF-\n36) \n\u2022 Depresi\u00f3n (CES-D) \n\u2022 Ansiedad (STAI) \n\u2022 Estr\u00e9s percibido (PSS) \nLehrer \n(1983)[102], \nEE.UU. 2 Ansiedad N = 61 \nEdad media: N.I. \nMujeres: N.I. 5 sesiones individuales y grupales de \n90 min, una a la semana \u2022 Relajaci\u00f3n muscular \nprogresiva  \n\u2022 Grupo de intervenci\u00f3n \ndiferida  \n5 semanas \nSeguimiento a \nlos 4 meses \u2022 Ansiedad (STAI; IPAT; \nLWASQ) \n\u2022 Sintomatolog\u00eda general \n(SCL-90 \u00edndice global y \nsubescala depresi\u00f3n) \nMichalsen \n(2016)[106], \nAlemania \n Dolor lumbar \ncr\u00f3nico N = 68 aleatorizados \nEdad media: 55 a\u00f1os \nMujeres: 75% Una sesi\u00f3n semanal de 90 min en \nformato grupal, durante 8 semanas + \npr\u00e1ctica individual de 20-30 min al d\u00eda \u2022 Ejercicio f\u00edsico  8 semanas \nNo seguimiento \u2022 Dolor (EVA) \n\u2022 Discapacidad f\u00edsica \n(RMDQ) \n\u2022 Estr\u00e9s percibido (PSS) \n\u2022 Ansiedad y depresi\u00f3n \n(HADS) \n\u2022 Calidad de vida (SF-36) \n\u2022 Efectos adversos \nParker \n(1978)[117], \nEE.UU. Adultos con \nansiedad y \nalcoholismo N = 30 aleatorizados  \nEdad media: 45.1 a\u00f1os \nMujeres: 0%  Sesiones grupales de 30min, 3 veces \npor semana \u2022 Relajaci\u00f3n muscular \nprogresiva \n\u2022 Descanso  3 semanas \nintervenci\u00f3n \nNo seguimiento \u2022 Ansiedad (STAI) \n\u2022 Presi\u00f3n sangu\u00ednea  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  134 Puryear \n(1976)[119], \nEE.UU. Voluntarios N = 159 aleatorizados \n Edad media: 38,35 a\u00f1os  \nMujeres: 69.18% 3h de estudio con manual en \nmeditaci\u00f3n training + 20 min al d\u00eda \ndurante 28 d\u00edas \u2022 No intervenci\u00f3n 28 d\u00edas \nNo seguimiento \u2022 Ansiedad (IPAT) \nVaccarino \n(2013)[133], \nEE.UU.  \n S\u00edndrome \nmetab\u00f3lico \n N = 68 aleatorizados \nEdad media: 51.8 a\u00f1os \nMujeres: 78.95% 4 sesiones grupales de 60-90 min en 4 \nd\u00edas consecutivos + 17 sesiones de \nrefuerzo + pr\u00e1ctica diaria de 20 min dos \nveces al d\u00eda \u2022 Educaci\u00f3n para la \nsalud 12 meses \nNo seguimiento \u2022 Vasodilataci\u00f3n \nmediada por flujo \ndependiente del \nendotelio y por \nnitroglicerina \nindependiente del \nendotelio \n\u2022 Presi\u00f3n sangu\u00ednea  \n\u2022 Ansiedad (STAI) \n\u2022 Estr\u00e9s percibido (PSS) \n\u2022 Depresi\u00f3n (BDI-II) \nVasudev \n(2016)[134] & \nIonson \n(2019)[135],  \nCanad\u00e1 Personas \nmayores con \ndepresi\u00f3n \nmayor leve o \nmoderada N = 95 aleatorizados  \nEdad media: 68.9 a\u00f1os \nMujeres: 68.7% Sesiones grupales de 120 min, 4 veces \npor semana + 11 sesiones de refuerzo \nde 60 min \u2022 Atenci\u00f3n habitual 12 semanas \nNo seguimiento \u2022 Depresi\u00f3n (HAM-D; \nGDS)  \n\u2022 Ansiedad (GAI) \n\u2022 Gravedad s\u00edntomas \n(CGI) \n\u2022 Calidad de vida \n(QOLSV) \n\u2022 Efectos adversos \n(TSES)  \nWachholtz \n(2005)[136], \nEE.UU. Estudiantes N = 68 aleatorizados \nEdad media: 19.13 a\u00f1os  \nMujeres: 32% \n Sesiones individuales y grupales de 20 \nmin durante 2 semanas \u2022 Mantra secular  \n\u2022 Relajaci\u00f3n 2 semanas \nNo seguimiento  \u2022 Ansiedad (STAI) \nWachholtz \n(2008)[137], \nEE.UU. Estudiantes \ncon Migra\u00f1a N = 92 aleatorizados \nEdad media: 19.1 a\u00f1os \nMujeres: 90% \n Curso inicial (1 hora) y elecci\u00f3n de \nfrases para meditar siguiendo un \nprotocolo en los siguientes 30 d\u00edas 20 \nmin diarios \u2022 Mantra secular interno \n\u2022 Mantra secular externo \n\u2022 Relajaci\u00f3n 4 semanas \nNo seguimiento \u2022 Frecuencia y severidad \nde migra\u00f1as  \n\u2022 Ansiedad (STAI) \n\u2022 Depresi\u00f3n (CES-D) \n\u2022 Calidad de vida \n(MSQOL)   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 135 \u2022 Auto-efectividad en el \nmanejo de la migra\u00f1a \n(HMSE) \nPoblaci\u00f3n no cl\u00ednica \nAnderson \n(1999)[62], \nEE.UU. Profesores N = 91 aleatorizados \nRango edad: 22-60 a\u00f1os  \nMujeres: 84.6% \n sesiones de 90 min una vez a la \nsemana + pr\u00e1ctica individual de 20 min, \ndos veces al d\u00eda durante 5 semanas + \nsesi\u00f3n de refuerzo al mes \u2022 Grupo de intervenci\u00f3n \ndiferida  5 semanas \n \nSeguimiento a \nlas 9 semanas \u2022 Burnout percibido \n(MBI) \n\u2022 Ansiedad (STAI) \n\u2022 Estr\u00e9s ocupacional \n(TSI) \nBoswell \n(1979)[70], \nEE.UU. Estudiantes \ncon \npuntuaciones en \nansiedad N = 80 aleatorizados \nEdad media: N.I. \nMujeres: 50% Sesiones de 15 min, dos veces al d\u00eda \ndurante 2 semanas \u2022 Placebo \n\u2022 Relajaci\u00f3n progresiva \n\u2022 No intervenci\u00f3n 2 semanas \nNo seguimiento \u2022 Ansiedad (STAI) \nDunne \n(2019)[82], \nIrlanda y \nEE.UU. Trabajadores de \nemergencias N = 51 aleatorizados \nEdad media: N.I. \nMujeres: N.I. 4 sesiones grupales (4h/sesi\u00f3n) durante \n7 semanas + pr\u00e1ctica individual de 20 \nmin, dos veces al d\u00eda durante 7 d\u00edas \u2022 No intervenci\u00f3n 8 semanas \nSeguimiento a \nlos 2 meses \u2022 Burnout percibido \n(MBI) \n\u2022 Ansiedad, depresi\u00f3n y \nestr\u00e9s (DASS-21) \nHeide \n(1980)[90], \nEE.UU. Estudiantes \nvoluntarios N = 63 aleatorizados \nEdad media: N.I. \nMujeres: 39.65% 1 sesi\u00f3n grupal de 60 min + pr\u00e1ctica \nindividual de 20 min dos veces al d\u00eda \ndurante 7 d\u00edas \u2022 No intervenci\u00f3n 1 semana  \nNo seguimiento \u2022 Ansiedad (STAI) \nKirkland \n(1980)[148], \nEE.UU. Estudiantes N = 60 aleatorizados \nEdad media: N.I. \nMujeres: N.I. 5 sesiones grupales de 90 min \u2022 Entrenamiento en \nhabilidades sociales \n\u2022 Relajaci\u00f3n \n\u2022 No intervenci\u00f3n 5 d\u00edas \nNo seguimiento \u2022 Ansiedad (CSAQ-C) \nManocha \n(2011)[103], \nAustralia Trabajadores N = 180 aleatorizados \nEdad media: 42 a\u00f1os \nMujeres: N.I. 4 sesiones de 60 min, dos veces por \nsemana durante 8 semanas + pr\u00e1ctica \nindividual de 10-20 min dos veces al d\u00eda \u2022 Relajaci\u00f3n \n\u2022 Grupo de intervenci\u00f3n \ndiferida 8 semanas \nNo seguimiento \u2022 Ansiedad (STAI) \n\u2022 Depresi\u00f3n (POMS) \n\u2022 Estr\u00e9s (PSQ)  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  136 Murphy \n(1986)[108], \nEE.UU. 2 Consumo \nsocial de \nalcohol N =60 \nEdad media: 21-30 a\u00f1os  \nMujeres: 0% Sesiones grupales tres veces por \nsemana + indicaci\u00f3n de meditar 20 min \ndos veces al d\u00eda \u2022 Ejercicio aer\u00f3bico \n\u2022 No tratamiento 8 semanas \nSeguimiento a \nlas 6 semanas \u2022 Consumo medio de \nalcohol \nOman \n(2006)[115], \nEE.UU. Profesionales \nsanitarios N = 61 \nEdad media: N.I. \nMujeres: 86% 8 sesiones de 120 min una vez a la \nsemana durante 8 semanas \u2022 Grupo de intervenci\u00f3n \ndiferida 8 semanas \nSeguimiento a \nlas 8 y 19 \nsemanas \u2022 Estr\u00e9s percibido (PSS) \n\u2022 Calidad de vida (MOS) \n\u2022 Burnout (MBI) \nSevertsen \n(1986)[127], \nEE.UU. Estudiantes \nde \nenfermer\u00eda \nvoluntarias N = 10 \nEdad media: 25.3 a\u00f1os \nMujeres: 100% Pr\u00e1ctica individual de 15-20 min \ndurante 7 semanas \u2022 Aerobic  7 semanas \nNo seguimiento \u2022 Estr\u00e9s percibido \n(HRSRS; SUSLT) \nWolf \n(2003)[141], \nEE.UU. Poblaci\u00f3n \ngeneral N = 93 aleatorizados \nEdad media: 24.7 a\u00f1os \nMujeres: 50.8% Sesiones de 20-25 min diarias durante \n28 d\u00edas \u2022 Placebo \n\u2022 No intervenci\u00f3n 4 semanas \nNo seguimiento \u2022 Depresi\u00f3n (GCS) \n\u2022 Estr\u00e9s (ICS) \nMEDITACI\u00d3N RELIGIOSA / ESPIRITUAL  \nPoblaci\u00f3n cl\u00ednica \nBeiranvand \n(2014)[65],  \nIr\u00e1n Mujeres \ncandidatas a \nces\u00e1rea N = 160 aleatorizadas \nEdad media: 27.5 a\u00f1os \nMujeres: 100% 20 min de meditaci\u00f3n de rezo con \nauriculares \u2022 No intervenci\u00f3n 20 minutos \nSeguimiento a \nlos 30, 60, 180 \ny 360 min \u2022 Dolor (EVA) \n\u2022 Presi\u00f3n sangu\u00ednea \nCole \n(2012)[78], \nEE.UU. Melanoma \nmetast\u00e1sico N = 83 aleatorizados \nEdad media: 54 a\u00f1os \nMujeres: 45% 5 sesiones de 60 min durante 4 meses \u2022 Atenci\u00f3n habitual 16 semanas \nSeguimiento a \nlos 2 y 4 meses \u2022 Depresi\u00f3n (CES-D) \n\u2022 Calidad de vida \n(MQOL) \nPoblaci\u00f3n no cl\u00ednica \nChirico \n(2020)[77], \nItalia Profesores \nescuela \ncat\u00f3lica N = 50 aleatorizados \nEdad media: 36.53 a\u00f1os  \nMujeres: 100% 2 sesiones grupales de 30 min a la \nsemana durante 8 semanas \u2022 Atenci\u00f3n habitual 8 semanas \nSeguimiento a \nlos 4 meses \u2022 Burnout (MBI) \n\u2022 Sintomatolog\u00eda general \n(GHQ)   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 137 Knabb \n(2020)[99], \nEE.UU. Estudiantes N = 101 aleatorizados \nEdad media: 21.16 a\u00f1os  \nMujeres: 81.7% 1 sesi\u00f3n grupal de 60 min semanal + \nactividades espirituales entre sesiones \u2022 Grupo de intervenci\u00f3n \ndiferida 4 semanas \nNo seguimiento \u2022 Ansiedad (subescala \nDASS-21) \nMEDITACI\u00d3N FOCALIZADA EN LA RESPIRACI\u00d3N  Y/O ESCANEO CORPORAL  \nPoblaci\u00f3n cl\u00ednica \nChandler \n(2020)[75], \nEE.UU. Pre-hipertensi\u00f3n \n(presi\u00f3n \nsangu\u00ednea \nsist\u00f3lica 130-\n139 mmHg) N = 30 aleatorizados \nEdad media: 45 a\u00f1os \nMujeres: 50% 2 sesiones diarias de 15 min durante el \nprimer mes, 2 sesiones diarias de 10 \nmin durante los meses 2 y 3, y sesiones \nde 5 mins durante el resto de la \nintervenci\u00f3n de 12 meses \u2022 Programa educativo de \nestilo de vida 12 meses \nNo seguimiento \u2022 Presi\u00f3n sangu\u00ednea  \n\u2022 Estr\u00e9s percibido (PSS) \nGagrani \n(2018)[85], \nIndia Glaucoma N = 60 aleatorizados \nEdad media: 57.3 a\u00f1os \nMujeres: 35% 1 sesi\u00f3n diaria de 45 min durante 6 \nsemanas \u2022 Cuidado habitual 6 semanas \nNo seguimiento \u2022 Presi\u00f3n intraocular  \n\u2022 Calidad de vida \n(WHOQOL) \nPoblaci\u00f3n no cl\u00ednica \nJanyacharoen \n(2018)[91], \nTailandia Personas \nmayores N = 34 aleatorizados \nEdad media: 72.7 a\u00f1os \nMujeres: 70.6% Sesiones grupales de 60 min, 3 veces \npor semana durante 8 semanas \u2022 Educaci\u00f3n en salud 8 semanas \nNo seguimiento \u2022 Funcionalidad f\u00edsica y \ncognitiva (6MWT; \nFTSST; TUGT; FRT) \n\u2022 Calidad de vida \n(WHOQOL) \nFatima \n(2014)[53], \nBrasil Poblaci\u00f3n \ngeneral N = 65 aleatorizados \nEdad media: 67.1 a\u00f1os \nMujeres: 64% 1 sesi\u00f3n grupal a la semana de 60 min \n+ 2 pr\u00e1cticas diarias de 20 min cada \nuna \u2022 No intervenci\u00f3n 12 semanas \nNo seguimiento \u2022 Calidad de vida \n(WHOQOL) \n\u2022 Presi\u00f3n sngu\u00ednea \nKindlon \n(1983)[97], \nEE.UU. Estudiantes N = 35 aleatorizados \nEdad media: N.I. \nMujeres: 54.3% 5 sesiones individuales + 8 sesiones \ngrupales + indicaci\u00f3n de meditar 30 min \ndiarios \u2022 Instrucciones para \ndormir mejor 11 semanas \nNo seguimiento \u2022 Ansiedad (Attitude \nInventory) \nMenezes \n(2013)[104], \nBrasil Estudiantes \nuniversitarios N = 100 aleatorizados \nEdad media: 25 a\u00f1os \nMujeres: 57% 6 sesiones de 90 min, una a la semana \ndurante 6 semanas + pr\u00e1ctica individual \u2022 Relajaci\u00f3n muscular \nprogresiva 6 semanas \nNo seguimiento Ansiedad (STAI)  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  138 \u2022 Grupo de intervenci\u00f3n \ndiferida \nMenezes \n(2015)[105], \nBrasil Estudiantes \nuniversitarios N = 46 aleatorizados \nEdad media: 24 a\u00f1os \nMujeres: 56.9% 5 sesiones consecutivas de 90 min, una \nal d\u00eda durante cinco d\u00edas \u2022 Grupo de intervenci\u00f3n \ndiferida 5 d\u00edas \nSeguimiento a \nla semana  \u2022 Ansiedad (STAI) \nYang \n(2009)[144], \nTaiwan Estudiantes \nuniversitarios N = 242 aleatorizados \nEdad media: 19-20 a\u00f1os  \nMujeres: 100% Sesiones de dos horas semanales \ndurante 18 semanas (en total 36 horas \nde pr\u00e1ctica) \u2022 No tratamiento 18 semanas \nNo seguimiento \u2022 Distr\u00e9s f\u00edsico y mental \n(LAS) \nMEDITACI\u00d3N BASADA EN LA BONDAD Y AMOR (LKM) / ENTRE NAMIENTO EN EL CULTIVO DE LA COMPASI\u00d3N  \nPoblaci\u00f3n cl\u00ednica \nCarson \n(2005)[73], \nEE.UU. 1 \n Dolor \ncr\u00f3nico de \nespalda N = 61 aleatorizados \nEdad media: 51.1 a\u00f1os \nMujeres: 61%  8 sesiones semanales grupales de 90 \nmin + pr\u00e1ctica individual diaria de 10-30 \nmin \u2022 Atenci\u00f3n habitual 8 semanas  \nNo seguimiento \u2022 Dolor (MPQ; BPI) \n\u2022 Distr\u00e9s (BSI-18) \nDion \n(2016)[81], \nEE.UU.  Mujeres con \nc\u00e1ncer de \nmama N = 38 aleatorizadas \nEdad media: 47.7 a\u00f1os \nMujeres: 100% Sesi\u00f3n individual diaria de 50 min \ndurante 3 d\u00edas (15 min de meditaci\u00f3n + \n20 min de masaje) \u2022 Masaje 3 d\u00edas \nSeguimiento a \nlas 3 semanas \u2022 Fatiga (EVA) \n\u2022 Dolor (EVA) \n\u2022 Estr\u00e9s percibido (PSS) \nWilliams \n(2005)[139], \nEE.UU. 4 VIH-SIDA N = 58 \nEdad media: 45.3 a\u00f1os \nMujeres: 41% Sesi\u00f3n grupal de 90 min + pr\u00e1ctica \ndiaria de 30 min durante 5 d\u00edas a la \nsemana \u2022 Masaje \n\u2022 LKM + masaje  \n\u2022 Atenci\u00f3n habitual 4 semanas \nSeguimiento a \nlas 8 y 68 \nsemanas \u2022 Calidad de vida \n(MVQOLI) \nWren \n(2019)[142], \nEE.UU. Biopsia y \ncirug\u00eda de \nc\u00e1ncer de \nmama N = 138 aleatorizadas \nEdad media: 56 a\u00f1os \nMujeres: 100% Pr\u00e1ctica individual de 20 min diarios \u2022 M\u00fasica \n\u2022 Atenci\u00f3n habitual 3 semanas \nSeguimiento a \nla semana \u2022 Ansiedad (STAI) \n\u2022 Dolor (BPI)  \n\u2022 Fatiga (FACIT) \n\u2022 Presi\u00f3n sangu\u00ednea   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 139 Poblaci\u00f3n no cl\u00ednica \nBrito-Pons \n(2018)[71], \nChile Adultos \nsanos N = 50 aleatorizados \nEdad media: 36.16 a\u00f1os  \nMujeres: 50% 9 sesiones grupales de 120 min, una a \nla semana + pr\u00e1ctica diaria individual de \n30 min \u2022 Grupo de intervenci\u00f3n \ndiferida 9 semanas \nSeguimiento a \nlos 2 meses \u2022 Ansiedad (BAI) \n\u2022 Depresi\u00f3n (BDI) \n\u2022 Estr\u00e9s percibido (PSS) \nGalante \n(2016)[86], \nReino Unido Poblaci\u00f3n \ngeneral N = 809 aleatorizados \nEdad media: 34 a\u00f1os \nMujeres: 80% 20 sesiones de 10 min, una diaria \ndurante 4 semanas \u2022 Ejercicio f\u00edsico ligero 4 semanas \nNo seguimiento \u2022 Ansiedad y depression \n(IDA) \nJazaieri \n(2013)[93], \nEE.UU. 4 Adultos \nsanos N = 100 aleatorizados \nEdad media: 43.08 a\u00f1os  \nMujeres: 72% 9 sesiones de 120 min una vez a la \nsemana + pr\u00e1ctica individual diaria \u2022 Grupo de intervenci\u00f3n \ndiferida 9 semanas \nNo seguimiento \u2022 Estr\u00e9s percibido (PSS) \n\u2022 Ansiedad (PSWQ) \nShahar \n(2014)[128], \nIsrael Personas \ncon altos \nniveles de \nautocr\u00edtica N = 38 aleatorizados  \nEdad media: 31 a\u00f1os \nMujeres: 60.53% 1 sesi\u00f3n grupal semanal de 90 min + \npr\u00e1ctica individual diaria \u2022 Grupo de intervenci\u00f3n \ndiferida 6 semanas \nSeguimiento a \nlos 3 meses   \n\u2022 Depresi\u00f3n, ansiedad y \nestr\u00e9s (DASS-21) \nWeibel \n(2016)[138], \nEE.UU. 4 Estudiantes N = 71 aleatorizados \nEdad media: 19.1 a\u00f1os \nMujeres 77% 4 sesiones grupales de 90 min una vez \na la semana \u2022 Grupo de intervenci\u00f3n \ndiferida 4 semanas \nSeguimiento a \nlos 2 meses \u2022 Ansiedad (STAI) \nMEDITACIONES MIXTAS  \nPoblaci\u00f3n cl\u00ednica \nCuriati \n(2005)[79], \nBrasil Insuficiencia \ncard\u00edaca \ncongestiva N = 19 aleatorizados \nEdad media: 75 a\u00f1os \nMujeres: 26.3% Atenci\u00f3n focalizada \nen la respiraci\u00f3n + \nrepetici\u00f3n palabra \n\u201cpaz\u201d + imaginaci\u00f3n \nguiada de un \ncoraz\u00f3n sano 1 sesi\u00f3n diaria \nde 60 min \u2022 Sesi\u00f3n semanal para \nhablar sobre el estr\u00e9s 13 semanas \nNo seguimiento \u2022 Nivel de norepinefrina \nen sangre: Ventilaci\u00f3n \npor unidad de aumento \nde la producci\u00f3n de \ndi\u00f3xido de carbono \n(VE/VCO2)  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  140 \u2022 Calidad de vida \n(MLWHFQ) \nGaston \n(1988)[87], \nCanad\u00e1 Psoriasis N = 18 aleatorizados \nEdad media: 34 a\u00f1os \nMujeres: 54.2% Escaneo corporal + \nimaginaci\u00f3n guiada \nde mejor\u00eda de \ns\u00edntomas de \npsoriasis 1 sesi\u00f3n \nsemanal de 60 \nmin + pr\u00e1ctica \nindividual diaria \nde 30 min \u2022 Meditaci\u00f3n + \nimaginaci\u00f3n \n\u2022 Grupo de intervenci\u00f3n \ndiferida 4 semanas de \nl\u00ednea base  \n12 semanas \nintervenci\u00f3n  \nSeguimiento a \nlas 4 semanas \u2022 Severidad s\u00edntomas \npsoriasis \nHafner \n(1982)[88], \nAustralia Hipertensi\u00f3n N = 21 aleatorizados \nEdad media: 49 a\u00f1os \nMujeres: 43% \n Atenci\u00f3n focalizada \nen la respiraci\u00f3n + \natenci\u00f3n focalizada \nen una imagen \nmental + repetir una \nfrase relajante 1 sesi\u00f3n \nsemanal de 60 \nmin durante 8 \nsemanas + \npr\u00e1ctica \nindividual diaria  \u2022 Meditaci\u00f3n + \nBiofeedback \n\u2022 No tratamiento 8 semanas  \nSeguimiento a \nlos 3 meses \u2022 Presi\u00f3n sangu\u00ednea \nLee \n(2015)[101],  \nEE.UU. Mujeres \nsupervivientes \nde trauma \ninterpersonal N =63 \nEdad media: 38.6 a\u00f1os \nMujeres: 100% Atenci\u00f3n focalizada \nen la respiraci\u00f3n + \nMeditaci\u00f3n LKM + \nMeditaci\u00f3n Tonglen Sesiones \ngrupales e \nindividuales 2 \nveces al d\u00eda \ndurante 90 min, \ncinco d\u00edas a la \nsemana. 2 \nsemanas de \ncada tipo de \nmeditaci\u00f3n \u2022 Atenci\u00f3n habitual 6 semanas \nNo seguimiento \u2022 S\u00edntomas TEPT \n(MPSS) \n\u2022 Sintomatolog\u00eda general \n(SDS) \nMilbury \n(2013)[107], \nEE.UU. Deterioro \ncognitivo en \npacientes \ncon c\u00e1ncer \nde mama N = 46 aleatorizados \nEdad media: 56.3 a\u00f1os \nMujeres: 100% Meditaci\u00f3n basada \nmantras y sonidos \ntibetanos + atenci\u00f3n \nfocalizada en la \nrespiraci\u00f3n 2 sesiones \nsemanales de \n60 min, durante \n6 semanas \u2022 Grupo de intervenci\u00f3n \ndiferida 6 semanas \nSeguimiento al \nmes \u2022 Funcionamiento \ncognitivo (FACT-Cog) \n\u2022 Fatiga (BFI) \n\u2022 Depresi\u00f3n (CES-D) \n\u2022 Calidad de sue\u00f1o \n(PSQI) \n\u2022 Calidad de vida (SF-36)    \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 141 Nanthakwang \n(2020)[109], \nTailandia  \n Mayores de \n60 a\u00f1os con \ncalidad de \nsue\u00f1o pobre N = 51 aleatorizados \nEdad media: 70.27 a\u00f1os  \nMujeres: 76.3% Meditaci\u00f3n de \nescaneo corporal + \nrespiraci\u00f3n \nprofunda \ncombinada con \nm\u00fasica  Sesiones \nsemanales de \n30 min + \npr\u00e1ctica \nindividual de 30 \nmin diarios \u2022 Atenci\u00f3n habitual  8 semanas \nNo seguimiento \u2022 Calidad de sue\u00f1o \n(PSQI) \n\u2022 Calidad de vida (PTQL)  \nWu \n(2019)[143], \nChina  Adultos \ntrabajadores \ncon angustia \nmoderada N =122 aleatorizados \nEdad media: 46.57 a\u00f1os  \nMujeres: 71.3% Lectura y reflexi\u00f3n \nsobre un texto \nbudista + mantra \nespiritual + LKM 6 sesiones de 3 \nhoras + 2 \nretiros de fin de \nsemana \u2022 Grupo de intervenci\u00f3n \ndiferida 13 semanas \nSeguimiento a \nlos 3 meses \u2022 Estr\u00e9s percibido (PSS) \n\u2022 Sintomatolog\u00eda general \n(GHQ) \nPoblaci\u00f3n no cl\u00ednica \nBasso \n(2019)[64], \nEE.UU. Adultos \nsanos N = 42 aleatorizados \nEdad media: 18-45 a\u00f1os  \nMujeres: 64.29% Journey meditation \n(ejercicios de \nrespiraci\u00f3n + \nescaneo corporal) Sesiones \ndiarias de 13 \nmin de \nmeditaci\u00f3n \nguiada durante \n8 semanas \u2022 Sesiones de escucha \nde podcast 8 semanas \nNo seguimiento \u2022 Calidad de sue\u00f1o \n(PSQI) \n\u2022 Ansiedad (STAI; BAI) \n1 Estudios incluidos en la RS de Orme-Johnson et al. (2 014) [59]   \n2 Estudios incluidos en la RS de Goyal elt al. (2014) [ 4] \n3 Estudios incluidos en la RS de Gathright (2019) [60] \n4 Estudios incluidos en la RS de Galante et al. (2014) [51] \n \n6MWT: six-minute walk distance test; ACL: Adjective Che ck List scale of anxiety; AqoL-8D: Assessment of Quality of  Life 8-dimension; BAI: Beck Anxiety Inventory; BAM: B ehavioral Anxiety \nMeasure; BDI-II: Beck Depression Inventory II; BFI: Bri ef Fatigue Inventory; BIS: Brain Integration Scale; B PI: Brief Pain Inventory; BSI-18: Brief Symptom Invento ry-18; CAPS: Clinician-\nAdministered PTSD Scale; CCG: Clinical Global Impressi on; CES-D: Center for Epidemiologic Studies Depression  Scale; CGI: Clinical Global Impression; CMCL: State Anxiety \u2010 Current Mood \nChecklist; CPSR: Composite Primary IBS Symptom Reductio n; CSAQ-C: Cognitive scale of the Cognitive-Somatic An xiety Questionnaire; CSI: Children Somatisation Invento ry; DASS-21: \ndepression, Anxiety and Stress Scale; DAS-SCP: Dysfunction al Attitude Scale, self-critical perfectionism; DSM-I II: Diagnostic and Statistical Manual of Mental Disor ders, version III; DST: Dementia \nScreening Test; EVA: Escala visual anal\u00f3gica; FACIT: Fa tigue scale; FACT-B: Functional Assessment of Cancer The rapy\u2013Breast; FACT-Cog: Functional Assessment of Cancer Th erapy; FAHI: \nFunctional Assessment of HIV Infection; FRT: functional  reach test; FTSST: five times sit to stand test; GAI: Geriatric Anxiety Inventory; GC: grupo control; GCS: Generalized Contentment Scale; \nGDS: Geriatric Depression Scale; GHQ: General Health Questionnaire; GI: grupo intervenci\u00f3n; HADS: Hospital  Anxiety Depression Scale; HAM-D: Hamilton Depression Ra ting Scale; HMSE: \nHeadache Management Self-Efficay Scale; HRSD: Hamilt on Rating Scale for Depression; HRSRS: Holmes-Rahe Soc ial Readjustment Scale; ICS: Index of Clinical Stress;  IDA: Irritability, \nDepression and Anxiety scale; IES-R: Impact of Events Sc ale-Revised; IPAT: Institute of Personality and Ability T esting_Depression Scale; ISI: Insomnia Severity Index; LAS : Life Adaptation Scale; \nLWASQ: Lehrer-Woolfolk Trimodal Anxiety Symptom Questi onnaire; MBI: Maslach Burnout Inventory; MHI-5: Mental  Health Inventory-5; MLWHFQ: Minnesota Living with Hea rt Failure \nQuestionnaire; MOS: Medical Outcomes Study; MPQ: McGil l Pain Questionnaire; MPSS: Modified PTSD Symptom Sca le; MQOL: McGill quality of life scale; MSQOL: Migrai ne Specific Quality of \nLife Scale; MVQOLI: Missoula-VITAS Quality of Life Ind ex; N: n\u00famero de participantes; N.I.: No informa; NP AD: Neck Pain and Disability Scale; PASE: Physical Act ivity Scale for the Elderly; PCL-5: \nPCL-S PTSD Checklist \u2013 Specific; PCL-C: PTSD Checklist -Civilian Version; PCL-M: PTSD Checklist\u2013Military Version ; PCQ: 39-item Dutch Pain Coping Questionnaire; PHQ- 9: Patient Health \nQuestionarie-9; POMS: Profile of Mood States Total Mo od Disturbance scale; PRCS: Personal Report of Confide nce as a Speaker; PSQ: Psychological Strain Questionnai re; PSQI: Pittsburgh Sleep  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  142 Quality Index; PSS: Perceived Stress Scale; PSSS: Perce ived Social Support Scale; PSWQ: Penn State Worry Que stionnaire; PTQL: Pictorial Thai Quality of Life; PTS D: Posttraumatic stress \ndisorder; Q-LES-Q: Quality of Life Enjoyment and Sati sfaction Questionnaire; Q-LES-Q:SF: Quality of Life E njoyment and Satisfaction Questionnaire-Short Form; Q OLSV: Quality of Life Profile \nSeniors Version; RCADS-25: Revised Children\u2019s Anxiety and  Depression Scale-25; RMDQ: Roland Morris Disability Ind ex; SCL-90: Symptom Checklist-90; SDS: Symptom Distres s Scale; SF-12: \nShort Form-12 Health Survey; SF-36: Short Form-36 Hea lth Survey; SHQ: Social History Questionnaire; SIDA: S\u00ed ndrome de inmunodeficiencia adquirida; S-R: Inventor y of Anxiousness; SRDS: \nSelf-Rating Depression Scale; STAI: State-Trait Anxie ty Inventory; SUSLT: Stanford University Stress Level Test; T EPT: Trastorno por estr\u00e9s postraum\u00e1tico; TMAS: Taylor Manifest Anxiety Scale; \nTSC-40: Trauma Symptom Checklist \u2013 40; TSES: Toronto S ide Effects Scale; TSI: Teacher's Stress Inventory; TUGT:  timed up and go test; VE/VCO2: Nivel de norepinefrina  en sangre: Ventilaci\u00f3n \npor unidad de aumento de la producci\u00f3n de di\u00f3xido d e carbono; VIH: Virus de la inmunodeficiencia humana ; WHOQOL: World Health Organization Quality of Life b rief form \n   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 143 Anexo Anexo Anexo Anexo 66 66. . . . Calidad metodol\u00f3gica de Calidad metodol\u00f3gica de Calidad metodol\u00f3gica de Calidad metodol\u00f3gica de los estudios incluidos los estudios incluidos los estudios incluidos los estudios incluidos        \nEscala AMSTAR-2 para evaluar el riesgo de sesgo de las RS incluidas \nTabla 6. Nivel de calidad de las Revisiones Sistem\u00e1ticas i ncluidas. Escala AMSTAR -2 \n Galante \n(2014)[51]  Gathright \n(2019)[60] Goyal \n(2014)[4] Orme-Johnson \n(2014)[59] \n1.  \u00bfLas preguntas de investigaci\u00f3n y los criterios de inclusi\u00f3n para la revisi\u00f3n incluyen los componentes  PICO? S\u00ed S\u00ed S\u00ed S\u00ed \n2.  \u00bfEl reporte de la revisi\u00f3n contiene una declaraci\u00f3n  expl\u00edcita de que los m\u00e9todos de la revisi\u00f3n fueron  \nestablecidos con anterioridad a su realizaci\u00f3n y ju stifica cualquier desviaci\u00f3n significativa del prot ocolo? S\u00ed S\u00ed S\u00ed S\u00ed \n3.  \u00bfLos autores de la revisi\u00f3n explicaron su decisi\u00f3n sobre los dise\u00f1os de estudio a incluir en la revisi \u00f3n? S\u00ed S\u00ed S\u00ed S\u00ed \n4.  \u00bfLos autores de la revisi\u00f3n usaron una estrategia d e b\u00fasqueda bibliogr\u00e1fica exhaustiva? S\u00ed S\u00ed S\u00ed N.I. \n5.  \u00bfLos autores de la revisi\u00f3n realizaron la selecci\u00f3n  de estudios por pares? S\u00ed S\u00ed S\u00ed No \n6.  \u00bfLos autores de la revisi\u00f3n realizaron la extracci\u00f3 n de datos por pares? S\u00ed S\u00ed S\u00ed No \n7.  \u00bfLos autores de la revisi\u00f3n proporcionaron una list a de estudios excluidos y justificaron las exclusio nes? S\u00ed No No No \n8.  \u00bfLos autores de la revisi\u00f3n describieron los estudi os incluidos con suficiente detalle? S\u00ed S\u00ed S\u00ed S\u00ed \n9.  \u00bfLos autores de la revisi\u00f3n usaron una t\u00e9cnica sati sfactoria para evaluar el riesgo de sesgo de los es tudios \nindividuales incluidos en la revisi\u00f3n? S\u00ed S\u00ed S\u00ed S\u00ed \n10.  \u00bfLos autores de la revisi\u00f3n reportaron las fuentes de financiaci\u00f3n de los estudios incluidos en la rev isi\u00f3n? No No No No \n11.  Si se realiz\u00f3 un MA, \u00bflos autores de la revisi\u00f3n us aron m\u00e9todos apropiados para la combinaci\u00f3n estad\u00eds tica \nde resultados? S\u00ed S\u00ed S\u00ed S\u00ed \n12.  Si se realiz\u00f3 un MA, \u00bflos autores de la revisi\u00f3n ev aluaron el impacto potencial del riesgo de sesgo en  \nestudios individuales sobre los resultados del MA u  otra s\u00edntesis de evidencia? N.I. N.I. N.I. N.I. \n13.  \u00bfLos autores de la revisi\u00f3n consideraron el riesgo de sesgo de los estudios individuales al interpreta r/discutir \nlos resultados de la revisi\u00f3n? S\u00ed S\u00ed S\u00ed S\u00ed \n14.  \u00bfLos autores de la revisi\u00f3n proporcionaron una expl icaci\u00f3n satisfactoria y discutieron cualquier \nheterogeneidad observada en los resultados de la re visi\u00f3n? S\u00ed S\u00ed S\u00ed S\u00ed \n15.  Si se realiz\u00f3 s\u00edntesis cuantitativa \u00bflos autores de  la revisi\u00f3n llevaron a cabo una adecuada investiga ci\u00f3n del \nsesgo de publicaci\u00f3n (sesgo de estudio peque\u00f1o) y d iscutieron su probable impacto en los resultados de  la \nrevisi\u00f3n? S\u00ed S\u00ed S\u00ed S\u00ed \n16.  \u00bfLos autores de la revisi\u00f3n informaron de cualquier  fuente potencial de conflicto de intereses, incluy endo \ncualquier financiamiento recibido para llevar a cab o la revisi\u00f3n? S\u00ed S\u00ed S\u00ed S\u00ed \nRS: Revisiones Sistem\u00e1ticas; MA: Meta-an\u00e1lisis; N.I.: No i nformaci\u00f3n  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  144 Resumen de la valoraci\u00f3n del riesgo de sesgo (Escal a RoB-2 de la \nColaboraci\u00f3n Cochrane) \nTabla 7. Riesgo de sesgo de los estudios primarios incluid os (resumen). \nEscala RoB-2 Cochrane \n \nDominio 1: \nDerivado del \nproceso de \naleatorizaci\u00f3n  Dominio 2 : \nDebido a \ndesviaciones de \nlas intervenciones \nprevistas (efecto \nde la asignaci\u00f3n a \nla intervenci\u00f3n) Dominio 3:  \nDatos de \nresultados \nfaltantes Dominio 4: \nEn la \nmedici\u00f3n del \nresultado Dominio 5:  \nEn la \nselecci\u00f3n \ndel \nresultado \nreportado RIESGO DE \nSESGO \nGENERAL \nMEDITACI\u00d3N TRASCENDENTAL  \nAlexander (1989)[61] Incierto Alto Bajo Bajo Incierto Alto \nBarnes (2012)[63] Incierto Incierto Bajo Bajo Incierto Alto \nBokhari (2019)[66] \nM. Objetiva \nM. Auto-reportada Incierto \nIncierto Alto \nAlto Alto \nAlto Bajo \nAlto Bajo \nBajo Alto \nAlto \nBrooks (1985)[72] Incierto Alto Bajo Incierto Incierto Alto \nCastillo-Richmond \n(2000)[74] Bajo Incierto Bajo Bajo Incierto Incierto \nChhatre (2013)[76] Incierto Incierto Bajo Incierto Incierto Alto \nDillbeck (1977)[80] Incierto Alto Bajo Incierto Incierto Alto \nDuraimani (2015)[83] Bajo Incierto Bajo Bajo Incierto Incierto \nElder (2014)[84] Bajo Incierto Alto Alto Incierto Alto \nHeffner (2016)[147] \nM. Hetero-reportada \nM. Auto-reportada Incierto \nInicierto Alto \nAlto Alto \nAlto Alto \nIncierto Incierto \nIncierto Alto \nAlto \nJayadevappa (2007)[92]  \nM. Objetiva \nM. Auto-reportada Bajo \nBajo Incierto \nIncierto Bajo \nBajo Bajo \nIncierto Incierto \nIncierto Incierto \nAlto \nJong (2019)[95] Incierto Incierto Bajo Incierto Bajo Alto \nLeach (2015)[100] Bajo Incierto Bajo Bajo Bajo Incierto \nNidich (2009a)[110] \nM. Objetiva \nM. Auto-reportada Bajo \nBajo  Alto \nAlto Alto \nAlto Bajo \nAlto Incierto \nIncierto Alto \nAlto \nNidich (2009b)[111] Bajo Alto Incierto Bajo Incierto Alto  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 145 Tabla 7. Riesgo de sesgo de los estudios primarios incluid os (resumen). \nEscala RoB-2 Cochrane \n \nDominio 1: \nDerivado del \nproceso de \naleatorizaci\u00f3n  Dominio 2 : \nDebido a \ndesviaciones de \nlas intervenciones \nprevistas (efecto \nde la asignaci\u00f3n a \nla intervenci\u00f3n) Dominio 3:  \nDatos de \nresultados \nfaltantes Dominio 4: \nEn la \nmedici\u00f3n del \nresultado Dominio 5:  \nEn la \nselecci\u00f3n \ndel \nresultado \nreportado RIESGO DE \nSESGO \nGENERAL \nM. Objetiva \nM. Auto-reportada Bajo  Alto Incierto Alto Incierto Alto \nNidich (2016)[112] Incierto Incierto Bajo Alto Incierto Alto \nNidich (2017)[113] Incierto Incierto Bajo Alto Incierto Alto \nNidich (2018)[114] \nM. Hetero-reportada \nM. Auto-reportada Incierto \nIncierto  Incierto \nIncierto Incierto \nIncierto Bajo \nIncierto Incierto \nIncierto Alto \nAlto \nOttens (1975)[116] Incierto Incierto Bajo Incierto Incierto Alto \nPaul-Labrador \n(2006)[118] Incierto Alto Alto Bajo Incierto Alto \nRaskin (1980)[120] Incierto Incierto Alto Incierto Incierto Alto \nRees (2013)[121] Alto Incierto Bajo Alto Incierto Alto \nSchneider (1995)[122]  \nAlexander (1996)[123] Incierto Alto Bajo Bajo Incierto Alto \nSchneider (2005)[124] Incierto Incierto Incierto Bajo Incierto Alto \nSchneider (2012)[125] \nM. Objetiva \nM. Auto-reportada Bajo \nBajo Incierto \nIncierto Incierto  \nIncierto Bajo \nIncierto Incierto \nIncierto Alto \nAlto \nSeer (1980)[126] Incierto Alto Alto Bajo Incierto Alto \nSheppard (1997)[129]  \nM. Objetiva \nM. Auto-reportada Incierto \nIncierto Alto \nAlto Bajo \nBajo Bajo \nIncierto Incierto \nIncierto Alto \nAlto \nSo (2001)[130] \nEstudio 1 \nEstudio 2 \nEstudio 3 Incierto \nIncierto \nIncierto Alto \nAlto \nAlto Incierto \nIncierto \nBajo Incierto \nIncierto \nIncierto Incierto \nIncierto \nIncierto Alto \nAlto \nAlto \nTuab (1994)[131] Incierto Alto Bajo Incierto Incierto Alto \nTravis (2018)[132] Incierto Alto Bajo Bajo Incierto Incierto  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  146 Tabla 7. Riesgo de sesgo de los estudios primarios incluid os (resumen). \nEscala RoB-2 Cochrane \n \nDominio 1: \nDerivado del \nproceso de \naleatorizaci\u00f3n  Dominio 2 : \nDebido a \ndesviaciones de \nlas intervenciones \nprevistas (efecto \nde la asignaci\u00f3n a \nla intervenci\u00f3n) Dominio 3:  \nDatos de \nresultados \nfaltantes Dominio 4: \nEn la \nmedici\u00f3n del \nresultado Dominio 5:  \nEn la \nselecci\u00f3n \ndel \nresultado \nreportado RIESGO DE \nSESGO \nGENERAL \nWilson (1975)[140] \nM. Objetiva \nM. Auto-reportada Incierto \nIncierto Alto \nAlto Incierto \nIncierto Bajo \nIncierto Incierto \nIncierto Alto \nAlto \nZuroff (1978)[145] \nM. Hetero-reportada \nM. Auto-reportada Incierto \nIncierto Incierto \nIncierto Bajo \nBajo Incierto \nIncierto Incierto  \nIncierto  Alto \nAlto \nOTRAS MEDITACIONES BASADAS EN MANTRAS  \nAnderson (1999)[62] Incierto Alto Alto Alto Incierto Alto \nBormann (2006)[67] Incierto Alto Bajo Incierto Incierto Alto \nBormann (2008)[146]  \nM. Hetero-reportada \nM. Auto-reportada Incierto \nIncierto Incierto \nIncierto Bajo \nBajo Bajo \nIncierto Incierto \nIncierto Alto \nAlto \nBormann (2013)[68] \nM. Hetero-reportada \nM. Auto-reportada Bajo \nBajo Incierto \nIncierto Bajo \nBajo Bajo \nAlto Bajo \nBajo Incierto \nAlto \nBormann (2018)[69] \nM. Hetero-reportada \nM. Auto-reportada Bajo \nBajo Incierto \nIncierto Bajo \nBajo Bajo \nIncierto Bajo \nBajo Incierto \nIncierto \nBoswell (1979)[70] Incierto Alto Alto Incierto Incierto Alto \nDunne (2019)[149] Incierto Incierto Bajo Bajo Bajo Incierto \nHager (1978)[89] Alto Alto Alto Bajo Incierto Alto \nHeide (1980)[90] Incierto Alto Alto Alto Incierto Alto \nJeitler (2015)[94] Bajo Incierto Bajo Incierto Bajo Incierto \nKeefer (2001)[96] Incierto Alto Alto Alto Incierto Alto \nKirkland (1980)[148] Incierto Alto Incierto Incierto Incierto Alto \nKirsch (1979)[98]  Incierto Alto Alto Alto Incierto Alto \nLehrer (1983)[102] Incierto Alto Alto Incierto Incierto Alto  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 147 Tabla 7. Riesgo de sesgo de los estudios primarios incluid os (resumen). \nEscala RoB-2 Cochrane \n \nDominio 1: \nDerivado del \nproceso de \naleatorizaci\u00f3n  Dominio 2 : \nDebido a \ndesviaciones de \nlas intervenciones \nprevistas (efecto \nde la asignaci\u00f3n a \nla intervenci\u00f3n) Dominio 3:  \nDatos de \nresultados \nfaltantes Dominio 4: \nEn la \nmedici\u00f3n del \nresultado Dominio 5:  \nEn la \nselecci\u00f3n \ndel \nresultado \nreportado RIESGO DE \nSESGO \nGENERAL \nManocha (2011)[103] Bajo Incierto Incierto Incierto Incierto Alto \nMichalsen (2016)[106] Bajo Incierto Bajo Incierto Bajo Incierto \nMurphy (1986)[108] Incierto Alto Alto Incierto Incierto Alto \nOman (2006)[115]  Bajo Incierto Bajo Alto Incierto Alto \nParker (1978)[117] \nM. Objetiva \nM. Auto-reportada  Incierto \nIncierto Alto \nAlto Alto \nAlto Bajo \nIncierto Incierto \nIncierto Alto \nAlto \nPuryear (1976)[119] Incierto Alto Alto Alto Incierto Alto \nSevertsen (1986)[127] Alto Alto Bajo Incierto Incierto Alto \nVaccarino (2013)[133] \nM. Objetiva \nM. Auto-reportada Bajo \nBajo Bajo \nBajo Bajo \nBajo Bajo \nBajo Incierto \nIncierto Incierto \nIncierto \nVasudev (2016)[134] \nIonson (2019)[135] Bajo Incierto Bajo Alto Bajo Alto \nWachholtz (2005)[136] Incierto Incierto Bajo Incierto Incierto Alto \nWachholtz (2008)[137] Bajo Incierto Alto Incierto Incierto Alto \nWolf (2003)[141] Incierto Alto Incierto Incierto Incierto Alto \nMEDITACI\u00d3N RELIGIOSA/ESPIRITUAL  \nBeiranvand (2014)[65] \nM. Objetiva \nM. Auto-reportada Bajo \nBajo Incierto \nIncierto Bajo \nBajo Bajo \nAlto Incierto \nIncierto Incierto \nAlto \nChirico (2020)[77] Incierto Incierto Bajo Alto Incierto Alto \nCole (2012)[78] Bajo Incierto Bajo Alto Incierto Alto \nKnabb (2020)[99] Alto Incierto Bajo Alto Incierto Alto \nMEDITACI\u00d3N FOCALIZADA EN LA RESPIRACI\u00d3N  Y/O ESCANEO CORPORAL   \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  148 Tabla 7. Riesgo de sesgo de los estudios primarios incluid os (resumen). \nEscala RoB-2 Cochrane \n \nDominio 1: \nDerivado del \nproceso de \naleatorizaci\u00f3n  Dominio 2 : \nDebido a \ndesviaciones de \nlas intervenciones \nprevistas (efecto \nde la asignaci\u00f3n a \nla intervenci\u00f3n) Dominio 3:  \nDatos de \nresultados \nfaltantes Dominio 4: \nEn la \nmedici\u00f3n del \nresultado Dominio 5:  \nEn la \nselecci\u00f3n \ndel \nresultado \nreportado RIESGO DE \nSESGO \nGENERAL \nChandler (2020)[75] \nM. Objetiva \nM. Auto-reportada Incierto \nIncierto Alto \nAlto Alto \nAlto Bajo \nIncierto Bajo \nBajo Alto \nAlto \nFatima (2014)[53] \nM. Objetiva \nM. Auto-reportada Incierto \nIncierto Alto \nAlto Bajo \nBajo Bajo \nAlto Incierto \nIncierto Alto \nAlto \nGagrani (2018)[85] \nM. Objetiva \nM. Auto-reportada Bajo \nBajo Incierto \nIncierto Bajo \nBajo Bajo \nAlto Bajo \nBajo Incierto \nAlto \nJanyacharoen (2018)[91] \nM. Objetiva \nM. Auto-reportada Bajo \nBajo Alto \nAlto Incierto \nIncierto Bajo \nAlto Incierto \nIncierto Alto \nAlto \nKindlon (1963)[97] Incierto Incierto Bajo Incierto Incierto Alto \nMenezes (2013)[104] Incierto Alto Incierto Incierto Incierto Alto \nMenezes (2015)[105]  Incierto Alto Incierto Alto Incierto Alto \nYang (2009)[144]  Incierto Alto Bajo Alto Incierto Alto \nMEDITACI\u00d3N BASADA EN LA BONDAD Y AMOR (LKM) + ENTREN AMIENTO EN EL CULTIVO DE LA COMPASI\u00d3N  \nBrito-Pons (2018)[71] Incierto Incierto Bajo Alto Incierto Alto \nCarson (2005)[73] Bajo Alto Bajo Incierto Incierto Alto \nDion (2016)[81] Incierto Incierto Bajo Incierto Bajo Alto \nGalante (2016)[86] Incierto Incierto Bajo Incierto Bajo Alto \nJazaieri (2013)[93] Incierto Incierto Bajo Alto Incierto Alto \nShahar (2014)[128] Incierto Incierto Bajo Alto Incierto Alto \nWeibel (2016)[138] Incierto Incierto Incierto Alto Incierto Alto \nWilliams (2005)[139] Incierto Incierto Bajo Incierto Incierto Alto \nWren (2019)[142] Incierto Incierto Incierto  Incierto Alto  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 149 Tabla 7. Riesgo de sesgo de los estudios primarios incluid os (resumen). \nEscala RoB-2 Cochrane \n \nDominio 1: \nDerivado del \nproceso de \naleatorizaci\u00f3n  Dominio 2 : \nDebido a \ndesviaciones de \nlas intervenciones \nprevistas (efecto \nde la asignaci\u00f3n a \nla intervenci\u00f3n) Dominio 3:  \nDatos de \nresultados \nfaltantes Dominio 4: \nEn la \nmedici\u00f3n del \nresultado Dominio 5:  \nEn la \nselecci\u00f3n \ndel \nresultado \nreportado RIESGO DE \nSESGO \nGENERAL \nM. Objetiva \nM. Auto-reportada Incierto Incierto Incierto Bajo \nAlto Incierto Alto \nMEDITACIONES MIXTAS  \nBasso (2019)[64] Incierto Alto Bajo Incierto Incierto Alto \nCuriati (2005)[79] \nM. Objetiva \nM. Auto-reportada Incierto \nIncierto Alto \nAlto Alto \nAlto Bajo \nAlto Incierto \nIncierto Alto \nAlto \nGaston (1988)[87] Incierto Alto Incierto Bajo Incierto Alto \nHafner (1982)[88] Incierto Incierto Bajo Bajo Incierto Alto \nLee (2015)[101]  Incierto  Alto Bajo Alto Incierto Alto \nMilbury (2013)[107] \nM. Objetiva \nM. Auto-reportada Incierto \nIncierto Incierto \nIncierto Bajo \nBajo Bajo \nAlto Bajo \nBajo Incierto \nAlto \nNanthakwang \n(2020)[109] Incierto Incierto Bajo Bajo Incierto Alto \nWu (2019)[143] Bajo Incierto Bajo Alto Incierto Alto \nECAs: ensayos controlados aleatorizados \n \n  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  150 Escala RoB-2 (Colaboraci\u00f3n Cochrane) para evaluar e l riesgo  de sesgo de los ECAs incluidos  \nEstudio: Alexander (1989)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Funci\u00f3n cognitiva (bater\u00eda de pruebas); Ansiedad (STA I). \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the numeric result \n(e.g. RR = 1.52 (95% CI 0.83 to 2.77) and/or a refe rence (e.g. to a table, figure or paragraph) that u niquely defines the result being \nassessed. En la comparaci\u00f3n planificada general, no hubo diferen cias entre los grupos en cuanto a \nansiedad y depresi\u00f3n (Tabla 3). \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 e ffect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n   X    Journal article(s) with results of the trial  \n \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling quest ions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n, pero no se describe  el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par t icipants were enrolled and \nassigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem with \nthe randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due t o deviations from the intended interventions (effec t of assignment to intervention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista \ndebidos al contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3: Were these deviations likely t o have affected the outcome?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations from intended intervention \nbalanced between groups? No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6: Was there potential for a su bstantial impact (on the result) of \nthe failure to analyse participants in the group to  which they were randomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo \nen que fueron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Los datos estuvieron disponibles para todos o pr\u00e1cti camente todos los participantes (5% \nde p\u00e9rdidas) Yes / Probably yes / Probably No / No / No \nInformation   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 151 3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by missing \noutcome data?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.3 If N/PN to 3.2: Could missingness in the outcom e depend on its true value?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on its \ntrue value?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para recoger los resultados parece haber si do el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed between \nintervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the intervention \nreceived by study participants?  Los cuidadores y evaluadores estaban cegados a la condi ci\u00f3n de los participantes No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced by \nknowledge of intervention received?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4 : Is it likely that assessment of the outcome was i nfluenced by \nknowledge of intervention received?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los \nan\u00e1lisis previstos Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the basis \nof the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las \nmedidas y los puntos temporal fueron acordes con lo pl aneado Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos \nde an\u00e1lisis que utilizaron fueron acordes con lo plane ado Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  152  Estudio: Anderson (1999)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Burnout percibido (MBI); Ansiedad (STAI); Estr\u00e9s ocup acional (TSI) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being \npresented, specify the numeric result (e.g. RR = 1.52 ( 95% CI 0.83 to 2.77) and/or a reference \n(e.g. to a table, figure or paragraph) that uniquel y defines the result being assessed. Se encontraron diferencias significativas entre los g rupos en la posprueba (p <.001) y en el seguimiento (p <.001) para las \nmedidas de Ansiedad estatal (SA) y Ansiedad rasgo ( TA) del STAI, as\u00ed como para el Agotamiento emocional  (EE) subescala del \nMBI (p <.001). Sin embargo, hubo una diferencia sig nificativa entre los grupos en la puntuaci\u00f3n total de  la prueba del TSI en la \nposprueba (p <.006) y en el seguimiento (p <.001).  \nIs the review team\u2019s aim for this result\u2026?  \nX to assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n   X    Journal article(s) with results of the trial  \n \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n, pero no se describe  el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled and \nassigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment t o intervention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista \ndebidos al contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations likely to have affected the  \noutcome?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations from intended intervention \nbalanced between groups? No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to e stimate the effect of assignment to \nintervention?  No hay suficiente informaci\u00f3n para valorar este domin io Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e result) \nof the failure to analyse participants in the group  to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo \nen que fueron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all , participants \nrandomized?  No se ofrece suficiente informaci\u00f3n para valorar si los datos de la medida de resultado \nest\u00e1n disponibles para todos o casi todos los partici pantes aleatorizados Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN /NI to 3.1 : Is there evidence that the result was not biased by missing \noutcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo No applicable / Yes / Probably yes / Probably no / \nNo   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 153 3.3 If N/PN to 3.2: Could missingness in the outcom e depend on its true value?  No se ofrece suficiente informaci\u00f3n acerca de las p\u00e9rd idas y sus motivos No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it li kely that missingness in the outcome depended on \nits true value?  No se ofrece suficiente informaci\u00f3n acerca de las p\u00e9rd idas y sus motivos No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para recoger los resultados parece haber si do el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed between \nintervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/P N/NI to 4.1 and 4.2 : Were outcome assessors aware of the intervention \nreceived by study participants?  No se informa sobre el cegamiento de los evaluadores  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influenced by \nknowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos \npor el conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  La medida es auto-reportada y la intervenci\u00f3n s\u00f3lo s e compara con un grupo de \u201cno \ntratamiento\u201d, por lo que es probable que los result ados se vean influenciados por el \nconocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los \nan\u00e1lisis previstos Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2 . ... multiple outcome measurements (e.g. scales, d efinitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las \nmedidas y los puntos temporal fueron acordes con lo pl aneado Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  Los efectos del tratamiento se evaluaron mediante un  an\u00e1lisis de covarianza, ajustado por \nel nivel de la prueba previa en aquellas variables para las que estaban disponibles las \npuntuaciones de la prueba previa. Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n Estudio: Barnes (2012) \nStudy design  \nx Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed fo r risk of bias:  Masa del ventr\u00edculo izquierdo del coraz\u00f3n; Presi\u00f3n sang u\u00ednea. \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the numeric result \n(e.g. RR = 1.52 (95% CI 0.83 to 2.77) and/or a refe rence (e.g. to a table, figure or paragraph) that u niquely defines the result being \nassessed. Los cambios en la posprueba no fueron estad\u00edsticament e significativos entre el grupo de \nmeditaci\u00f3n y el grupo control en el postest (4 meses) -3,2\u00b120,2; 4 meses de seguimiento -\n9,1\u00b120,2 (P < 0.04). \n Is the review team\u2019s aim for this result\u2026?  \n \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n        X Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process   \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  154 Signalling questions  Comment s Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado. Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants wer e enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations  from the intended interventions (effect of assignme nt to intervention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Los participantes no estaban cegados a la condici\u00f3n  Yes / Probably yes / Probably No / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n. Sin embargo, lo s t\u00e9cnicos que recopilaron \nlos datos estaban cegados a la asignaci\u00f3n de los part icipantes Yes / Probably yes / Probably No / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental Yes / Probably yes / Probably No / No / No \ninformation \n2.4. If Y/PY to 2.3 : Were these deviations likely to have  affected the \noutcome?  No aplica No applicable / Yes / Probably yes / Probably No / \nNo / No information \n2.5 If Y/PY/NI to 2.4 : Were these deviations from intended intervention \nbalanced between groups?  No aplica No applicable / Yes / Probably yes / Probably No / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably No / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No parece que haya habido un impacto sustancial en los resultados debido a la falta de \nan\u00e1lisis de los participantes en el grupo en que fu eron asignados No applicable / Yes / Probably yes / Probably No / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data  for this outcome available for all, or nearly all, participants \nrandomized?  Hubo un 60% de p\u00e9rdidas Yes / Probably yes / Probably No / No / No \ninformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo Yes / Probably yes / Probably no / No / No \ninformation \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  Los motivos de las p\u00e9rdidas parecen ser independient es a la intervenci\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n3.4 If Y/PY/NI to 3.3: Is it likely that missingnes s in the outcome depended on \nits true value?  Las p\u00e9rdidas son similares entre los diferentes gru pos, por lo que es posible que no est\u00e9n \nrelacionadas con la intervenci\u00f3n en s\u00ed misma pese a q ue no est\u00e9n suficientemente \ndocumentadas Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low /High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4. 2 Could measurement or ascertainment of the outcome  have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4. 1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  El evaluador estuvo cegado a la condici\u00f3n del partici pante Yes / Probably yes / Probably no / No / No \ninformation \n4.4 If Y/PY/NI to 4.3 : Could assessment of the ou tcome have been influenced \nby knowledge of intervention received?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4 : Is it likely that assessment of the outcome was i nfluenced \nby knowledge of intervention received?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low /High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produce d this result analysed in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos Yes / Probably yes / Probably no / No / No \ninformation    \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 155 Is the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?   El protocolo del estudio no est\u00e1 disponible, por ta nto, no se puede comparar si las \nmedidas y los puntos temporal fueron acordes con lo pl aneado Yes / Probably yes / Probably no / No / No \ninformation  \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos de \nan\u00e1lisis que utilizaron fueron acordes con lo planeado  Yes / Probably yes / Probably no / No / No \ninformation  \nRisk -of -bias judgement  Riesgo de sesgo in cierto  Low /High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low /High / Some concerns \n  Estudio: Basso (2019) \nStudy design  \nx Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Calidad de sue\u00f1o (PSQI); Ansiedad (STAI; BAI); Depr esi\u00f3n (BAI); Estr\u00e9s social (TSST); Estado de \u00e1nimo ( POMS) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being \npresented, specify the numeric result (e.g. RR = 1.52 ( 95% CI 0.83 to 2.77) and/or a reference \n(e.g. to a table, figure or paragraph) that uniquel y defines the result being assessed. Se encontr\u00f3 un efecto de interacci\u00f3n significativo para  la puntuaci\u00f3n de ansiedad del estado entre estos do s puntos de tiempo \n(tiempo * grupo F (1,35) = 4.128, p = 0.050, \u03b72 parcial = 0.105; Meditaci\u00f3n 33.550 \u00b1 2.271 / 39.20 0 \u00b1 2.973; Control 35.444 \u00b1 2.058 / \n46.222 \u00b1 3.190), con ocho semanas de meditaci\u00f3n reducie ndo significativamente la respuesta de estr\u00e9s conductu al al TSST (Fig. \n6A). Los controles mostraron una mejora significativa  en la calidad del sue\u00f1o (t (20) = 3.408, p = 0.003)  y los meditadores no \nmostraron cambios en el tiempo (t (20) = \u22121.227, p =  0.234). Los meditadores mostraron una disminuci\u00f3n n o significativa de la \nansiedad (t (20) = 1.633, p = 0.118) mientras que l os controles mostraron un aumento no significativo d e la ansiedad (t (20) = - \n1.418, p = 0.172). \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n        X Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n, pero no se describe  el m\u00e9todo utilizado.  \nYes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended inte rventions (effect of assignment to intervention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n Yes / Probably yes / Probably No / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations likely to have affected the  \noutcome?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  156 2.5 If Y/PY/NI to 2.4 : Were these deviations from intended intervention \nbalanced between groups?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate the effect  of assignment to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there pot ential for a substantial impact (on the \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo en \nque fueron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 W ere data for this outcome available for all, or nea rly all, participants \nrandomized?  Hubo un 18.4% de p\u00e9rdidas Yes / Probably yes / Probably no / No / No \ninformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  Se llev\u00f3 a cabo un an\u00e1lisis para determinar el efect o de los abandonos y exclusiones en \nambos grupos. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida Yes / Probably yes / Probably no / No / No \ninformation \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  El grupo comparador fue un control activo con protocolo similar al del grupo de \nintervenci\u00f3n, por lo que es probable que las difere ncias no se deban al conocimiento de la \nintervenci\u00f3n recibida Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo d e sesgo incierto  Low /High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos Yes / Probably yes / Probably no / No / No \ninformation  \nIs the numerical result being assessed likely to ha ve been selecte d, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?   El protocolo del estudio no est\u00e1 disponible, por ta nto, no se puede comparar si las \nmedidas y los puntos temporal fueron acordes con lo pl aneado Yes / Probably yes / Probably no / No / No \ninformation  \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos de \nan\u00e1lisis que utilizaron fueron acordes con lo planead o Yes / Probably yes / Probably no / No / No \ninformation  \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low /High / Some concerns \n Estudio: Beiranvand (2014) \nStudy design  \nx Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bia s:  Dolor (VAS); Presi\u00f3n sangu\u00ednea   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 157 Specify the numerical result being assessed. In case of  multiple alternative analyses being presented, \nspecify the numeric result (e.g. RR = 1.52 (95% CI 0. 83 to 2.77) and/or a reference (e.g. to a table, \nfigure or paragraph) that uniquely defines the resu lt being assessed. Se encontr\u00f3 una mejora estad\u00edsticamente significativa en la puntuaci\u00f3n de dolor 3 y 6 horas despu\u00e9s de la m editaci\u00f3n de \noraci\u00f3n (1,5 \u00b1 0,3 frente a 3 \u00b1 1,3, P = 0,030) y (1 ,3 \u00b1 0,8 frente a 3 \u00b1 1,1, P = 0,003) (Figura 2). S in embargo, no hubo \ndiferencias significativas en las respuestas fisiol\u00f3g icas (presi\u00f3n arterial sist\u00f3lica y diast\u00f3lica, respira ci\u00f3n y frecuencia \ncard\u00edaca) en ning\u00fan momento entre los grupos. \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n        X Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Los pacientes fueron asignados al azar en dos grupos utilizando n\u00fameros aleatorios \ngenerados por ordenador.  \nYes / Probably yes / Probably No / No / No informatio n \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No informatio n \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No informatio n \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment  to intervention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados Yes / Probably yes / Probably No / No / No informatio n \n2.2. Were carers and people delivering the interven tions aware of \nparticipants' assigned intervention during the tria l?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably No / No / No informatio n \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista \ndebidos al contexto experimental No applicable / Yes / Probably yes / Probably No / No / \nNo information \n2.4. If Y/PY to 2.3 : Were these deviations likely to have affected the  \noutcome?  No aplica. No applicable / Yes / Probably yes / Probably no / No / \nNo information \n2.5 If Y/PY/NI to 2.4 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / No / \nNo information \n2.6 Was an appropriate analysis used to estim ate the effect of assignment to \nintervention?   Los an\u00e1lisis se realizaron con todos los participante s elegibles despu\u00e9s de la \naleatorizaci\u00f3n Yes / Probably yes / Probably no / No / No informatio n \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantia l impact (on the \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No aplica. No applicable / Yes / Probably yes / Probably no / No / \nNo information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Presi\u00f3n sangu\u00ednea: Los datos estuvieron disponible para todos o pr\u00e1cticamente todos \nlos participantes (no se informan p\u00e9rdidas) Cuestionario: Los datos estuvieron disponible para todos o pr\u00e1cticamente todos los \nparticipantes (no se informan p\u00e9rdidas Objetiva: Yes / Probably yes / Probably No / No / No \nInformation \nAuto-reportada: Yes / Probably yes / Probably No / No  / \nNo Information \n3.2 If N/PN/NI to 3.1: Is there evidence that the r esult was not biased by \nmissing outcome data?  Presi\u00f3n sangu\u00ednea: No aplica Cuestionario: No aplica Objetiva: No applicable / Yes / Probably yes / Probab ly \nno / No / No information \nAuto-reportada: No applicable / Yes / Probably yes / \nProbably no / No / No information \n3.3 If N/PN to 3.2: Could missingness in the outcom e depend on its true \nvalue?  Presi\u00f3n sangu\u00ednea: No aplica Cuestionario: No aplica Objetiva: No applicable / Yes / Probably yes / Probab ly \nno / No / No information \nAuto-reportada: No applicable / Yes / Probably yes / \nProbably no / No / No information \n3.4 If Y/PY/NI to 3.3: Is it likely that missingnes s in the outcome depended \non its true value?  Presi\u00f3n sangu\u00ednea: No aplica Cuestionario: No aplica Objetiva: No applicable / Yes / Probably yes / Probab ly \nno / No / No information \nAuto-reportada: No applicable / Yes / Probably yes /  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  158 Probably no / No / No information \nRisk-of-bias judgement  Presi\u00f3n  sangu\u00ednea: Bajo riesgo de sesgo  \nCuestionario: Bajo riesgo de sesgo  Objetiva: Low /High / Some concerns \nAuto-reportada: Low /High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  Presi\u00f3n sangu\u00ednea: El m\u00e9todo para medir los resulta dos parece haber sido el \napropiado Cuestionario: El m\u00e9todo para medir los resultados p arece haber sido el apropiado Objetiva: Yes / Probably yes / Probably no / No / No \ninformation \nAuto-reportada: Yes / Probably yes / Probably no / No  / \nNo information \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  Presi\u00f3n sangu\u00ednea: El m\u00e9todo para medir los resulta dos parece haber sido comparable \nen todos los grupos Cuestionario: El m\u00e9todo para medir los resultados p arece haber sido comparable en \ntodos los grupos Objetiva: Yes / Probably yes / Probably no / No / No \ninformation \nAuto-reportada: Yes / Probably yes / Probably no / No  / \nNo information \n4.3 If N/PN/NI to 4.1 and 4.2: Were outcome assesso rs aware of the \nintervention received by study participants?  Presi\u00f3n sangu\u00ednea: No se informa sobre el cegamiento  de los evaluadores \nCuestionario: La medida es auto-reportada y parece po co probable que los \nparticipantes est\u00e9n cegados a la asignaci\u00f3n Objetiva: No applicable / Yes / Probably yes / Probab ly \nno / No / No information \nAuto-reportada: No applicable / Yes / Probably yes / \nProbably no / No / No information \n4.4 If Y/PY/NI to 4.3: Could assessment of the outc ome have been influenced \nby knowledge of intervention received?  Presi\u00f3n sangu\u00ednea: La medida es objetiva y parece poco  probable que los \nparticipantes/evaluador pueda influir en los resulta dos \nCuestionario: La medida es auto-reportada, por lo q ue es posible que los resultados se \nvean influidos por el conocimiento de la intervenci\u00f3n recibida Objetiva: Yes / Probably yes / Probably no / No / No \ninformation \nAuto-reportada: No applicable / Yes / Probably yes / \nProbably no / No / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was \ninfluenced by knowledge of intervention received?  Presi\u00f3n sangu\u00ednea: No aplica Cuestionario: La medida es auto-reportada y la inter venci\u00f3n s\u00f3lo se compara con un \ngrupo de \u201cno tratamiento\u201d, por lo que es probable q ue los resultados se vean \ninfluenciados por el conocimiento de la intervenci\u00f3n recibida Objetiva: No applicable / Yes / Probably yes / Probab ly \nno / No / No information \nAuto-reportada: No applicable / Yes / Probably yes / \nProbably no / No / No information \nRisk-of-bias judgement  Presi\u00f3n sangu\u00ednea: Bajo ries go de sesgo  \nCuestionario: Alto riesgo de sesgo  Objetiva Objetiva: Low / High / Some concerns \nAuto-reportada: Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a \npre-specified analysis plan that was finalized befor e unblinded outcome \ndata were available for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los \nan\u00e1lisis previstos Objetiva: Yes / Probably yes / Probably no / No / No \ninformation \nAuto-reportada: Yes / Probably yes / Probably no / No  / \nNo information  \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales, definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las \nmedidas y los puntos temporal fueron acordes con lo pl aneado Yes / Probably yes / Probably no / No / No informatio n \n \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos \nde an\u00e1lisis que utilizaron fueron acordes con lo plane ado Yes / Probably yes / Probably no / No / No informatio n \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nOverall risk of bias   \nRisk-of-bias judgement  Presi\u00f3n sangu\u00ednea: Riesgo de sesgo incierto  \nCuestionario: Alto riesgo de sesgo  Objetiva: Low /High / Some concerns \nAuto-reportada: Low /High / Some concerns \n Estudio: Bokhari (2019) \nStudy design  \nx Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being a ssessed for risk of bias:  Reserva de flujo mioc\u00e1rdico (MFR), presi\u00f3n sangu\u00ednea,  Distr\u00e9s y Depresi\u00f3n. \nSpecify the numerical result being assessed. In case of  multiple alternative analyses \nbeing presented, specify the numeric result (e.g. RR = 1.52 (95% CI 0.83 to 2.77) \nand/or a reference (e.g. to a table, figure or parag raph) that uniquely defines the Hubo un cambio desde el inicio hasta el postest desp u\u00e9s de 12 semanas de intervenci\u00f3n para los grupos d e meditaci\u00f3n (TM) combinados \n(Rehabilitaci\u00f3n cardiaca + TM y TM solo) versus los gru pos combinados sin TM (Rehabilitaci\u00f3n cardiaca solo y at enci\u00f3n habitual). La reserva \nde flujo mioc\u00e1rdico global aument\u00f3 un 14% en el grupo  combinado de TM (ES = 0.56, tanto ajustando como sin  ajustar por RPP), pero   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 159 result being assessed. permaneci\u00f3 pr\u00e1cticamente sin cambios (- 2.0%) en el gru po sin TM (ES = - 0.08 sin ajustar, ES = 0.05 ajust ado para RPP). Estas diferencias \nentre los grupos combinados de TM y sin TM no fueron significativas (P = 0,23 sin ajustar para RPP, de do s colas; P = 0,29 ajustado para \nRPP, de dos colas). En el cuestionario BD) el tama\u00f1o del efecto de la meditaci\u00f3n fue de - 0.29, en la pre si\u00f3n sangu\u00ednea sist\u00f3lica fue de 0.31 y \nen la presi\u00f3n sangu\u00ednea diast\u00f3lica 0.55. \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n        X Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  El bioestad\u00edstico del estudio ocult\u00f3 la secuencia de as ignaci\u00f3n Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the intervent ions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no pudieron \nestar cegados a su condici\u00f3n Yes / Probably yes / Probably No / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista \ndebidos al contexto experimental Yes / Probably yes / Probably No / No / No \ninformation \n2.4. If Y/PY to 2.3 : Were these deviations likely to have affected the  \noutcome?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If Y/PY/NI to 2.4 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo \nen que fueron asignados. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low /High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  MFR: Hubo un 34% de p\u00e9rdidas Cuestionario: Hubo un 34% de p\u00e9rdidas Objetiva: Yes / Probably yes / Probably no / No / \nNo information \nAurto-reportada: Yes / Probably yes / Probably no / \nNo / No information \n3.2 If N/PN/NI to 3.1: Is there evidence that the r esult was not biased by \nmissing outcome data?  MFR: Es posible que el resultado estuviese sesgado porque no se utiliz\u00f3 ning\u00fan m\u00e9todo \nde an\u00e1lisis para corregir el sesgo Cuestionario: Es posible que el resultado estuviese  sesgado porque no se utiliz\u00f3 ning\u00fan \nm\u00e9todo de an\u00e1lisis para corregir el sesgo Objetiva: Yes / Probably yes / Probably no / No / \nNo information \nAurto-reportada: Yes / Probably yes / Probably no / \nNo / No information \n3.3 If N/PN to 3.2: Could missingness in the outcom e depend on its true \nvalue?  MFR: Algunos motivos de p\u00e9rdidas no quedan suficien temente documentados \nCuestionario: Algunos motivos de p\u00e9rdidas no quedan  suficientemente documentados Objetiva: No applicable / Yes / Probably yes / \nProbably No / No / No information \nAurto-reportada: No applicable / Yes / Probably yes \n/ Probably No / No / No information \n3.4 If Y/PY/NI to 3.3: Is it likely that missingnes s in the outcome depended on \nits true value?  MFR: Algunos motivos de p\u00e9rdidas no quedan suficien temente documentados \nCuestionario: Algunos motivos de p\u00e9rdidas no quedan  suficientemente documentados Objetiva:  No applicable / Yes / Probably yes / \nProbably No / No / No information \nAurto-reportada: No applicable / Yes / Probably yes  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  160 / Probably No / No / No information \nRisk-of-bias judgement  MFR: Alto riesgo de sesgo  \nCuestionario: Alto riesgo de sesgo  MFR: Low /High / Some concerns \nCuestionario: Low /High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  MFR: El m\u00e9todo para medir los resultados parece habe r sido el apropiado \nCuestionario: El m\u00e9todo para medir los resultados p arece haber sido el apropiado Objetiva: Yes / Probably yes / Probably no / No / \nNo information \nAurto-reportada: Yes / Probably yes / Probably no / \nNo / No information \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  MFR: El m\u00e9todo para medir los resultados parece habe r sido comparable en todos los \ngrupos Cuestionario: El m\u00e9todo para medir los resultados p arece haber sido comparable en \ntodos los grupos Objetiva: Yes / Probably yes / Probably no / No / \nNo information \nAurto-reportada: Yes / Probably yes / Probably no / \nNo / No information \n4.3 If N/PN/NI to 4.1 and 4.2: Were outcome assesso rs aware of the \nintervention received by study participants?  MFR: Los investigadores, los profesionales m\u00e9dicos y el personal de recopilaci\u00f3n de \ndatos estaban cegados al estado del tratamiento. Cuestionario: La medida es auto-reportada y parece po co probable que los participantes \nest\u00e9n cegados a la asignaci\u00f3n Objetiva: No applicable / Yes / Probably yes / \nProbably No / No / No information \nAurto-reportada: No applicable / Yes / Probably yes \n/ Probably No / No / No information \n4.4 If Y/PY/NI to 4.3: Could assessment of the outc ome have been influenced \nby knowledge of intervention received?  MFR: No aplica Cuestionario: La medida es auto-reportada, por lo q ue es posible que los resultados se \nvean influidos por el conocimiento de la intervenci\u00f3n recibida Objetiva: No applicable / Yes / Probably yes / \nProbably No / No / No information \nAurto-reportada: No applicable / Yes / Probably yes \n/ Probably No / No / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  MFR: No aplica Cuestionario: La medida es auto-reportada y la inter venci\u00f3n s\u00f3lo se compara con un grupo \nde \u201cno tratamiento\u201d, por lo que es probable que los  resultados se vean influenciados por el \nconocimiento de la intervenci\u00f3n recibida Objetiva: No applicable / Yes / Probably yes / \nProbably No / No / No information \nAurto-reportada: No applicable / Yes / Probably yes \n/ Probably No / No / No information \nRisk-of-bias judgement  MFR: Bajo riesgo de sesgo  \nCuestionario: Alto riesgo de sesgo  Objetiva: Low /High / Some concerns \nAurto-reportada: Low /High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio est\u00e1 disponible (NCT0181002 9) Yes / Probably yes / Probably no / No / No \ninformation  \nIs the numerical result being assessed likely to ha ve been selected, on t he \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  Se realizaron an\u00e1lisis de comparaciones entre grupos co n los mismos instrumentos Yes / Probably yes / Probably no / No / No \ninformation  \n5.3 ... multiple eligible analyses of the data?  Los resultados se analizaron atendiendo al plan de a n\u00e1lisis previo al inicio del estudio Yes / Probably yes / Probably no / No / No \ninformation  \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low /High / Some concerns \nOverall risk of bias   \nRisk-of-bias judgement  MFR: Alto riesgo de sesgo  \nCuestionario: Alto riesgo de sesgo  Objetiva: Low /High / Some concerns \nAuto-reportada: Low /High / Some concerns \n  Estudio: Bormann (2006) \nStudy desi gn  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Estr\u00e9s percibido (PSS); Ansiedad (STAI); Depresi\u00f3n ( CES-D); Calidad de vida (Q-LES-Q) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the \nnumeric result (e.g. RR = 1.52 (95% CI 0.83 to 2.77)  and/or a reference (e.g. to a table, figure or para graph) that \nuniquely defines the result being assessed. No se encontr\u00f3 un efecto significativo del grupo sobr e las medidas de estr\u00e9s percibido, rasgo de ansiedad  o nivel \nde depresi\u00f3n, aunque se observaron reducciones a lo la rgo de tiempo. Tablas 2 y 3: ANOVAS de medidas \nrepetidas para las distintas variables de resultado .   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 161  Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to interventi on  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n     X    Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation seque nce concealed until participants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No /  No \ninformation \n1.3 Did baseline differences between intervention g roups  suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDoma in 2: Risk of bias due to deviations from the inten ded interventions (effect of assignment to interven tion)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No hay suficiente informaci\u00f3n para valorar este domin io No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appr opriate analysis used to estimate the effect of ass ignment to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on the \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo en \nque fueron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were dat a for this outcome available for all, or nearly all , participants \nrandomized?  Hubo un 26.9% de p\u00e9rdidas a las 10 semanas y un 29% de p\u00e9rdidas a las 22 semanas. Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence  that the result was not biased by \nmissing outcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could mi ssingness in the outcome depend on its true \nvalue?  Los motivos de las p\u00e9rdidas parecen ser independient es a la intervenci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depended on \nits true value?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4 : Is it likely that assessment of the outcome was i nfluenced El grupo comparador fue un control activo con protocolo similar al del grupo de No applicable / Yes / Probably yes / Probably no /  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  162 by knowledge of intervention received?  intervenci\u00f3n, por lo que es probable que las difere ncias no se deban al conocimiento de la \nintervenci\u00f3n recibida No / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  res ult  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , def initions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no parece estar disponible p ara contrastar si la medici\u00f3n se analiz\u00f3 \nde m\u00faltiples maneras. Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo in cierto  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n  Estudio: Bormann (2008) \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Sintomatolog\u00eda TETP (CAPS; PTSD Checklist); Distr\u00e9s ( BSI-18); Calidad de vida (Q-LES-Q:SF) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the \nnumeric result (e.g. RR = 1.52 (95% CI 0.83 to 2.77)  and/or a reference (e.g. to a table, figure or para graph) that \nuniquely defines the result being assessed. Se encontr\u00f3 tama\u00f1os del efecto grandes en la reducci\u00f3n de la severidad de la sintomatolog\u00eda (d=-0.72) y el \ndistr\u00e9s (d=-0.73), as\u00ed como un incremento en la calid ad de vida (d=0.70). Tabla 3. Cambios pre-post \nintervenci\u00f3n en los dos grupos y tama\u00f1o del efecto. \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n     X    Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  La secuencia es aleatoria (tabla de n\u00fameros generada por ordenador). Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto.  Low /High / Some concerns  \nDomain 2: Risk of bias due to deviations from the in tended interventions (effect of assignment to interv ention) \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 163 2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e  effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron con todos los participante s elegibles despu\u00e9s de la aleatorizaci\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact  (on the \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo en \nque fueron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 3: Missing outcome data \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Escala de s\u00edntomas TEPT (CAPS):  Los datos estuviero n disponible para todos o \npr\u00e1cticamente todos los participantes. Medidas auto-reportadas: Los datos estuvieron dispo nible para todos o pr\u00e1cticamente \ntodos los participantes. Hetero-reportadas: Yes / Probably yes / Probably \nNo / No / No Information \nAuto-reportadas: Yes / Probably yes / Probably No \n/ No / No Information \n3.2 If N/PN/NI to 3.1: Is there evidence that the r esult was not biased by \nmissing outcome data?  Escala de s\u00edntomas TEPT (CAPS): No aplica. Medidas auto-reportadas: No aplica. Hetero-reportadas: No applicable / Yes / Probably \nyes / Probably no / No \nAuto-reportadas: No applicable / Yes / Probably \nyes / Probably no / No \n3.3 If N/PN to 3.2: Could missingness in the outcom e depend on its true \nvalue?  Escala de s\u00edntomas TEPT (CAPS): No aplica. Medidas auto-reportadas: No aplica. Hetero-reportadas: No applicable / Yes / Probably \nyes / Probably no / No \nAuto-reportadas: No applicable / Yes / Probably \nyes / Probably no / No \n3.4 If Y/PY/NI to 3.3: Is it likely that missingnes s in the outcome depended on \nits true value?  Escala de s\u00edntomas TEPT (CAPS): No aplica. Medidas auto-reportadas: No aplica. Hetero-reportadas: No applicable / Yes / Probably \nyes / Probably no / No \nAuto-reportadas: No applicable / Yes / Probably \nyes / Probably no / No \nRisk-of-bias judgement  Escala de s\u00edntomas TEPT (CAPS): Bajo riesgo de sesg o  \nMedidas auto-reportadas: Bajo riesgo de sesgo Hetero-reportadas: Low / High / Some concerns \nAuto-reportadas: Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcome \n4.1 Was the method of measuring the outcome inappro priate?  Escala de s\u00edntomas TEPT (CAPS): El m\u00e9todo para medir  los resultados parece ser \napropiado. Medidas auto-reportadas: El m\u00e9todo para medir los r esultados parece ser apropiado Hetero-reportadas: Yes / Probably yes / Probably \nno / No / No information \nAuto-reportadas: Yes / Probably yes / Probably no / \nNo / No information \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  Escala de s\u00edntomas TEPT (CAPS): El m\u00e9todo para medir  los resultados parece haber sido \ncomparable en todos los grupos. Medidas auto-reportadas: El m\u00e9todo para medir los r esultados parece haber sido \ncomparable en todos los grupos. Hetero-reportadas: Yes / Probably yes / Probably \nno / No / No information \nAuto-reportadas: Yes / Probably yes / Probably no / \nNo / No information \n4.3 If N/PN/NI to 4.1 and 4.2: Were outcome assesso rs aware of the \nintervention received by study participants?  Escala de s\u00edntomas TEPT (CAPS): El evaluador estuvo cegado a la condici\u00f3n del \nparticipante Medidas auto-reportadadas: La medida es auto-report ada y parece poco probable que los \nparticipantes est\u00e9n cegados a la asignaci\u00f3n Hetero-reportadas: Yes / Probably yes / Probably \nno / No / No information \nAuto-reportadas: Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3: Could assessment of the outc ome have been influenced \nby knowledge of intervention received?  Escala de s\u00edntomas TEPT (CAPS): No aplica.  Medidas auto-reportadas: La medida es auto-reportad a, por lo que es posible que los \nresultados se vean influidos por el conocimiento de la intervenci\u00f3n recibida Hetero-reportadas: No applicable / Yes / Probably \nyes / Probably no / No \nAuto-reportadas: No aplicable / Yes / Probably yes \n/ Probably no / No / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  Escala de s\u00edntomas TEPT (CAPS): No aplica. Medidas auto-reportadas: El grupo comparador fue un control activo con protocolo similar \nal del grupo de intervenci\u00f3n, por lo que es probable  que las diferencias no se deban al \nconocimiento de la intervenci\u00f3n recibida Hetero-reportadas: No applicable / Yes / Probably \nyes / Probably no / No \nAuto-reportadas: No aplicable / Yes / Probably yes \n/ Probably no / No / No information \nRisk-of-bias judgement  Escala de s\u00edntomas TEPT (CAPS). Bajo riesgo de sesg o  \nMedidas auto-reportadas: Riesgo de sesgo incierto Hetero-reportadas: Low / High / Some concerns \nAuto-reportadas: Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported r esult \n5.1 Were the data that produced this result analyse d in accordance with a pre - El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis Yes / Probably yes / Probably no / No / No  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  164 specified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  previstos. information \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no parece estar disponible p ara contrastar si la medici\u00f3n se analiz\u00f3 \nde m\u00faltiples maneras. Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nOverall risk of bias  \nRisk-of-bias judgement  Es cala de s\u00edntomas TEPT (CAPS): Alto riesgo de sesgo  \nMedidas auto-reportadas: Alto riesgo de sesgo Hetero-reportadas: Low / High / Some concerns \nAuto-reportadas: Low / High / Some concerns \n  Estudio: Bormann (2013) \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Sintomatolog\u00eda TETP (CAPS; PCL); Ansiedad y Depresi\u00f3 n (BSI-18); Calidad de vida (SF-12 y FACIT-sp) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy \nthe numeric result (e.g. RR = 1.52 (95% CI 0.83 to 2.77) and/or a reference (e.g. to a table, figure or  \nparagraph) that uniquely defines the result being as sessed. Tabla 2. El 24% de los sujetos en el grupo de medit aci\u00f3n + atenci\u00f3n habitual tuvieron una mejor\u00eda cl\u00edni camente \nsignificativa de los s\u00edntomas de TEPT despu\u00e9s del tr atamiento en comparaci\u00f3n con el 12% de los del grupo d e \natenci\u00f3n habitual (prueba exacta de Fisher, p .047). Los participantes de meditaci\u00f3n + atenci\u00f3n habitual tambi\u00e9n \ndemostraron reducciones significativas en la depresi\u00f3n  (p = .0001), pero no la ansiedad (p = 0,31), en com paraci\u00f3n \ncon los sujetos de atenci\u00f3n habitual.  \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n        X Journal article(s) with results of the tri al \n        X Non-commercial trial registry record (e.g. C linicalTrials.gov record) \nDomain 1: Risk of bias arising  from the randomization process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Listas selladas de n\u00fameros aleatorios generados por  ordenador. Yes / Probably yes / Probably no / No / No \ninformation \n1.2 Was the allo cation sequence concealed until participants were e nrolled \nand assigned to interventions?  Se us\u00f3 asignaci\u00f3n abierta (los participantes fueron informados de la asignaci\u00f3n en el \nmomento de la asignaci\u00f3n al azar) Yes / Probably yes / Probably no / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participant s' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no pudieron \nestar cegados a su condici\u00f3n Yes / Probably yes / Probably No / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were t here deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental Yes / Probably yes / Probably No / No / No \ninformation   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 165 2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If Y/PY/NI to 2.4 : Were these deviations likely to have affect ed the \noutcome?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Se llev\u00f3 a cabo un an\u00e1lisis por intenci\u00f3n de tratar Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Auto-reportadas: Hubo un 7% de p\u00e9rdidas CAPS: Hubo un 7% de p\u00e9rdidas Auto-reportada: Yes / Probably yes / Probably No / \nNo / No information \nCAPS: Yes / Probably yes / Probably No / No / No \ninformation \n3.2 If N/PN/NI to 3.1: Is there evidence that the r esult was not biased by \nmissing outcome data?  Auto-reportadas: Es posible que el resultado estuvi ese sesgado porque no se utiliz\u00f3 ning\u00fan \nm\u00e9todo de an\u00e1lisis para corregir el sesgo. CAPS: Es posible que el resultado estuviese sesgado porque no se utiliz\u00f3 ning\u00fan m\u00e9todo \nde an\u00e1lisis para corregir el sesgo. Auto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nCAPS: No applicable / Yes / Probably yes / \nProbably no / No / No information \n3.3 If N/PN to 3.2: Could missingness in the outcom e depend on its true \nvalue?  Auto-reportadas: Los motivos de las p\u00e9rdidas parecen  ser independientes a la intervenci\u00f3n. \nCAPS: Los motivos de las p\u00e9rdidas parecen ser indepe ndientes a la intervenci\u00f3n. Auto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information  \nCAPS: No applicable / Yes / Probably yes / \nProbably no / No / No information \n3.4 If Y/PY/NI to 3.3: Is it likely that missingnes s in the outcome depended on \nits true value?  Auto-reportadas: No aplica. CAPS: No aplica. Auto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nCAPS: No applicable / Yes / Probably yes / \nProbably no / No / No information \nRisk-of-bias judgement  Auto -reportadas: Bajo riesgo de sesgo  \nCAPS: Bajo riesgo de sesgo Low /High / Some concerns \nLow /High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  Auto-reportadas: El m\u00e9todo para medir los resultado s parece haber sido el apropiado \nCAPS: El m\u00e9todo para medir los resultados parece hab er sido el apropiado Auto-reportada: Yes / Probably yes / Probably no / \nNo / No information \nCAPS: Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  Auto-reportadas: El m\u00e9todo para medir los resultado s parece haber sido comparable en \ntodos los grupos CAPS: El m\u00e9todo para medir los resultados parece hab er sido comparable en todos los \ngrupos Auto-reportada: Yes / Probably yes / Probably no / \nNo / No information \nCAPS: Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2: Were outcome assesso rs aware of the \nintervention received by study participants?  Auto-reportadas: La medida es auto-reportada y parece  poco probable que los \nparticipantes est\u00e9n cegados a la asignaci\u00f3n CAPS: El evaluador estuvo cegado a la condici\u00f3n del p articipante Auto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nCAPS: No applicable / Yes / Probably yes / \nProbably no / No / No information  \n4.4 If Y/PY/NI to 4.3: Could assessment of the outc ome have been influenced \nby knowledge of intervention received?  Auto-reportadas: La medida es auto-reportada, por l o que es posible que los resultados se \nvean influidos por el conocimiento de la intervenci\u00f3n recibida \nCAPS: No aplica. Auto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nCAPS: No applicable / Yes / Probably yes / \nProbably no / No / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  Auto-reportadas: La medida es auto-reportada y la in tervenci\u00f3n s\u00f3lo se compara con un \ngrupo de \u201ctratamiento habitual\u201d, por lo que es prob able que los resultados se vean \ninfluenciados por el conocimiento de la intervenci\u00f3n r ecibida \nCAPS: No aplica. Auto-reportada: No applicable / Yes / Probably yes \n/ Probably No / No / No information \nCAPS: No applicable / Yes / Probably yes / \nProbably no / No / No information \nRisk-of-bias judgement  Auto -reportadas: Alto riesgo de sesgo  \nCAPS: Bajo riesgo de sesgo Auto-reportada: Low /High / Some concerns \nCAPS: Low /High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this re sult analysed in accordance with a pre - El protocolo del estudio est\u00e1 disponible (NCT0012062 7) Yes / Probably yes / Probably no / No / No  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  166 specified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  information \nIs t he numerical result being assessed likely to have b een selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  Se realizaron an\u00e1lisis de comparaciones entre grupos co n los mismos instrumentos Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  Los resultados se analizaron atendiendo al plan de a n\u00e1lisis previo al inicio del estudio Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low /High / Some concerns \nOverall risk of bias   \nRisk-of-bias judgement  Auto -reportadas: Alto riesgo de sesgo  \nCAPS: Riesgo de sesgo incierto Auto-reportada: Low /High / Some concerns \nCAPS: Low /High / Some concerns \n Estudios: Bormann (2018) \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is bein g assessed for risk of bias:  Sintomatolog\u00eda TETP (CAPS; PCLM); Insomnio (Insomni a Severity Index); Depresi\u00f3n (PHQ-9); Ansiedad (STA I); \nCalidad de vida (WHOQOL) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy \nthe numeric result (e.g. RR = 1.52 (95% CI 0.83 to 2.77) and/or a reference (e.g. to a table, figure or  \nparagraph) that uniquely defines the result being as sessed. Table 2. Clinician-Administered PTSD Scale. Baseline GI = 77.46 (95% CI 73.99 a 80.93). Baseline GC = 75 .61 \n(95% CI 71.96 a 79.26). Post GI = 52.39 (95% CI 46. 91 a 57.82). Post GC = 62.07 (95% CI 56.56 a 67.57) . 2 meses \nseguimiento GI = 50.61 (95% CI 44.86 a 56.37). 2 me ses seguimiento GC = 59.00 (95% CI 53.61 a 64.39).  \n Is the review team\u2019s aim for this result\u2026? \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n        X Journal article(s) with results of the tri al \n        X Non-commercial trial registry record (e.g. C linicalTrials.gov record)  \nDomain 1: Risk of bias arising from the randomizatio n proce ss  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Listas selladas de n\u00fameros aleatorios generados por  ordenador. Yes / Probably yes / Probably no / No / No \ninformation \n1.2 Was the allocation sequence concealed unt il participants were enrolled \nand assigned to interventions?  Se us\u00f3 asignaci\u00f3n abierta (los participantes fueron informados de la asignaci\u00f3n en el \nmomento de la asignaci\u00f3n al azar) Yes / Probably yes / Probably no / No / No \ninformation \n1.3 Did baseline di fferences between intervention groups suggest a pro blem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Bajo riesgo de sesg o Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no pudieron \nestar cegados a su condici\u00f3n Yes / Probably yes / Probably No / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the inte nded \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental Yes / Probably yes / Probably No / No / No \ninformation \n2.4. If Y/PY to 2 .3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If Y/PY/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 167 2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Se llev\u00f3 a cabo un an\u00e1lisis por intenci\u00f3n de tratar Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  CAPS: Hubo un 10,75% de p\u00e9rdidas Auto-reportadas: Hubo un 10,75% de p\u00e9rdidas CAPS: Yes / Probably yes / Probably no / No / No \ninformation \nCAPS: Yes / Probably yes / Probably no / No / No \ninformation \n3.2 If N/PN/NI to 3.1: Is there evidence that the r esult was not biased by \nmissing outcome data?  CAPS: Se llev\u00f3 a cabo un an\u00e1lisis de sensibilidad pa ra corregir el sesgo \nAuto-reportadas: Se llev\u00f3 a cabo un an\u00e1lisis de sens ibilidad para corregir el sesgo CAPS: Yes / Probably yes / Probably no / No / No \ninformation \nAuto-reportadas: CAPS: Yes / Probably yes / \nProbably no / No / No information \n3.3 If N/PN to 3.2: Could missingness in the outcom e depend on its true \nvalue?  CAPS: No aplica. Auto-reportadas: No aplica CAPS: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportadas: No applicable / Yes / Probably \nyes / Probably no / No / No information \n3.4 If Y/PY/NI to 3.3: Is it likely that missingnes s in the outcome depended on \nits true value?  CAPS: No aplica. Auto-reportadas: No aplica CAPS: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportadas: No applicable / Yes / Probably \nyes / Probably no / No / No information \nRisk-of-bias judgement  CAPS: Bajo riesgo de sesgo  \nAuto-reportadas: Bajo riesgo de sesgo CAPS: Low /High / Some concerns \nAuto-reportadas: Low /High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  CAPS: El m\u00e9todo para medir los resultados parece hab er sido el apropiado \nAuto-reportadas: El m\u00e9todo para medir los resultado s parece haber sido el apropiado CAPS: Yes / Probably yes / Probably no / No / No \ninformation \nAuto-reportadas: Yes / Probably yes / Probably no / \nNo / No information \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  CAPS: El m\u00e9todo para medir los resultados parece hab er sido comparable en todos los \ngrupos Auto-reportadas: El m\u00e9todo para medir los resultado s parece haber sido comparable en \ntodos los grupos CAPS: Yes / Probably yes / Probably no / No / No \ninformation \nAuto-reportadas: Yes / Probably yes / Probably no / \nNo / No information \n4.3 If N/PN/NI to 4.1 and 4.2: Were outcome assesso rs aware of the \nintervention received by study participants?  CAPS: El evaluador estuvo cegado a la condici\u00f3n del p articipante \nAuto-reportadas: La medida es auto-reportada y parece  poco probable que los \nparticipantes est\u00e9n cegados a la asignaci\u00f3n CAPS: No applicable / Yes / Probably yes / \nProbably no / No / No information  \nAuto-reportadas: No applicable / Yes / Probably \nyes / Probably no / No / No information \n4.4 If Y/PY/NI to 4.3: Could assessment of the outc ome have been influenced \nby knowledge of intervention received?  CAPS: No aplica. Auto-reportadas: La medida es auto-reportada, por l o que es posible que los resultados se \nvean influidos por el conocimiento de la intervenci\u00f3n recibida CAPS: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportadas: No applicable / Yes / Probably \nyes / Probably no / No / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  CAPS: No aplica. Auto-reportadas: El grupo comparador fue un control a ctivo con protocolo similar al del \ngrupo de intervenci\u00f3n, por lo que es probable que l as diferencias no se deban al \nconocimiento de la intervenci\u00f3n recibida CAPS: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportadas: No applicable / Yes / Probably \nyes / Probably no / No / No information \nRisk-of-bias judgement  CAP S: Bajo riesgo de sesgo  \nAuto-reportadas: Riesgo de sesgo incierto CAPS: Low /High / Some concerns \nAuto-reportadas: : Low /High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d  in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio est\u00e1 disponible (NCT0150632 3) Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to have been selected,  on the \nbasis of the results, from...     \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  168 5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  Se realizaron an\u00e1lisis de comparaciones entre grupos co n los mismos instrumentos Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  Los resultados se analizaron atendiendo al plan de a n\u00e1lisis previo al inicio del estudio Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low /High / Some concerns \nOverall risk of bias   \nRisk-of-bias judgement  CAPS: Riesgo de sesgo incierto  \nAuto-reportadas: Riesgo de sesgo incierto Low /High / Some concerns \nLow /High / Some concerns \n Estudio: Boswell (1979)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Ansiedad (STAI) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the numeric result \n(e.g. RR = 1.52 (95% CI 0.83 to 2.77) and/or a refe rence (e.g. to a table, figure or paragraph) that u niquely defines the result being \nassessed. No hubo evidencia de ninguna de las medidas de que l a meditaci\u00f3n redujera la ansiedad m\u00e1s \nall\u00e1 de lo que se muestra en las tres condiciones de control. \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n   X    Journal article(s) with results of the trial  \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering t he interventions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations likely to have affected the  \noutcome?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were t hese deviations from intended intervention \nbalanced between groups? No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  No hay suficiente informaci\u00f3n para valorar este domin io Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo en \nque fueron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 169 Risk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  No se ofrece suficiente informaci\u00f3n para valorar si los datos de la medida de resultado \nest\u00e1n disponibles para todos o casi todos los partici pantes aleatorizados Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on i ts true \nvalue?  No se ofrece suficiente informaci\u00f3n acerca de las p\u00e9rd idas y sus motivos No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No se ofrece suficiente informaci\u00f3n acerca de las p\u00e9rd idas y sus motivos No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement o f the outcome  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para recoger los resultados parece haber si do el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me hav e differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of t he outcome have been influenced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  El grupo comparador fue un control activo con protocolo similar al del grupo de \nintervenci\u00f3n, por lo que es probable que las difere ncias no se deban al conocimiento de la \nintervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 5: Risk of bias in s election of the reported result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome mea surements (e.g. scales, definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos de \nan\u00e1lisis que utilizaron fueron acordes con lo planeado  Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n  Estudio: Brito-Pons (2018) \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of bias:  Ansiedad (BAI); Depresi\u00f3n (BDI); Estr\u00e9s percibido (P SS) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being \npresented, specify the numeric result (e.g. RR = 1.52 ( 95% CI 0.83 to 2.77) and/or a reference (e.g. \nto a table, figure or paragraph) that uniquely defi nes the result being assessed. En comparaci\u00f3n con el grupo de intervenci\u00f3n diferida, los participantes de la meditaci\u00f3n mostraron mejoras significativas en la \ndisminuci\u00f3n de la depresi\u00f3n (F(1,48) = 16.472; p<.05 ; \u03b72 = .255) y disminuci\u00f3n del estr\u00e9s(F(1,48) = 16.612;  p<.05; \u03b72 = .257) \n(Tabla 3).No se encontraron efectos de interacci\u00f3n si gnificativos para la medida de ansiedad (BAI)  \n Is the review team\u2019s aim for this result\u2026?  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  170 X to assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the eff ect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n        X Journal article(s) with results of the tri al  \nDomain 1: Risk of bias ar ising from the randomization process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Uso un generador de n\u00fameros computerizado. Yes / Probably yes / Probably no / No / No \ninformation \n1.2 Was the allocation sequence  concealed until participants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups su ggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the intended  interventions (effect of assignment to interventio n)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados Yes / Probably yes / Probably No / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no pudieron \nestar cegados a su condici\u00f3n Yes / Probably yes / Probably No / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably No / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations fr om intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If Y/PY/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Se llev\u00f3 a cabo un an\u00e1lisis por intenci\u00f3n de tratar Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgemen t Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Hubo un 8% de p\u00e9rdidas Yes / Probably yes / Probably no / No / No \ninformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  Se llev\u00f3 a cabo un an\u00e1lisis de sensibilidad para corr egir el sesgo No applicable / Yes / Probably yes / Probably no / \nNo / \n3.3 If N/PN to 3.2 : Could missingnes s in the outcome depend on its true \nvalue?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low /High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n No applicable / Yes / Probably yes / Probably No / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably No / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  La medida es auto-reportada y la intervenci\u00f3n s\u00f3lo s e compara con un grupo de \u201cno \ntratamiento\u201d, por lo que es probable que los result ados se vean influenciados por el \nconocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably No / \nNo / No information   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 171 Risk -of -bias judgement  Alto riesgo de sesgo  Low /High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos Yes / Probably yes / Probably no / No / No \ninformation  \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?   El protocolo del estudio no est\u00e1 disponible, por ta nto, no se puede comparar si las \nmedidas y los puntos temporal fueron acordes con lo pl aneado Yes / Probably yes / Probably no / No / No \ninformation  \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos de \nan\u00e1lisis que utilizaron fueron acordes con lo planeado  Yes / Probably yes / Probably no / No / No \ninformation  \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low /High / Some concerns \n  Estudio: Brooks (1985) \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Gravedad del TEPT (entrevista DSM-III); Ansiedad (T MAS); Depresi\u00f3n (BDI-II) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy \nthe numeric result (e.g. RR = 1.52 (95% CI 0.83 to 2.77) and/or a reference (e.g. to a table, figure or  \nparagraph) that uniquely defines the result being as sessed. El an\u00e1lisis de covarianza revel\u00f3 un efecto de tratamie nto significativo para TM en comparaci\u00f3n con la psicoter apia \nen el grado de PTSD, F (1, 14) = 5.26, p <.05; ansi edad, F (1, 15) = 14.74, p <.005 y depresi\u00f3n, F (1, 15) = 7.05, p \n<.025. \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment  to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n     X    Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No /  No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the inter ventions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No hay suficiente informaci\u00f3n para valorar este domin io No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4.  If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  172 2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo en \nque fueron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judg ement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Los datos estuvieron disponible para todos o pr\u00e1ctica mente todos los participantes Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missing ness in the outcome depend on its true \nvalue?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  El grupo comparador fue un control activo con protocolo similar al del grupo de \nintervenci\u00f3n, por lo que es probable que las difere ncias no se deban al conocimiento de la \nintervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably no / No / No \ninformation \nIs the num erical result being assessed likely to have been se lected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no parece estar disponible p ara contrastar si la medici\u00f3n se analiz\u00f3 \nde m\u00faltiples maneras. Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n Estudio: Carson (2005) \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 173 Specify which outcome is being asses sed for risk of bias:  Dolor (MPQ; BPI); Distr\u00e9s (BSI-18) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, \nspecify the numeric result (e.g. RR = 1.52 (95% CI 0. 83 to 2.77) and/or a reference (e.g. to a table, \nfigure or paragraph) that uniquely defines the resu lt being assessed. Los an\u00e1lisis del postratamiento y el seguimiento mos traron reducciones significativamente superiores en do lor y distr\u00e9s en \nel grupo de LKM, mientras que no se observaron cambi os en el grupo control. Tabla 1. Medias pre/post y de sviaciones \nt\u00edpicas para las distintas variables de resultado. \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess t he effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n     X    Journal article(s) with results of the tri al \nDomain 1: Risk of b ias arising from the randomization process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  La aleatorizaci\u00f3n la lleva a cabo una persona ajena a la investigaci\u00f3n haciendo uso de \nuna tabla de n\u00fameros aleatorios. Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled and \nassigned to interventions?  La aleatorizaci\u00f3n la lleva a cabo una persona ajena a la investigaci\u00f3n haciendo uso de \nuna tabla de n\u00fameros aleatorios. Yes / Probably yes / Probably No / No /  No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interventions aware of pa rticipants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No hay suficiente informaci\u00f3n para valorar este domin io No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely  to have affected the \noutcome?  No aplica.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e result) \nof the failure to analyse participants in the group  to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo \nen que fueron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Hubo un 56.3% de p\u00e9rdidas en el grupo de meditaci\u00f3n  y un 56.7% en el grupo control. Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1: Is there evidence that the r esult was not biased by missing \noutcome data?  Comparan caracter\u00edsticas de las personas que completan y las que se pierden y no \nencuentran diferencias. Asimismo, las tasas de abando no son similares en los dos \ngrupos. Reportan motivos de p\u00e9rdidas y los m\u00e1s frecue ntes son ajenos a la intervenci\u00f3n.  No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2: Could missingness in the outcom e depend on its true value?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  174 between intervention groups?  information \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the intervention \nreceived by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados \na la asignaci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced by \nknowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos \npor el conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  El grupo comparador fue un control activo con protocolo similar al del grupo de \nintervenci\u00f3n, por lo que es probable que las difere ncias no se deban al conocimiento de la \nintervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result an alysed in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los \nan\u00e1lisis previstos. Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las \nmedidas y los puntos temporal fueron acordes con lo pl aneado Yes / Probably yes / Probably no / No / No \ninformatio n \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no parece estar disponible p ara contrastar si la medici\u00f3n se \nanaliz\u00f3 de m\u00faltiples maneras. Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n Estudio: Castillo-Richmond (2000) \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Presi\u00f3n sangu\u00ednea; Medida de aterosclerosis (espesor  \u00edntima-media carot\u00eddeo) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the numeric result \n(e.g. RR = 1.52 (95% CI 0.83 to 2.77) and/or a refe rence (e.g. to a table, figure or paragraph) that u niquely defines the result being \nassessed. El grupo de meditaci\u00f3n mostr\u00f3 una disminuci\u00f3n signif icativa en la prueba de grosor de la \n\u00edntima-media carot\u00eddea en comparaci\u00f3n con el grupo de co ntrol de educaci\u00f3n para la salud \n(Figura 1). Tabla 2: diferencias intra e inter en p resi\u00f3n sangu\u00ednea. \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n     X    Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Tabla de n\u00fameros aleatorios generada por ordenador.  Yes / Probably yes / Probably No / No / No  \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  La asignaci\u00f3n se mantuvo cegada hasta que se tomaron los primeros datos. Yes / Probably yes / Probably No / No /  No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the t rial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del Yes / Probably yes / Probably no / No / No   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 175 grupo al que hab\u00edan sido asignados information \n2.2. Were carers and people delivering the interven tions aware of partic ipants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : W ere there deviations from the intended \nintervention that arose because of the experimental  context?  No hay suficiente informaci\u00f3n para valorar este domin io No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were th ese deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No parece que haya habido un impacto sustancial en los resultados debido a la falta de \nan\u00e1lisis de los participantes en el grupo en que fu eron asignados. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 3: M issing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Hubo un 56.5% de p\u00e9rdidas. Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was n ot biased by \nmissing outcome data?  Buscan predictores de las p\u00e9rdidas y encuentran que los  participantes con menor nivel \neducativo y mayores niveles de discapacidad eran m\u00e1s pr oclives a abandonar. No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  El evaluador estuvo cegado a la condici\u00f3n del partici pante No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4 : Is it likely that assessment of the outcome was i nfluenced \nby knowledge of intervention received?  No aplica.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely  to have been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no parece estar disponible p ara contrastar si la medici\u00f3n se analiz\u00f3 \nde m\u00faltiples maneras. Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \n   \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  176 Estudio: Chhatre (2013) \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Calidad de vida (FAHI); Calidad de vida (SF-36); De presi\u00f3n (CES-D); Estr\u00e9s percibido (PSS) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the numeric \nresult (e.g. RR = 1.52 (95% CI 0.83 to 2.77) and/or  a reference (e.g. to a table, figure or paragraph) that uniquely defines \nthe result being assessed. En el grupo de meditaci\u00f3n se observaron reducciones en estr\u00e9s percibido y depresi\u00f3n, mientras que en \nel grupo control no se observaron diferencias. Asimis mo, se observaron mejor\u00edas estad\u00edsticamente \nsignificativas en el dominio de vitalidad de SF-36 ( p=0.0133). Tabla 2. Comparaci\u00f3n de outcomes. \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n     X    Journal article(s) with results of the tri al       \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No /  No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of-bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of particip ants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Wer e there deviations from the intended \nintervention that arose because of the experimental  context?  No hay suficiente informaci\u00f3n para valorar este domin io No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were thes e deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Se llev\u00f3 a cabo un an\u00e1lisis por intenci\u00f3n de tratar Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Hubo un 9% de p\u00e9rdidas en el seguimiento. Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  Los motivos de las p\u00e9rdidas parecen ser independient es a la intervenci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on No aplica. No applicable / Yes / Probably yes / Probably no /   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 177 its true value?  No / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outcome have di ffered \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4. 2: Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  El grupo comparador fue un control activo con protocolo similar al del grupo de \nintervenci\u00f3n, por lo que es probable que las difere ncias no se deban al conocimiento de la \nintervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no parece estar disponible p ara contrastar si la medici\u00f3n se analiz\u00f3 \nde m\u00faltiples maneras. Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n  Estudio: Chandler (2020) \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Presi\u00f3n sangu\u00ednea; Estr\u00e9s percibido (PSS) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the \nnumeric result (e.g. RR = 1.52 (95% CI 0.83 to 2.77)  and/or a reference (e.g. to a table, figure or para graph) that \nuniquely defines the result being assessed. El grupo de meditaci\u00f3n mostr\u00f3 mayores reducciones de l a presi\u00f3n arterial sist\u00f3lica en los meses 3 (8,0 \nfrente a 1,9), 6 (10,0 frente a \u22120,7) y 12: (11,6 frente a \u22120,4 mmHg; todos los val ores de p <0,04) (Tabla 2). \nNo hubo diferencias significativas en las puntuaciones  de estr\u00e9s percibido entre los grupos en ning\u00fan \nmomento evaluado. \n Is the review team\u2019s aim for this result\u2026? \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to i ntervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply) \n        X Journal article(s) with results of the trial \nDomain 1: Risk of bias arising from the rando mization process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado. Yes / Probably yes / Probably No / No / No  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  178 information \n1.2 Was the alloca tion sequence concealed until participants were enr olled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervent ion groups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Los participantes no estaban cegados a la condici\u00f3n  Yes / Probably yes / Probably No / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n.  Yes / Probably yes / Probably No / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably No / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica No applicable / Yes / Probably yes / Probably No / \nNo / No information \n2.5 If Y/YN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica No applicable / Yes / Probably yes / Probably No / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Los an\u00e1lisis no se realizaron con todos los participa ntes elegibles despu\u00e9s de la \naleatorizaci\u00f3n. S\u00f3lo analizan una peque\u00f1a submuestra con media en presi\u00f3n sist\u00f3lica entre \n130 y 139 mmHG Yes / Probably yes / Probably No / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo en \nque fueron asignados No applicable / Yes / Probably yes / Probably No / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low /High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Presi\u00f3n sangu\u00ednea: Hubo un 13.3% de p\u00e9rdidas Cuestionario: Hubo un 13.3% de p\u00e9rdidas Objetiva: Yes / Probably yes / Probably No / No / \nNo information \nAuto-reportada: Yes / Probably yes / Probably No / \nNo / No information \n3.2 If N/PN/NI to 3.1: Is there evidence that the r esult was not biased by \nmissing outcome data?  Presi\u00f3n sangu\u00ednea: Es posible que el resultado estu viese sesgado porque no se utiliz\u00f3 \nning\u00fan m\u00e9todo de an\u00e1lisis para corregir el sesgo Cuestionario: Es posible que el resultado estuviese  sesgado porque no se utiliz\u00f3 ning\u00fan \nm\u00e9todo de an\u00e1lisis para corregir el sesgo Objetiva: No applicable /Yes / Probably yes / \nProbably no / No \nAuto-reportada: No applicable /Yes / Probably yes / \nProbably no / No \n3.3 If N/PN to 3.2: Could missingness in the outcom e depend on its true \nvalue?  Presi\u00f3n sangu\u00ednea: Algunos motivos de p\u00e9rdidas no q uedan suficientemente \ndocumentados Cuestionario: Algunos motivos de p\u00e9rdidas no quedan  suficientemente documentados Objetiva: No applicable /Yes / Probably yes / \nProbably no / No \nAuto-reportada: No applicable /Yes / Probably yes / \nProbably no / No \n3.4 If Y/PY/NI to 3.3: Is it likely that missingnes s in the outcome depended on \nits true value?  Presi\u00f3n sangu\u00ednea: Algunos motivos de p\u00e9rdidas no q uedan suficientemente \ndocumentadas para garantizar que no est\u00e9n relacionadas  con la intervenci\u00f3n en s\u00ed misma  \nCuestionario: Algunos motivos de p\u00e9rdidas no quedan  suficientemente documentadas para \ngarantizar que no est\u00e9n relacionadas con la intervenc i\u00f3n en s\u00ed misma  Objetiva: No applicable / Yes / Probably yes / \nProbably No / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably No / No / No information \nRisk-of-bias judgement  Presi\u00f3n sangu\u00ednea: Alto riesgo de sesgo  \nCuestionario: Alto riesgo de sesgo Objetiva: Low /High / Some concerns \nAuto-reportada: Low /High / Some concerns \nDomain 4:  Risk of bias in measurement of the outcome  \n4.1 Was the method of measuring the outcome inappro priate?  Presi\u00f3n sangu\u00ednea: El m\u00e9todo para medir los resulta dos parece haber sido el apropiado \nCuestionario: El m\u00e9todo para medir los resultados p arece haber sido el apropiado Objetiva: Yes / Probably yes / Probably no / No / \nNo information \nAuto-reportada: Yes / Probably yes / Probably no / \nNo / No information \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  Presi\u00f3n sangu\u00ednea: El m\u00e9todo para medir los resulta dos parece haber sido comparable en \ntodos los grupos Cuestionario: El m\u00e9todo para medir los resultados p arece haber sido comparable en todos \nlos grupos Objetiva: Yes / Probably yes / Probably no / No / \nNo information \nAuto-reportada: Yes / Probably yes / Probably no / \nNo / No information \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  Presi\u00f3n sangu\u00ednea: No se informa sobre el cegamiento  de los evaluadores \nCuestionario: La medida es auto-reportada y parece po co probable que los participantes Objetiva Objetiva: Yes / Probably yes / Probably \nNo / No / No information   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 179 est\u00e9n cegados a la asignaci\u00f3n Auto-reportada: Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3: Could assessment of the outc ome have been influenced \nby knowledge of intervention received?  Presi\u00f3n sangu\u00ednea: La medida es objetiva y parece poco  probable que los \nparticipantes/evaluador pueda influir en los resulta dos \nCuestionario: La medida es auto-reportada, por lo q ue es posible que los resultados se \nvean influidos por el conocimiento de la intervenci\u00f3n recibida Objetiva: Yes / Probably yes / Probably no / No / \nNo information \nAuto-reportada: Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  Presi\u00f3n sangu\u00ednea: No aplicable Cuestionario: El grupo comparador fue un control activo  con protocolo similar al del grupo \nde intervenci\u00f3n, por lo que es probable que las dif erencias no se deban al conocimiento de \nla intervenci\u00f3n recibida Objetiva: No applicable / Yes / Probably yes / \nProbably No / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably No / No / No information \nRisk-of-bias judgement  Presi\u00f3n sangu\u00ednea: Bajo riesgo de sesgo  \nCuestionario: Riesgo de sesgo incierto Objetiva: Low /High / Some concerns \nAuto-reportada: Low /High / Some concerns \nDomain 5: Risk of bias in se lection of the reported result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio est\u00e1 disponible (NCT0316878 9) Yes / Probably yes / Probably no / No / No \ninformation  \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  Se realizaron an\u00e1lisis de comparaciones entre grupos co n los mismos instrumentos Yes / Probably yes / Probably no / No / No \ninformation  \n5.3 ... multiple eligible analyses of the data?  Los resultados se analizaron atendiendo al plan de a n\u00e1lisis previo al inicio del estudio Yes / Probably yes / Probably no / No / No \ninformation  \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low /High / Some concerns \nOverall risk of bias   \nRisk-of-bias judgement  Presi\u00f3n sangu\u00ednea: Alto riesgo de se sgo  \nCuestionario: Alto riesgo de sesgo Low /High / Some concerns \nLow /High / Some concerns \n Estudio: Chirico (2020) \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Burnout (MBI); Sintomatolog\u00eda general (GHQ) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being \npresented, specify the numeric result (e.g. RR = 1.52 ( 95% CI 0.83 to 2.77) and/or a reference (e.g. \nto a table, figure or paragraph) that uniquely defi nes the result being assessed. Durante el seguimiento, se observ\u00f3 una mejora signi ficativa de todas las medidas de resultado. El agot amiento emocional \n(16,80\u20134,92, p <0,001), los niveles de despersonali zaci\u00f3n (3,72\u20130,60, p <0,001) y el deterioro psicol\u00f3gico  (10,08\u20132,04, p \n<0,001) disminuyeron significativamente, y la satisfa cci\u00f3n laboral (45,96\u201377,00, p < 0,001) se increment\u00f3  en el grupo de \nintervenci\u00f3n (Tablas 1 y 2) \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n        X Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response  options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n, pero no se describe  el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled  \nand assigned to interventions?  El estad\u00edstico del estudio ocult\u00f3 la asignaci\u00f3n de gru pos y s\u00f3lo se relevaron cuando los \nparticipantes del estudio completaron las pruebas de referencia y estaban listos para Yes / Probably yes / Probably No / No / No \ninformation  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  180 comenzar el tratamiento \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven t ions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no pudieron \nestar cegados a su condici\u00f3n Yes / Probably yes / Probably No / No / No \ninformation \n2.3. If Y/PY /NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental Yes / Probably yes / Probably No / No / No \ninformation \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If Y/PY/NI to 2.4 : Were these deviati ons likely to have affected the \noutcome?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron con todos los participante s elegibles despu\u00e9s de la aleatorizaci\u00f3n Yes / Probably yes / Probably No / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for a ll, or nearly all, participants \nrandomized?  Los datos estuvieron disponibles para todos o pr\u00e1cti camente todos los participantes  Yes / Probably yes / Probably no / No / No \ninformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased  by \nmissing outcome data?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low /High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could m easurement or ascertainment of the outcome have dif fered \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n No applicable / Yes / Probably yes / Probably No / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably No / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  La medida es auto-reportada y la intervenci\u00f3n s\u00f3lo s e compara con un grupo de \u201cno \ntratamiento\u201d, por lo que es probable que los result ados se vean influenciados por el \nconocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably No / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesg o Low /High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no parece estar disponible p ara contrastar si se llevaron a cabo los \nan\u00e1lisis previstos Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on th e \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?   El protocolo del estudio no est\u00e1 disponible para con trastar si se llevaron a cabo los an\u00e1lisis \nprevistos Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas Yes / Probably yes / Probably no / No / No   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 181 y los puntos temporal fueron acordes con lo planeado information \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n \nEstudio: Cole (2012)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Depresi\u00f3n (CES-D); Calidad de vida (MQOL) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being \npresented, specify the numeric result (e.g. RR = 1.52 ( 95% CI 0.83 to 2.77) and/or a reference (e.g. \nto a table, figure or paragraph) that uniquely defi nes the result being assessed. No hubo diferencias significativas entre las condicion es del estudio en el lapso de tiempo promedio entre  los cuestionarios \n(Tabla 2). Usando comparaciones m\u00faltiples por pares d e Tukey-Kramer, el control de atenci\u00f3n habitual y los grupos de \ntratamiento de meditaci\u00f3n fueron significativamente diferentes (t (76) = 2.69, p = 0.023), reportando s ignificativamente menos \ndepresi\u00f3n los grupos de intervenci\u00f3n frente al grupo  control. \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of ass ignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n        X Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  La aleatorizaci\u00f3n la lleva a cabo una persona ajena a la investigaci\u00f3n haciendo uso de \nuna tabla de n\u00fameros aleatorios. Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  La aleatorizaci\u00f3n la lleva a cabo una persona ajena a la investigaci\u00f3n haciendo uso de \nuna tabla de n\u00fameros aleatorios. Yes / Probably yes / Probably No / No /  No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to intervention )  \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados Yes / Probably yes / Probably No / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no pudieron \nestar cegados a su condici\u00f3n Yes / Probably yes / Probably No / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably No / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If Y/PY/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an  appropriate analysis used to estimate the effect of  assignment to \nintervention?  Se llev\u00f3 a cabo un an\u00e1lisis por intenci\u00f3n de tratar Yes / Probably yes / Probably no / No \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 3: Missi ng outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants Hubo un 23.2% de p\u00e9rdidas  Yes / Probably yes / Probably No / No / No  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  182 randomized?  information \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not b iased by \nmissing outcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo No applicable / Yes / Probably yes / Probably no / \nNo information  \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its true \nvalue?  Los motivos de las p\u00e9rdidas parecen ser independient es a la intervenci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information  \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low /High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n No applicable / Yes / Probably yes / Probably No / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably No / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  La medida es auto-reportada y la intervenci\u00f3n s\u00f3lo s e compara con un grupo de \u201cno \ntratamiento\u201d, por lo que es probable que los result ados se vean influenciados por el \nconocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably No / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low /High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no parece estar disponible p ara contrastar si se llevaron a cabo los \nan\u00e1lisis previstos Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales ,  definitions, time points) \nwithin the outcome domain?   El protocolo del estudio no est\u00e1 disponible para con trastar si se llevaron a cabo los an\u00e1lisis \nprevistos Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n \nEstudio: Curiati (2005)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Nivel de norepinefrina en sangre: Ventilaci\u00f3n por un idad de aumento de la producci\u00f3n de di\u00f3xido de \ncarbono (VE/VCO2); Calidad de vida (MLWHFQ) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the numeric \nresult (e.g. RR = 1.52 (95% CI 0.83 to 2.77) and/or  a reference (e.g. to a table, figure or paragraph) that uniquely defines \nthe result being assessed. La meditaci\u00f3n redujo el nivel de norepinefrina en sa ngre (p= 0.008), mejor\u00f3 la calidad de vida (p=0.02) \ny redujo la pendiente ventilaci\u00f3n por unidad de aume nto de la producci\u00f3n de di\u00f3xido de carbono (p= \n0.04) en comparaci\u00f3n al grupo control \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n   X    Journal article(s) with results of the trial    \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 183 Domain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n, pero no se describe  el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended intervention s (effect of assignment to intervention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations likely to have affected the  \noutcome?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations from intended intervention \nbalanced between groups? No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate a nalysis used to estimate the effect of assignment t o \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a sub stantial impact (on the \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo en \nque fueron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Auto-reportada: Hubo un 21% de p\u00e9rdidas  Objetivas: Hubo un 21% de p\u00e9rdidas Auto-reportada: Yes / Probably yes / Probably No / \nNo / No Information \nObjetiva: Yes / Probably yes / Probably No / No / \nNo Information \n3.2 If N/PN/NI to 3.1: Is there evidence that the r esult was not biased by \nmissing outcome data?  Auto-reportada: Es posible que el resultado estuvie se sesgado porque no se utiliz\u00f3 ning\u00fan \nm\u00e9todo de an\u00e1lisis para corregir el sesgo Objetiva: Es posible que el resultado estuviese ses gado porque no se utiliz\u00f3 ning\u00fan \nm\u00e9todo de an\u00e1lisis para corregir el sesgo Auto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No \nObjetiva: No applicable / Yes / Probably yes / \nProbably no / No \n3.3 If N/PN to 3.2: Could missingness in the outcom e depend on its true \nvalue?  Auto-reportada: Los motivos de las p\u00e9rdidas no est\u00e1 n suficientemente justificados \nObjetiva: Los motivos de las p\u00e9rdidas no est\u00e1n sufic ientemente justificados Auto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nObjetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \n3.4 If Y/PY/NI to 3.3: Is it likely that missingnes s in the outcome depended on \nits true value?  Auto-reportada: Algunos motivos de p\u00e9rdidas no qued an suficientemente documentados \nObjetiva: Algunos motivos de p\u00e9rdidas no quedan suf icientemente documentados Auto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nRisk-of-bias judgement  Auto -reportada: Alto riesgo de sesgo  \nObjetiva: Alto riesgo de sesgo Auto-reportada: Low / High / Some concerns \nObjetiva: Low / High / Some concerns \nDomain 4: R isk of bias in measurement of the outcome  \n4.1 Was the method of measuring the outcome inappro priate?  Auto-reportada: El m\u00e9todo para recoger los resultado s parece haber sido el apropiado \nObjetiva: El m\u00e9todo para recoger los resultados pare ce haber sido el apropiado Auto-reportada: Yes / Probably yes / Probably no / \nNo / No information \nObjetiva: Yes / Probably yes / Probably no / No / \nNo information \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  Auto-reportada: El m\u00e9todo para medir los resultados  parece haber sido comparable en \ntodos los grupos Objetiva: El m\u00e9todo para medir los resultados parece  haber sido comparable en todos los \ngrupos Auto-reportada: Yes / Probably yes / Probably no / \nNo / No information \nObjetiva: Yes / Probably yes / Probably no / No / \nNo information  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  184 4.3 If N/PN/NI to 4.1 and 4.2: Were outcome assesso rs aware of the \nintervention received by study participants?  Auto-reportada: La medida es auto-reportada y parece poco probable que los participantes \nest\u00e9n cegados a la asignaci\u00f3n Objetiva: El evaluador estuvo cegado a la condici\u00f3n d el participante Auto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nObjetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \n4.4 If Y/PY/NI to 4.3: Could assessment of the outc ome have been influenced \nby knowledge of intervention received?  Auto-reportada: La medida es auto-reportada, por lo  que es posible que los resultados se \nvean influidos por el conocimiento de la intervenci\u00f3n recibida \nObjetiva: No aplica Auto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nNo applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  Auto-reportada: La medida es auto-reportada y la int ervenci\u00f3n s\u00f3lo se compara con un \ngrupo de \u201creuniones semanales\u201d, por lo que es probab le que los resultados se vean \ninfluenciados por el conocimiento de la intervenci\u00f3n r ecibida \nObjetiva: No aplica Auto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nNo applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk-of-bias judgement  Auto -reportada: Alto riesgo de sesgo  \nObjetiva: Bajo riesgo de sesgo Auto-reportada: Low / High / Some concerns \nObjetiva: Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no parece estar disponible p ara contrastar si se llevaron a cabo los \nan\u00e1lisis previstos Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos de \nan\u00e1lisis que utilizaron fueron acordes con lo planeado  Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \nOverall risk of bias   \nRisk-of-bias judgement  Auto -reportada: Alto riesgo de sesgo  \nObjetiva: Alto riesgo de sesgo Auto-reportada: Low / High / Some concerns \nObjetiva: Low / High / Some concerns \n \nEstudio: Dillbeck (1977)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Ansiedad (STAI) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the numeric result (e.g. RR = \n1.52 (95% CI 0.83 to 2.77) and/or a reference (e.g. to a table, figure or paragraph) that uniquely defin es the result being assessed. Tabla 1. El efecto sobre la ansiedad de la meditaci \u00f3n (medida con el STAI) frente a \nla relajaci\u00f3n result\u00f3 ser significativo (F (1, 32) =  8.48, p <.01). \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n     X    Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem No se comparan las caracter\u00edsticas en l\u00ednea base entre los grupos Yes / Probably yes / Probably No / No / No   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 185 with the randomization process?   information \nRisk -of -bias judge ment  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there devi ations from the intended \nintervention that arose because of the experimental  context?  No hay suficiente informaci\u00f3n para valorar este domin io No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations  from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron con todos los participante s elegibles despu\u00e9s de la aleatorizaci\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo en \nque fueron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesg o Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Los datos estuvieron disponible para todos o pr\u00e1ctica mente todos los participantes Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depen d on its true \nvalue?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  El grupo comparador fue un control activo con protocolo  similar al del grupo de \nintervenci\u00f3n, por lo que es probable que las difere ncias no se deban al conocimiento de la \nintervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being asses sed likely to have been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no parece estar disponible p ara contrastar si la medici\u00f3n se analiz\u00f3 \nde m\u00faltiples maneras. Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  186 Overall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n  \nEstudio: Dion (2016)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Intensidad o frecuencia sintomatol\u00f3gica (VAS); Estr\u00e9s percibido (PSS) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the numeric \nresult (e.g. RR = 1.52 (95% CI 0.83 to 2.77) and/or  a reference (e.g. to a table, figure or paragraph) that uniquely defines \nthe result being assessed. Las puntuaciones medias totales del VAS antes y despu \u00e9s de la intervenci\u00f3n mejoraron \nsignificativamente en ambos grupos (p <0,001), pero no se produjeron diferencias significativas entre \nlos grupos. Las puntuaciones de PSS-14 no difirieron  significativamente entre los 2 grupos en ning\u00fan \nmomento temporal (Tabla 3). \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intent ion -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n        X Journal article(s) with results of the tri al \n        X Non-commercial trial registry record (e.g. C linicalTrials.gov record) \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  M\u00e9todo de aleatorizaci\u00f3n computerizado. Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled and \nassigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem with \nthe randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base. Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Los participantes no estuvieron cegados a su condici\u00f3n  (open-label) Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there dev iations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista \ndebidos al contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention balanced \nbetween groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If Y/PY/NI to 2.4: Were these deviations likely  to have affected the outcome?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e result) of \nthe failure to analyse participants in the group to  which they were randomized?  No parece que haya habido un impacto sustancial en los resultados debido a la falta \nde an\u00e1lisis de los participantes en el grupo en que  fueron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo in cierto  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Los datos estuvieron disponibles para todos o pr\u00e1cti camente todos los participantes \n(5% de p\u00e9rdidas) Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by missing No aplica. No applicable / Yes / Probably yes / Probably no /   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 187 outcome data?  No \n3.3 If N/PN to 3.2: Could missingness in the outcom e depend on its true value?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on its \ntrue value?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed between \nintervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los \ngrupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the intervention \nreceived by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n \ncegados a la asignaci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced by \nknowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean \ninfluidos por el conocimiento de la intervenci\u00f3n recibi da No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced by \nknowledge of intervention received?  El grupo comparador fue un control activo con protocolo similar al del grupo de \nintervenci\u00f3n, por lo que es probable que las difere ncias no se deban al conocimiento \nde la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordan ce with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio est\u00e1 disponible Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed like ly to have been selected, on the basis \nof the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) within \nthe outcome domain?  Se realizaron an\u00e1lisis de comparaciones entre grupos co n los mismos instrumentos Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  Los resultados se analizaron atendiendo al plan de a n\u00e1lisis previo al inicio del estudio Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bi as judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n \nEstudio: Dunne (2019)  \nStudy design  \nx Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Burnout percibido (MBI); Ansiedad, depresi\u00f3n y estr\u00e9s  (DASS-21) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, \nspecify the numeric result (e.g. RR = 1.52 (95% CI 0. 83 to 2.77) and/or a reference (e.g. to a table, \nfigure or paragraph) that uniquely defines the resu lt being assessed. Hubo una disminuci\u00f3n significativa en las puntuacione s de estr\u00e9s a lo largo del tiempo entre T1 y T2 para el grupo de \nintervenci\u00f3n con una diferencia significativa entre lo s grupos para las puntuaciones de estr\u00e9s en T2 (Fig.  2B). Tambi\u00e9n se \nobserv\u00f3 una disminuci\u00f3n significativa para las puntua ciones de ansiedad entre T1 y T2 para el grupo de int ervenci\u00f3n (Fig. \n2B). \n Is the review team\u2019s aim for this result\u2026?  \nx \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n        X Journal article(s) with results of the tri al \n        X Non-commercial trial registry record (e.g. C linicalTrials.gov record)  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  188 Domain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Utilizan una herramienta de aleatorizaci\u00f3n online.  Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No se comparan las caracter\u00edsticas en l\u00ednea base entre los grupos Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias  judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Los participantes conoc\u00edan la asignaci\u00f3n (simple ciego ). Yes / Probably yes / Probably No / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably No / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4 If Y/PY to 2.3 : Were these deviation s likely to have affected the \noutcome?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5. If Y/PY to 2.4 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No parece que haya habido un impacto sustancial en los resultados debido a la falta de \nan\u00e1lisis de los participantes en el grupo en que fu eron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 3: Missing outcome da ta  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Hubo un 27% de p\u00e9rdidas. Yes / Probably yes / Probably No / No / No \ninformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.3 If N/PN to 3.2 : Could missingness in the outcome  depend on its true \nvalue?  Los motivos de las p\u00e9rdidas parecen ser independient es a la intervenci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably No / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably No / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  El evaluador estuvo cegado a la condici\u00f3n del partici pante Yes / Probably yes / Probably No / No / No \ninformation \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4 : Is it likely that assessment of the outcome was i nfluenced \nby knowledge of intervention received?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bi as judgement   Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio est\u00e1 disponible (NCT0288730 0) Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the     \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 189 basis of the results, from...  \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  Se realizaron an\u00e1lisis de comparaciones entre grupos co n los mismos instrumentos Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  Los resultados se analizaron atendiendo al plan de a n\u00e1lisis previo al inicio del estudio Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \n  \nEstudio: Duraimani (2015 ) \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Presi\u00f3n sangu\u00ednea \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being \npresented, specify the numeric result (e.g. RR = 1.52 ( 95% CI 0.83 to 2.77) and/or a \nreference (e.g. to a table, figure or paragraph) tha t uniquely defines the result being \nassessed. Ambos grupos mostraron reducciones en la PA sist\u00f3lica . Los cambios ajustados fueron SR = -5,7 mm Hg, p <0 ,01; EHE = -9,0 mm Hg, \np <0,001 sin diferencias estad\u00edsticamente significati vas entre los grupos. Hubo una reducci\u00f3n significativa  de la PA diast\u00f3lica en el \ngrupo de educaci\u00f3n para la salud (-5,3 mm Hg, p <0,00 1) pero no en el grupo de meditaci\u00f3n (-1,2 mm Hg, p  = 0,42); la diferencia entre \ngrupos fue significativa (p = 0,04). \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n     X    Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSigna lling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  La secuencia de asignaci\u00f3n es aleatoria.  Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  Un bioestad\u00edstico mantuvo cegada la secuencia de asigna ci\u00f3n. Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended in terventions (effect of assignment to intervention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No hay suficiente informaci\u00f3n para valorar este domin io No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignmen t to \nintervention?  Se llev\u00f3 a cabo un an\u00e1lisis por intenci\u00f3n de tratar Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  190 randomized?  \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outc ome available for all, or nearly all, participants \nrandomized?  Hubo un 16.7% de p\u00e9rdidas. Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  Los motivos de las p\u00e9rdidas parecen ser independient es a la intervenci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  El evaluador estuvo cegado a la condici\u00f3n del partici pante No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4 : Is it likely that assessment of the outcome was i nfluenced \nby knowledge of intervention received?  No aplica.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de s esgo  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no parece estar disponible p ara contrastar si la medici\u00f3n se analiz\u00f3 \nde m\u00faltiples maneras. Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \n  \nEstudio: Elder (2014)  \nStudy des ign  \nx Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Estr\u00e9s percibido (PSS); Depresi\u00f3n (MHI-5); Burnout ( Maslach Burnout Inventory) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the numeric result (e.g. RR = \n1.52 (95% CI 0.83 to 2.77) and/or a reference (e.g. to a table, figure or paragraph) that uniquely defin es the result being assessed. Los resultados de las pruebas F univariadas mostrar on una reducci\u00f3n significativa del \nestr\u00e9s percibido (F [1,32] = 13,42; p = <0,001) y la depresi\u00f3n (F [1,32] = 6,92; p = \n0,013). \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)    \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 191  to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n        X Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Emplean un m\u00e9todo de aleatorizaci\u00f3n simple para gene rar la secuencia. Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  El estad\u00edstico mantuvo la secuencia cegada hasta complet ar la evaluaci\u00f3n en l\u00ednea \nbase. Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of as signment to intervention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n Yes / Probably yes / Probably No / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably No / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambi os en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4 If Y/PY to 2.3 : Were these deviations likely to have affected the  \noutcome?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5. If Y/PY to 2.4 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate the effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial  impact (on the \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No parece que haya habido un impacto sustancial en los resultados debido a la falta de \nan\u00e1lisis de los participantes en el grupo en que fu eron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, partici pants \nrandomized?  Hubo un 5% de p\u00e9rdidas en el grupo control y un 15%  en el grupo intervenci\u00f3n.  Yes / Probably yes / Probably No / No / No \ninformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  Los motivos de las p\u00e9rdidas no est\u00e1n suficientemente  justificados No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  Algunos motivos de p\u00e9rdidas no quedan suficientemen te documentadas No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low /High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably No / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably No / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been infl uenced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4. 5 If Y/PY/NI to 4.4 : Is it likely that assessment of the outcome was i nfluenced \nby knowledge of intervention received?  La medida es auto-reportada y la intervenci\u00f3n s\u00f3lo s e compara con un grupo de \u201cno \ntratamiento No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low /High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result   \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  192 5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos Yes / Probably yes / Probably No / No / No \ninformation \nIs the nume rical result being assessed likely to have been sel ected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably No / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos de \nan\u00e1lisis que utilizaron fueron acordes con lo planeado  Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias  judgement  Alto riesgo de sesgo  Low /High / Some concerns \n \nEstudio: Fatima (2014)  \nStudy design  \nx Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecif y which outcome is being assessed for risk of bias:  Presi\u00f3n sangu\u00ednea; Calidad de vida (WHOQOL) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the numeric result (e.g. \nRR = 1.52 (95% CI 0.83 to 2.77) and/or a reference ( e.g. to a table, figure or paragraph) that uniquely  defines the result being assessed. Overall quality of life and overall health perception : Grupo Control (67,3\u00b114,8) Grupo \nIntervenci\u00f3n (78,0\u00b114,1) P=0,003 \n Is the review team\u2019s aim for this result\u2026?  \nx \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n        x Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to i ntervention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n Yes / Probably yes / Probably No / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably No / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4 If Y/PY to 2.3 : Were these deviations likely to have affected the  \noutcome?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5. If Y/PY to 2.4 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estim ate the effect of assignment to \nintervention?  Los an\u00e1lisis no se realizaron con todos los participa ntes elegibles despu\u00e9s de la \naleatorizaci\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substant ial impact (on the Es posible que haya habido un impacto sustancial en lo s resultados debido a la falta de No applicable / Yes / Probably yes / Probably no /   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 193 result) of the failure to analyse participants in t he group to which they were \nrandomized?  an\u00e1lisis de los participantes en el grupo en que fu eron asignados No / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low /High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Presi\u00f3n sangu\u00ednea: Hubo un 9.2% de p\u00e9rdidas (complet an 59/65) \nCalidad de vida: Hubo un 9.2% de p\u00e9rdidas (completan  58/65) Objetiva: Yes / Probably yes / Probably No / No / \nNo information \nAuto-reportada: Yes / Probably yes / Probably No / \nNo / No information \n3.2 If N/PN/NI to 3.1: Is there evidence that the r esult was not biased by \nmissing outcome data?  Presi\u00f3n sangu\u00ednea: Es posible que el resultado estu viese sesgado porque no se utiliz\u00f3 \nning\u00fan m\u00e9todo de an\u00e1lisis para corregir el sesgo. Calidad de vida: Es posible que el resultado estuvi ese sesgado porque no se utiliz\u00f3 ning\u00fan \nm\u00e9todo de an\u00e1lisis para corregir el sesgo Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \n3.3 If N/PN to 3.2: Could missingness in the outcom e depend on its true \nvalue?  Presi\u00f3n sangu\u00ednea: Los motivos de las p\u00e9rdidas pare cen ser independientes a la \nintervenci\u00f3n. Calidad de vida: Los motivos de las p\u00e9rdidas parecen  ser independientes a la intervenci\u00f3n. Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \n3.4 If Y/PY/NI to 3.3: Is it likely that missingnes s in the outcome depended on \nits true value?  Presi\u00f3n sangu\u00ednea: No aplica. Calidad de vida: No aplica. Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nRisk-of-bias judgement  Presi\u00f3n sangu\u00ednea: Bajo riesgo de sesgo  \nCalidad de vida: Bajo riesgo de sesgo Objetiva: Low /High / Some concerns \nAuto-reportada: Low /High / Some concerns \nDomain 4: Risk of bias in measurement of the o utcome  \n4.1 Was the method of measuring the outcome inappro priate?  Presi\u00f3n sangu\u00ednea: El m\u00e9todo para medir los resulta dos parece haber sido el apropiado \nCalidad de vida: El m\u00e9todo para medir los resultado s parece haber sido el apropiado Objetiva: Yes / Probably yes / Probably No / No / \nNo information \nAuto-reportada: Yes / Probably yes / Probably No / \nNo / No information \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  Presi\u00f3n sangu\u00ednea: El m\u00e9todo para medir los resulta dos parece haber sido comparable en \ntodos los grupos Calidad de vida: El m\u00e9todo para medir los resultado s parece haber sido comparable en \ntodos los grupos Objetiva: Yes / Probably yes / Probably No / No / \nNo information \nAuto-reportada: Yes / Probably yes / Probably No / \nNo / No information \n4.3 If N/PN/NI to 4.1 and 4.2: Were outcome assesso rs aware of the \nintervention received by study participants?  Presi\u00f3n sangu\u00ednea: No se informa sobre el cegamiento  de los evaluadores \n Calidad de vida: La medida es auto-reportada y parece  poco probable que los participantes \nest\u00e9n cegados a la asignaci\u00f3n Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \n4.4 If Y/PY/NI to 4.3: Could assessment of the outc ome have been influenced \nby knowledge of intervention received?  Presi\u00f3n sangu\u00ednea: La medida es objetiva y parece poco  probable que el evaluador pueda \ninfluir en los resultados Calidad de vida: La medida es auto-reportada, por l o que es posible que los resultados se \nvean influidos por el conocimiento de la intervenci\u00f3n recibida Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  Presi\u00f3n sangu\u00ednea: No aplica. Calidad de vida: La medida es auto-reportada y la in tervenci\u00f3n s\u00f3lo se compara con un \ngrupo de \u201cno tratamiento Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nRisk-of-bias judgement  Presi\u00f3n sang u\u00ednea: Bajo riesgo de sesgo.  \nCalidad de vida: Alto riesgo de sesgo. Objetiva: Low /High / Some concerns \nAuto-reportada: Low /High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analy sed in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos Yes / Probably yes / Probably No / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably No / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos de Yes / Probably yes / Probably No / No / No  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  194 an\u00e1lisis que utilizaron fueron acordes con lo planeado  information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nOverall risk of bias   \nRisk-of-bias judgement  Presi\u00f3n sangu\u00ednea: Alto riesgo de sesgo  \nCalidad de vida: Alto riesgo de sesgo Objetiva: Low /High / Some concerns \nAuto-reportada: Low /High / Some concerns \n \nEstudio: Gagrani (2018)  \nStudy design  \nx Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Presi\u00f3n intraocular; Calidad de vida (WHOQOL) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, \nspecify the numeric result (e.g. RR = 1.52 (95% CI 0. 83 to 2.77) and/or a reference (e.g. to a table, \nfigure or paragraph) that uniquely defines the resu lt being assessed. Se observ\u00f3 que el nivel medio de presi\u00f3n intraocular  disminuy\u00f3 significativamente en el grupo de interven ci\u00f3n (15.9 \u00b1 1.8 \nmmHg to 14.4 \u00b1 1.21 mm Hg, p-value 0.0001) en compar aci\u00f3n con el grupo de control (15.7 \u00b1 1.4 mmHg to 15.6 5 \u00b1 1.41, \np-value 0.41). La meditaci\u00f3n se asoci\u00f3 con una mejora  significativa en la calidad de vida. \n Is the review team\u2019s aim for this result\u2026?  \n \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adherin g to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n        X Journal article(s) with results of the tri al \n      X             Non-commercial trial registry recor d (e.g. ClinicalTrials.gov record) \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Aleatorizaci\u00f3n por ordenador usando bloques permutad os. Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  La secuencia se mantuvo cegada en sobres sellados.  Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n Yes / Probably yes / Probably No / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of parti cipants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably No / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4 If Y/PY to 2.3 : Were these deviations likely to have affected the  \noutcome?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5. If Y/PY to 2.4 : Were these deviations from intended int ervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Se llev\u00f3 a cabo un an\u00e1lisis por intenci\u00f3n de tratar Yes / Probably yes / Probably No / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants Medidas objetivas: Hubo un 6.7% de p\u00e9rdidas. Objetiva: Yes / Probably yes / Probably No / No /   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 195 randomized?  Calidad de vida: Hubo un 6.7% de p\u00e9rdidas. No information \nAuto-reportada: Yes / Probably yes / Probably No / \nNo / No information \n3.2 If N/PN/NI to 3.1: Is there evidence that the r esult was not biased by \nmissing outcome data?  Medidas objetivas: Se llev\u00f3 a cabo un an\u00e1lisis por i ntenci\u00f3n de tratar. \nCalidad de vida: Se llev\u00f3 a cabo un an\u00e1lisis por int enci\u00f3n de tratar. Objetiva: No applicable / Yes / Probably yes / \nProbably no / No \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No \n3.3 If N/PN to 3.2: Could missingness in the outcom e depend on its true \nvalue?  Medidas objetivas: No aplica. Calidad de vida: No aplica. Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \n3.4 If Y/PY/NI to 3.3: Is it likely that missingnes s in the outcome depended on \nits true value?  Medidas objetivas: No aplica. Calidad de vida: No aplica. Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nRisk-of-bias judgement  Medidas objetivas: Bajo riesgo d e sesgo.  \nCalidad de vida: Bajo riesgo de sesgo. Objetiva: Low /High / Some concerns \nAuto-reportada: Low /High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  Medidas objetivas: El m\u00e9todo para medir los resulta dos parece haber sido el apropiado \nCalidad de vida: El m\u00e9todo para medir los resultado s parece haber sido el apropiado Objetiva: Yes / Probably yes / Probably No / No / \nNo information \nYes / Probably yes / Probably No / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  Medidas objetivas: El m\u00e9todo para medir los resulta dos parece haber sido comparable en \ntodos los grupos Calidad de vida: El m\u00e9todo para medir los resultado s parece haber sido comparable en \ntodos los grupos Objetiva: Yes / Probably yes / Probably No / No / \nNo information \n \nYes / Probably yes / Probably No / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2: Were outcome assesso rs aware of the \nintervention received by study participants?  Medidas objetivas: No se informa sobre el cegamiento  de los evaluadores \n Calidad de vida: No se informa sobre el cegamiento d e los evaluadores Objetiva: No applicable / Yes / Probably yes / \nProbably No / No / No information \nNo applicable / Yes / Probably yes / Probably No / \nNo / No information \n4.4 If Y/PY/NI to 4.3: Could assessment of the outc ome have been influenced \nby knowledge of intervention received?  Medidas objetivas: La medida es objetiva y parece poco  probable que los evaluador pueda \ninfluir en los resultados Calidad de vida: La medida es auto-reportada, por l o que es posible que los resultados se \nvean influidos por el conocimiento de la intervenci\u00f3n recibida Objetiva: No applicable / Yes / Probably yes / \nProbably No / No / No information \nNo applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  Medidas objetivas: No aplica. Calidad de vida: La medida es auto-reportada y la in tervenci\u00f3n s\u00f3lo se compara con un \ngrupo de \u201cno tratamiento Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nNo applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk-of-bias judgement  Medidas objetivas: Bajo riesgo de sesgo.  \nCalidad de vida: Alto riesgo de sesgo. Objetiva: Low /High / Some concerns \nLow /High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data th at produced this result analysed in accordance with  a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio est\u00e1 disponible Yes / Probably yes / Probably No / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  Se realizaron an\u00e1lisis de comparaciones entre grupos co n los mismos instrumentos Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  Los resultados se analizaron atendiendo al plan de a n\u00e1lisis previo al inicio del estudio Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Medidas objetivas: Riesgo de sesgo incierto  Objetiva: Low / High / Some concerns  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  196 Calidad de vida: Alto riesgo de sesgo  Low /High / Some concerns \n \nEstudio: Galante (2016)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of bias:  Depresi\u00f3n (IDA) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the numeric \nresult (e.g. RR = 1.52 (95% CI 0.83 to 2.77) and/or  a reference (e.g. to a table, figure or paragraph) that uniquely defines the \nresult being assessed. Los participantes del grupo de meditaci\u00f3n tuvieron una puntuaci\u00f3n inferior en esta escala en \ncomparaci\u00f3n a los participantes del grupo control (\u00df = 0.22, IC del 95% [0.43, 0.02], p = .03) tras \nfinalizar la intervenci\u00f3n. \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n        X    Journal article(s) with results of the trial \n      X             Non-commercial trial registry recor d (e.g. ClinicalTrials.gov record) \nDomain 1: Risk of bias arising from the randomization  process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  La secuencia de aleatorizaci\u00f3n fue realizada con un prog rama de ordenador Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention group s suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Ries go de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n, sin embargo, la  administraci\u00f3n de la \nintervenci\u00f3n estuvo automatizada por medio de Intern et  Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations likely to have affected the  \noutcome?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations from intended intervention \nbalanced between groups? No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No parece que haya habido un impacto sustancial en los resultados debido a la falta de \nan\u00e1lisis de los participantes en el grupo en que fu eron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Hubo un 82% de p\u00e9rdidas Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evid ence that the result was not biased by \nmissing outcome data?  Se llev\u00f3 a cabo un an\u00e1lisis de caso completo ajustado por variables de l\u00ednea de base \nutilizando modelos de regresi\u00f3n, v\u00e1lido bajo el prin cipio de intenci\u00f3n de tratar para ECA No applicable / Yes / Probably yes / Probably no / \nNo   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 197 con un punto de medici\u00f3n de resultado post-intervenc i\u00f3n y tan eficiente como la imputaci\u00f3n \nm\u00faltiple para analizar el efecto de los datos faltan tes. \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para recoger los resultados parece haber si do el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  El grupo comparador fue un control activo con protocolo similar al del grupo de \nintervenci\u00f3n, por lo que es probable que las difere ncias no se deban al conocimiento de la \nintervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio est\u00e1 disponible y las medida s analizadas coinciden con las \nreportadas en el protocolo del estudio Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  Se realizaron an\u00e1lisis de comparaciones entre grupos co n los mismos instrumentos Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  Los efectos del tratamiento se evaluaron mediante un  an\u00e1lisis de varianza Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n \nEstudio: Gaston (1988)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Severidad s\u00edntomas psoriasis \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the numeric result (e.g. \nRR = 1.52 (95% CI 0.83 to 2.77) and/or a reference ( e.g. to a table, figure or paragraph) that uniquely  defines the result being \nassessed. Se observ\u00f3 una diferencia significativa entre las cal ificaciones medias de psoriasis de los \ngrupos de tratamiento y de control despu\u00e9s del tratam iento (r parcial = .30, p <0.01). \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018 intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n   X    Journal article(s) with results of the trial  \nDomain 1: Risk of bias arising from the randomizatio n process   \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  198 Signalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of  participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or  2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations likely to have affected the  \noutcome?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations from inte nded intervention \nbalanced between groups? No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo en \nque fueron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Hubo un 25% de p\u00e9rdidas Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  Los motivos de las p\u00e9rdidas no est\u00e1n suficientemente  justificados No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3: Is it likely that missingnes s in the outcome depended on \nits true value?  Las p\u00e9rdidas son similares entre los diferentes gru pos, por lo que es posible que no est\u00e9n \nrelacionadas con la intervenci\u00f3n en s\u00ed misma pese a q ue no est\u00e9n suficientemente \ndocumentadas No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La gravedad de los s\u00edntomas de la psoriasis fue eva luada por dos dermat\u00f3logos ciegos a la \npertenencia al grupo No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been in fluenced \nby knowledge of intervention received?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4 : Is it likely that assessment of the outcome was i nfluenced \nby knowledge of intervention received?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result ana lysed in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...      \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 199 5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos de \nan\u00e1lisis que utilizaron fueron acordes con lo planeado  Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n \nEstudio: Hafner (1982)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Presi\u00f3n sangu\u00ednea \nSpecify the numerical result being assessed. In case of  multiple alternative \nanalyses being presented, specify the numeric result ( e.g. RR = 1.52 (95% CI 0.83 \nto 2.77) and/or a reference (e.g. to a table, figure  or paragraph) that uniquely \ndefines the result being assessed. Presi\u00f3n sangu\u00ednea: Hubo un efecto significativo dent ro de los grupos tanto para la presi\u00f3n arterial sis t\u00f3lica (F (4, 38) = 2.68, p <0.05) como \npara la presi\u00f3n arterial diast\u00f3lica (F (4, 38) = 4.0 6, p < .008), sin embargo, no hubo efectos significat ivos entre los grupos. \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (th e \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n   X    Journal article(s) with results of the trial          Personal communication with the sponsor \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and p eople delivering the interventions aware of partici pants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations likely to have affected the  \noutcome?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN /NI to 2.4 : Were these deviations from intended intervention \nbalanced between groups? No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No parece que haya habido un impacto sustancial en los resultados debido a la falta de \nan\u00e1lisis de los participantes en el grupo en que fu eron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  200 Domain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Los datos estuvieron disponible para todos o pr\u00e1ctica mente todos los participantes (1 \nabandono en el grupo control) Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?   No aplica  No applicable / Yes / Probably yes / Probably no / \nNo  \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  No aplica  No applicable / Yes / Probably yes / Probably no / \nNo \n3.4 If Y/PY/NI to 3.3: Is it likely that missingnes s in the outcome depended on \nits true value?  No aplica  No applicable / Yes / Probably yes / Probably no / \nNo \n \nRisk -of -bias judgement  Bajo riesgo de sesgo   Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado \n  Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos \n  Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  No se informa sobre el cegamiento de los evaluadores  \n  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3: Could assessment of the outc ome have been influenced \nby knowledge of intervention received?  La medida es objetiva y parece poco probable que los evaluadores puedan influir en los \nresultados  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  El grupo comparador fue un control activo con protocolo similar al del grupo de \nintervenci\u00f3n, por lo que es probable que las difere ncias no se deban al conocimiento de la \nintervenci\u00f3n recibida  No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical r esult being assessed likely to have been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos de \nan\u00e1lisis que utilizaron fueron acordes con lo planeado  Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgem ent  Alto riesgo de sesgo  Low / High / Some concerns \n \nEstudio: Hager (197 8) \n \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify whic h outcome is being assessed for risk of bias:  Presi\u00f3n sangu\u00ednea \nSpecify the numerical result being assessed. In case of  multiple alternative \nanalyses being presented, specify the numeric result ( e.g. RR = 1.52 (95% CI \n0.83 to 2.77) and/or a reference (e.g. to a table, f igure or paragraph) that uniquely \ndefines the result being assessed. Siete sujetos de retroalimentaci\u00f3n y diez de meditaci \u00f3n-relajaci\u00f3n completaron el programa. Ambas t\u00e9cnicas produjeron reducciones sist\u00f3licas y \ndiast\u00f3licas significativas sist\u00f3lica y diast\u00f3lica dentr o de las sesiones de pr\u00e1ctica y reducciones diast\u00f3licas durante semanas de entrenamiento. \nNinguna de las dos t\u00e9cnicas mejor\u00f3 las reducciones ni r edujo los niveles iniciales de presi\u00f3n sist\u00f3lica dur ante las cuatro semanas. Las \ndiferencias entre el biofeedback y la meditaci\u00f3n-relaj aci\u00f3n en las reducciones de la presi\u00f3n dentro de la s esi\u00f3n no fueron significativas.   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 201  Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -trea t\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n        X Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado. Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?    No se informa si la secuencia de aleatorizaci\u00f3n se ma ntuvo oculta. Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  Hay diferencias significativas entre los grupos en l\u00ed nea base. Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High  / Some concerns  \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados. Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n. Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations  from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?   No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affec ted the \noutcome?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  No hay suficiente informaci\u00f3n para valorar este domin io Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo en \nque fueron asignados. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alt o riesgo de sesgo  Low / High  / Some concerns  \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Hubo un 43% de p\u00e9rdidas. Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo. No applicable / Yes / Probably yes / Probably no / \nNo/ No information \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  Los motivos de las p\u00e9rdidas no est\u00e1n suficientemente  justificados No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to  3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  Algunos motivos de p\u00e9rdidas no quedan suficientemen te documentada No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de s esgo  Low / High  / Some concerns  \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parecer haber si do el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  No se informa sobre el cegamiento de los evaluadores  Yes / Probably yes / Probably no / No / No \ninformation \n4.4 If Y/PY/NI to 4.3 : Could assessment  of the outcome have been influenced \nby knowledge of intervention received?  La medida es objetiva y parece poco probable que los participantes/evaluador puedan \ninfluir en los resultados. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4 : Is it likely that assessment of the outcome was i nfluenced No aplica No applicable / Yes / Probably yes / Probably no /  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  202 by knowledge of intervention received?  No / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low  / High / Some concerns  \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado. Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos de \nan\u00e1lisis que utilizaron fueron acordes con lo planeado . Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n \nEstudio: Heffn er (2016)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Sintomatolog\u00eda TEPT (CAPS; PCL-S) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the numeric \nresult (e.g. RR = 1.52 (95% CI 0.83 to 2.77) and/or  a reference (e.g. to a table, figure or paragraph) that uniquely defines \nthe result being assessed. En conjunto, los an\u00e1lisis mostraron tama\u00f1os de efecto  medianos de la meditaci\u00f3n en comparaci\u00f3n con \nel tratamiento habitual para la gravedad del TEPT ( hetero-reportada:  tama\u00f1o del efecto (ES) 0,32; \nautoinforme: ES 0,39). Tabla 2.  \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n     X    Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No se comparan las caracter\u00edsticas en l\u00ednea base entre los grupos Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the in tended interventions (effect of assignment to interv ention) \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  No aplica.  No applicable / Yes / Probably yes / Probably no /   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 203 outcome?  No / No information \n2.6 Was an appropriate an alysis used to estimate the effect of assignment to  \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a subs tantial impact (on the \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo en \nque fueron asignados. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Hetero-reportada: Hubo un 22.2% de p\u00e9rdidas en el g rupo de MT, un 4% en el grupo de \nmantra y un 11.1% en el grupo control.  Auto-reportada: Hubo un 22.2% de p\u00e9rdidas en el gru po de MT, un 4% en el grupo de \nmantra y un 11.1% en el grupo control.  Hetero-reportada: Yes / Probably yes / Probably No \n/ No / No Information \nAuto-reportada: Yes / Probably yes / Probably No / \nNo / No Information \n3.2 If N/PN/NI to 3.1: Is there evidence that the r esult was not biased by \nmissing outcome data?  Hetero-reportada: Es posible que el resultado estuv iese sesgado porque no se utiliz\u00f3 \nning\u00fan m\u00e9todo de an\u00e1lisis para corregir el sesgo Auto-reportada: Es posible que el resultado estuvie se sesgado porque no se utiliz\u00f3 ning\u00fan \nm\u00e9todo de an\u00e1lisis para corregir el sesgo Hetero-reportada: No applicable / Yes / Probably \nyes / Probably no / No \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No \n3.3 If N/PN to 3.2: Could missingness in the outcom e depend on its true \nvalue?  Hetero-reportada: Los motivos de las p\u00e9rdidas no es t\u00e1n suficientemente justificados \nAuto-reportada: Los motivos de las p\u00e9rdidas no est\u00e1 n suficientemente justificados Hetero-reportada: No applicable / Yes / Probably \nyes / Probably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \n3.4 If Y/PY/NI to 3.3: Is it likely that missingnes s in the outcome depended on \nits true value?  Hetero-reportada: Algunos motivos de p\u00e9rdidas no qu edan suficientemente documentadas \nAuto-reportada: Algunos motivos de p\u00e9rdidas no qued an suficientemente documentadas Hetero-reportada: No applicable / Yes / Probably \nyes / Probably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nRisk-of-bias judgement  Hetero -reportada: Alto riesgo de sesgo  \nAuto-reportada: Alto riesgo de sesgo Hetero-reportada: Low / High / Some concerns \nAuto-reportada: Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcome \n4.1 Was the method of measuring the outcome inappro priate?  Hetero-reportada: El m\u00e9todo para medir los resultad os parece ser apropiado. \nAuto-reportada: El m\u00e9todo para medir los resultados  parece ser apropiado. Hetero-reportada: Yes / Probably yes / Probably no \n/ No / No information \nAuto-reportada: Yes / Probably yes / Probably no / \nNo / No information \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  Hetero-reportada: El m\u00e9todo para medir los resultad os parece haber sido comparable en \ntodos los grupos Auto-reportada: El m\u00e9todo para medir los resultados  parece haber sido comparable en \ntodos los grupos Hetero-reportada: Yes / Probably yes / Probably no \n/ No / No information \nAuto-reportada: Yes / Probably yes / Probably no / \nNo / No information \n4.3 If N/PN/NI to 4.1 and 4.2: Were outcome assesso rs aware of the \nintervention received by study participants?  Hetero-reportada: No se informa sobre el cegamiento de los evaluadores \nAuto-reportada: La medida es auto-reportada y parece poco probable que los participantes \nest\u00e9n cegados a la asignaci\u00f3n Hetero-reportada: Yes / Probably yes / Probably no \n/ No / No information \nAuto-reportada: Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3: Could assessment of the outc ome have been influenced \nby knowledge of intervention received?  Hetero-reportada: No hay suficiente informaci\u00f3n para  valorar este dominio \nAuto-reportada: La medida es auto-reportada, por lo  que es posible que los resultados se \nvean influidos por el conocimiento de la intervenci\u00f3n recibida Hetero-reportada: Yes / Probably yes / Probably no \n/ No / No information \nAuto-reportada: Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  Hetero-reportada: No hay suficiente informaci\u00f3n para  valorar este dominio. \nAuto-reportada: El grupo comparador fue un control ac tivo con protocolo similar al del \ngrupo de intervenci\u00f3n, por lo que es probable que l as diferencias no se deban al \nconocimiento de la intervenci\u00f3n recibida Hetero-reportada: No applicable / Yes / Probably \nyes / Probably no / No / No information \nAuto-reportada No applicable / Yes / Probably yes / \nProbably no / No / No information \nRisk-of-bias judgement  Hetero -reportada: Alto riesgo de sesgo  \nAuto-reportada: Riesgo de sesgo incierto Hetero-reportada: Low / High / Some concerns \nAuto-reportada: Low / High / Some concerns \nDomain 5: Risk of bias in selec tion of the reported result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the    \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  204 basis of the results, from...  \n5.2. ... multiple outcome measur ements (e.g. scales, definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no parece estar disponible p ara contrastar si la medici\u00f3n se analiz\u00f3 \nde m\u00faltiples maneras. Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judg ement  Riesgo de sesgo incierto  Low / High / Some concerns \nOverall risk of bias  \nRisk-of-bias judgement  Hetero -reportada: Alto riesgo de sesgo  \nAuto-reportada: Alto riesgo de sesgo Hetero-reportada: Low / High / Some concerns \nAuto-reportada: Low / High / Some concerns \n  \nEstudio: Heide (1980)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Ansiedad (STAI) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the numeric result \n(e.g. RR = 1.52 (95% CI 0.83 to 2.77) and/or a refe rence (e.g. to a table, figure or paragraph) that u niquely defines the result being \nassessed. Las personas de grupo de meditaci\u00f3n mostraron mayore s reducciones en el rasgo de \nansiedad que las personas del grupo control tras una  semana de intervenci\u00f3n. Tabla 1. Medias \ny desviaciones t\u00edpicas en ansiedad rasgo y ansiedad est ado \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n     X    Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No se comparan las caracter\u00edsticas en l\u00ednea base entre los grupos Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended inte rventions (effect of assignment to intervention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 W as an appropriate analysis used to estimate the eff ect of assignment to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on the \nresult) of the failure to analyse participants in t he group to which they were No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo en No applicable / Yes / Probably yes / Probably no / \nNo / No information   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 205 randomized?  que fueron asignados \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  5 de los 63 voluntarios (7.9%) que inicialmente par ticipan, se pierden al no completar las \ntres sesiones requeridas (evaluaci\u00f3n pre-intervenci\u00f3 n, intervenci\u00f3n y evaluaci\u00f3n post-\nintervenci\u00f3n), pero no se especifica cu\u00e1ntos se perdie ron despu\u00e9s de la aleatorizaci\u00f3n. Yes / Probably yes / Probably No / No / No \ninformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  Los motivos de las p\u00e9rdidas no est\u00e1n suficientemente  justificados No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  Algunos motivos de p\u00e9rdidas no quedan suficientemen te documentadas No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  La medida es auto-reportada y la intervenci\u00f3n s\u00f3lo s e compara con un grupo de \u201cno \ntratamiento\u201d, por lo que es probable que los result ados se vean influenciados por el \nconocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably No / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , defini tions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably No / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no parece estar disponible p ara contrastar si la medici\u00f3n se analiz\u00f3 \nde m\u00faltiples maneras. Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incie rto  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n  \nEstudio: Janyacharoen (2018)  \nStudy design  \nx Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Movilidad (medidas objetivas) y calidad de vida (auto -reportada) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses \nbeing presented, specify the numeric result (e.g. RR = 1.52 (95% CI 0.83 to 2.77) and/or \na reference (e.g. to a table, figure or paragraph) t hat uniquely defines the result being \nassessed. Se observ\u00f3 una puntuaci\u00f3n significativamente menor en  el tiempo empleado en levantarse de una silla, cami nar en l\u00ednea recta una \ndistancia de 3 metros, girarse y volver caminando hacia  la silla para sentarse nuevamente en el grupo de m editaci\u00f3n en comparaci\u00f3n con \nel grupo control (6,4 frente a 8,3 segundos; p <0,01 ), mientras que la puntuaci\u00f3n en mantenerse est\u00e1tico s cerca de una pared y \nextenderse a lo largo de ella lo m\u00e1ximo posible fue significativamente m\u00e1s alta en el grupo de meditaci\u00f3n  en comparaci\u00f3n con el grupo  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  206 control (26,0 frente a 21,0 cm; p <0,01) (Tabla 3). Los otros resultados fueron comparables entre ambos grupos, incluidos los de la \nevaluaci\u00f3n de 6MWT, FTSST y QoL \nIs the review team\u2019s aim for this result\u2026?  \nx to assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 e ffect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n   x      Journal article(s) with results of the tria l \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention gr oups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations fro m the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the \noutcome?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Los an\u00e1lisis no se realizaron con todos los participa ntes elegibles despu\u00e9s de la \naleatorizaci\u00f3n. Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo en \nque fueron asignados. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Medidas objetivas: Hubo un 19% de p\u00e9rdidas. Cuestionario: Hubo un 19% de p\u00e9rdidas. Objetiva: Yes / Probably yes / Probably No / No / \nNo Information \nAuto-reportada: Yes / Probably yes / Probably No / \nNo / No Information \n3.2 If N/PN/NI to 3.1: Is there evidence that the r esult was not biased by \nmissing outcome data?  Medidas objetivas: Es posible que el resultado estu viese sesgado porque no se utiliz\u00f3 \nning\u00fan m\u00e9todo de an\u00e1lisis para corregir el sesgo Cuestionario: Es posible que el resultado estuviese  sesgado porque no se utiliz\u00f3 ning\u00fan \nm\u00e9todo de an\u00e1lisis para corregir el sesgo Objetiva: No applicable / Yes / Probably yes / \nProbably no / No \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No \n3.3 If N/PN to 3.2: Could missingness in the outcom e depend on its true \nvalue?  Medidas objetivas: Los motivos de las p\u00e9rdidas no e st\u00e1n suficientemente justificados \nCuestionario: Los motivos de las p\u00e9rdidas no est\u00e1n suficientemente justificados Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \n3.4 If Y/PY/NI to 3.3: Is it likely that missingnes s in the outcome depended on \nits true value?  Medidas objetivas: Las p\u00e9rdidas son similares entre  los diferentes grupos, por lo que es \nposible que no est\u00e9n relacionadas con la intervenci\u00f3n  en s\u00ed misma pese a que no est\u00e9n \nsuficientemente documentadas Cuestionario: Las p\u00e9rdidas son similares entre los diferentes grupos, por lo que es posible \nque no est\u00e9n relacionadas con la intervenci\u00f3n en s\u00ed mi sma pese a que no est\u00e9n \nsuficientemente documentadas Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada:No applicable / Yes / Probably yes / \nProbably no / No / No information \nRisk -of -bias judgement  Medidas objetivas: Ri esgo de sesgo incierto  Medidas objetivas: Low / High / Some concerns   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 207 Cuestionario: Riesgo de sesgo incierto  Auto-reportada: Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  Medidas objetivas: El m\u00e9todo para medir los resulta dos parece haber sido el apropiado \nCuestionario: El m\u00e9todo para medir los resultados p arece haber sido el apropiado Objetiva: Yes / Probably yes / Probably no / No / \nNo information \nAuto-reportada: Yes / Probably yes / Probably no / \nNo / No information \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  Medidas objetivas: El m\u00e9todo para medir los resulta dos parece haber sido comparable en \ntodos los grupos Cuestionario: El m\u00e9todo para medir los resultados p arece haber sido comparable en todos \nlos grupos Objetiva: Yes / Probably yes / Probably no / No / \nNo information \nAuto-reportada: Yes / Probably yes / Probably no / \nNo / No information \n4.3 If N/PN/NI to 4.1 and 4.2: Were outcome assesso rs aware of the \nintervention received by study participants?  Medidas objetiva: No se informa sobre el cegamiento de los evaluadores \nCuestionario: La medida es auto-reportada y parece po co probable que los participantes \nest\u00e9n cegados a la asignaci\u00f3n Objetiva: Yes / Probably yes / Probably no / No / \nNo information \nAuto-reportada: Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3: Could assessment of the outc ome have been influenced \nby knowledge of intervention received?  Medidas objetivas: La medida es objetiva y parece poco  probable que los \nparticipantes/evaluador pueda influir en los resulta dos \nCuestionario: La medida es auto-reportada, por lo q ue es posible que los resultados se \nvean influidos por el conocimiento de la intervenci\u00f3n recibida Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  Medidas objetivas: El grupo comparador fue un control  activo con protocolo similar al del \ngrupo de intervenci\u00f3n, por lo que es probable que l as diferencias no se deban al \nconocimiento de la intervenci\u00f3n recibida Cuestionario: El grupo comparador fue un control activo  con protocolo similar al del grupo \nde intervenci\u00f3n, por lo que es probable que las dif erencias no se deban al conocimiento de \nla intervenci\u00f3n recibida.  Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nRisk-of-bias judgement  Medidas objetivas: Bajo riesgo de sesgo  \nCuestionario: Alto riesgo de sesgo Objetiva: Low / High / Some concerns \nAuto-reportada: Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being a ssessed likely to have been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado. Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos de \nan\u00e1lisis que utilizaron fueron acordes con lo planeado . Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nOverall risk of bias   \nRisk-of-bias judgement  Medidas  objetivas: Alto riesgo de sesgo  \nCuestionario: Alto riesgo de sesgo Objetiva: Low / High / Some concerns \nAuto-reportada: Low / High / Some concerns \n  \nEstudio: Jayadevappa (2007)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Calidad de vida (MLHFQ; QWB-SA); Calidad de vida (S F-36); Depresi\u00f3n (CES-D); Estr\u00e9s (PSS); Funcionalid ad (Six-minute-walk test) \nSpecify the numerical result being assessed. In case of  multiple alternative \nanalyses being presented, specify the numeric result ( e.g. RR = 1.52 (95% CI 0.83 \nto 2.77) and/or a reference (e.g. to a table, figure  or paragraph) that uniquely Para la capacidad funcional, el grupo de meditaci\u00f3n me jor\u00f3 significativamente en la prueba de caminata de s eis minutos en comparaci\u00f3n con el \ngrupo de educaci\u00f3n para la salud (P = .034). En las m edidas de resultado secundarias, el grupo de meditaci \u00f3n mostr\u00f3 mejor\u00eda en las \nsubescalas SF-36 y en la puntuaci\u00f3n total en la escala Minnesota Living with Heart Failure. En depresi\u00f3n, el grupo de meditaci\u00f3n mostr\u00f3 una  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  208 defines the result being assessed. disminuci\u00f3n significativa desde el inicio hasta los s eis meses en comparaci\u00f3n con el grupo de educaci\u00f3n para  la salud (P = .03). \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the  \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n     X    Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  La secuencia de asignaci\u00f3n es aleatoria, utilizan una s ecuencia aleatoria de n\u00fameros \ngenerados por ordenador. Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  El coordinador del estudio notific\u00f3 a los participant es su asignaci\u00f3n, pero no particip\u00f3 \nen la recolecci\u00f3n de datos. Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of partic ipants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : W ere there deviations from the intended \nintervention that arose because of the experimental  context?  No hay suficiente informaci\u00f3n para valorar este domin io No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were th ese deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Se llev\u00f3 a cabo un an\u00e1lisis por intenci\u00f3n de tratar Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRis k-of -bias judgement  Riesgo de sesgo incierto.  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Funcionalidad: Los datos estuvieron disponible para todos o pr\u00e1cticamente todos los \nparticipantes (5% de p\u00e9rdidas) Medidas auto-reportadas:  Los datos estuvieron disp onible para todos o pr\u00e1cticamente \ntodos los participantes (5% de p\u00e9rdidas) Objetiva: Yes / Probably yes / Probably No / No / \nNo Information \nAuto-reportada: Yes / Probably yes / Probably No / \nNo / No Information \n3.2 If N/PN/NI to 3.1: Is there evidence that the r esult was not biased by \nmissing outcome data?  Funcionalidad: No aplica. Medidas auto-reportadas: No aplica. Objetiva: No applicable / Yes / Probably yes / \nProbably no / No \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No \n3.3 If N/PN to 3.2: Could missingness in the outcom e depend on its true \nvalue?  Funcionalidad: No aplica. Medidas auto-reportadas: No aplica. Objetiva: No applicable / Yes / Probably yes / \nProbably no / No \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No \n3.4 If Y/PY/NI to 3.3: Is it likely that missingnes s in the outcome depended on \nits true value?  Funcionalidad: No aplica. Medidas auto-reportadas: No aplica. Objetiva: No applicable / Yes / Probably yes / \nProbably no / No \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No \nRisk-of-bias judgement  Funcionalidad: Bajo riesgo de sesgo  \nMedidas auto-reportadas: Bajo riesgo de sesgo Objetiva: Low / High / Some concerns \nAuto-reportada: Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e    \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 209 4.1 Was the method of measuring the outcome inappro priate?  Funcionalidad: El m\u00e9todo para medir los resultados p arece haber sido el apropiado \nMedidas auto-reportadas: El m\u00e9todo para medir los r esultados parece haber sido el \napropiado Objetiva: Yes / Probably yes / Probably no / No / \nNo information \nAuto-reportada: Yes / Probably yes / Probably no / \nNo / No information \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  Funcionalidad: El m\u00e9todo para medir los resultados p arece haber sido comparable en \ntodos los grupos. Medidas auto-reportadas: El m\u00e9todo para medir los r esultados parece haber sido \ncomparable en todos los grupos. Objetiva: Yes / Probably yes / Probably no / No / \nNo information \nAuto-reportada: Yes / Probably yes / Probably no / \nNo / No information \n4.3 If N/PN/NI to 4.1 and 4.2: Were outcome assesso rs aware of the \nintervention received by study participants?  Funcionalidad: El evaluador estuvo cegado a la condici \u00f3n del participante. \nMedidas auto-reportadas: La medida es auto-reportad a y parece poco probable que los \nparticipantes est\u00e9n cegados a la asignaci\u00f3n Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \n4.4 If Y/PY/NI to 4.3: Could assessment of the outc ome have been influenced \nby knowledge of intervention received?  Funcionalidad: No aplica.  Medidas auto-reportadas: La medida es auto-reportad a, por lo que es posible que los \nresultados se vean influidos por el conocimiento de la intervenci\u00f3n recibida Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  Funcionalidad: No aplica.  Medidas auto-reportadas: El grupo comparador fue un control activo con protocolo similar \nal del grupo de intervenci\u00f3n, por lo que es probable  que las diferencias no se deban al \nconocimiento de la intervenci\u00f3n recibida Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nRisk-of-bias judgement  Funcionalidad: Bajo riesgo de sesgo  \nMedidas auto-reportadas: Riesgo de sesgo incierto Objetiva: Low / High / Some concerns \nAuto-reportada: Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before u nblinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being as sessed likely to have been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no parece estar disponible p ara contrastar si la medici\u00f3n se analiz\u00f3 \nde m\u00faltiples maneras. Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nOverall risk of bias   \nRisk-of-bias judgement  Funcionalidad: Riesgo de sesgo incierto  \nMedidas auto-reportadas: Alto riesgo de sesgo Objetiva: Low / High / Some concerns \nAuto-reportada: Low / High / Some concerns \n  \nEstudio: Jazaieri (2013)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Ansiedad (PSWQ) y estr\u00e9s percibido (PSS) \nSpecify the numerical result being assessed. In case of  multiple alternative \nanalyses being presented, specify the numeric result ( e.g. RR = 1.52 (95% CI 0.83 \nto 2.77) and/or a reference (e.g. to a table, figure  or paragraph) that uniquely \ndefines the result being assessed. Para la preocupaci\u00f3n (PSWQ), hubo un efecto principal de tiempo (F1,79 = 5.88, p <0.02), ning\u00fan efecto de grupo (p> 0.31) y una interacci\u00f3n \nsignificativa de grupo por tiempo (F1 , 79 = 9,94, p  <.002). Para el estr\u00e9s percibido (PSS), no hubo int eracci\u00f3n de grupo por tiempo (p> 0,91). \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)   \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  210  Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n     X    Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  La secuencia de asignaci\u00f3n es aleatoria, utilizan una s ecuencia aleatoria de n\u00fameros \ngenerados por ordenador. Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignm ent to intervention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis u sed to estimate the effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on the \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No parece que haya habido un impacto sustancial en los resultados debido a la falta de \nan\u00e1lisis de los participantes en el grupo en que fu eron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto.  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, partici pants \nrandomized?  Hubo un 15% de p\u00e9rdidas en el grupo de intervenci\u00f3n  y un 25% en el grupo control. Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  Se llev\u00f3 a cabo un an\u00e1lisis de las p\u00e9rdidas.  No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo \n3.4 If Y/PY/N I to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measureme nt of the outcome  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me h ave differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of  the outcome have been influenced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  La medida es auto-reportada y la intervenci\u00f3n s\u00f3lo s e compara con un grupo de \u201cno \ntratamiento\u201d, por lo que es probable que los result ados se vean influenciados por el \nconocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 5: Risk  of bias in selection of the reported result    \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 211 5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multip le outcome measurements (e.g. scales, definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no parece estar disponible p ara contrastar si la medici\u00f3n se analiz\u00f3 \nde m\u00faltiples maneras. Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n  \nEstudio: Jeitler (2015)  \n \nStudy design  \nx Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Dolor (VAS; NPAD); Calidad de vida (SF-36); Depresi \u00f3n (CES-D); Ansiedad (STAI); Estr\u00e9s percibido (PSS) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being \npresented, specify the numeric result (e.g. RR = 1.52 ( 95% CI 0.83 to 2.77) and/or a \nreference (e.g. to a table, figure or paragraph) tha t uniquely defines the result being \nassessed. Se observ\u00f3 una diferencia significativamente favorab le al grupo de meditaci\u00f3n en la reducci\u00f3n del dolor cer vical en reposo (EVA 0-100) \n(diferencia media = 13.2 mm (IC95%: 2.1, 24.4; p = 0.02)) con un tama\u00f1o del efecto de magnitud media (g = 0.58). No se encontr\u00f3 un \nefecto significativo para las medidas psicol\u00f3gicas y la  calidad de vida, aunque el grupo de meditaci\u00f3n most r\u00f3 mejoras mayores no \nsignificativas en comparaci\u00f3n con el grupo de ejercicio.  \n Is the review team\u2019s aim for this result\u2026?  \nx \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n        X Journal article(s) with results of the tri al  \n      X             Non-commercial trial registry recor d (e.g. ClinicalTrials.gov record) \nDomain 1: Risk of bias arising from the randomizatio n process  \nSi gnalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Aleatorizaci\u00f3n por bloques con secuencia generada por o rdenador.  Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until participants were enrolled \nand assigned to interventions?  La secuencia se mantuvo oculta en sobres opacos. Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from  the intended interventions (effect of assignment to  intervention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados Yes / Probably yes / Probably No / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably No / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4 If Y/PY to 2.3 : Were these deviations likely to have affected the  \noutcome?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  212 2.5. If Y/PY to 2.4 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Se llev\u00f3 a cabo un an\u00e1lisis por intenci\u00f3n de tratar Yes / Probably yes / Probably No / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substan tial impact (on the \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Hubo un 38% de p\u00e9rdidas. Yes / Probably yes / Probably No / No / No \ninformation \n3.2 If N/PN/NI to 3.1 : Is there evidenc e that the result was not biased by \nmissing outcome data?  Se llev\u00f3 a cabo un an\u00e1lisis por intenci\u00f3n de tratar No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low /High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  El grupo comparador fue un control activo con protocolo similar al del grupo de \nintervenci\u00f3n, por lo que es probable que las difere ncias no se deban al conocimiento de la \nintervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRi sk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio est\u00e1 disponible (DRKS000003 7) Yes / Probably yes / Probably No / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  Se realizaron an\u00e1lisis de comparaciones entre grupos co n los mismos instrumentos Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  Los resultados se analizaron atendiendo al plan de a n\u00e1lisis previo al inicio del estudio Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \n \nEstudio: Jong (2019)  \nStudy design  \nx Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched)  trial \n \nSpecify which outcome is being assessed for risk of  bias:  Frecuencia dolor de cabeza; Depresi\u00f3n y ansiedad (RCADS- 25); Afrontamiento del dolor (PCQ); Somatizaci\u00f3n (CSI )   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 213 Specify the numerical result being assessed. In case of  multiple alternative analyses being presented, \nspecify the numeric result (e.g. RR = 1.52 (95% CI 0. 83 to 2.77) and/or a reference (e.g. to a table, fig ure or \nparagraph) that uniquely defines the result being as sessed. Se observ\u00f3 una reducci\u00f3n cl\u00ednicamente relevante del do lor de cabeza ( \u2265 50%) en el 41% y el 47% de los ni\u00f1os a los 3 \ny 9 meses respectivamente, sin diferencias significativas  entre los grupos. No se observaron diferencias en l as \nmedidas de ansiedad y depresi\u00f3n entre los grupos de intervenci\u00f3n. \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n        X Journal article(s) with results of the tri al \n        X       Non-commercial trial registry record ( e.g. ClinicalTrials.gov record) \nDomain 1: Risk of bias arising from the randomization process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Lista generada por ordenador \u201cRandomised using sepa rate randomisation lists as \ngenerated by the computerised Random Allocation Softwa re Program employing a \nrandom block size of six to guarantee balanced allocation \u201d. Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled and \nassigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of ass ignment to intervention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados Yes / Probably yes / Probably No / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably No / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista \ndebidos al contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4 If Y/PY to 2.3: Were these deviations likely to  have affected the outcome?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5. If Y/PY to 2.4 : Were these deviations from intended intervention balanced \nbetween groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to e stimate the effect of assignment to \nintervention?  Se llev\u00f3 a cabo un an\u00e1lisis por intenci\u00f3n de tratar Yes / Probably yes / Probably No / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e result) \nof the failure to analyse participants in the group  to which they were \nrandomized?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 3: Missing outcome da ta  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Hubo un 0% de p\u00e9rdidas en el grupo de hipnosis, un 11.9% en el grupo de meditaci\u00f3n y \nun 6.8% en el grupo control. Yes / Probably yes / Probably No / No / No \ninformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by missing \noutcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2: Could missingness in the outcom e depend on its true value?  Los motivos de las p\u00e9rdidas parecen ser independient es a la intervenci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/ NI to 3.3 : Is it likely that missingness in the outcome depe nded on its \ntrue value?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of  bias in measurement of the outcome  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainmen t of the outcome have differed between \nintervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  214 4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors a ware of the intervention \nreceived by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n \ncegados a la asignaci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : C ould assessment of the outcome have been influenced  by \nknowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos \npor el conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  El grupo comparador fue un control activo con protocolo similar al del grupo de \nintervenci\u00f3n, por lo que es probable que las difere ncias no se deban al conocimiento de \nla intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio est\u00e1 disponible (NTR 2955, 28 June 2011) Yes / Probably yes / Probably No / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the basis \nof the results, from...    \n5.2. ... multiple outcome measurements (e.g. sca les, definitions, time points) \nwithin the outcome domain?  Se realizaron an\u00e1lisis de comparaciones entre grupos co n los mismos instrumentos Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  Los resultados se analizaron atendiendo al plan de a n\u00e1lisis previo al inicio del estudio Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto r iesgo de sesgo  Low / High / Some concerns \n \nEstudio: Keefer (2001)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome  is being assessed for risk of bias:  S\u00edntomas gastrointestinales (CPSR) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the \nnumeric result (e.g. RR = 1.52 (95% CI 0.83 to 2.77)  and/or a reference (e.g. to a table, figure or para graph) that uniquely \ndefines the result being assessed. Se realiz\u00f3 una prueba t independiente para comparar l as puntuaciones en CPRS del grupo de meditaci\u00f3n \n(M=0.51) y del grupo control (M=-0.15) y se encontr\u00f3 qu e la meditaci\u00f3n era superior al grupo de \nintervenci\u00f3n diferida (t(11)=1.97, p=0.04) \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to interventi on  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n    X     Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo \nutilizado Yes / Probably yes / Probably No / No / No informatio n \n1.2 Was the allocation seque nce concealed until participants were \nenrolled and assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No informatio n \n1.3 Did baseline differences between intervention g roups  suggest \na problem with the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No informatio n \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDoma in 2: Risk of bias due to deviations from the inten ded interventions (effect of assignment to interven tion)  \n2.1. Were participants aware of their assigned inte rvention during \nthe trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable \nque los participantes estuvieran cegados a su condici\u00f3n  Yes / Probably yes / Probably no / No / No informatio n \n2.2. Were carers and people delivering the interven tions aware of Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la Yes / Probably yes / Probably no / No / No informatio n   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 215 participants' assigned intervention during the tria l?  meditaci\u00f3n no pudieron estar cegados a su condici\u00f3n \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the \nintended intervention that arose because of the exp erimental \ncontext?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n \nprevista debidos al contexto experimental No applicable / Yes / Probably yes / Probably no / No / No information \n2.4. If Y/PY to 2.3 : Were these de viations from intended \nintervention balanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / No / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have \naffected the outcome?  No aplica.  No applicable / Yes / Probably yes / Probably no / No / No information \n2.6 Was an appropriate analysis used to estimate th e effect of \nassignment to intervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el \nestudio Yes / Probably yes / Probably no / No / No informatio n \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact \n(on the result) of the failure to analyse participa nts in the group to \nwhich they were randomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de \nimpacto sustancial en los resultados debido a la falt a de an\u00e1lisis de los \nparticipantes en el grupo en que fueron asignados No applicable / Yes / Probably yes / Probably no / No / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, \nparticipants randomized?  Hubo un 12.5% de p\u00e9rdidas tras la aleatorizaci\u00f3n Yes / Probably yes / Probably No / No / No Informatio n \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not \nbiased by missing outcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan \nm\u00e9todo de an\u00e1lisis para corregir el sesgo No applicable / Yes / Probably yes / Probably no / No \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on \nits true value?  Los motivos de las p\u00e9rdidas no est\u00e1n suficientemente  justificados No applicable / Yes / Probably yes / Probably no / No / No information \n3.4 If Y/PY/NI to 3.3 : Is it li kely that missingness in the outcome \ndepended on its true value?  Algunos motivos de p\u00e9rdidas no quedan suficientemen te documentadas No applicable / Yes / Probably yes / Probably no / No / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No informatio n \n4.2 Could measurement or ascertainment of the outco me have \ndiffered between intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos \nlos grupos Yes / Probably yes / Probably no / No / No informatio n \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of \nthe intervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes \nest\u00e9n cegados a la asignaci\u00f3n No applicable / Yes / Probably yes / Probably no / No / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been \ninfluenced by knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se \nvean influidos por el conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / No / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome \nwas influenced by knowledge of intervention receive d?  La medida es auto-reportada y la intervenci\u00f3n s\u00f3lo s e compara con un grupo \nde \u201cno tratamiento\u201d, por lo que es probable que los  resultados se vean \ninfluenciados por el conocimiento de la intervenci\u00f3n r ecibida No applicable / Yes / Probably yes / Probably no / No / No information \nRisk -of -bias judgement  Alto rie sgo de sesgo  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in \naccordance with a pre-specified analysis plan that was finalized \nbefore unblinded outcome data were available for an alysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a \ncabo los an\u00e1lisis previstos. Yes / Probably yes / Probably no / No / No informatio n \nIs the numerical result being assessed likely to ha ve been \nselected, on the basis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, \ntime points) within the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar \nsi las medidas y los puntos temporal fueron acordes co n lo planeado Yes / Probably yes / Probably no / No / No informatio n \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no parece estar disponible p ara contrastar si la \nmedici\u00f3n se analiz\u00f3 de m\u00faltiples maneras. Yes / Probably yes / Probably no / No / No informatio n \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nOverall risk of bias    \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n \nEstudio: Kindlon (1983)  \nStu dy designmar  \nX Individually-randomized parallel-group trial  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  216  Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Ansiedad (Attitude Inventory) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the numeric \nresult (e.g. RR = 1.52 (95% CI 0.83 to 2.77) and/or  a reference (e.g. to a table, figure or paragraph) that uniquely defines the \nresult being assessed. Pese a que hubo una reducci\u00f3n de la ansiedad, no hubo  diferencias estad\u00edsticamente significativas \nentre las medias de los grupos en ninguna medida de  ansiedad ante los ex\u00e1menes (Tabla 1). \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n   X    Journal article(s) with results of the trial  \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe  el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers an d people delivering the interventions aware of part icipants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations likely to have affected the  \noutcome?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N /PN/NI to 2.4 : Were these deviations from intended intervention \nbalanced between groups? No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Parecen haber analizado a todos los participantes incl uidos en la aleatorizaci\u00f3n. Se llev\u00f3 a \ncabo un an\u00e1lisis por intenci\u00f3n de tratar Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial  impact (on the \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Los datos estuvieron disponible para todos o pr\u00e1ctica mente todos los participantes (an\u00e1lisis \npor intenci\u00f3n de tratar) Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its true \nvalue?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 217 information \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  El grupo comparador fue un control activo con protocolo similar al del grupo de \nintervenci\u00f3n, por lo que es probable que las difere ncias no se deban al conocimiento de la \nintervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pr e-\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos de \nan\u00e1lisis que utilizaron fueron acordes con lo planeado  Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \nOverall risk of  bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n  \nEstudio: Kirkland (1980)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Ansiedad (CSAQ-C) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the numeric \nresult (e.g. RR = 1.52 (95% CI 0.83 to 2.77) and/or  a reference (e.g. to a table, figure or paragraph) that uniquely defines the \nresult being assessed. La comparaci\u00f3n planeada entre los grupos de relajaci\u00f3n  y meditaci\u00f3n en el componente cognitivo de \nla ansiedad (CSAQ-C) no mostr\u00f3 resultados significat ivos. Tabla 1. Medias pre y post, desviaciones \nt\u00edpicas y comparaciones post-hoc para las variables depe ndientes. \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n     X    Journal article(s) with results of the tri al \nDomain 1:  Risk of bias arising from the randomization process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did bas eline differences between intervention groups sugge st a problem \nwith the randomization process?  No se comparan las caracter\u00edsticas en l\u00ednea base entre los grupos Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesg o incierto  Low /High / Some concerns  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  218 Domain 2: Risk of bias due to deviations from the in tended interventions (effect of assignment to interv ention) \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados Yes / Probably yes / Probably No / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the int ended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo en \nque fueron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Hubo un 16.7% de p\u00e9rdidas tras la aleatorizaci\u00f3n. Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  Los motivos de las p\u00e9rdidas no est\u00e1n suficientemente  justificados No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No existe informaci\u00f3n suficiente que permita valorar  los motivos de abandono, pero las \ntasas de p\u00e9rdidas son equivalentes en los diferente s grupos.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto.  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcome \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable qu e los participantes est\u00e9n cegados a \nla asignaci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  El grupo comparador fue un control activo con protocolo similar al del grupo de \nintervenci\u00f3n, por lo que es probable que las difere ncias no se deban al conocimiento de la \nintervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported r esult \n5.1 Were the data that produced this result analysed in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably No / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably No / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no parece estar disponible p ara contrastar si la medici\u00f3n se analiz\u00f3 \nde m\u00faltiples maneras. Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nOverall risk o f bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 219  \nEstudio: Kirsch (1979)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Ansiedad (PRCS) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the \nnumeric result (e.g. RR = 1.52 (95% CI 0.83 to 2.77)  and/or a reference (e.g. to a table, figure or para graph) that \nuniquely defines the result being assessed. Las comparaciones univariadas indicaron que esta super ioridad de los sujetos experimentales sobre los de \ncontrol se limitaba \u00fanicamente a las medidas de autoi nforme: Cambios en ansiedad, F (1, 34) = 18,73, p <  \n.001; Term\u00f3metro del miedo: F (1,34) = 8,07, p < 0, 008. \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n        X Journal article(s) with results of the tri al \nDomain 1:  Risk of bias arising from the randomization process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado. Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?   No se informa si la secuencia de aleatorizaci\u00f3n se ma ntuvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did b aseline differences between intervention groups sug gest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base. Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo i ncierto de sesgo  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados. Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Los asistentes de la prueba estuvieron ciegos a la condici\u00f3n de asignaci\u00f3n durante \nla intervenci\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used  to estimate the effect of assignment to \nintervention?  No hay suficiente informaci\u00f3n para valorar este domin io. Yes / Probably yes / Probably No / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo al \nque fueron asignados. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nea rly all, participants \nrandomized?  No hay informaci\u00f3n sobre si hubo o no p\u00e9rdidas. Yes / Probably yes / Probably No / No / No \ninformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo. No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  No hay informaci\u00f3n sobre si hubo o no p\u00e9rdidas. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on No existe suficiente informaci\u00f3n para valorar este  dominio No applicable / Yes / Probably yes / Probably no /  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  220 its true value?  No / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado. Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos. Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n. Yes / Probably yes / Probably no / No / No \ninformation \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  La medida es auto-reportada y la intervenci\u00f3n s\u00f3lo s e compara con un grupo de \u201cno \ntratamiento\u201d, por lo que es probable que los result ados se vean influenciados por el \nconocimiento de la intervenci\u00f3n recibida. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result anal ysed in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably No / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado. Yes / Probably yes / Probably No / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por ta nto, no se puede comparar si los tipos de \nan\u00e1lisis que utilizaron fueron acordes con lo planeado . Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n \nEstudio: Knabb (2020)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Ansiedad (subescala DASS-21) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being \npresented, specify the numeric result (e.g. RR = 1.52 ( 95% CI 0.83 to 2.77) and/or a reference \n(e.g. to a table, figure or paragraph) that uniquel y defines the result being assessed. Las puntuaciones de ansiedad en la subescala del Depr ession, Anxiety, and Stress Scale-21 (DASS-21), los re sultados de \nANCOVA, OF 0.93, p .34 apoyaron los efectos de la int ervenci\u00f3n no significativos. A pesar de las interacci ones no significativas, \nhubo peque\u00f1os efectos de intervenci\u00f3n en estas varia bles, seg\u00fan la interpretaci\u00f3n de Cohen. \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n   X    Journal article(s) with results of the trial  \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  La secuencia de aleatorizaci\u00f3n fue realizada con un prog rama de ordenador Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 221 1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  Se comenta que hubo una diferencia entre los grupos en las puntuaciones de ansiedad al \ninicio del estudio Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended intervent ions (effect of assignment to intervention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations likely to have affected the  \noutcome?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations from intended intervention \nbalanced between groups? No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an ap propriate analysis used to estimate the effect of a ssignment to \nintervention?  Parecen haber analizado a todos los participantes incl uidos en la aleatorizaci\u00f3n. Se llev\u00f3 a \ncabo un an\u00e1lisis por intenci\u00f3n de tratar Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Hubo un 25% de p\u00e9rdidas Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  Los motivos de las p\u00e9rdidas parecen ser independient es a la intervenci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measureme nt or ascertainment of the outcome have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were o utcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If  Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  La medida es auto-reportada y la intervenci\u00f3n s\u00f3lo s e compara con un grupo de \u201cno \ntratamiento\u201d, por lo que es probable que los result ados se vean influenciados por el \nconocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no parece estar disponible p ara contrastar si se llevaron a cabo los \nan\u00e1lisis previstos Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?   El protocolo del estudio no est\u00e1 disponible para con trastar si se llevaron a cabo los an\u00e1lisis \nprevistos Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformation  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  222 Risk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n  \nEstudio: Leach (2015)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Calidad de vida (AqoL-8D); Ansiedad, depresi\u00f3n y est r\u00e9s (WebNeuro stress) \nSpecify the numerical result being assessed. In case of  multiple alternative \nanalyses being presented, specify the numeric result ( e.g. RR = 1.52 (95% CI 0.83 \nto 2.77) and/or a reference (e.g. to a table, figure  or paragraph) that uniquely \ndefines the result being assessed. Se observ\u00f3 una tendencia hacia una mejora mayor en la s puntuaciones de utilidad de AQoL-8D en el grupo de  meditaci\u00f3n en la semana 12 \n(Fig.2), pero las diferencias entre grupos no fueron  estad\u00edsticamente significativas a lo largo del tiemp o (F (1,15) = 0,025, p = 0,878, \u03b72 = \n0,002). Los cambios en las puntuaciones de estr\u00e9s ent re los grupos no fueron estad\u00edsticamente significativ os (F (1,15) = 1.350, p = 0.263, \u03b72 = \n0.083); sin embargo, hubo una tendencia no significat iva hacia una mejora mayor en aquellos que recibieron m editaci\u00f3n (Fig. 3). Tampoco \nhubo diferencia significativa entre grupos en las pun tuaciones de depresi\u00f3n (F (1,15) = 0,034, p = 0,856,  \u03b72 = 0,002). Aunque se observ\u00f3 una \nmejora marginalmente significativa en las puntuacione s de ansiedad en el grupo de control en la semana 12  en comparaci\u00f3n con el grupo de \nmeditaci\u00f3n (DM = -1,10, DE = 2,07, p = 0,046) (Tabla  3), no hubo diferencias estad\u00edsticamente significativ as entre los grupos (F (1,15) = \n<0,001, p = 0,998, \u03b72 = <0,001) a lo largo del tiempo. \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n   X    Journal article(s) with results of the trial  \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Re sponse options  \n1.1 Was the allocation sequence random?  La secuencia de aleatorizaci\u00f3n fue realizada con un prog rama de ordenador Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enro lled \nand assigned to interventions?  La asignaci\u00f3n fue oculta por medio de sobres Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Bajo riesgo de sesgo Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended intervention s (effect of assignment to intervention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations likely to have affected the  \noutcome?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations from intended intervention \nbalanced between groups? No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appro priate analysis used to estimate the effect of assi gnment to \nintervention?  Parecen haber analizado a todos los participantes incl uidos en la aleatorizaci\u00f3n. Se llev\u00f3 a \ncabo un an\u00e1lisis por intenci\u00f3n de tratar Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 223 Risk -of -bias judgement  Riesgo de sesgo incierto Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Los datos estuvieron disponible para todos o pr\u00e1ctica mente todos los participantes Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN  to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  Los cuidadores y evaluadores estaban cegados a la cond ici\u00f3n de los participantes No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4 : Is it likely that assessment of the outcome was i nfluenced \nby knowledge of intervention received?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio est\u00e1 disponible y las medida  analizadas coinciden con las \nreportadas en el protocolo del estudio Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical re sult being assessed likely to have been selected, o n the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  Se realizaron an\u00e1lisis de comparaciones entre grupos co n los mismos instrumentos Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  Los efectos del tratamiento se evaluaron mediante un  an\u00e1lisis t-test Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of-bias judgement  Bajo riesgo de sesgo Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Riesgo de sesgo incierto Low / High / Some concerns \n \nEstudio: Lee (2015)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  S\u00edntomas TEPT (MPSS); Distr\u00e9s (SDS); S\u00edntomas (SCL- 10) \nSpecify the numerical result being assessed. In case of  multiple alternative \nanalyses being presented, specify the numeric result ( e.g. RR = 1.52 (95% CI \n0.83 to 2.77) and/or a reference (e.g. to a table, f igure or paragraph) that uniquely \ndefines the result being assessed. Las personas de de la condici\u00f3n de meditaci\u00f3n experim entaron cambios significativos en los s\u00edntomas de sal ud mental (t = 5,252, df = 31, p = \n.000) y en los s\u00edntomas de trauma (t = 6,009, df = 3 1, p = .000) y s\u00edntomas de trauma (t = 6,009, df = 31, p = .000) desde el pretratamiento hasta \nel postratamiento, mientras que se observaron cambios  no significativos entre los clientes de la condici\u00f3n de control. Hubo diferencias \nsignificativas entre los grupos de entre los clientes  de la condici\u00f3n de meditaci\u00f3n y los de la condici\u00f3n d e control en sus s\u00edntomas de salud \nmental, F(1, 54) = 13,438, p = 0,001, y s\u00edntomas de  trauma, F(1, 54) = 13,395, p = 0,001. (Tabla 2). \nIs the review team\u2019s aim for this result\u2026?  \nX to assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effe ct)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)   \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  224  Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n        X Journal article(s) with results of the tri al \nDo main 1: Risk of bias arising from the randomization process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  El m\u00e9todo de secuencia aleatoria utilizado fue un n\u00fame ro generado por ordenador. Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?    No se informa si la secuencia de aleatorizaci\u00f3n se ma ntuvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base. Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judge ment  Riesgo incierto de sesgo  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados. Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n. Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there de viations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to ha ve affected the \noutcome?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron con todos los participante s elegibles despu\u00e9s de la \naleatorizaci\u00f3n. Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No parece que haya habido un impacto sustancial en los resultados debido a la falta de \nan\u00e1lisis de los participantes en el grupo al que fu eron asignados. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alt o riesgo de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Hubo un 11% de p\u00e9rdidas  Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  Los motivos de las p\u00e9rdidas parecen ser independient es a la intervenci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is i t likely that missingness in the outcome depended o n \nits true value?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measure ment of the outcome  \n4.1 Was the method of measuring the outcome inappro priate? El m\u00e9todo para medir los resultados parece haber sid o el apropiado.  Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups? El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos. Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n. Yes / Probably yes / Probably no / No / No \ninformation \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outco me have been influenced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  La medida es auto-reportada y la intervenci\u00f3n s\u00f3lo s e compara con un grupo de \u201cno \ntratamiento\u201d, por lo que es probable que los result ados se vean influenciados por el \nconocimiento de la intervenci\u00f3n recibida. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 5: Risk of bias  in selection of the reported result    \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 225 5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outco me measurements (e.g. scales, definitions, time poi nts) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado. Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos de \nan\u00e1lisis que utilizaron fueron acordes con lo planeado . Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n  \nEstudio: Lehrer (1983)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Ansiedad (STAI; IPAT; LWASQ); S\u00edntomas (SCL-90) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses \nbeing presented, specify the numeric result (e.g. RR = 1.52 (95% CI 0.83 to 2.77) \nand/or a reference (e.g. to a table, figure or parag raph) that uniquely defines the \nresult being assessed. En relaci\u00f3n a la escala de psicopatolog\u00eda SCL-90, se observ\u00f3 que, en general, las puntuaciones disminuyero n m\u00e1s en el grupo de relajaci\u00f3n \nque en el grupo de meditaci\u00f3n y m\u00e1s en el grupo de me ditaci\u00f3n que en el grupo control. Este patr\u00f3n se obse rv\u00f3 para los s\u00edntomas obsesivo-\ncompulsivo (F(2,46)=6.86, p < 0.003), depresi\u00f3n (F(2 ,46)=3.74, p<0.04; intensidad de los s\u00edntomas (F(2, 46)=4.68, p<0.02) y s\u00edntomas \npositivos (F(2,46)=4.47, p<0.02). Tanto la meditaci \u00f3n como la relajaci\u00f3n muscular progresiva redujeron d e forma significativa el rasgo de \nansiedad (STAI-T), pero en el grupo de relajaci\u00f3n l as reducciones fueron mayores. Tabla 2. Puntuaciones p re-post de los diferentes grupos \nen las medidas auto-reportadas. \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n     X    Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe  el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No se comparan las caracter\u00edsticas en l\u00ednea base entre los grupos Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and  people delivering the interventions aware of partic ipants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No hay suficiente informaci\u00f3n para valorar este domin io No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  226 2.5 If N/PN/NI to 2.4 : Were these deviations likely to  have affected the \noutcome?  No aplica.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo en \nque fueron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Hubo un 18% de p\u00e9rdidas.  Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  Los motivos de las p\u00e9rdidas no est\u00e1n suficientemente  justificados No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  Algunos motivos de p\u00e9rdidas no quedan suficientemen te documentadas No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judg ement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  El grupo comparador fue un control activo con protocolo similar al del grupo de \nintervenci\u00f3n, por lo que es probable que las difere ncias no se deban al conocimiento de la \nintervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bia s judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably No / No / No \ninformation \nIs the numerical result being assessed likely  to have been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably No / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no parece estar disponible p ara contrastar si la medici\u00f3n se analiz\u00f3 \nde m\u00faltiples maneras. Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n  \nEstu dio: M anocha (2011)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 227 Specify which outcome is being assessed for risk of  bias:  Ansiedad (STAI); Depresi\u00f3n (POMS subescala de depres i\u00f3n); Estr\u00e9s (PSQ) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the numeric result (e.g. \nRR = 1.52 (95% CI 0.83 to 2.77) and/or a reference ( e.g. to a table, figure or paragraph) that uniquely  defines the result being \nassessed. En comparaci\u00f3n con el grupo de intervenci\u00f3n diferida y  la relajaci\u00f3n, en el grupo de \nmeditaci\u00f3n se observaron mejoras significativas en es tr\u00e9s (p=0.026) y depresi\u00f3n (p=0.019).  \nTabla 2: Diferencias entre l\u00ednea base y post-interve nci\u00f3n a las 8 semanas en las principales \nmedidas de resultado.  \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to as sess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n      X   Journal article(s) with results of the tri al \n      X  Non-commercial trial registry record (e.g. Cl inicalTrials.gov record) \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  La secuencia de asignaci\u00f3n es aleatoria (sistema de as ignaci\u00f3n de loter\u00eda con los ojos \nvendados).  Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  Un asistente, ajeno a los investigadores principales , inform\u00f3 a los participantes de la \nasignaci\u00f3n y no fue revelada a los investigadores.  Yes /Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from th e intended interventions (effect of assignment to i ntervention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Se llev\u00f3 a cabo un an\u00e1lisis por intenci\u00f3n de tratar Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substa ntial impact (on the \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Hubo un 32% de p\u00e9rdidas.  Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evide nce that the result was not biased by \nmissing outcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could  missingness in the outcome depend on its true \nvalue?  Los motivos de las p\u00e9rdidas no est\u00e1n suficientemente  justificados No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3: Is it likely that missingnes s in the outcome depended on \nits true value?  Las p\u00e9rdidas son similares entre los diferentes gru pos, por lo que es posible que no est\u00e9n \nrelacionadas con la intervenci\u00f3n en s\u00ed misma pese a q ue no est\u00e9n suficientemente \ndocumentadas No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  228 information \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  El grupo comparador fue un control activo con protocolo similar al del grupo de \nintervenci\u00f3n, por lo que es probable que las difere ncias no se deban al conocimiento de la \nintervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no parece estar disponible p ara contrastar si la medici\u00f3n se analiz\u00f3 \nde m\u00faltiples maneras. Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n \nEstudio: Menezes (2013)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which ou tcome is being assessed for risk of bias:  Ansiedad (STAI) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the \nnumeric result (e.g. RR = 1.52 (95% CI 0.83 to 2.77)  and/or a reference (e.g. to a table, figure or para graph) that \nuniquely defines the result being assessed. Tabla 1. El grupo de meditaci\u00f3n present\u00f3 una reducci\u00f3 n significativamente mayor del rasgo de ansiedad rasgo  \nentre la prueba previa y posterior [F (1, 13) = 6.0 1, p = .02, \u03b72 = .31], en comparaci\u00f3n con el grupo de control [ \nF (1, 18) = 0.3, p = .86, \u03b72 = .00]. \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n     X    Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (ef fect of assignment to intervention)    \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 229 2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados Yes / Probably yes / Probably No / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No hay suficiente informaci\u00f3n para valorar este domin io No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo en \nque fueron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High  / Some concerns  \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Hubo  un 26% de p\u00e9rdidas. Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  Los motivos de las p\u00e9rdidas no est\u00e1n suficientemente  justificados No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  Los autores justifican que las p\u00e9rdidas son similare s entre los diferentes grupos por lo que \nes posible que no est\u00e9n relacionadas con la interven ci\u00f3n en s\u00ed misma. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the  outcome  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have diffe red \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outc ome have been influenced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  El grupo comparador fue un control activo con protocolo similar al del grupo de \nintervenci\u00f3n, por lo que es probable que las difere ncias no se deban al conocimiento de la \nintervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 5: Risk of bias in selectio n of the reported result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para con trastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably No / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measureme nts (e.g. scales, definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably No / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no parece estar disponible p ara contrastar si la medici\u00f3n se analiz\u00f3 \nde m\u00faltiples maneras. Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgeme nt  Riesgo de sesgo incierto  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  230  \nEstudio: Menezes (2015)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Ansiedad (STAI) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the numeric \nresult (e.g. RR = 1.52 (95% CI 0.83 to 2.77) and/or  a reference (e.g. to a table, figure or paragraph) that uniquely defines the \nresult being assessed. Tabla 1. El grupo de meditaci\u00f3n present\u00f3 una reducci\u00f3n signifi cativamente mayor del rasgo de \nansiedad rasgo entre la prueba previa y posterior [F  (1, 13) = 6.01, p = .02, \u03b72 = .31], en comparaci\u00f3n \ncon el grupo de control [ F (1, 18) = 0.3, p = .86, \u03b72 = .00]. \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of  assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n    X     Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No /  No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people d elivering the interventions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No hay suficiente informaci\u00f3n para valorar este domin io No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have aff ected the \noutcome?  No aplica.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo en \nque fueron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo.  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Hubo un 28.3% de p\u00e9rdidas. Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  Los motivos de las p\u00e9rdidas no est\u00e1n suficientemente  justificados No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4  If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on Los autores justifican que las p\u00e9rdidas en el grupo intervenci\u00f3n est\u00e1n relacionados con las No applicable / Yes / Probably yes / Probably no /   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 231 its true value?  condiciones meteorol\u00f3gicas extremas de la \u00e9poca en la qu e tuvo lugar la intervenci\u00f3n.  No / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  La medida es auto-reportada y la intervenci\u00f3n s\u00f3lo s e compara con un grupo de \u201cno \ntratamiento\u201d, por lo que es probable que los result ados se vean influenciados por el \nconocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo.  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were t he data that produced this result analysed in accor dance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformatio n \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no parece estar disponible p ara contrastar si la medici\u00f3n se analiz\u00f3 \nde m\u00faltiples maneras. Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto.  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n  \nEstudio: Michalsen (2016)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Dolor (VAS); Discapacidad f\u00edsica (RMDQ); Estr\u00e9s percibi do (PSS); Ansiedad y depresi\u00f3n (HADS); Calidad de vi da (SF-36) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being \npresented, specify the numeric result (e.g. RR = 1.52 ( 95% CI 0.83 to 2.77) and/or a reference (e.g. \nto a table, figure or paragraph) that uniquely defi nes the result being assessed. El resultado primario, el dolor en reposo despu\u00e9s d e 8 semanas, se redujo de 59,3 \u00b1 13,9 mm a 40,8 \u00b1 2 1,8 mm con la \nmeditaci\u00f3n frente a 52,9 \u00b1 11,8 mm a 37,3 \u00b1 18,2 mm con el ejercicio (diferencia de grupo ajustada: -1,4 ( IC del 95%: 11,6; \n8,8; p = ns). El estr\u00e9s percibido se redujo significa tivamente m\u00e1s con la meditaci\u00f3n (p = 0,011). No se e ncontraron efectos del \ntratamiento significativos para otros resultados secu ndarios como la calidad de vida y las puntuaciones psi col\u00f3gicas. \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n      X   Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Secuencia aleatoria generada por ordenador.  Yes / Probably yes / Probably No / No / No \ninformation  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  232 1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  Se usaron sobres opacos. Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados Yes / Probably yes / Probably No / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of partici pants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably No / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : We re there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations l ikely to have affected the \noutcome?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Se llev\u00f3 a cabo un an\u00e1lisis por intenci\u00f3n de tratar Yes / Probably yes / Probably No / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Hubo un 23% de p\u00e9rdidas. Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  Los motivos de las p\u00e9rdidas parecen ser independient es a la intervenci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  El grupo comparador fue un control activo con protocolo similar al del grupo de \nintervenci\u00f3n, por lo que es probable que las difere ncias no se deban al conocimiento de la \nintervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo  de sesgo incierto  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio est\u00e1 disponible (DRKS000003 7) Yes / Probably yes / Probably No / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales, def initions, time points) \nwithin the outcome domain?  Se realizaron an\u00e1lisis de comparaciones entre grupos co n los mismos instrumentos Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple e ligible analyses of the data?  Los resultados se analizaron atendiendo al plan de a n\u00e1lisis previo al inicio del estudio Yes / Probably yes / Probably no / No / No   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 233 information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nOverall r isk of bias   \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \n \nEstudio: Milbury (2013)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Funcionamiento cognitivo (FACT-Cog); Fatiga (BFI); De presi\u00f3n (CES-D); Calidad de sue\u00f1o (PSQI); Calidad d e vida (SF-36) \nSpecify the numerical result being assessed. In case of  multiple alternative \nanalyses being presented, specify the numeric result ( e.g. RR = 1.52 (95% CI 0.83 \nto 2.77) and/or a reference (e.g. to a table, figure  or paragraph) that uniquely \ndefines the result being assessed. Prueba de aprendizaje verbal auditivo (p = 0,06), ta rea de memoria a corto plazo y velocidad de procesamien to (p = 0,09), mejora en la funci\u00f3n \ncognitiva (p = 0.06), habilidades cognitivas (p = 0.0 8) (Antes y despu\u00e9s de la intervenci\u00f3n). En comparaci \u00f3n con el grupo de WLC, el grupo de \nTSM revel\u00f3 una mejor memoria verbal (prueba RAVLT 1 : p = 0.06; medias de m\u00ednimos cuadrados: TSM = 0.44 vs.WLC = \u22120.22; efecto medio) \ny una mejor memoria a corto plazo y velocidad de proces amiento (Prueba de s\u00edmbolo de d\u00edgitos: p = 0,09; me dias de m\u00ednimos cuadrados: \nTSM = 0,75 frente a WLC = 0,49; efecto peque\u00f1o). En T2, las mujeres del grupo de meditaci\u00f3n informaron menos s\u00edntomas depresivos (CES-\nD; p = 0.05; medias de m\u00ednimos cuadrados: TSM = 8.2 vs. WLC = 12.6; efecto medio); mejor salud mental (S F-36 MCS: p <0.04; medias de \nm\u00ednimos cuadrados: TSM = 53.3 vs. WLC = 47.2; efecto medio). \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n      X   Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Aleatorizaci\u00f3n adaptativa (m\u00e9todo de minimizaci\u00f3n). Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n Yes / Probably yes / Probably No / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably No / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of a ssignment to \nintervention?  Se llev\u00f3 a cabo un an\u00e1lisis por intenci\u00f3n de tratar Yes / Probably yes / Probably No / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  234 Domain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Funcionamiento cognitivo objetivo: Los datos estuvier on disponible para todos o \npr\u00e1cticamente todos los participantes. Medidas auto-reportadas: Los datos estuvieron dispo nible para todos o pr\u00e1cticamente \ntodos los participantes. Objetiva: Yes / Probably yes / Probably No / No / \nNo Information \nAuto-reportada: Yes / Probably yes / Probably No / \nNo / No Information \n3.2 If N/PN/NI to 3.1: Is there evidence that the r esult was not biased by \nmissing outcome data?  Funcionamiento cognitivo objetivo: No aplica. Medidas auto-reportadas: No aplica Objetiva: No applicable / Yes / Probably yes / \nProbably no / No \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its true  \nvalue?  Funcionamiento cognitivo objetivo: No aplica. Medidas auto-reportadas: No aplica Objetiva: No applicable / Yes / Probably yes / \nProbably no / No \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingne ss in the outcome depended on \nits true value?  Funcionamiento cognitivo objetivo: No aplica. Medidas auto-reportadas: No aplica Auto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No \nRisk-of-bias judgement  Funcionamiento cognitivo objetivo: Bajo riesgo de sesgo  \nMedidas auto-reportadas: Bajo riesgo de sesgo Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  Funcionamiento cognitivo objetivo: El m\u00e9todo para med ir los resultados parece haber sido \nel apropiado Medidas auto-reportadas: El m\u00e9todo para medir los r esultados parece haber sido el \napropiado Objetiva: Yes / Probably yes / Probably No / No / \nNo information \nAuto-reportada: Yes / Probably yes / Probably No / \nNo / No information \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  Funcionamiento cognitivo objetivo: El m\u00e9todo para med ir los resultados parece haber sido \ncomparable en todos los grupos Medidas auto-reportadas:  El m\u00e9todo para medir los resultados parece haber sido \ncomparable en todos los grupos Objetiva: Yes / Probably yes / Probably No / No / \nNo information \nAuto-reportada: Yes / Probably yes / Probably No / \nNo / No information \n4.3 If N/PN/NI to 4.1 and 4.2: Were outcome assesso rs aware of the \nintervention received by study participants?  Funcionamiento cognitivo objetivo: La medida es objet iva (evaluaci\u00f3n neuropsicol\u00f3gica \ncomputarizada). Medidas auto-reportadas: La medida es auto-reportad a y parece poco probable que los \nparticipantes est\u00e9n cegados a la asignaci\u00f3n Objetiva: No applicable / Yes / Probably yes / \nProbably No / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably No / No / No information \n4.4 If Y/PY/NI to 4.3: Could assessment of the outc ome have been influenced \nby knowledge of intervention received?  Funcionamiento cognitivo objetivo: No aplica.  Medidas auto-reportadas: La medida es auto-reportad a, por lo que es posible que los \nresultados se vean influidos por el conocimiento de la intervenci\u00f3n recibida Objetiva: No applicable / Yes / Probably yes / \nProbably No / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably No / No / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  Funcionamiento cognitivo objetivo: No aplica. Medidas auto-reportadas: a medida es auto-reportada  y la intervenci\u00f3n s\u00f3lo se compara \ncon un grupo de \u201cno tratamiento\u201d, por lo que es prob able que los resultados se vean \ninfluenciados por el conocimiento de la intervenci\u00f3n r ecibida Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably No / No / No information \nRisk-of-bias judgement  Funcionamiento cognitivo objetivo: Bajo riesgo de s esgo.  \nMedidas auto-reportadas: Alto riesgo de sesgo. Objetiva: Low /High / Some concerns \nAuto-reportada: Low /High / Some concerns \nDomain 5: Risk of bias in selection  of the reported result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio est\u00e1 disponible (NCT0055621 8) Yes / Probably yes / Probably No / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  Se realizaron an\u00e1lisis de comparaciones entre grupos co n los mismos instrumentos Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  Los resultados se analizaron atendiendo al plan de a n\u00e1lisis previo al inicio del estudio Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nOverall risk of bias   \nRisk-of-bias judgement  Funcionamiento cognitivo objetivo: Riesgo de sesgo incierto  \nMedidas auto-reportadas: Alto riesgo de sesgo Objetiva: Low / High / Some concerns \nAuto-reportada: Low /High / Some concerns \n    \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 235 Estudio: Murphy (1986)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Consumo medio de alcohol \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the \nnumeric result (e.g. RR = 1.52 (95% CI 0.83 to 2.77)  and/or a reference (e.g. to a table, figure or para graph) that \nuniquely defines the result being assessed. Los ANOVA de un factor realizados para cada grupo a lo  largo del tiempo revelaron un decremento \nsignificativo del consumo a lo largo del tiempo tanto  en el grupo de meditaci\u00f3n (F(2,26) = 10.1, p<0.001) , \ncomo los grupos de ejercicio (F(2,24) = 25.1, p<0.001 ) y no tratamiento (F(2,30) = 3.6, p = 0.04. Figuras  1 y \n2.  \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n     X    Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No /  No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to intervention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No hay suficiente informaci\u00f3n para valorar este domin io No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI t o 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo en \nque fueron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Hubo un 28.3% de p\u00e9rdidas en el postratamiento y un  48.3% de p\u00e9rdidas en el \nseguimiento. Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  Los motivos de las p\u00e9rdidas no est\u00e1n suficientemente  justificados No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on Algunos motivos de p\u00e9rdidas no quedan suficientemen te documentadas No applicable / Yes / Probably yes / P robably no /  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  236 its true value?  No / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  El grupo comparador fue un control activo con protocolo similar al del grupo de \nintervenci\u00f3n, por lo que es probable que las difere ncias no se deban al conocimiento de la \nintervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produce d this result analysed in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformatio n \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no parece estar disponible p ara contrastar si la medici\u00f3n se analiz\u00f3 \nde m\u00faltiples maneras. Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n  \nEstudio: Nanthakwang (2020)  \nStudy design  \nx Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Calidad de sue\u00f1o (PSQI); Calidad de vida (PTQL) \nSpecify the numerical result being assessed. In case of  multiple alternative \nanalyses being presented, specify the numeric result ( e.g. RR = 1.52 (95% CI 0.83 \nto 2.77) and/or a reference (e.g. to a table, figure  or paragraph) that uniquely \ndefines the result being assessed. La media de puntuaci\u00f3n en el PSQI del grupo interve nci\u00f3n decreci\u00f3 significativamente (p = 0.001), mientra s que en el grupo control no cambi\u00f3. \nLas medias en Eficacia, calidad percibida y perturbaci\u00f3 n del sue\u00f1o decrecieron significativamente en el grupo  intervenido (p = 0.001, 0.001 y \n0.003). En el control no hubo diferencias en eficien cia y calidad, pero s\u00ed en perturbaci\u00f3n (p = 0.032). La  CdV aument\u00f3 significativamente en el \ngrupo de meditaci\u00f3n (p = 0.001),y permaneci\u00f3 estable en el control (p = 0.79). \n Is the review team\u2019s aim for this result\u2026?  \nx \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n   x     Journal article(s) with results of the trial  \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado. Yes / Probably yes / Probably No / No / No \ninformation   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 237 1.2 Was the allocation sequence concealed until par ticipants were enrolled and \nassigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \nInformation \nRisk -of -bias judgement  Riesgo de sesgo incierto.  Low / High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n. Yes / Probably yes / Probably No / No / No \ninformation \n2.2. Were carers and people delivering the interven tion s aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably No / No / No \ninformation \n2.3. If Y/PY/NI  to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista \ndebidos al contexto experimental No applicable / Yes / Probably yes / Probably No / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the \noutcome?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  No hay suficiente informaci\u00f3n para valorar este domin io. Yes / Probably yes / Probably No / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e result) \nof the failure to analyse participants in the group  to which they were \nrandomized?  No parece que haya habido un impacto sustancial en los resultados debido a la falta \nde an\u00e1lisis de los participantes en el grupo en que  fueron asignados. No applicable / Yes / Probably yes / Probably No / \nNo / No information \nRisk -of -bias judgement  Riesgo de s esgo incierto.  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Los datos estuvieron disponible para todos o pr\u00e1ctica mente todos los participantes \n(menos del 2% de p\u00e9rdidas) Yes / Probably yes / Probably No / No / No \ninformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by missing \noutcome data?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / \n3.3 If N/PN to 3.2: Could missingness in the outcom e depend on its true value?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo.  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably No / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed between \nintervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los \ngrupos Yes / Probably yes / Probably No / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the intervention \nreceived by study participants?  El evaluador estuvo cegado a la condici\u00f3n del partici pante No applicable / Yes / Probably yes / Probably No / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced by \nknowledge of intervention received?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4 : Is it likely that assessment of the outcome was i nfluenced \nby knowledge of intervention received?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgem ent  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los \nan\u00e1lisis previstos. Yes / Probably yes / Probably No / No / No \ninformation \nIs the numerical result being assessed likely to ha ve bee n selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las \nmedidas y los puntos temporal fueron acordes con lo pl aneado Yes / Probably yes / Probably No / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los Yes / Probably yes / Probably No / No / No  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  238 tipos de an\u00e1lisis que utilizaron fueron acordes con lo  planeado information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n  \nEstudio: Nidich (2009a)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of bias:  Calidad de vida (FACT-B); Calidad de vida (SF-36); Mortalidad \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the numeric \nresult (e.g. RR = 1.52 (95% CI 0.83 to 2.77) and/or  a reference (e.g. to a table, figure or paragraph) that uniquely defines \nthe result being assessed. Para la puntuaci\u00f3n total de FACT-B, el ANCOVA de me didas repetidas indic\u00f3 una mejora significativa \ndurante el per\u00edodo de intervenci\u00f3n en el grupo de M editaci\u00f3n Trascendental en comparaci\u00f3n con los \ncontroles (p = 0,037). \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol \u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n     X    Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling q uestions  Comments  Response options  \n1.1 Was the allocation sequence random?  Secuencia de aleatorizaci\u00f3n generada por ordenador. Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enroll ed \nand assigned to interventions?  El estad\u00edstico ocult\u00f3 la asignaci\u00f3n hasta que los par ticipantes completaron las pruebas \nde l\u00ednea base y cumplieron con los criterios de elegibi lidad. Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline  differences between intervention groups suggest a p roblem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Bajo riesgo de s esgo  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n. En las  primeras sesiones se explican las \nventajas de la meditaci\u00f3n. Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n. En las  primeras sesiones se explican las \nventajas de la meditaci\u00f3n. Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropri ate analysis used to estimate the effect of assignm ent to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on the \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo en \nque fueron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data    \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 239 3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Auto-reportada: Hubo un 21% de p\u00e9rdidas. Objetiva: No se ofrece suficiente informaci\u00f3n para v alorar si los datos de la medida de \nresultado est\u00e1n disponibles para todos o casi todos los participantes aleatorizados Auto-reportada: Yes / Probably yes / Probably No / \nNo / No Information \nObjetiva: Yes / Probably yes / Probably No / No / \nNo Information \n3.2 If N/PN/NI to 3.1: Is there evidence that the r esult was not biased by \nmissing outcome data?  Auto-reportada: Es posible que el resultado estuvie se sesgado porque no se utiliz\u00f3 ning\u00fan \nm\u00e9todo de an\u00e1lisis para corregir el sesgo Objetiva: Es posible que el resultado estuviese ses gado porque no se utiliz\u00f3 ning\u00fan \nm\u00e9todo de an\u00e1lisis para corregir el sesgo Auto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No \nObjetiva: No applicable / Yes / Probably yes / \nProbably no / No \n3.3 If N/PN to 3.2: Could missingness in the outcom e depend on its true \nvalue?  Auto-reportada: Los motivos de las p\u00e9rdidas no est\u00e1 n suficientemente justificados \nObjetiva: Los motivos de las p\u00e9rdidas no est\u00e1n sufic ientemente justificados Auto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nObjetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \n3.4 If Y/PY/NI to 3.3: Is it likely that missingnes s in the outcome depended on \nits true value?  Auto-reportada: Algunos motivos de p\u00e9rdidas no qued an suficientemente documentadas \nObjetiva: Algunos motivos de p\u00e9rdidas no quedan suf icientemente documentadas Auto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nObjetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nRisk-of-bias judgement  Auto -reportada: Alto rie sgo de sesgo  \nObjetiva: Alto riesgo de sesgo Auto-reportada: Low / High / Some concerns \nObjetiva: Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  Auto-reportada: El m\u00e9todo para medir los resultados  parece haber sido el apropiado \nObjetiva: El m\u00e9todo para medir los resultados parece  haber sido el apropiado Auto-reportada: Yes / Probably yes / Probably no / \nNo / No information \nObjetiva: Yes / Probably yes / Probably no / No / \nNo information \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  Auto-reportada: El m\u00e9todo para medir los resultados  parece haber sido comparable en \ntodos los grupos Objetiva: El m\u00e9todo para medir los resultados parece  haber sido comparable en todos los \ngrupos Auto-reportada: Yes / Probably yes / Probably no / \nNo / No information \nObjetiva: Yes / Probably yes / Probably no / No / \nNo information \n4.3 If N/PN/NI to 4.1 and 4.2: Were outcome assesso rs aware of the \nintervention received by study participants?  Auto-reportada: La medida es auto-reportada y parece poco probable que los participantes \nest\u00e9n cegados a la asignaci\u00f3n Objetiva: El evaluador estuvo cegado a la condici\u00f3n d el participante Auto-reportada: Yes / Probably yes / Probably no / \nNo / No information \nObjetiva: Yes / Probably yes / Probably no / No / \nNo information \n4.4 If Y/PY/NI to 4.3: Could assessment of the outc ome have been influenced \nby knowledge of intervention received?  Auto-reportada: La medida es auto-reportada, por lo  que es posible que los resultados se \nvean influidos por el conocimiento de la intervenci\u00f3n recibida \nObjetiva: No aplica Auto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nObjetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  Auto-reportada: La medida es auto-reportada y la int ervenci\u00f3n s\u00f3lo se compara con un \ngrupo de \u201cinformaci\u00f3n\u201d, por lo que es probable que los resultados se vean influenciados por \nel conocimiento de la intervenci\u00f3n recibida. Objetiva:  No aplica Auto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nObjetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nRisk-of-bias judgement  Auto -reportada: Alto riesgo de sesgo  \nObjetiva: Bajo riesgo de sesgo Auto-reportada: Low / High / Some concerns \nObjetiva: Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos de \nan\u00e1lisis que utilizaron fueron acordes con lo planeado  Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  240   \nEstudio: Nidich (2009b)  \nStudy desi gn  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Presi\u00f3n sangu\u00ednea; Estado de \u00e1nimo (POMS) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the \nnumeric result (e.g. RR = 1.52 (95% CI 0.83 to 2.77)  and/or a reference (e.g. to a table, figure or para graph) that \nuniquely defines the result being assessed. Los cambios en la PA sist\u00f3lica / diast\u00f3lica para la mu estra total fueron -2,0 / -1,2 mmHg para el grupo T M en \ncomparaci\u00f3n con + 0,4 / + 0,5 mmHg para los controles ( P = 0,15, P = 0,15, respectivamente). Se \nencontraron mejoras significativas en la angustia psi col\u00f3gica total, la ansiedad, la depresi\u00f3n, la ira / \nhostilidad y el afrontamiento (valores de p <0,05). \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effec t)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n     X    Journal article(s) with results of the tri al \nDom ain 1: Risk of bias arising from the randomization p rocess  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Usaron el m\u00e9todo de bloques aleatorios Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the a llocation sequence concealed until participants wer e enrolled \nand assigned to interventions?  La asignaci\u00f3n se mantuvo  en secreto por el estad\u00edsti co del grupo . Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between int ervention groups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No hay suficiente informaci\u00f3n para valorar este domin io No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo en \nque fueron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 3: Missing outcom e data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Presi\u00f3n sangu\u00ednea: Hubo un 30.6% de p\u00e9rdidas. POMS: Hubo un 30.6% de p\u00e9rdidas. Objetiva: Yes / Probably yes / Probably No / No / \nNo Information \nAuto-reportada: Yes / Probably yes / Probably No / \nNo / No Information \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by Presi\u00f3n sangu\u00ednea: Es posible que el resultado estu viese sesgado porque no se utiliz\u00f3 Objetiva: No applica ble / Yes / Probably yes /   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 241 missing outcome data?  ning\u00fan m\u00e9todo de an\u00e1lisis para corregir el sesgo POMS: Es posible que el resultado estuviese sesgado  porque no se utiliz\u00f3 ning\u00fan m\u00e9todo \nde an\u00e1lisis para corregir el sesgo Probably no / No \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No \n3.3 If N/PN to 3.2: Could missingness in the outcom e depend on its true \nvalue?  Presi\u00f3n sangu\u00ednea: Los motivos de las p\u00e9rdidas no e st\u00e1n suficientemente justificados \nPOMS: Los motivos de las p\u00e9rdidas no est\u00e1n suficien temente justificados Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \n3.4 If Y/PY/NI to 3.3: Is it likely that missingnes s in the outcome depended on \nits true value?  Presi\u00f3n sangu\u00ednea: Analizan las posibles variables q ue explican las diferencias entre los \nparticipantes que completan y los que abandonan. POMS: Analizan las posibles variables que explican la s diferencias entre los participantes \nque completan y los que abandonan. \n Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nRisk-of-bias judgement  Presi\u00f3n sangu\u00ednea: Riesgo de se sgo incierto.  \nPOMS: Riesgo de sesgo incierto. Objetiva: Low / High / Some concerns \nAuto-reportada: Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  Presi\u00f3n sangu\u00ednea: El m\u00e9todo para medir los resulta dos parece haber sido el apropiado \nPOMS: El m\u00e9todo para medir los resultados parece hab er sido el apropiado Objetiva: Yes / Probably yes / Probably no / No / \nNo information \nAuto-reportada: Yes / Probably yes / Probably no / \nNo / No information \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  Presi\u00f3n sangu\u00ednea: El m\u00e9todo para medir los resulta dos parece haber sido comparable en \ntodos los grupos POMS: El m\u00e9todo para medir los resultados parece hab er sido comparable en todos los \ngrupos Objetiva: Yes / Probably yes / Probably no / No / \nNo information \nAuto-reportada: Yes / Probably yes / Probably no / \nNo / No information \n4.3 If N/PN/NI to 4.1 and 4.2: Were outcome assesso rs aware of the \nintervention received by study participants?  Presi\u00f3n sangu\u00ednea: El evaluador estuvo cegado a la co ndici\u00f3n del participante \nPOMS: La medida es auto-reportada y parece poco probab le que los participantes est\u00e9n \ncegados a la asignaci\u00f3n Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \n4.4 If Y/PY/NI to 4.3: Could assessment of the outc ome have been influenced \nby knowledge of intervention received?  Presi\u00f3n sangu\u00ednea: No aplica.  POMS: La medida es auto-reportada, por lo que es po sible que los resultados se vean \ninfluidos por el conocimiento de la intervenci\u00f3n recibi da Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  Presi\u00f3n sangu\u00ednea: No aplica.  POMS: La medida es auto-reportada y la intervenci\u00f3n s \u00f3lo se compara con un grupo de \n\u201cno tratamiento\u201d, por lo que es probable que los re sultados se vean influenciados por el \nconocimiento de la intervenci\u00f3n recibida Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nRisk-of-bias judgement  Presi\u00f3n sangu\u00ednea: Bajo riesgo de sesgo  \nPOMS: Alto riesgo de sesgo. Objetiva: Low /High / Some concerns \nAuto-reportada: Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on th e \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformatio n \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no parece estar disponible p ara contrastar si la medici\u00f3n se analiz\u00f3 \nde m\u00faltiples maneras. Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto.  Low / High / Some concerns \nOverall risk of bias   \nRisk-of-bias judgement  Presi\u00f3n sangu\u00ednea: Alto riesgo de sesgo  \nPOMS: Alto riesgo de sesgo. Objetiva: Low / High / Some concerns \nAuto-reportada: Low / High / Some concerns \n \nEstudio: Nidich (2016)  \n  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  242 Study design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Sintomatolog\u00eda TETP (TSC-40 subescalas depresi\u00f3n, an siedad, problemas de sue\u00f1o); Estr\u00e9s percibido (PSS) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses \nbeing presented, specify the numeric result (e.g. RR = 1.52 (95% CI 0.83 to 2.77) \nand/or a reference (e.g. to a table, figure or parag raph) that uniquely defines the \nresult being assessed. Se encontraron reducciones significativas en los s\u00edntom as de trauma, ansiedad, depresi\u00f3ny subescalas de alte raci\u00f3n del sue\u00f1o y estr\u00e9s \npercibido en el grupo de meditaci\u00f3n en comparaci\u00f3n con el grupo control (todos los valores de p <0,001). El  an\u00e1lisis de subgrupos de alto \ntrauma mostr\u00f3 adem\u00e1s una mayor magnitud de efectos en  el grupo de meditaci\u00f3n en comparaci\u00f3n con los control es en todos los resultados, \ncon tama\u00f1os de efecto de Cohen que van desde 0,67 a 0 ,89. \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -tr eat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n   X    Journal article(s) with results of the trial  \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgeme nt  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Se comenta que es un estudio doble-ciego (pacientes e investigadores) Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these dev iations likely to have affected the \noutcome?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations from intended intervention \nbalanced between groups? No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No parece que haya habido un impacto sustancial en los resultados debido a la falta de \nan\u00e1lisis de los participantes en el grupo en que fu eron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 3: Missing outco me data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Hubo un 20% de p\u00e9rdidas totales Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not bias ed by \nmissing outcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depe nd on its true \nvalue?  Los motivos de las p\u00e9rdidas parecen ser independient es a la intervenci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 243 Risk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  La medida es auto-reportada y la intervenci\u00f3n s\u00f3lo s e compara con un grupo de \u201cno \ntratamiento\u201d, por lo que es probable que los result ados se vean influenciados por el \nconocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the d ata that produced this result analysed in accordanc e with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time point s) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos de \nan\u00e1lisis que utilizaron fueron acordes con lo planeado  Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo  incierto de sesgo  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n \nEstudio: Nidich (2017)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Sintomatolog\u00eda TETP (PCL-C) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the \nnumeric result (e.g. RR = 1.52 (95% CI 0.83 to 2.77)  and/or a reference (e.g. to a table, figure or para graph) that \nuniquely defines the result being assessed. Se encontraron reducciones significativas en los s\u00edntom as de trauma totales en el grupo de meditaci\u00f3n en \ncomparaci\u00f3n con el grupo control (F1,17 = 5.18, p <0.03 6), as\u00ed como en los pensamientos intrusivos (F1,17 \n= 5.96, p <0.026) e hiperactivaci\u00f3n (F1,17 = 4.76 , p <0.043) en el PCL-C. \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n   X    Journal article(s) with results of the trial  \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  244 with the randomization process?   information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Se comenta que es un estudio doble-ciego (pacientes e investigadores) Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware o f participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 o r 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations likely to have affected the  \noutcome?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations from int ended intervention \nbalanced between groups? No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No parece que haya habido un impacto sustancial en los resultados debido a la falta de \nan\u00e1lisis de los participantes en el grupo en que fu eron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Los datos estuvieron disponible para todos o pr\u00e1ctica mente todos los participantes (9% de \np\u00e9rdidas Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.3  If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  La medida es auto-reportada y la intervenci\u00f3n s\u00f3lo s e compara con un grupo de \u201cno \ntratamiento\u201d, por lo que es probable que los result ados se vean influenciados por el \nconocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analysed in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos de \nan\u00e1lisis que utilizaron fueron acordes con lo planeado  Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo incierto  de sesgo  Low / High / Some concerns   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 245 Overall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n \nEstudio: Nidich (2018)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Sintomatolog\u00eda TEPT (CAPS; PCL-M); Depresi\u00f3n (PHQ-9 ) ; Calidad de vida (Q-LES-Q); Estado de \u00e1nimo (POM S) \nSpecify the numerical result being assessed. In case of  multiple alternative \nanalyses being presented, specify the numeric result ( e.g. RR = 1.52 (95% CI 0.83 \nto 2.77) and/or a reference (e.g. to a table, figure  or paragraph) that uniquely \ndefines the result being assessed. La puntuaci\u00f3n del grupo de meditaci\u00f3n no fue signifi cativamente inferior a la terapia de exposici\u00f3n prolo ngada en el cambio en la puntuaci\u00f3n \nCAPS desde el inicio hasta los 3 meses posteriores a la prueba (diferencia entre los grupos en el cambi o medio -5 \u00b7 9, IC del 95%: \u201314 \u00b7 3 a 2 \n\u00b7 4, p = 0 \u00b7 0002). En las comparaciones de superiori dad est\u00e1ndar, se encontraron reducciones significativas  en los puntajes CAPS para el \ngrupo de meditaci\u00f3n versus educaci\u00f3n para la salud (\u20131 4 \u00b7 6 IC del 95%, \u201323 \u00b7 3 a \u20135 \u00b7 9, p = 0 \u00b7 0009), y la terapia de exposici\u00f3n prolongada \nversus la salud educaci\u00f3n (\u20138 \u00b7 7 IC 95%, \u201317 \u00b7 0 a \u2013 0 \u00b7 32, p = 0 \u00b7 041). Los an\u00e1lisis entre grupos en el Q-LES (calidad de vida) mostraron \ncambios generales en la calidad de vida en la direcci\u00f3 n esperada para el grupo de meditaci\u00f3n versus la ed ucaci\u00f3n para la salud (d = 0 \u00b7 45, p \n= 0 \u00b7 014) y la terapia de exposici\u00f3n prolongada vers us la educaci\u00f3n para la salud [d = 0 \u00b7 27, p = 0 \u00b7 12 ). \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n   X    Journal article(s) with results of the trial  \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people deliv ering the interventions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations likely to have affected the  \noutcome?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations from intended intervention \nbalanced between groups? No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Se llev\u00f3 a cabo un an\u00e1lisis por intenci\u00f3n de tratar Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r ne arly all, participants Auto-reportadas: Hubo un 18% de p\u00e9rdidas Auto-reportada: Yes / Probably yes / Probably No /  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  246 randomized?  Hetero-reportada: Hubo un 18% de p\u00e9rdidas No / No Information \nHetero-reportada: Yes / Probably yes / Probably No \n/ No / No Information \n3.2 If N/PN/NI to 3.1: Is there evidence that the r esult was not biased by \nmissing outcome data?  Auto-reportada: Es posible que el resultado estuvie se sesgado porque no se utiliz\u00f3 ning\u00fan \nm\u00e9todo de an\u00e1lisis para corregir el sesgo Hetero-reportada: Es posible que el resultado estuv iese sesgado porque no se utiliz\u00f3 \nning\u00fan m\u00e9todo de an\u00e1lisis para corregir el sesgo Auto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No \nHetero-reportada: No applicable / Yes / Probably \nyes / Probably no / No \n3.3 If N/PN to 3.2: Could missingness in the outcom e depend on its true \nvalue?  Auto-reportada: Los motivos de las p\u00e9rdidas parecen ser independientes a la intervenci\u00f3n \nHetero-reportada: Los motivos de las p\u00e9rdidas parece n ser independientes a la \nintervenci\u00f3n Auto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nHetero-reportada: No applicable / Yes / Probably \nyes / Probably no / No / No information \n3.4 If Y/PY/NI to 3.3: Is it likely that missingnes s in the outcome depended on \nits true value?  Auto-reportada: No aplica Hetero-reportada: No aplica Auto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nHetero-reportada: No applicable / Yes / Probably \nyes / Probably no / No / No information \nRisk-of-bias judgement  Auto -reportada: Riesgo de sesgo incierto  \nHetero-reportada: Riesgo de sesgo incierto Auto-reportada: Low / High / Some concerns \nHetero-reportada: Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  Auto-reportada: El m\u00e9todo para medir los resultados  parece haber sido el apropiado \nHetero-reportada: El m\u00e9todo para medir los resultad os parece haber sido el apropiado Auto-reportada: Yes / Probably yes / Probably no / \nNo / No information \nHetero-reportada: Yes / Probably yes / Probably no \n/ No / No information \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  Auto-reportada: El m\u00e9todo para medir los resultados  parece haber sido comparable en \ntodos los grupos Hetero-reportada: El m\u00e9todo para medir los resultad os parece haber sido comparable en \ntodos los grupos Auto-reportada: Yes / Probably yes / Probably no / \nNo / No information \nHetero-reportada: Yes / Probably yes / Probably no \n/ No / No information \n4.3 If N/PN/NI to 4.1 and 4.2: Were outcome assesso rs aware of the \nintervention received by study participants?  Auto-reportada: La medida es auto-reportada y parece poco probable que los participantes \nest\u00e9n cegados a la asignaci\u00f3n Hetero-reportada: El evaluador estuvo cegado a la con dici\u00f3n del participante Auto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nHetero-reportada: No applicable / Yes / Probably \nyes / Probably no / No / No information \n4.4 If Y/PY/NI to 4.3: Could assessment of the outc ome have been influenced \nby knowledge of intervention received?  Auto-reportada: La medida es auto-reportada, por lo  que es posible que los resultados se \nvean influidos por el conocimiento de la intervenci\u00f3n recibida \nHetero-reportada: No aplica Auto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nHetero-reportada: No applicable / Yes / Probably \nyes / Probably no / No / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  Auto-reportada: El grupo comparador fue un control ac tivo con protocolo similar al del \ngrupo de intervenci\u00f3n, por lo que es probable que l as diferencias no se deban al \nconocimiento de la intervenci\u00f3n recibida Hetero-reportada: No aplica Auto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nHetero-reportada: No applicable / Yes / Probably \nyes / Probably no / No / No information \nRisk-of-bias judgement  Auto -reportada: Riesgo de sesgo incierto  \nHetero-reportada: Bajo riesgo de sesgo Auto-reportada: Low / High / Some concerns \nHetero-reportada: Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were  the data that produced this result analysed in acco rdance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time  points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos de \nan\u00e1lisis que utilizaron fueron acordes con lo planeado  Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \nOverall risk of bias   \nRisk-of-bias judgement  Auto -reportada: Alto riesgo de sesgo  \nHetero-reportada: Alto riesgo de sesgo Auto-reportada: Low / High / Some concerns \nHetero-reportada: Low / High / Some concerns   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 247 Estudio: Oman (2006)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Estr\u00e9s percibido (CPS); Salud mental (MOS); Burnout (MBI) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the \nnumeric result (e.g. RR = 1.52 (95% CI 0.83 to 2.77)  and/or a reference (e.g. to a table, figure or para graph) that \nuniquely defines the result being assessed. Se observaron efectos beneficiosos del tratamiento s obre el estr\u00e9s ( p .0013) y la salud mental ( p 0.0 3). Los \nefectos del tratamiento sobre el estr\u00e9s estuvieron mediados por la adherencia a las pr\u00e1cticas (p 0.05). L a \nreducci\u00f3n del estr\u00e9s se mantuvo a las 19 semanas (84% de la desviaci\u00f3n est\u00e1ndar previa, p 0.006). (Tabla 2) \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intent ion -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n        X Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  El m\u00e9todo de secuencia aleatoria utilizado fueron n\u00fame ros generados por ordenador. Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?    La secuencia de la asignaci\u00f3n estuvo oculta hasta el proceso de asignaci\u00f3n a la \nintervenci\u00f3n.  Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base. Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Una vez asignados a la condici\u00f3n, y tras haber reali zado la medida pre-test, se inform\u00f3 a \nlos participantes a la condici\u00f3n que fueron asignado s. Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers a nd people delivering the interventions aware of par ticipants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n. Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Se llev\u00f3 a cabo un an\u00e1lisis por intenci\u00f3n de tratar.  Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No aplica    No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome ava ilable for all, or nearly all, participants \nrandomized?  Las p\u00e9rdidas fueron inferiores al 5% (4.9%) en ambo s grupos. Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?   No aplica No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  248 Risk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bia s in measurement of the outcome  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o los apropiado. Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outcome have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos. Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aw are of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados \na la asignaci\u00f3n. Yes / Probably yes / Probably no / No / No \ninformation \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influenced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  La medida es auto-reportada y la intervenci\u00f3n s\u00f3lo s e compara con un grupo de \u201cno \ntratamiento\u201d, por lo que es probable que los result ados se vean influenciados por el \nconocimiento de la intervenci\u00f3n recibida. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... mu ltiple outcome measurements (e.g. scales, definitio ns, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado. Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos de \nan\u00e1lisis que utilizaron fueron acordes con lo planeado . Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n \nEstudio: Ottens (1975)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Consumo de cigarrillos \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy \nthe numeric result (e.g. RR = 1.52 (95% CI 0.83 to 2.77) and/or a reference (e.g. to a table, figure or  \nparagraph) that uniquely defines the result being as sessed. Se llev\u00f3 a cabo un an\u00e1lisis de la varianza sobre el co nsumo semanal de cigarros tras diez semanas de inter venci\u00f3n \ny se encontr\u00f3 un efecto significativo del grupo de inte rvenci\u00f3n (p<0.01). Asimismo, la interacci\u00f3n intervenci\u00f3 n x \ntiempo result\u00f3 significativa (p<0.01) lo que sugiere  que la tendencia en el consumo de cigarros a lo larg o del tiempo \nfue significativamente diferente en los tres grupos.  Tablas 3, 4, 5 y 6. \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018 intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n     X    Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 249 1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRis k-of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  A los participantes de cada grupo se les explica que e l objetivo del estudio es evaluar el \nefecto de la intervenci\u00f3n que reciben sobre el consum o de tabaco. Se les hace saber qu\u00e9 \nt\u00e9cnica van a recibir.  Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e e ffect of assignment to \nintervention?  Los an\u00e1lisis se realizaron con todos los participante s elegibles despu\u00e9s de la aleatorizaci\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact ( on the \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  No se reportan p\u00e9rdidas. Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the re sult was not biased by \nmissing outcome data?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / no information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado. Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Cou ld measurement or ascertainment of the outcome have  differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and  4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n4.4 If Y/P Y/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada por lo que es posible q ue los resultados se vean \ninfluenciados por el conocimiento de la intervenci\u00f3n r ecibida. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  El grupo comparador fue un control activo con protocolo similar al del grupo de \nintervenci\u00f3n, por lo que es probable que las difere ncias no se deban al conocimiento de la \nintervenci\u00f3n recibida. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos de Yes / Probably yes / Probably no / No / No  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  250 an\u00e1lisis que utilizaron fueron acordes con lo planeado  information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n \nEstudio: Parker (1978)  \nSt udy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Ansiedad (STAI); Presi\u00f3n sangu\u00ednea \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the numeric result (e.g. \nRR = 1.52 (95% CI 0.83 to 2.77) and/or a reference ( e.g. to a table, figure or paragraph) that uniquely  defines the result being \nassessed. No se observaron diferencias entre los grupos en re laci\u00f3n a la medida de ansiedad (STAI). \nTras la intervenci\u00f3n, la reducci\u00f3n de la presi\u00f3n sangu \u00ednea sist\u00f3lica fue significativamente \nsuperior en el grupo de meditaci\u00f3n frente al grupo d e relajaci\u00f3n muscular progresiva \n(p<0.01) y el grupo control (p<0.01). Tablas 1 y 2. \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to in tervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n     X    Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the random ization process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Utilizan una tabla de n\u00fameros aleatorios. Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ti cipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No se comparan las caracter\u00edsticas en l\u00ednea base entre los grupos Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the in tended interventions (effect of assignment to interv ention) \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n  Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  No hay suficiente informaci\u00f3n para valorar este domin io Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there po tential for a substantial impact (on the \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo en \nque fueron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data \n3.1 Were data for this outcome available for all, or ne arly all, participants \nrandomized?  Presi\u00f3n sangu\u00ednea: No se ofrece suficiente informaci \u00f3n para valorar si los datos de la \nmedida de resultado est\u00e1n disponibles para todos o casi todos los participantes Objetiva: Yes / Probably yes / Probably No / No / \nNo Information   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 251 aleatorizados Ansiedad: Presi\u00f3n sangu\u00ednea: No se ofrece suficiente  informaci\u00f3n para valorar si los datos \nde la medida de resultado est\u00e1n disponibles para to dos o casi todos los participantes \naleatorizados Auto-reportada: Yes / Probably yes / Probably No / \nNo / No Information \n3.2 If N/PN/NI to 3.1: Is there evidence that the r esult was not biased by \nmissing outcome data?  Presi\u00f3n sangu\u00ednea: Es posible que el resultado estu viese sesgado porque no se utiliz\u00f3 \nning\u00fan m\u00e9todo de an\u00e1lisis para corregir el sesgo Ansiedad: Es posible que el resultado estuviese ses gado porque no se utiliz\u00f3 ning\u00fan \nm\u00e9todo de an\u00e1lisis para corregir el sesgo Objetiva: No applicable / Yes / Probably yes / \nProbably no / No \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No \n3.3 If N/PN to 3.2: Could missingness in the outcom e depend on its true \nvalue?  Presi\u00f3n sangu\u00ednea: No se ofrece suficiente informaci \u00f3n acerca de las p\u00e9rdidas y sus \nmotivos  Ansiedad: No se ofrece suficiente informaci\u00f3n acerca de  las p\u00e9rdidas y sus motivos Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \n3.4 If Y/PY/NI to 3.3: Is it likely that missingnes s in the outcome depended on \nits true value?  Presi\u00f3n sangu\u00ednea: Algunos motivos de p\u00e9rdidas no q uedan suficientemente \ndocumentadas Ansiedad:  Algunos motivos de p\u00e9rdidas no quedan su ficientemente documentadas Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nRisk-of-bias judgement  Presi\u00f3n sangu\u00ednea: Alto riesgo de sesgo  \nAnsiedad: Alto riesgo de sesgo Objetiva: Low / High / Some concerns \nAuto-reportada: Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcome \n4.1 Was the method of measuring the outcome inappro priate?  Presi\u00f3n sangu\u00ednea: El m\u00e9todo para medir los resulta dos parece haber sido el apropiado \nAnsiedad: El m\u00e9todo para medir los resultados parece  haber sido el apropiado Objetiva: Yes / Probably yes / Probably no / No / \nNo information \nAuto-reportada: Yes / Probably yes / Probably no / \nNo / No information \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  Presi\u00f3n sangu\u00ednea: El m\u00e9todo para medir los resulta dos parece haber sido comparable en \ntodos los grupos Ansiedad: El m\u00e9todo para medir los resultados parece  haber sido comparable en todos los \ngrupos Objetiva: Yes / Probably yes / Probably no / No / No information \nAuto-reportada: Yes / Probably yes / Probably no / \nNo / No information \n4.3 If N/PN/NI to 4.1 and 4.2: Were outcome assesso rs aware of the \nintervention received by study participants?  Presi\u00f3n sangu\u00ednea: No se informa sobre el cegamiento  de los evaluadores \nAnsiedad: La medida es auto-reportada y parece poco pr obable que los participantes est\u00e9n \ncegados a la asignaci\u00f3n Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \n4.4 If Y/PY/NI to 4.3: Could assessment of the outc ome have been influenced \nby knowledge of intervention received?  Presi\u00f3n sangu\u00ednea: La medida es objetiva y parece poco  probable que los \nparticipantes/evaluador pueda influir en los resulta dos \nAnsiedad: La medida es auto-reportada, por lo que e s posible que los resultados se vean \ninfluidos por el conocimiento de la intervenci\u00f3n recibi da Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  Presi\u00f3n sangu\u00ednea: No aplica.   Ansiedad: El grupo comparador fue un control activo co n protocolo similar al del grupo de \nintervenci\u00f3n, por lo que es probable que las difere ncias no se deban al conocimiento de la \nintervenci\u00f3n recibida  \nObjetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nRisk-of-bias judgement  Presi\u00f3n sangu\u00ednea: Bajo riesgo de sesgo  \nAnsiedad: Riesgo de sesgo incierto Objetiva: Low / High / Some concerns \nAuto-reportada: Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported r esult \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result bein g assessed likely to have been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos de \nan\u00e1lisis que utilizaron fueron acordes con lo planeado  Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nOverall risk of bias   \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  252 Risk-of-bias judgement  Presi\u00f3 n sangu\u00ednea: Alto riesgo de sesgo  \nAnsiedad: Alto riesgo de sesgo Objetiva: Low / High / Some concerns \nAuto-reportada: Low / High / Some concerns \n  \nEstudio: Paul -Labrador (2006)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Presi\u00f3n sangu\u00ednea  \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the \nnumeric result (e.g. RR = 1.52 (95% CI 0.83 to 2.77)  and/or a reference (e.g. to a table, figure or para graph) that \nuniquely defines the result being assessed. El grupo de meditaci\u00f3n obtuvo mejoras en la presi\u00f3n  arterial sist\u00f3lica ajustada (\u22123,4 \u00b1 2,0 frente a 2, 8 \u00b1 2,1 mm \nHg; p = 0,04), resistencia a la insulina ( \u22120,75 \u00b1 2,04 frente a 0,52 \u00b1 2,84; p = 0,01) y vari abilidad de la frecuencia \ncard\u00edaca (0,10 \u00b1 0,17 vs -0,50 \u00b1 0,17; p = 0,07) en co mparaci\u00f3n con el grupo de educaci\u00f3n sanitaria. \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n     X    Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Generaci\u00f3n de una secuencia aleatoria en bloques por m edio de un programa de \nordenador. Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to intervention )  \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No hay suficiente informaci\u00f3n para valorar este domin io No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignm ent to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo en \nque fueron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, pa rticipants \nrandomized?  Hubo un 18.5% de p\u00e9rdidas. Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo No applicable / Yes / Probably yes / Probably no / \nNo   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 253 3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  Los motivos de las p\u00e9rdidas no est\u00e1n suficientemente  justificados No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  Algunos motivos de p\u00e9rdidas no quedan suficientemen te documentadas No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  El evaluador estuvo cegado a la condici\u00f3n del partici pante  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4 : Is it likely that assessment of the outcome was i nfluenced \nby knowledge of intervention received?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo rie sgo de sesgo  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformatio n \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no parece estar disponible p ara contrastar si la medici\u00f3n se analiz\u00f3 \nde m\u00faltiples maneras. Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n  \nEstudio: Puryear (1976)  \n \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Ansiedad (IPAT) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being \npresented, specify the numeric result (e.g. RR = 1.52 ( 95% CI 0.83 to 2.77) and/or a reference (e.g. \nto a table, figure or paragraph) that uniquely defi nes the result being assessed. Se utiliz\u00f3 el an\u00e1lisis de la varianza (medidas repeti das) para comparar las medias de los grupos de las p untuaciones de las \nescalas obtenidas por dos instrumentos, la Escala de Ansiedad IPAT (formulario de autoan\u00e1lisis de autoan \u00e1lisis) y la Lista de \ncomprobaci\u00f3n de problemas de Mooney. A diferencia del  grupo de control, el grupo de tratamiento inform\u00f3 d e una una \nreducci\u00f3n altamente significativa en las puntuaciones d e la Escala de Ansiedad IPAT despu\u00e9s de 28 d\u00edas de m editar con el \nnuevo enfoque, pero no se encontraron diferencias sig nificativas en las variables de la lista de comprobaci \u00f3n, tanto en el \ngrupo de tratamiento como en el de control. \nIs the review team\u2019s aim for this result\u2026?  \nX to assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n       X  Journal article(s) with results of the tri al  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  254 Domain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado. Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?   No se informa de si la secuencia de asignaci\u00f3n se man tuvo oculta. Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base. Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bi as judgement  Riesgo incierto de sesgo  Low /High / Some concerns  \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial? No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados. Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participant s' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n. Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations like ly to have affected the \noutcome?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  No hay suficiente informaci\u00f3n para valorar este domin io. Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo en \nque fueron asignados. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  No se ofrece suficiente informaci\u00f3n para valorar si los datos de la medida de resultado \nest\u00e1n disponibles para todos o casi todos los partici pantes aleatorizados. Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo. No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  Los motivos de las p\u00e9rdidas no est\u00e1n suficientemente  justificados. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No existe informaci\u00f3n para evaluar este dominio. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low  / High  / Some concerns  \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate? El m\u00e9todo para medir los resultados parece haber sid o el apropiado. Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos. Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n. Yes / Probably yes / Probably no  / No / No \ninformation \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  La medida es auto-reportada y la intervenci\u00f3n s\u00f3lo s e compara con un grupo de \u201cno \ntratamiento\u201d, por lo que es probable que los result ados se vean influenciados por el \nconocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produce d this result analysed in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos Yes / Probably yes / Probably no / No / No \ninformation   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 255 Is the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado\u201d Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos de \nan\u00e1lisis que utilizaron fueron acordes con lo planeado \u201d Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo incierto de s esgo  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n \nEstudio: Raskin (1980)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Ansiedad (TMAS; CMCL); Calidad del sue\u00f1o (registro diario) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being \npresented, specify the numeric result (e.g. RR = 1.52 ( 95% CI 0.83 to 2.77) and/or a \nreference (e.g. to a table, figure or paragraph) tha t uniquely defines the result being \nassessed. Treinta y un sujetos completaron la primera parte del  estudio y se les ha hecho un seguimiento de tres a 1 8 meses. El cuarenta por \nciento de los sujetos tuvo una disminuci\u00f3n cl\u00ednicamen te significativa disminuci\u00f3n de su ansiedad. No hubo  diferencias entre los \ntratamientos con respecto a la eficacia del tratamient o, el inicio de la de los s\u00edntomas o el mantenimien to de los logros terap\u00e9uticos.  \nNo se encontraron pruebas que sugirieran que el grado  de relajaci\u00f3n muscular inducido por cualquiera de los tratamientos est\u00e9 \nrelacionado con el resultado terap\u00e9utico (tabla 2) \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n        X Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado. Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?    No se informa si la secuencia de aleatorizaci\u00f3n se ma ntuvo oculta. Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  Hay diferencias significativas entre los grupos en l\u00ed nea base. Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (eff ect of assignment to intervention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n. Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropria te analysis used to estimate the effect of assignme nt to \nintervention?  No hay suficiente informaci\u00f3n para valorar este domin io. Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on the No parece que haya habido un impacto sustancial en los resultados debido a la falta de No applicable / Yes / Probably yes / Probably no /  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  256 result) of the failure to analyse participants in t he group to which they were \nrandomized?  an\u00e1lisis de los participantes en el grupo en que fu eron asignados No / No information \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Las p\u00e9rdidas fueron superiores al 5% (10% de p\u00e9rdid as). Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo. No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  Los motivos de las p\u00e9rdidas no est\u00e1n suficientemente  justificados No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  Algunos motivos de p\u00e9rdidas no quedan suficientemen te documentadas No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High  / Some concerns  \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado. \n Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n. Yes / Probably yes / Probably no / No / No \ninformation \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  El grupo comparador fue un control activo con protocolo similar al del grupo de \nintervenci\u00f3n, por lo que es probable que las difere ncias no se deban al conocimiento de la \nintervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in  accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado. Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos de \nan\u00e1lisis que utilizaron fueron acordes con lo planeado  Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n \nEstudio: Rees (2013)  \n \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched)  trial \n \nSpecify which outcome is being assessed for risk of  bias:  Sintomatolog\u00eda TEPT (PCL-C) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, \nspecify the numeric result (e.g. RR = 1.52 (95% CI 0. 83 to 2.77) and/or a reference (e.g. to a table, \nfigure or paragraph) that uniquely defines the resu lt being assessed. Las puntuaciones del PCL-C (Lista de comprobaci\u00f3n del  trastorno de estr\u00e9s postraum\u00e1tico-civil) en el grupo  de control \ntendieron a aumentar. Por el contrario, las puntuacio nes de la PCL-C en el grupo de Meditaci\u00f3n Transcenden tal pasaron \nde una media de 65 en la l\u00ednea de base, que indicaba  s\u00edntomas graves de TEP, a una media inferior a 30 despu\u00e9s de 30 \nd\u00edas de pr\u00e1ctica de Meditaci\u00f3n Trascendental, y se mant uvieron bajas a los 135 d\u00edas. El tama\u00f1o del efecto f ue alto (p >   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 257 1,0). (Tabla 1) \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to  assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n        X Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomization process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  El m\u00e9todo de secuencia aleatoria utilizado fue un n\u00fame ros generados por ordenador. Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?    La secuencia de la asignaci\u00f3n se rompi\u00f3 durante el p roceso de reclutamiento y \nasignaci\u00f3n. Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base. Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High  / Some concerns  \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n. Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Los profesionales que administraron las pruebas y re cogieron los datos eran ciegos \na la pertenencia del grupo. Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : W ere there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista \ndebidos al contexto experimental. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the \noutcome?  No aplica  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Se llev\u00f3 a cabo un an\u00e1lisis por intenci\u00f3n de tratar.  Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No aplica     No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Parece que no hubo p\u00e9rdidas durante el per\u00edodo del e studio. Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome de pended on \nits true value?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado. Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos. Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2: Were outcome assesso rs aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por No applicable / Yes / Probably yes / Probably no /  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  258 by knowledge of inte rvention received?  el conocimiento de la intervenci\u00f3n recibida. No / No information  \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  La medida es auto-reportada y la intervenci\u00f3n s\u00f3lo s e compara con un grupo de \u201cno \ntratamiento\u201d, por lo que es probable que los result ados se vean influenciados por el \nconocimiento de la intervenci\u00f3n recibida. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analysed in  accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions,  time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos de \nan\u00e1lisis que utilizaron fueron acordes con lo planeado  Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judge ment  Riesgo incierto de sesgo  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n \nEstudios: Schneider (1995); Alexander (1996)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Presi\u00f3n sangu\u00ednea \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the numeric result \n(e.g. RR = 1.52 (95% CI 0.83 to 2.77) and/or a refe rence (e.g. to a table, figure or paragraph) that u niquely defines the result \nbeing assessed. En el grupo de meditaci\u00f3n se observaron reducciones significativamente superiores en la presi\u00f3n \nsangu\u00ednea sist\u00f3lica (p=0.02) y diast\u00f3lica (p=0.03) en  comparaci\u00f3n con el grupo de relajaci\u00f3n \nmuscular progresiva. Tabla 2.  Cambios en presi\u00f3n sa ngu\u00ednea. \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess  the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n     X    Journal article(s) with results of the tri al         \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Despu\u00e9s de completar la l\u00ednea de base, los sujetos f ueron asignados al azar a uno de los \ngrupos de tratamiento de acuerdo con un modelo de asi gnaci\u00f3n de n\u00fameros  \nadaptativos. Yes / Probably yes / Probably No / No / No information \n1.2 Was the allocation sequence concealed until par t icipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns  \nDomain 2: Risk of bias due t o deviations from the intended interventions (effec t of assignment to intervention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 259 2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No hay suficiente informaci\u00f3n para valorar este domin io No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis  used to estimate the effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantia l impact (on the \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo en \nque fueron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High  / Some concerns  \nDomain 3: Missing outcome data  \n3.1 Were data for this outco me available for all, or nearly all, participants \nrandomized?  Hubo un 12.6% de p\u00e9rdidas. Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  Los motivos de las p\u00e9rdidas parecen ser independient es a la intervenci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  El evaluador estuvo cegado a la condici\u00f3n del partici pante.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4 : Is it likely that assessment of the outcome was i nfluenced \nby knowledge of intervention received?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de s esgo  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no parece estar disponible p ara contrastar si la medici\u00f3n se analiz\u00f3 \nde m\u00faltiples maneras. Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n  \nEstudio: Schneider (2005)  \nStudy des ign  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  260  Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Presi\u00f3n sangu\u00ednea  \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy \nthe numeric result (e.g. RR = 1.52 (95% CI 0.83 to 2.77) and/or a reference (e.g. to a table, figure or  paragraph) \nthat uniquely defines the result being assessed. El grupo de meditaci\u00f3n mostr\u00f3 reducciones en la pres i\u00f3n arterial sist\u00f3lica / diast\u00f3lica en comparaci\u00f3n con l a \nrelajaci\u00f3n progresiva o educaci\u00f3n para la salud (p =  0,12 a 0,17 para la presi\u00f3n arterial sist\u00f3lica, p =  .01 para \npresi\u00f3n arterial diast\u00f3lica). \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n     X    Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Generaci\u00f3n de una secuencia aleatoria por medio de un programa de ordenador. Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concern s \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect o f assignment to intervention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No hay suficiente informaci\u00f3n para valorar este domin io No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5  If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Se llev\u00f3 a cabo un an\u00e1lisis por intenci\u00f3n de tratar Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all , or nearly all, participants \nrandomized?  Hubo un 23.8% de p\u00e9rdidas. Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  Los motivos de las p\u00e9rdidas no est\u00e1n suficientemente  justificados No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No existe informaci\u00f3n suficiente que permita valorar  los motivos de abandono, pero las \ntasas de p\u00e9rdidas son equivalentes en los diferente s grupos.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 4: Risk of bia s in measurement of the outcome  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 261 information \n4.2 Could measurement or ascertainment of  the outcome have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware  of the \nintervention received by study participants?  El evaluador estuvo cegado a la condici\u00f3n del partici pante No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4 : Is it likely that assessment of the outcome was i nfluenced \nby knowledge of intervention received?  No aplica.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analy sed in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no parece estar disponible p ara contrastar si la medici\u00f3n se analiz\u00f3 \nde m\u00faltiples maneras. Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nOverall risk of bia s  \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n  \nEstudio: Schneider (2012)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Presi\u00f3n sangu\u00ednea, Depresi\u00f3n (CES-D), Mortalidad, I nfarto de miocardio, Hospitalizaci\u00f3n, Revascularizaci\u00f3n \ncoronaria \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the \nnumeric result (e.g. RR = 1.52 (95% CI 0.83 to 2.77)  and/or a reference (e.g. to a table, figure or para graph) that \nuniquely defines the result being assessed. El grupo de meditaci\u00f3n mostr\u00f3 reducciones  en la pre si\u00f3n arterial sist\u00f3lica / diast\u00f3lica en comparaci\u00f3n con la \nrelajaci\u00f3n progresiva o educaci\u00f3n para la salud (p =  0,12 a 0,17 para la presi\u00f3n arterial sist\u00f3lica, p =  .01 para \npresi\u00f3n arterial diast\u00f3lica). \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n     X    Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Generaci\u00f3n de una secuencia aleatoria por medio de un dise\u00f1o de bloques. Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  La secuencia se mantuvo en secreto por parte del bioes tad\u00edstico del grupo.  Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)   \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  262 2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interventions awar e of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No hay suficiente informaci\u00f3n para valorar este domin io No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations  likely to have affected the \noutcome?  No aplica.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Se llev\u00f3 a cabo un an\u00e1lisis por intenci\u00f3n de tratar Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Medidas objetivas: Hubo un 23% de p\u00e9rdidas. Depresi\u00f3n: Hubo un 23% de p\u00e9rdidas. Objetiva: Yes / Probably yes / Probably No / No / \nNo Information \nAuto-reportada: Yes / Probably yes / Probably No / \nNo / No Information \n3.2 If N/PN/NI to 3.1: Is there evidence that the r esult was not biased by \nmissing outcome data?  Medidas objetivas: Es posible que el resultado estu viese sesgado porque no se utiliz\u00f3 \nning\u00fan m\u00e9todo de an\u00e1lisis para corregir el sesgo Depresi\u00f3n: Es posible que el resultado estuviese se sgado porque no se utiliz\u00f3 ning\u00fan \nm\u00e9todo de an\u00e1lisis para corregir el sesgo Objetiva: No applicable / Yes / Probably yes / \nProbably no / No \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No \n3.3 If N/PN to 3.2: Could missingness in the outcom e depend on its true \nvalue?  Medidas objetivas: Los motivos de las p\u00e9rdidas no e st\u00e1n suficientemente justificados \n Depresi\u00f3n: : Los motivos de las p\u00e9rdidas no est\u00e1n s uficientemente justificados Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \n3.4 If Y/PY/NI to 3.3: Is it likely that missingnes s in the outcome depended on \nits true value?  Medidas objetivas: Las p\u00e9rdidas son similares entre  los diferentes grupos, por lo que es \nposible que no est\u00e9n relacionadas con la intervenci\u00f3n  en s\u00ed misma pese a que no est\u00e9n \nsuficientemente documentadas Depresi\u00f3n: Las p\u00e9rdidas son similares entre los dif erentes grupos, por lo que es posible \nque no est\u00e9n relacionadas con la intervenci\u00f3n en s\u00ed mi sma pese a que no est\u00e9n \nsuficientemente documentadas Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nRisk-of-bias judgement  Medidas objetivas: riesgo de sesgo incierto  \nDepresi\u00f3n: riesgo de sesgo incierto Objetiva: Low / High / Some concerns \nAuto-reportada: Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  Medidas objetivas: El m\u00e9todo para medir los resulta dos parece haber sido el apropiado \nDepresi\u00f3n: El m\u00e9todo para medir los resultados pare ce haber sido el apropiado Objetiva: Yes / Probably yes / Probably no / No / \nNo information \nAuto-reportada: Yes / Probably yes / Probably no / \nNo / No information \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  Medidas objetivas: El m\u00e9todo para medir los resulta dos parece haber sido comparable en \ntodos los grupos Depresi\u00f3n: El m\u00e9todo para medir los resultados pare ce haber sido comparable en todos los \ngrupos Objetiva: Yes / Probably yes / Probably no / No / \nNo information \nAuto-reportada: Yes / Probably yes / Probably no / \nNo / No information \n4.3 If N/PN/NI to 4.1 and 4.2: Were outcome assesso rs aware of the \nintervention received by study participants?  Medidas objetivas: El evaluador estuvo cegado a la co ndici\u00f3n del participante \nDepresi\u00f3n: La medida es auto-reportada y parece poco p robable que los participantes \nest\u00e9n cegados a la asignaci\u00f3n Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \n4.4 If Y/PY/NI to 4.3: Could assessment of the outc ome have been influenced \nby knowledge of intervention received?  Medidas objetivas: No aplica.  Depresi\u00f3n: La medida es auto-reportada, por lo que es posible que los resultados se vean \ninfluidos por el conocimiento de la intervenci\u00f3n recibi da Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 263 4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  Medidas objetivas: No aplica. Depresi\u00f3n: El grupo comparador fue un control activo c on protocolo similar al del grupo de \nintervenci\u00f3n, por lo que es probable que las difere ncias no se deban al conocimiento de la \nintervenci\u00f3n recibida  Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nRisk-of-bias judgement  Medidas objetivas: Bajo riesgo de sesgo  \nDepresi\u00f3n: Riesgo de sesgo incierto Objetiva: Low / High / Some concerns \nAuto-reportada: Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no parece estar disponible p ara contrastar si la medici\u00f3n se analiz\u00f3 \nde m\u00faltiples maneras. Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nOverall risk of bias   \nRisk-of-bias judgement  Medidas ob jetivas: Alto riesgo de sesgo  \nDepresi\u00f3n: Alto riesgo de sesgo Objetiva: Low / High / Some concerns \nAuto-reportada: Low / High / Some concerns \n  \nEstudio: Seer (1980)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Presi\u00f3n sangu\u00ednea \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being \npresented, specify the numeric result (e.g. RR = 1.52 ( 95% CI 0.83 to 2.77) and/or a reference (e.g. \nto a table, figure or paragraph) that uniquely defi nes the result being assessed. Los resultados mostraron modestas reducciones de la p resi\u00f3n arterial en los grupos SRELAX y NSRELAX, en co mparaci\u00f3n \ncon los controles sin tratamiento, con reducciones porce ntuales diast\u00f3licas que alcanzaron la significaci\u00f3n (p < 0.05). Hubo \nuna considerable variaci\u00f3n en la respuesta de los su jetos, con un descenso medio general de la presi\u00f3n ar terial diast\u00f3lica de \ncon un descenso medio de la presi\u00f3n arterial diast\u00f3li ca del 8-10% a los 3 meses de seguimiento. (Tabla 1) . \nIs the review team\u2019s aim for this result\u2026?  \nX to assess the effect of assignment to intervention  (the \u2018intention -to -treat \u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n        X Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado. Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?    No se informa si la secuencia de aleatorizaci\u00f3n se ma ntuvo oculta. Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base. Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias jud gement  Riesgo incierto de sesgo  Low / High  / Some concerns  \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los part icipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados. Yes / Probably yes / Probably no / No / No \ninformation  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  264 2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  El psic\u00f3logo con formaci\u00f3n m\u00e9dica era ciego a las condi ciones experimentales y el \nexperimentador que explic\u00f3 los resultados de la pres i\u00f3n sangu\u00ednea a los sujetos no \nconoc\u00eda los resultados de las sesiones de evaluaci\u00f3n.  Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate the effect of assignment to \nintervention?  Los an\u00e1lisis no se realizaron con todos los participa ntes elegibles despu\u00e9s de la \naleatorizaci\u00f3n. Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial  impact (on the \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  Es posible que haya habido un impacto sustancial en lo s resultados debido a la falta de \nan\u00e1lisis de los participantes en el grupo al que fu eron asignados. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participa nts \nrandomized?  Hubo un 12% de p\u00e9rdidas Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo. No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  Algunos motivos de p\u00e9rdidas no quedan suficientemen te documentados. \n No applicable / Yes / Probably yes / Probably no / \n No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  Algunos motivos de p\u00e9rdidas no quedan suficientemen te documentadas. No applicable / Yes / Probably yes / Probably no /  \nNo information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado. Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos. Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2: Were outcome assesso rs aware of the \nintervention received by study participants?  El experimentador estuvo ciego al conocimiento de los  resultados, aunque la medida es \nobjetiva (presi\u00f3n sangu\u00ednea), parece poco probable qu e el experimentador pueda influir en \nlos resultados. Yes / Probably yes / Probably no / No / No \ninformation \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influe nced \nby knowledge of intervention received?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4 : Is it likely that assessment of the outcome was i nfluenced \nby knowledge of intervention received?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sego  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d  in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado. Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos de \nan\u00e1lisis que utilizaron fueron acordes con lo planeado . Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n     \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 265 Estudio: Sever tsen (1986)  \nStudy design  \nx Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Estr\u00e9s percibido (HRSRS; SUSLT) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, \nspecify the numeric result (e.g. RR = 1.52 (95% CI 0. 83 to 2.77) and/or a reference (e.g. to a table, \nfigure or paragraph) that uniquely defines the resu lt being assessed. La proporci\u00f3n de ondas alfa aument\u00f3 en ambas interve nciones (de 17,6+/- 17 a 19,8 \u00b1 3,2 en el grupo de m editaci\u00f3n y de \n23,6 \u00b1 3,4 a 25,6 \u00b1 2,1 en el grupo de aerobic).  En  la Holmes-Rahe Social Readjustment scale la media pr e intervenci\u00f3n \nfue 310,4 (rango 237-415) en el grupo de meditaci\u00f3n  y 686,2 (171-1896) y post 261 (203-317) y 531,2 (360- 635). La media \nen el Stanford University Stress Level Test bajaron de 7,4 a 6,8 en el grupo de meditaci\u00f3n y de 10,4 a 8  en el grupos de \naer\u00f3bic. Los resultados no fueron estad\u00edsticamente s ignificativos \nIs the review team\u2019s aim for this result\u2026?  \nx to assess the effec t of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n       x     Journal article(s) with results of the t rial \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado.  Yes / Probably yes / Probably No / No / No \ninformation  \n1.2 Was the allocation sequence concealed until par ticipants were enrolled and \nassigned to interventions?   No se informa si la secuencia de aleatorizaci\u00f3n se ma ntuvo oculta. Yes / Probably yes / Probably No / No / No \ninformation  \nProbably No  \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?   Hay diferencias significativas entre los grupos en l\u00ed nea base. Yes / Probably yes / Probably No / No / No \ninformation  \nProbably No  \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignado Yes / Probably yes / Probably No / No / No \ninformation \n2.2. W ere carers and people delivering the interventions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no pudieron \nestar cegados a su condici\u00f3n Yes / Probably yes / Probably No / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista \ndebidos al contexto experimental No applicable / Yes / Probably yes / Probably No / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignmen t to \nintervention?  No hay suficiente informaci\u00f3n para valorar este domin io. Yes / Probably yes / Probably No / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e result) \nof the failure to analyse participants in the group  to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo al \nque fueron asignados. No applicable / Yes / Probably yes / Probably No / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?   Los datos estuvieron disponible para todos los par ticipantes (0% de p\u00e9rdidas) Yes / Probably yes / Probably No / No / No \ninformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by missing \noutcome data?   No aplica No applicable / Yes / Probably yes / Probably no / \nNo /  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  266 3.3 If N/PN to 3.2: Could missingness in the outcom e depend on its true value?   No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness  in the outcome depended on \nits true value?   No aplica  No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement   Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?   El m\u00e9todo para medir los resultados parece haber si do el apropiado. Yes / Probably yes / Probably No / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?   El m\u00e9todo para medir los resultados parece haber si do comparable en todos los grupos. Yes / Probably yes / Probably No / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the intervention \nreceived by study participants?   No se informa sobre el cegamiento de los evaluadore s. No applicable / Yes / Probably yes / Probably No / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos \npor el conocimiento de la intervenci\u00f3n recibida. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  El grupo comparador fue un control activo con protocolo similar al del grupo de \nintervenci\u00f3n, por lo que es probable que las difere ncias no se deban al conocimiento de la \nintervenci\u00f3n recibida. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that prod uced this result analysed in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los \nan\u00e1lisis previstos. Yes / Probably yes / Probably No / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las \nmedidas y los puntos temporal fueron acordes con lo pl aneado Yes / Probably yes / Probably No / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los \ntipos de an\u00e1lisis que utilizaron fueron acordes con lo  planeado Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement     Riesgo incierto  de sesgo  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo  Low / High / Some concerns \n  \nEstudio: Shahar (2014)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Depresi\u00f3n, ansiedad y estr\u00e9s (DASS-21) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the \nnumeric result (e.g. RR = 1.52 (95% CI 0.83 to 2.77)  and/or a reference (e.g. to a table, figure or para graph) that \nuniquely defines the result being assessed. Los efectos univariados pretratamiento-postratamient o, informados en la Tabla 2, indicaron que las \npuntuaciones del grupo de intervenci\u00f3n disminuyeron s ignificativamente la depresi\u00f3n (p<0.05) en \ncomparaci\u00f3n con la condici\u00f3n del grupo control  en la es cala DASS-21. \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of  assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n   X    Journal article(s) with results of the trial  \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options    \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 267 1.1 Was the allocation sequence random?  La secuencia de aleatorizaci\u00f3n fue realizada con un prog rama de ordenador Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people del ivering the interventions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations likely to have affected the  \noutcome?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2. 4: Were these deviations from intended intervention \nbalanced between groups? No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Se llev\u00f3 a cabo un an\u00e1lisis por intenci\u00f3n de tratar Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Hubo un 16% de p\u00e9rdidas Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  Se analizaron los resultados por intenci\u00f3n de tratar y por protocolo, por lo que \nposiblemente los resultados no estuvieran sesgados No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?   La medida es auto-reportada y la intervenci\u00f3n s\u00f3lo se compara con un grupo de \u201cno \ntratamiento\u201d, por lo que es probable que los result ados se vean influenciados por el \nconocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of-bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely  to have been selected, on the \nbasis of the results, from...     \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  268 5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos de \nan\u00e1lisis que utilizaron fueron acordes con lo planeado  Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n  \nEstudio: Sheppard (1997)  \n \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being asse ssed for risk of bias:  Ansiedad (STAI), Depresi\u00f3n (IPAT), Presi\u00f3n sangu\u00edne a \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the numeric result (e.g. \nRR = 1.52 (95% CI 0.83 to 2.77) and/or a reference ( e.g. to a table, figure or paragraph) that uniquely  defines the result being \nassessed. Tras tres meses de intervenci\u00f3n las medidas de ansi edad-rasgo (p<0.025) y depresi\u00f3n \n(p<0.05) fueron significativamente menores en el gru po de meditaci\u00f3n que en el grupo \ncontrol. Las diferencias en el resto de medidas no f ueron significativas. En el seguimiento a \nlos 3 a\u00f1os se observaron diferencias significativas fa vorables al grupo de meditaci\u00f3n en \nestado de ansiedad (p<0.025), rasgo de ansiedad (p< 0.05) y depresi\u00f3n (p<0.01). Tabla 1: \nANCOVA. \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n     X    Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Respo nse options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enroll ed \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the in tended interventions (effect of assignment to interv ention) \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 269 2.7 If N/PN/NI to 2.6:  Was  there potential for a substantial impact (on the \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo en \nque fueron asignados. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Presi\u00f3n sangu\u00ednea: Hubo un 27.3% de p\u00e9rdidas. Medidas auto-reportadas: Hubo un 27.3% de p\u00e9rdidas.  Objetiva: Yes / Probably yes / Probably No / No / \nNo Information \nAuto-reportada: Yes / Probably yes / Probably No / \nNo / No Information \n3.2 If N/PN/NI to 3.1: Is there evidence that the r esult was not biased by \nmissing outcome data?  Presi\u00f3n sangu\u00ednea: Es posible que el resultado estu viese sesgado porque no se utiliz\u00f3 \nning\u00fan m\u00e9todo de an\u00e1lisis para corregir el sesgo Medidas auto-reportadas: Es posible que el resultad o estuviese sesgado porque no se \nutiliz\u00f3 ning\u00fan m\u00e9todo de an\u00e1lisis para corregir el se sgo Objetiva: No applicable / Yes / Probably yes / \nProbably no / No \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No \n3.3 If N/PN to 3.2: Could missingness in the outcom e depend on its true \nvalue?  Presi\u00f3n sangu\u00ednea: Los motivos de las p\u00e9rdidas pare cen ser independientes a la \nintervenci\u00f3n: 8 dejaron la empresa y 4 alegan falta de tiempo. \n Medidas auto-reportadas: Los motivos de las p\u00e9rdida s parecen ser independientes a la \nintervenci\u00f3n: 8 dejaron la empresa y 4 alegan falta de tiempo. Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \n3.4 If Y/PY/NI to 3.3: Is it likely that missingnes s in the outcome depended on \nits true value?  Presi\u00f3n sangu\u00ednea: No aplica. Medidas auto-reportadas: No aplica.  Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nRisk-of-bias judgement  Presi\u00f3n sangu\u00ednea: Bajo riesgo de sesgo  \nMedidas auto-reportadas: Bajo riesgo de sesgo Objetiva: Low / High / Some concerns \nAuto-reportada: Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcome \n4.1 Was the method of measuring the outcome inappro priate?  Presi\u00f3n sangu\u00ednea: El m\u00e9todo para medir los resulta dos parece haber sido el apropiado \nMedidas auto-reportadas: El m\u00e9todo para medir los r esultados parece haber sido el \napropiado Objetiva: Yes / Probably yes / Probably no / No / \nNo information \nAuto-reportada: Yes / Probably yes / Probably no / \nNo / No information \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  Presi\u00f3n sangu\u00ednea: El m\u00e9todo para medir los resulta dos parece haber sido comparable en \ntodos los grupos Medidas auto-reportadas: El m\u00e9todo para medir los r esultados parece haber sido \ncomparable en todos los grupos Objetiva: Yes / Probably yes / Probably no / No / \nNo information \nAuto-reportada: Yes / Probably yes / Probably no / \nNo / No information \n4.3 If N/PN/NI to 4.1 and 4.2: Were outcome assesso rs aware of the \nintervention received by study participants?  Presi\u00f3n sangu\u00ednea: El evaluador estuvo cegado a la co ndici\u00f3n del participante \nMedidas auto-reportadas: La medida es auto-reportad a y parece poco probable que los \nparticipantes est\u00e9n cegados a la asignaci\u00f3n Objetiva: Yes / Probably yes / Probably no / No / \nNo information \nAuto-reportada: Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3: Could assessment of the outc ome have been influenced \nby knowledge of intervention received?  Presi\u00f3n sangu\u00ednea: No aplica.   Medidas auto-reportadas: La medida es auto-reportad a, por lo que es posible que los \nresultados se vean influidos por el conocimiento de la intervenci\u00f3n recibida Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  Presi\u00f3n sangu\u00ednea: No aplica.  Medidas auto-reportadas: El grupo comparador fue un control activo con protocolo similar \nal del grupo de intervenci\u00f3n, por lo que es probable  que las diferencias no se deban al \nconocimiento de la intervenci\u00f3n recibida Objetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nRisk-of-bias judgement  Presi\u00f3n sangu\u00ednea: Bajo riesgo de sesgo.  \nMedidas auto-reportadas: Riesgo de sesgo incierto. Objetiva: Low / High / Some concerns \nAuto-reportada: Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported r esult \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical re sult being assessed likely to have been selected, o n the \nbasis of the results, from...     \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  270 5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no parece estar disponible p ara contrastar si la medici\u00f3n se analiz\u00f3 \nde m\u00faltiples maneras. Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto.  Low / High / Some concerns \nOverall risk of bias  \nRisk-of-bias judgement  Presi\u00f3n sangu\u00ednea: Alto ries go de sesgo.  \nMedidas auto-reportadas: Alto riesgo de sesgo. Objetiva: Low / High / Some concerns \nAuto-reportada: Low / High / Some concerns \n \nEstudio: So (2001a)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Ansiedad (STAI) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the numeric result \n(e.g. RR = 1.52 (95% CI 0.83 to 2.77) and/or a refe rence (e.g. to a table, figure or paragraph) that u niquely defines the result \nbeing assessed. En comparaci\u00f3n con la siesta y la no intervenci\u00f3n, el g rupo de meditaci\u00f3n mostr\u00f3 una reducci\u00f3n \nsignificativa en ansiedad rasgo (p<0.001) y ansiedad estado (p<0.001). Tabla 1. Experimento 1: \nresumen de ANCOVA univariante en las puntuaciones pr e y post sobre el STAI. \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignme nt to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n     X    Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n, pero no se describe  el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No se comparan las caracter\u00edsticas en l\u00ednea base entre los grupos Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering t he interventions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/N I to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo en \nque fueron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 271 Domain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Hubo un 9.6% de p\u00e9rdidas. Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  Los motivos de las p\u00e9rdidas no est\u00e1n suficientemente  justificados No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No existe informaci\u00f3n suficiente que permita valorar  los motivos de abandono, pero las \ntasas de p\u00e9rdidas son equivalentes en los diferente s grupos.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  La medida es auto-reportada y la intervenci\u00f3n se comp ara con un grupo de \u201cno \ntratamiento\u201d, sin embargo, se les dice a los partici pantes que la evaluaci\u00f3n forma parte del \nprograma de evaluaci\u00f3n habitual del colegio y no sab\u00ed an que ten\u00eda como objetivo medir el \nefecto de la meditaci\u00f3n.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably No / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably No / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no parece estar disponible p ara contrastar si la medici\u00f3n se analiz\u00f3 \nde m\u00faltiples maneras. Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n \nEstudio: So (2001b ) \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Ansiedad (STAI) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy \nthe numeric result (e.g. RR = 1.52 (95% CI 0.83 to 2.77) and/or a reference (e.g. to a table, figure or  paragraph) \nthat uniquely defines the result being assessed. En comparaci\u00f3n con la meditaci\u00f3n contemplativa, el grup o de meditaci\u00f3n trascendental mostr\u00f3 una reducci\u00f3n \nsignificativa en ansiedad rasgo (p=0.002) y ansiedad estado (p<0.001). En comparaci\u00f3n con el grupo control, en \nel grupo de meditaci\u00f3n trascendental se observ\u00f3 una r educci\u00f3n significativa del estado de ansiedad (p=0.01 6). \nTabla 3. Experimento 1: resumen de ANCOVA univarian te en las puntuaciones pre y post sobre el STAI. \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)   \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  272  to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n     X    Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No se comparan las caracter\u00edsticas en l\u00ednea base entre los grupos Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of  participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or  2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these devi ations likely to have affected the \noutcome?  No aplica.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo en \nque fueron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Hubo un 9.3% de p\u00e9rdidas. Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  Los motivos de las p\u00e9rdidas no est\u00e1n suficientemente  justificados No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No existe informaci\u00f3n suficiente que permita valorar  los motivos de abandono, pero las \ntasas de p\u00e9rdidas son equivalentes en los diferente s grupos.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  La medida es auto-reportada pero se les dice a los p articipantes que la evaluaci\u00f3n forma \nparte del programa de evaluaci\u00f3n habitual del colegio  y no sab\u00edan que ten\u00eda como objetivo \nmedir el efecto de la meditaci\u00f3n. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 273 Domain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analysed in acco rdance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably No / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time  points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably No / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no parece estar disponible p ara contrastar si la medici\u00f3n se analiz\u00f3 \nde m\u00faltiples maneras. Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n \nEstudio: So (2001c)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Ansiedad (STAI) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the numeric \nresult (e.g. RR = 1.52 (95% CI 0.83 to 2.77) and/or  a reference (e.g. to a table, figure or paragraph) that uniquely defines the \nresult being assessed. En comparaci\u00f3n con la no intervenci\u00f3n, el grupo de med itaci\u00f3n trascendental mostr\u00f3 una reducci\u00f3n \nsignificativa en ansiedad rasgo (p<0.001) y ansiedad estado (p<0.001). Tabla 4. Experimento 1: \nresumen de ANCOVA univariante en las puntuaciones pr e y post sobre el STAI. \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the  \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n     X    Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No se comparan las caracter\u00edsticas en l\u00ednea base entre los grupos Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware o f participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 o r 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these dev iations likely to have affected the \noutcome?  No aplica.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to Los an\u00e1lisis se realizaron con todos los participante s elegibles despu\u00e9s de la aleatorizaci\u00f3n Yes / Probably yes / Probably no / No / No  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  274 intervention?  information \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo en \nque fueron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Los datos estuvieron disponible para todos o pr\u00e1ctica mente todos los participantes Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  La medida es auto-reportada pero se les dice a los p articipantes que la evaluaci\u00f3n forma \nparte del programa de evaluaci\u00f3n habitual del colegio  y no sab\u00edan que ten\u00eda como objetivo \nmedir el efecto de la meditaci\u00f3n. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analysed in accordance wi th a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably No / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably No / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no parece estar disponible p ara contrastar si la medici\u00f3n se analiz\u00f3 \nde m\u00faltiples maneras. Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n  \nEstudio: Travis (2018)  \nStudy design  \nx Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Estado de \u00e1nimo (POMS) subescalas ansiedad y depresi\u00f3 n \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the numeric result \n(e.g. RR = 1.52 (95% CI 0.83 to 2.77) and/or a refe rence (e.g. to a table, figure or paragraph) that u niquely defines the result El MANCOVA mostr\u00f3 un efecto significativo de la MT so bre el POMS en comparaci\u00f3n con el \ncontrol (Wilks lambda= .725 (F(7, 72)=3.9, p = .001).    \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 275 being assessed. \n Is the review team\u2019s aim for this result\u2026?  \nx \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -pr otocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n   x    Journal article(s) with results of the trial \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalli ng questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado.  Yes / Probably yes / Probably No / No / No \ninformation  \n1.2 Was the allocation sequence concealed until par ticipants were enrolled and \nassigned to interventions?   No se informa si la secuencia de aleatorizaci\u00f3n se ma ntuvo oculta. Yes / Probably yes / Probably No / No / No \ninformation  \nProbably No  \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?   No parece haber diferencias aparentes entre los gru pos en l\u00ednea base. Yes / Probably yes / Probably No / No / No \ninformation  \nProbably No  \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados. Yes / Probably yes / Probably No / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n. Yes / Probably yes / Probably No / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista \ndebidos al contexto experimental No applicable / Yes / Probably yes / Probably No / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio. Yes / Probably yes / Probably No / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e result) \nof the failure to analyse participants in the group  to which they were \nrandomized?  Es posible que haya habido un impacto sustancial en lo s resultados debido a la falta de \nan\u00e1lisis de los participantes en el grupo al que fu eron asignados. No applicable / Yes / Probably yes / Probably No / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 3:  Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Hubo un porcentaje de p\u00e9rdidas de 8% para cuestionari o sobre el perfil del estado de \n\u00e1nimo.    Yes / Probably yes / Probably No / No / No information \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by missing \noutcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo. No applicable / Yes / Probably yes / Probably no / \nNo / \n3.3 If N/PN to 3.2: Could missingness in the outcom e depend on its true value?  Los motivos de las p\u00e9rdidas parecen ser independient es a la intervenci\u00f3n. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y /PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on its \ntrue value?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk  of bias in measurement of the outcome  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado.  \nYes / Probably yes / Probably No / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed between \nintervention groups?   El m\u00e9todo para medir los resultados parece haber si do el apropiado  \nYes / Probably yes / Probably No / No / No \ninformation  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  276 4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the  intervention \nreceived by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados \na la asignaci\u00f3n. Yes / Probably yes / Probably no / No / No \ninformation \n4.4 If Y/PY/NI to 4.3 : Could assessment of the out come have been influenced by \nknowledge of intervention received?  No aplica  No applicable / Yes / Probably yes / Probably no / \nNo / No information  \n4.5 If Y/PY/NI to 4.4 : Is it likely that assessment of the outcome was i nfluenced \nby knowledge of intervention received?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produc ed this result analysed in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los \nan\u00e1lisis previstos. Yes / Probably yes / Probably No / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las \nmedidas y los puntos temporal fueron acordes con lo pl aneado Yes / Probably yes / Probably No / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los \ntipos de an\u00e1lisis que utilizaron fueron acordes con lo  planeado Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement     Riesgo incierto d e sesgo  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \n  \nEstudio: Tuab (1994)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Consumo de alcohol auto-reportado (SHQ); Estado de \u00e1 nimo (POMS)  \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the numeric result \n(e.g. RR = 1.52 (95% CI 0.83 to 2.77) and/or a refe rence (e.g. to a table, figure or paragraph) that u niquely defines the result \nbeing assessed. En el seguimiento a los 6, 12 y 18 meses, los grupo s de meditaci\u00f3n trascendental y biofeedback \nmostraron un n\u00famero considerablemente mayor de d\u00edas s in consumo que los grupos de \nneuroterapia y tratamiento habitual. El porcentaje de  personas completamente abstinentes en los \ngrupos de meditaci\u00f3n trascendental y biofeedback fue 1. 5-2.5 veces mayor que en los grupos de \nneuroterapia y tratamiento habitual, con un mayor efect o a los 18 meses. Tablas 1, 2 y 3.  \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n     X    Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No se comparan las caracter\u00edsticas en l\u00ednea base entre los grupos Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during th e trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del Yes / Probably yes / Probably no / No / No   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 277 grupo al que hab\u00edan sido asignados information \n2.2. Were carers and people delivering the interven tions aware of par ticipants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No hay suficiente informaci\u00f3n para valorar este domin io No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were  these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo en \nque fueron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Los datos estuvieron disponible para todos o pr\u00e1ctica mente todos los participantes (5% de \np\u00e9rdidas) Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness  in the outcome depend on its true \nvalue?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo/ No Information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo/ No Information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  El grupo comparador fue un control activo con protocolo similar al del grupo de \nintervenci\u00f3n, por lo que es probable que las difere ncias no se deban al conocimiento de la \nintervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance w ith a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably No / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably No / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no parece estar disponible p ara contrastar si la medici\u00f3n se analiz\u00f3 \nde m\u00faltiples maneras. Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias ju dgement  Alto riesgo de sesgo  Low / High / Some concerns \n \nEstudio: Vaccarino (2013)   \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  278 Study design  \nx Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpeci fy which outcome is being assessed for risk of bias :  Vasodilataci\u00f3n mediada por flujo dependiente del end otelio y por nitroglicerina independiente del endotel io, Endurecimiento arterial; Presi\u00f3n \nsangu\u00ednea; Ansiedad (STAI); Estr\u00e9s percibido (PSS); Depresi\u00f3n (BDI-II) \nSpecify the numerical result being assessed. In case of  multiple alternative \nanalyses being presented, specify the numeric result ( e.g. RR = 1.52 (95% CI 0.83 \nto 2.77) and/or a reference (e.g. to a table, figure  or paragraph) that uniquely \ndefines the result being assessed. DMF sin diferencias significativas en l\u00ednea base (3. 9%, SD 2.4%, vs. 5.1%,SD 4.2%, p=0.18) con mejoras s ignificativas en 12 meses en grupo \nTM (cambio en media 2.1%, 95% IC, 0.5 a 3.7%, p=0.00 9) y menos en el control  (cambio en media  1.4%, 95% CI, -0.2 a 2.9%, p=0.094). \nNMD no se modific\u00f3 significativamente. La adherencia a  las clases no se correlacion\u00f3 con el cambio en  DMF (Pe arson r=-0.08, p=0.79 en TM \ny Pearson 'sr=-0.21, p=0.49 en control). El perfil me tab\u00f3lico  \nEn el perfil metab\u00f3lico, los cambios del grupo TM ent re l\u00ednea base y 12 meses fueron significativos para p resi\u00f3n sangu\u00ednea  (-6.2 mm Hg, 95% \nCI, -11.7 to -0.8 mm Hg, p=0.026), y peso (-2.5 kg, 9 5% CI, -0.2 to -4.8 kg,p=0.033). Ambas intervencione s mejoraron significativamente los \ns\u00edntomas depresivos y las puntuaciones en ansiedad pe ro no las medidas de ira y hostilidad ni en el ejerc icio f\u00edsico moderado.  \nIs the review team\u2019s aim for this result\u2026?  \nx to assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n  x       Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que la aleatorizaci\u00f3n se realiz\u00f3 mediante u na aleatorizaci\u00f3n bloqueada \ncon estratificaci\u00f3n con g\u00e9nero. Yes / Probably yes / Probably No / No / No \ninformation  \n1.2 Was the allocation sequence concealed until par ticipants were enrolled and \nassigned to interventions?  La secuencia de aleatorizaci\u00f3n se realiz\u00f3 en sobres sel lados. Yes / Probably yes / Probably No / No / No \ninformation  \nProbably No  \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base. Yes / Probably yes / Probably No / No / No \ninformation  \nProbably No  \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Los participantes fueron enmascarados a la hip\u00f3tesis  del estudio. El comparador es un \ngrupo activo similar, y ambas intervenciones se pres entaron como promotoras de la \nsalud, por tanto, es poco probable que los participan tes hayan sido conscientes del \ngrupo al que fueron asignados. Yes / Probably yes / Probably No / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n.  Yes / Probably yes / Probably No / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2: Were there deviation s from the intended \nintervention that arose because of the experimental  context? No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista \ndebidos al contexto experimental. No applicable / Yes / Probably yes / Probably No / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention balanced \nbetween groups?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Se llev\u00f3 a cabo un an\u00e1lisis por intenci\u00f3n de tratar.  Yes / Probably yes / Probably No / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e result) \nof the failure to analyse participants in the group  to which they were \nrandomized?  No aplica No applicable / Yes / Probably yes / Probably No / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Medidas objetivas: Hubo un  en MT, 36,36% en 6 mese s, 42,42 en 12 y en el grupo \ncontrol, 34,28% y 45,71% respectivamente Objetivas: Yes / Probably yes / Probably No / No / \nNo information   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 279 Medidas auto-reportadas: Hubo un  en MT, 36,36% en 6 meses, 42,42 en 12 y en el \ngrupo control, 34,28% y 45,71% respectivamente Auto-reportadas: Yes / Probably yes / Probably No \n/ No / No information \n3.2 If N/PN/NI to 3.1: Is there evidence that the r esult was not biased by missing \noutcome data?  Medidas objetivas: Se han realizado c\u00e1lculos para corre gir sesgos por la falta de balance \nde datos, aunque se asume que pueden no ser suficient es para la generalizaci\u00f3n de los \nresultados.  Medidas auto-reportadas: Se han realizado c\u00e1lculos par a corregir sesgos por la falta de \nbalance de datos, aunque se asume que pueden no ser suficientes para la \ngeneralizaci\u00f3n de los resultados.  Objetivas: No applicable / Yes / Probably yes / \nProbably no / No / \nAuto-reportadas: No applicable / Yes / Probably \nyes / Probably no / No / \n3.3 If N/PN to 3.2: Could missingness in the outcom e depend on its true value?  No aplica Objetivas: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportadas: No applicable / Yes / Probably \nyes / Probably no / No / No information \n3.4 If Y/PY/NI to 3.3: Is it likely that missingnes s in the outcome depended on its \ntrue value?  No aplica No Objetivas: No applicable / Yes / Probably yes / \nProbably no / No / No information \nAuto-reportadas: No applicable / Yes / Probably \nyes / Probably no / No / No information \nRisk-of-bias judgement  Medidas o bjetivas: Bajo riesgo de sesgo  \nMedidas auto-reportadas: Bajo riesgo de sesgo Objetivas: Low / High / Some concerns \nAuto-reportadas: Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate? Medidas Objetivas (Vasodilataci\u00f3n y presi\u00f3n arterial ): El m\u00e9todo para medir los \nresultados parece haber sido el apropiado. Medidas auto-reportadas (Estr\u00e9s, Ansiedad,Depresi\u00f3n ): El m\u00e9todo para medir los \nresultados parece haber sido el apropiado. Objetivas: Yes / Probably yes / Probably No / No / \nNo information \nAuto-reportadas: Yes / Probably yes / Probably No \n/ No / No information \n4.2 Could measurement or ascertainment of the outco me have differed between \nintervention groups?  Medidas Objetivas (Vasodilataci\u00f3n y presi\u00f3n arterial ): El m\u00e9todo para medir los \nresultados parece haber sido comparable en todos los grupos. \nMedidas auto-reportadas (Estr\u00e9s, Ansiedad,Depresi\u00f3n ): El m\u00e9todo para medir los \nresultados parece haber sido comparable en todos los grupos. Objetivas: Yes / Probably yes / Probably No / No / \nNo information \nSubjetivas: Yes / Probably yes / Probably No / No / \nNo information \n4.3 If N/PN/NI to 4.1 and 4.2: Were outcome assesso rs aware of the intervention \nreceived by study participants?  Medidas objetivas (Vasodilataci\u00f3n y presi\u00f3n arteria l): Los evaluadores estuvieron ciegos \na la condici\u00f3n del participante Medidas auto-reportadas: La medida es auto-reportad a y parece poco probable que los \nparticipantes est\u00e9n cegados a la asignaci\u00f3n. Sin embar go, se especifica que ambas \nintervenciones se presentaron a los participantes co mo promotoras de la salud. Objetivas: Yes / Probably yes / Probably no / No / \nNo information \nAuto-reportadas: Yes / Probably yes / Probably no / \nNo / No information \n4.4 If  Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced by \nknowledge of intervention received?  No aplica Objetivas: No applicable / Yes / Probably yes / \nProbably no / No / No information  \n4.5 If Y/PY/NI to 4.4 : Is it likely that assessment of  the outcome was influenced \nby knowledge of intervention received?  No aplica Auto-reportadas: No applicable / Yes / Probably \nyes / Probably no / No / No information \nRisk-of-bias judgement  Medidas objetivas: Bajo riesgo de sesgo  \nMedidas auto-reportadas: Bajo riesgo de sesgo Objetivas: Low / High / Some concerns \nAuto-reportadas: Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los \nan\u00e1lisis previstos. Yes / Probably yes / Probably No / No / No \ninformation \nIs the n umerical result being assessed likely to have been selected, on the basis \nof the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las \nmedidas y los puntos temporal fueron acordes con lo pl aneado Yes / Probably yes / Probably No / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los \ntipos de an\u00e1lisis que utilizaron fueron acordes con lo  planeado Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement     Riesgo incierto de sesgo  Low / High / Some concerns \nOverall risk of bias   \nRisk-of-bias judgement  Medidas objetivas: Riesgo de sesgo incierto  \nMedidas auto-reportadas: Riesgo de sesgo incierto Objetivas: Low / High / Some concerns \nAuto-reportadas: Low / High / Some concerns \n   \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  280  \nEstudio: Vasuded (2016); Ionson (2019)  \nStudy design  \nx Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Depresi\u00f3n (HAM-D; GDS); Ansiedad (GAI); Gravedad s\u00ed ntomas (CGI); Calidad de vida (QOLSV); Efectos adver sos (TSES) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being \npresented, specify the numeric result (e.g. RR = 1.52 ( 95% CI 0.83 to 2.77) and/or a \nreference (e.g. to a table, figure or paragraph) tha t uniquely defines the result being assessed. La variabilidad de la frecuencia cardiaca no cambi\u00f3 sig nificativamente en ninguno de los grupos; sin embarg o, s\u00ed hubo una mejora \nen depresi\u00f3n en el grupo de meditaci\u00f3n frente al tr atamiento habitual (diferencia de medias, 2,66; IC d el 95%: 0,26 a 5,05; P = \n0,03)).HAM-D muestra resultados similares en linea base en ambos grupos (TM media 14.5, s.d 4.3; LE 5. 7, 4.2). En la semana 4 la \nmedia bajo en 3.3 y 1.2 puntos en los grupos de TM y LE respectivamente. En la semana 12, 50% de los par ticpantes de TM \nlograron la remisi\u00f3n (<8 puntos en HAM-D, media 9.2 , s.d 4.3)\u00b4y 8% de los 9% de LE (14.5, s.d.=4.8). El  an\u00e1lisis ANOVA muestra \ncambios significativos en HAM-D en 12 semans (F(2.489 , 112.027)=14.986, P<0.001, \u03b7p 2=0.250). La reducci\u00f3n de la severidad de \nla depresi\u00f3n aument\u00f3 con el tiempo (F(2.489, 112.027 )=5.178, P<0.05, \u03b7p 2=0.103). En las escalas GDSy GAI el ANOVA mostr\u00f3 \ncambios significativos con el paso del tiempo (GDS: F( 2.507, 112.834)=7.073, P=0.001, \u03b7p 2=0.136; GAI: F(2.414, 108.614) =5.413, \nP<0.05, \u03b7p 2=0.107). En la escala CCGI-I el efecto de la TM t ambi\u00e9n fue significativo (F(1, 45)=8.137, P<0.001, \u03b7p 2=0.153). No \nhubo cambios significativos en la puntuaci\u00f3n del QOLS V , ni en la actividad f\u00edsica, PASE y TSES \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n        X Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Aleatorizaci\u00f3n usando una secuencia aleatoria generada  por ordenador. Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enroll ed \nand assigned to interventions?  La secuencia se mantuvo oculta en un gabinete cerrado b ajo llave.  Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n Yes / Probably yes / Probably No / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably No / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4 If Y/PY to 2.3 : Were these deviations likely to have affected the  \noutcome?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5. If Y/PY to 2.4 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Wa s there potential for a substantial impact (on the \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No parece que haya habido un impacto sustancial en los resultados debido a la falta de \nan\u00e1lisis de los participantes en el grupo en que fu eron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 3: Missing outcome data    \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 281 3.1 Were data for this outcome availa ble for all, or nearly all, participants \nrandomized?  Hubo un 5% de p\u00e9rdidas en el grupo control y un 15% en el grupo intervenci\u00f3n.  Yes / Probably yes / Probably No / No / No \ninformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not bia sed by \nmissing outcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome dep end on its true \nvalue?  Los motivos de las p\u00e9rdidas parecen ser independient es a la intervenci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low /High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably No / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably No / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n. No applicable / Yes / Probably yes / Probably No / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably No / \nNo / No information \n4.5 If Y/PY/NI to 4.4 : Is it likel y that assessment of the outcome was influenced \nby knowledge of intervention received?  La medida es auto-reportada y la intervenci\u00f3n s\u00f3lo s e compara con un grupo de \u201cno \ntratamiento No applicable / Yes / Probably yes / Probably No / \nNo / No information \nRis k-of -bias judgement  Alto riesgo de sesgo.  Low /High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio est\u00e1 disponible (NCT0214981 0) Yes / Probably yes / Probably No / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  Se realizaron an\u00e1lisis de comparaciones entre grupos co n los mismos instrumentos Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  Los resultados se analizaron atendiendo al plan de a n\u00e1lisis previo al inicio del estudio Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low /High / Some concerns \n \nEstudio: Wachholtz (2005)  \nStudy design  \nx Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Ansiedad (STAI-T) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the numeric result (e.g. \nRR = 1.52 (95% CI 0.83 to 2.77) and/or a reference ( e.g. to a table, figure or paragraph) that uniquely  defines the result being \nassessed. STAI-T (rasgo): diferencias posttest F=4.62 (p<.01)  a favor del grupo de meditaci\u00f3n \nespiritual  \n Is the review team\u2019s aim for this result\u2026?  \nx \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n     x    Journal article(s) with results of the tria l  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  282 Domain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to i ntervention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate t he effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No parece que haya habido un impacto sustancial en los resultados debido a la falta de \nan\u00e1lisis de los participantes en el grupo en que fu eron asignados No applicable / Yes / Probably yes / Probably no  / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Hubo un 14.3% de p\u00e9rdidas. Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1: Is there evidence that the r esult was not biased by \nmissing outcome data?  Analizan y comparan las caracter\u00edsticas de los participan tes que dejan el estudio o los que \nfueron excluidos del an\u00e1lisis por no seguir el patr \u00f3n de tratamiento y no encuentran \ndiferencias. No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRi sk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  El grupo comparador fue un control activo con protocolo similar al del grupo de \nintervenci\u00f3n, por lo que es probable que las difere ncias no se deban al conocimiento de la \nintervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias  judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos Yes / Probably yes / Probably no / No / No \ninformation   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 283 Is the numerical result being assessed likely t o have been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  Se realizaron an\u00e1lisis de comparaciones entre grupos co n los mismos instrumentos Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos de \nan\u00e1lisis que utilizaron fueron acordes con lo planeado  Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n  \nEstudio: Wachholtz (2008)  \n \nStudy design  \nx Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Frecuencia y severidad de migra\u00f1as autorreportadas; D olor inducido en laboratorio mientras se \nmedita. \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the numeric result \n(e.g. RR = 1.52 (95% CI 0.83 to 2.77) and/or a refe rence (e.g. to a table, figure or paragraph) that u niquely defines the result \nbeing assessed. El grupo activo mostr\u00f3 una disminuci\u00f3n significativa de la ira (p=0,005) y del dolor de la migra\u00f1a \n(p=0,002) a lo largo del tiempo. Un an\u00e1lisis m\u00e1s de tallado mostr\u00f3 que la mayor parte del cambio \nen el grupo de gesti\u00f3n activa se produjo en los \u00falti mos 10 d\u00edas, despu\u00e9s de 20 d\u00edas de pr\u00e1ctica \nde la t\u00e9cnica (p < 0,05). \n Is the review team\u2019s aim for this result\u2026?  \nx \nto assess the effect of assignment to intervention  (the \u2018intention -to-treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n  x     Journal article(s) with results of the trial  \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  La secuencia se estableci\u00f3 a trav\u00e9s de un generador de  n\u00fameros aleatorios \nRANDBETWEEN de Microsoft Excel.  Yes / Probably yes / Probably No / No / No \ninformation  \n1.2 Was the allocation sequence concealed until par ticipants were enrolled and \nassigned to interventions?  La secuencia de aleatorizaci\u00f3n estuvo oculta. Yes / Probably yes / Probably No / No / No \ninformation  \nProbably No  \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base. Yes / Probably yes / Probably No / No / No \ninformation  \nProbably No  \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Parece que los participantes no fueron conscientes dur ante el ensayo de la intervenci\u00f3n \nasignada.  Yes / Probably yes / Probably No / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of pa rticipants' \nassigned intervention during the trial?  Los psic\u00f3logos que aplicaron la intervenci\u00f3n no eran conscientes de la asignaci\u00f3n de los \nparticipantes a las intervenciones. Yes / Probably yes / Probably No / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No aplica No applicable / Yes / Probably yes / Probably No / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended interven tion \nbalanced between groups?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  No aplica No applicable / Yes / Probably yes / Probably no /  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  284 outcome?  No / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio. Yes / Probably yes / Probably No / No / No \ninformation \n2.7 If N/PN/NI to 2.6: Was there potential for a substanti al impact (on the result) \nof the failure to analyse participants in the group  to which they were \nrandomized? No parece que haya habido un impacto sustancial en los resultados debido a la falta de \nan\u00e1lisis de los participantes en el grupo al que fu eron asignados. No applicable / Yes / Probably yes / Probably No / \nNo / No information \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, or nearly all, part icipants \nrandomized?  Hubo un porcentaje de p\u00e9rdidas del 9,78%. Yes / Probably yes / Probably No / No / No \ninformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by missing \noutcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo. No applicable / Yes / Probably yes / Probably no / \nNo / \n3.3 If N/PN to 3.2: Could missingness in the outcom e depend on its true value?  Los motivos de las p\u00e9rdidas no est\u00e1n suficientemente  justificados. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  Algunos motivos de p\u00e9rdidas no quedan suficientemen te documentados. No applicable  / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado. Yes / Probably yes / Probably No / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed between \nintervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos. Yes / Probably yes / Probably No / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the intervention \nreceived by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados \na la asignaci\u00f3n. No applicable / Yes / Probably yes / Probably No / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have b een influenced by \nknowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos \npor el conocimiento de la intervenci\u00f3n recibida. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  El grupo comparador fue un control activo con protocolo similar al del grupo de \nintervenci\u00f3n, por lo que es probable que las difere ncias no se deban al conocimiento de la \nintervenci\u00f3n recibida. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the  reported result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los \nan\u00e1lisis previstos. Yes / Probably yes / Probably No / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g . scales, definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las \nmedidas y los puntos temporal fueron acordes con lo pl aneado Yes / Probably yes / Probably No / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los \ntipos de an\u00e1lisis que utilizaron fueron acordes con lo  planeado Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement     Riesgo incierto de sesgo  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n \nEstudio: Weibel (2016)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Ansiedad (STAI) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the Las puntuaciones en ansiedad no difirieron sig nificativamente entre las condiciones en el postratami ento o el   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 285 numeric result (e.g. RR = 1.52 (95% CI 0.83 to 2.77)  and/or a reference (e.g. to a table, figure or para graph) that \nuniquely defines the result being assessed. seguimiento (p = 0.130), sin embargo, hubo efectos significativos intra grupo entre el pretratamiento y el \npostratamiento (p = .002, d = 0.60) \n Is the review team\u2019s aim for this result\u2026?  \nX \nto as sess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n   X    Journal article(s) with results of the trial  \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  La secuencia de aleatorizaci\u00f3n fue realizada a trav\u00e9s d e cartas aleatorias Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were car ers and people delivering the interventions aware o f participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations likely to have affected the  \noutcome?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2. 5 If N/PN/NI to 2.4 : Were these deviations from intended intervention \nbalanced between groups? No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron con todos los participante s elegibles despu\u00e9s de la aleatorizaci\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome  data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Hubo un 15% de p\u00e9rdidas  Yes / Probably yes / Probably no / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  Los valores faltantes se reemplazaron usando la medi a de puntos cercanos No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  Los motivos de las p\u00e9rdidas parecen ser independient es a la intervenci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por No applicable / Yes / Probably yes / Probably no /  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  286 by knowledge of intervention received?  el conocimiento de la intervenci\u00f3n recibida No / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  La medida es auto-reportada y la intervenci\u00f3n s\u00f3lo s e compara con un grupo de \u201cno \ntratamiento\u201d, por lo que es probable que los result ados se vean influenciados por el \nconocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accord ance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no parece estar disponible p ara contrastar si se llevaron a cabo los \nan\u00e1lisis previstos Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos de \nan\u00e1lisis que utilizaron fueron acordes con lo planeado  Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n  \nEstudio: Williams (2005)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Calidad de vida (MVQOLI)  \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, \nspecify the numeric result (e.g. RR = 1.52 (95% CI 0. 83 to 2.77) and/or a reference (e.g. to a table, \nfigure or paragraph) that uniquely defines the resu lt being assessed. El grupo combinado mostr\u00f3 una mejora en las puntuacio nes generales (p = 0,005) y trascendentes (p = 0,01)  desde el \ninicio hasta las 8 semanas, un cambio significativame nte mayor (p = 0,05) que los grupos de meditaci\u00f3n, ma saje y control. \nTabla 4. \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat \u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n     X    Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Generaci\u00f3n de una secuencia aleatoria por medio de un ordenador.  Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did  baseline differences between intervention groups su ggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  No hay suficiente informaci\u00f3n para conocer si los parti cipantes fueron conscientes del \ngrupo al que hab\u00edan sido asignados Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended No hay suficiente informaci\u00f3n para valorar este domin io No applicable / Yes / Probably yes / Probably no /   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 287 intervention that arose because of the experimental  context?  No / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intend ed intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Se llev\u00f3 a cabo un an\u00e1lisis por intenci\u00f3n de tratar Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo  de sesgo incierto  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Los datos estuvieron disponible para todos o pr\u00e1ctica mente todos los participantes (5% de \np\u00e9rdidas) Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Coul d missingness in the outcome depend on its true \nvalue?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n No applicable /Yes / Probably yes / Probably no / \nNo / No information \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  El grupo comparador fue un control activo con protocolo similar al del grupo de \nintervenci\u00f3n, por lo que es probable que las difere ncias no se deban al conocimiento de la \nintervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably no / No / No \ninformation \nIs  the numerical result being assessed likely to have been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no parece estar disponible p ara contrastar si la medici\u00f3n se analiz\u00f3 \nde m\u00faltiples maneras. Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns  \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High  / Some concerns  \n  \nEstudio : Wilson (1975)  \nStudy design  \n Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  288 x Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is be ing assessed for risk of bias:  Gravedad y duraci\u00f3n sintomatolog\u00eda autorreportadas; Funci\u00f3n pulmonar \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the numeric result \n(e.g. RR = 1.52 (95% CI 0.83 to 2.77) and/or a refe rence (e.g. to a table, figure or paragraph) that u niquely defines the result \nbeing assessed. En comparaci\u00f3n con los valores iniciales registrados a ntes del inicio de la meditaci\u00f3n o la \nlectura, se observ\u00f3 una mejora significativa del volu men espiratorio forzado en 1 segundo, la \ntasa de flujo espiratorio m\u00e1ximo y la resistencia de l as v\u00edas respiratorias en el grupo A (TM \nprimero) inmediatamente despu\u00e9s del per\u00edodo de TM. Tabla 1.  \n Is the review team\u2019s aim for this result\u2026?  \nx \nto a ssess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n     x    Journal article(s) with results of the tria l \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interventions awar e of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  El contexto experimental produjo cambios respecto a la  intervenci\u00f3n esperada. Los \nparticipantes continuaron meditando a pesar de haberse  indicado que dejaran de hacerlo. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  Los cambios en las intervenci\u00f3n esperada no fueron con sistentes en los diferentes grupos.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  Estas desviaciones pudieron afectar a los resultados.  No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  No hay suficiente informaci\u00f3n para valorar este domin io Yes / P robably yes / Probably no / No / No \ninformatio n \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo en \nque fueron asignados. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Auto-reportadas: Hubo un 19% de p\u00e9rdidas. Objetivas: Hubo un 19% de p\u00e9rdidas Auto-reportadas: Yes / Probably yes / Probably No \n/ No / No Information \nObjetivas: Yes / Probably yes / Probably No / No / \nNo Information \n3.2 If N/PN/NI to 3.1: Is there evidence that the r esult was not biased by \nmissing outcome data?  Auto-reportadas: Es posible que el resultado estuvi ese sesgado porque no se utiliz\u00f3 ning\u00fan \nm\u00e9todo de an\u00e1lisis para corregir el sesgo Objetivas: Es posible que el resultado estuviese se sgado porque no se utiliz\u00f3 ning\u00fan \nm\u00e9todo de an\u00e1lisis para corregir el sesgo Auto-reportadas: No applicable / Yes / Probably \nyes / Probably no / No \nObjetivas: No applicable / Yes / Probably yes / \nProbably no / No \n3.3 If N/PN to 3.2: Could missingness in the outcom e depend on its true \nvalue?  Auto-reportadas: Los motivos de las p\u00e9rdidas no est \u00e1n suficientemente justificados \nObjetivas: Los motivos de las p\u00e9rdidas no est\u00e1n suf icientemente justificados Auto-reportadas: No applicable / Yes / Probably \nyes / Probably no / No / No information \nObjetivas: No applicable / Yes / Probably yes / \nProbably no / No / No information   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 28 93.4 If Y/PY/NI to 3.3: Is it likely that missingnes s in the outcome depended on \nits true value?  Auto-reportadas: Las p\u00e9rdidas son similares entre lo s diferentes grupos, por lo que es \nposible que no est\u00e9n relacionadas con la intervenci\u00f3n  en s\u00ed misma pese a que no est\u00e9n \nsuficientemente documentadas Objetivas: Las p\u00e9rdidas son similares entre los dif erentes grupos, por lo que es posible que \nno est\u00e9n relacionadas con la intervenci\u00f3n en s\u00ed misma  pese a que no est\u00e9n \nsuficientemente documentadas Auto-reportadas: No applicable / Yes / Probably \nyes / Probably no / No / No information \nObjetivas: No applicable / Yes / Probably yes / \nProbably no / No / No information \nRisk-of-bias judgement  Auto -reportadas: Riesgo de sesgo incierto  \nObjetivas: Riesgo de sesgo incierto Auto-reportadas: Low / High / Some concerns \nObjetivas: Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  Auto-reportadas: El m\u00e9todo para medir los resultado s parece haber sido el apropiado \nObjetivas: El m\u00e9todo para medir los resultados pare ce haber sido el apropiado Auto-reportadas: Yes / Probably yes / Probably no / \nNo / No information \nObjetivas: Yes / Probably yes / Probably no / No / \nNo information \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  Auto-reportadas: El m\u00e9todo para medir los resultado s parece haber sido comparable en \ntodos los grupos Ojetivas: El m\u00e9todo para medir los resultados parece  haber sido comparable en todos los \ngrupos Auto-reportadas: Yes / Probably yes / Probably no / \nNo / No information \nObjetivas: Yes / Probably yes / Probably no / No / \nNo information \n4.3 If N/PN/NI to 4.1 and 4.2: Were outcome assesso rs aware of the \nintervention received by study participants?  Auto-reportada: La medida es auto-reportada y parece poco probable que los participantes \nest\u00e9n cegados a la asignaci\u00f3n Objetivas: El evaluador estuvo cegado a la condici\u00f3n del participante Auto-reportadas: Yes / Probably yes / Probably no / \nNo / No information \nObjetivas: Yes / Probably yes / Probably no / No / \nNo information \n4.4 If Y/PY/NI to 4.3: Could assessment of the outc ome have been influenced \nby knowledge of intervention received?  Auto-reportada: La medida es auto-reportada, por lo  que es posible que los resultados se \nvean influidos por el conocimiento de la intervenci\u00f3n recibida \nObjetivas: No aplica. Auto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nObjetivas: No applicable / Yes / Probably yes / \nProbably no / No / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  Auto-reportada: Hay dos grupos de comparaci\u00f3n activa con  protocolos similares, por lo que \nes probable que las diferencias no se deban al conocim iento de la intervenci\u00f3n recibida \nObjetivas: No aplica. Auto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nObjetivas: No applicable / Yes / Probably yes / \nProbably  no / No / No information \nRisk-of-bias judgement  Auto -reportadas: Riesgo de sesgo incierto  \nObjetivas: Bajo riesgo de sesgo Auto-reportadas: Low / High / Some concerns \nObjetivas: Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reporte d result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales ,  definitions, time points) \nwithin the outcome domain?  Se realizaron an\u00e1lisis de comparaciones entre grupos co n los mismos instrumentos Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos de \nan\u00e1lisis que utilizaron fueron acordes con lo planeado  Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n \nEstudio: Wolf (2003)  \n \nStudy design  \nx Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  290 Specify which outcome is being assessed for risk of  bias:  Depresi\u00f3n (GCS); Estr\u00e9s (ICS) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the \nnumeric result (e.g. RR = 1.52 (95% CI 0.83 to 2.77)  and/or a reference (e.g. to a table, figure or para graph) that \nuniquely defines the result being assessed. Medidas repetidas: ICS: Pretest-postest F=6.79 (p<. 05). Pretest-seguimiento F=4.81 (p<.05); GCS: Prete st-\npostest F=13.17 (p<.01). Pretest-seguimiento F=1.90  (n.s) \n Is the review team\u2019s aim for this result\u2026?  \nx \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 ef fect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n     x    Journal article(s) with results of the tria l \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling quest ions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ti cipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No se comparan las caracter\u00edsticas en l\u00ednea base entre los grupos Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to de viations from the intended interventions (effect of  assignment to intervention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended inter vention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron s\u00f3lo con los participantes que completaron el estudio Yes / Probably yes / Probably no / No / No \ninformation \n2.7  If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo en \nque fueron asignados No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDoma in 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Hubo un 34% de p\u00e9rdidas. Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its true \nvalue?  Los motivos de las p\u00e9rdidas no est\u00e1n suficientemente  justificados No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3: Is it likely that missingnes s in the outcome depended on \nits true value?  Las p\u00e9rdidas son similares entre los diferentes gru pos, por lo que es posible que no est\u00e9n \nrelacionadas con la intervenci\u00f3n en s\u00ed misma pese a q ue no est\u00e9n suficientemente \ndocumentadas No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado. Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 291 between intervention groups?  information \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  El grupo comparador fue un control activo con protocolo similar al del grupo de \nintervenci\u00f3n, por lo que es probable que las difere ncias no se deban al conocimiento de la \nintervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result bei ng assessed likely to have been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  Se realizaron an\u00e1lisis de comparaciones entre grupos co n los mismos instrumentos Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos de \nan\u00e1lisis que utilizaron fueron acordes con lo planeado  Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n  \nEstudio: Wren (201 9)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Ansiedad (STAI), Dolor (BPI), Fatiga (FACIT), Presi \u00f3n sangu\u00ednea \nSpecify the numerical result being assessed. In case of  multiple alternative analyses \nbeing presented, specify the numeric result (e.g. RR = 1.52 (95% CI 0.83 to 2.77) \nand/or a reference (e.g. to a table, figure or parag raph) that uniquely defines the \nresult being assessed. Al comparar las puntuaciones del grupo de meditaci\u00f3n y el grupo de atenci\u00f3n habitual, la interacci\u00f3n tratam iento \u00d7 tiempo fue significativa (p = \n0,046), lo que indica que el grupo de atenci\u00f3n habit ual mostr\u00f3 mayores aumentos en la ansiedad con el tie mpo en comparaci\u00f3n con el grupo \nde meditaci\u00f3n. Las puntuaciones del grupo de meditaci \u00f3n y del grupo de m\u00fasica no difirieron significativame nte con el tiempo (p = 0,21). La \ninteracci\u00f3n total tratamiento \u00d7 tiempo no fue signif icativa para la fatiga [F (2,59) = 0,45, p = 0,64], l o que sugiere que no hay diferencias entre \nlos grupos. \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect ) \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n   X    Journal article(s) with results of the trial  \nDomain  1: Risk of bias arising from the randomization proce ss  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  La secuencia de aleatorizaci\u00f3n fue realizada con un prog rama de ordenador Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did b aseline differences between intervention groups sug gest a problem \nwith the randomization process?  No hay diferencias aparentes entre las caracter\u00edsticas de los grupos incluidos Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  292 Domain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations likely to have affected the  \noutcome?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations from intended intervention  \nbalanced between groups? No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Se llev\u00f3 a cabo un an\u00e1lisis por intenci\u00f3n de tratar Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Auto-reportadas: Hubo un 7% de p\u00e9rdidas. Objetiva: Hubo un 7% de p\u00e9rdidas. Auto-reportadas: Yes / Probably yes / Probably No \n/ No / No Information \nObjetivas: Yes / Probably yes / Probably No / No / \nNo Information \n3.2 If N/PN/NI to 3.1: Is there evidence that the r esult was not biased by \nmissing outcome data?  Auto-reportadas: Es posible que el resultado estuvi ese sesgado porque no se utiliz\u00f3 ning\u00fan \nm\u00e9todo de an\u00e1lisis para corregir el sesgo Objetiva: Es posible que el resultado estuviese ses gado porque no se utiliz\u00f3 ning\u00fan \nm\u00e9todo de an\u00e1lisis para corregir el sesgo Auto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No \nObjetiva: No applicable / Yes / Probably yes / \nProbably no / No \n3.3 If N/PN to 3.2: Could missingness in the outcom e depend on its true \nvalue?  Auto-reportadas: Algunos motivos de p\u00e9rdidas no que dan suficientemente documentados. \nObjetiva: Algunos motivos de p\u00e9rdidas no quedan suf icientemente documentados Auto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nObjetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \n3.4 If Y/PY/NI to 3.3: Is it likely that missingnes s in the outcome depended on \nits true value?  Auto-reportadas:  Las p\u00e9rdidas son similares entre los diferentes gru pos, por lo que es \nposible que no est\u00e9n relacionadas con la intervenci\u00f3n  en s\u00ed misma pese a que no est\u00e9n \nsuficientemente documentadas Objetiva: Las p\u00e9rdidas son similares entre los dife rentes grupos, por lo que es posible que \nno est\u00e9n relacionadas con la intervenci\u00f3n en s\u00ed misma  pese a que no est\u00e9n \nsuficientemente documentadas Auto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nObjetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nRisk-of-bias judgement  Auto -reportadas: Riesgo de sesgo incierto  \nObjetiva: Riesgo de sesgo incierto Auto-reportadas: Low / High / Some concerns \nObjetiva: Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  Auto-reportadas: El m\u00e9todo para medir los resultado s parece haber sido el apropiado \nObjetiva: El m\u00e9todo para medir los resultados parece  haber sido el apropiado Auto-reportadas: Yes / Probably yes / Probably no / \nNo / No information \nObjetiva: Yes / Probably yes / Probably no / No / \nNo information \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  Auto-reportadas: El m\u00e9todo para medir los resultado s parece haber sido comparable en \ntodos los grupos Objetiva: Auto-reportadas: El m\u00e9todo para medir los  resultados parece haber sido \ncomparable en todos los grupos Auto-reportadas: Yes / Probably yes / Probably no / \nNo / No information \nObjetiva: Auto-reportadas: Yes / Probably yes / \nProbably no / No / No information \n4.3 If N/PN/NI to 4.1 and 4.2: Were outcome assesso rs aware of the \nintervention received by study participants?  Auto-reportadas: La medida es auto-reportada y parece  poco probable que los \nparticipantes est\u00e9n cegados a la asignaci\u00f3n Objetiva: El evaluador estuvo cegado a la condici\u00f3n d el participante Auto-reportadas: No applicable / Yes / Probably \nyes / Probably no / No / No information \nAuto-reportadas: No applicable / Yes / Probably \nyes / Probably no / No / No information \n4.4 If Y/PY/NI to 4.3: Could assessment of the outc ome have been influenced \nby knowledge of intervention received?  Auto-reportadas: La medida es auto-reportada, por l o que es posible que los resultados se \nvean influidos por el conocimiento de la intervenci\u00f3n recibida \nObjetiva: No aplica Auto-reportadas: No applicable / Yes / Probably \nyes / Probably no / No / No information \nObjetiva: No applicable / Yes / Probably yes /   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 293 Probably no / No / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  Auto-reportadas: La medida es auto-reportada y la in tervenci\u00f3n s\u00f3lo se compara con un \ngrupo de \u201cno tratamiento\u201d, por lo que es probable q ue los resultados se vean influenciados \npor el conocimiento de la intervenci\u00f3n recibida Objetiva: No aplica Auto-reportadas: No applicable / Yes / Probably \nyes / Probably no / No / No information \nObjetiva: No applicable / Yes / Probably yes / \nProbably no / No / No information \nRisk-of-bias judgement  Auto -reportadas: Alto riesgo de se sgo  \nObjetiva: Bajo riesgo de sesgo Auto-reportadas: Low / High / Some concerns \nObjetiva: Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no parece estar disponible p ara contrastar si se llevaron a cabo los \nan\u00e1lisis previstos Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos de \nan\u00e1lisis que utilizaron fueron acordes con lo planeado  Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \nOverall ri sk of bias   \nRisk-of-bias judgement  Auto -reportadas: Alto riesgo de sesgo  \nObjetiva: Alto riesgo de sesgo Auto-reportada: Low / High / Some concerns \nObjetiva: Low / High / Some concerns \n  \nEstudio: Wu (2019)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Estr\u00e9s percibido (PSS), calidad de vida (GHQ) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the \nnumeric result (e.g. RR = 1.52 (95% CI 0.83 to 2.77)  and/or a reference (e.g. to a table, figure or para graph) that \nuniquely defines the result being assessed. Los datos mostraron mejoras significativas en el gru po de intervenci\u00f3n sobre los controles para todas la s \nmedidas de resultado en postest y 3 meses despu\u00e9s (N ivel de estr\u00e9s post y post-3: \u03b7p 2 = 0,15 y 0,16). \nTabla 3. \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n        X Journal article(s) with results of the tri al \n \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Respon se options  \n1.1 Was the allocation sequence random?  El m\u00e9todo de secuencia aleatoria utilizado fueron n\u00fame ros generados por ordenador. Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were  enrolled \nand assigned to interventions?    La secuencia de asignaci\u00f3n estuvo oculta hasta la asi gnaci\u00f3n de la condici\u00f3n. Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base. Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Bajo riesgo de sesgo  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the intended interventions (effect of assignment to intervention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Los participantes estuvieron ciegos a la condici\u00f3n h asta que finalizaron la evaluaci\u00f3n en Yes / Probably yes / Probably no / No / No  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  294 l\u00ednea base. information \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n. Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate the  effect of assignment to \nintervention?  Se llev\u00f3 a cabo un an\u00e1lisis por intenci\u00f3n de tratar y per protocol. Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential  for a substantial impact (on the \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Los datos estuvieron disponibles para todos o pr\u00e1cti camente todos los participantes \n(inferiores al 5% (4.9%)). Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evidence that the result was not biased by \nmissing outcome data?  Es posible que el resultado estuviese sesgado porqu e no se utiliz\u00f3 ning\u00fan m\u00e9todo de \nan\u00e1lisis para corregir el sesgo. No applicable / Yes / Probably yes / Probably no / \nNo \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  Los motivos de las p\u00e9rdidas parecen ser independient es a la intervenci\u00f3n. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Bajo riesgo d e sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado. Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos. Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n. Yes / Probably yes / Probably no / No / No \ninformation \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  La medida es auto-reportada y la intervenci\u00f3n s\u00f3lo s e compara con un grupo de \u201cno \ntratamiento\u201d, por lo que es probable que los result ados se vean influenciados por el \nconocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto  riesgo de sesgo  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been select ed, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado. Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos de \nan\u00e1lisis que utilizaron fueron acordes con lo planead o. Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n    \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 295 Estudio: Yang (2009)  \nStudy design  \nX Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  bias:  Angustia f\u00edsica y mental medido a trav\u00e9s de 35 s\u00edntom as a trav\u00e9s de una encuesta \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy \nthe numeric result (e.g. RR = 1.52 (95% CI 0.83 to 2.77) and/or a reference (e.g. to a table, figure or  \nparagraph) that uniquely defines the result being as sessed. Los resultados mostraron que el efecto del tratamien to experimental fue significativo cuando se controlaro n las \npuntuaciones a la prueba de distr\u00e9s f\u00edsico y mental de  los estudiantes. Los s\u00edntomas f\u00edsicos y mentales en el grupo \nexperimental fueron m\u00e1s bajos que los del grupo de control. Tabla 2, 3 y 4.   \n Is the review team\u2019s aim for this result\u2026?  \nX \nto assess the effect of assignment to intervention  (the \u2018i ntention -to -treat\u2019 effect)  \n to assess the effect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n        X Journal article(s) with results of the tri al \nDomain 1: Risk of bias arising from the randomizatio n process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado. Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?    No se informa si la secuencia de aleatorizaci\u00f3n se ma ntuvo oculta. Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differences between intervention g roups suggest a problem \nwith the randomization process?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base. Yes / Probably yes / Probably No / No / No \ninformation \nRisk -of -bias judgement  Riesgo incierto de sesgo  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  No parece haber diferencias aparentes entre los grupo s en l\u00ednea base Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar    cegados a su condici\u00f3n. Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intended \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4. If Y/ PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  No hay suficiente informaci\u00f3n para valorar este domin io. Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No se dispone de suficiente informaci\u00f3n para conocer s i hubo posibilidad de impacto \nsustancial en los resultados debido a la falta de an \u00e1lisis de los participantes en el grupo al \nque fueron asignados. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  No hubo p\u00e9rdidas. Yes / Probably yes / Probably No / No / No \nInformation \n3.2 If N/PN/NI to 3.1 : Is there evide nce that the result was not biased by \nmissing outcome data?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.3 If N/PN to 3.2 : Could missingness in the outcome depend on its tr ue \nvalue?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information \n3.4 If Y/PY/NI to 3.3 : Is it likely that missingness in the outcome depe nded on \nits true value?  No aplica No applicable / Yes / Probably yes / Probably no / \nNo / No information  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  296 Risk -of -bias judgement  Bajo rie sgo de sesgo  Low / High / Some concerns \nDomain 4: Risk of bias in measurement of the outcom e  \n4.1 Was the method of measuring the outcome inappro priate?  El m\u00e9todo para medir los resultados parece haber sid o el apropiado. Yes / Probably yes / Probably no / No / No \ninformation \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  El m\u00e9todo para medir los resultados parece haber sid o comparable en todos los grupos Yes / Probably yes / Probably no / No / No \ninformation \n4.3 If N/PN/NI to 4.1 and 4.2 : Were outcome assessors aware of the \nintervention received by study participants?  La medida es auto-reportada y parece poco probable que  los participantes est\u00e9n cegados a \nla asignaci\u00f3n Yes / Probably yes / Probably no / No / No \ninformation \n4.4 If Y/PY/NI to 4.3 : Could assessment of the outcome have been influen ced \nby knowledge of intervention received?  La medida es auto-reportada, por lo que es posible que los resultados se vean influidos por \nel conocimiento de la intervenci\u00f3n recibida No applicable / Yes / Probably yes / Probably no / \nNo / No information \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  La medida es auto-reportada y la intervenci\u00f3n s\u00f3lo s e compara con un grupo de \u201cno \ntratamiento\u201d, por lo que es probable que los result ados se vean influenciados por el \nconocimiento de la intervenci\u00f3n recibida. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos. Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being assessed likely to ha ve been sel ected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si las medidas \ny los puntos temporal fueron acordes con lo planeado. Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos de \nan\u00e1lisis que utilizaron fueron acordes con lo planeado . Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo incierto de sesgo   Low / High / Some concerns \nOverall risk of bias   \nRisk -of -bias judgement  Alto riesgo de sesgo  Low / High / Some concerns \n \nEstudio: Zuroff (1978)  \nStudy design  \nx Individually-randomized parallel-group trial \n Cluster-randomized parallel-group trial \n Individually randomized cross-over (or other matched) trial \n \nSpecify which outcome is being assessed for risk of  b ias:  Ansiedad (ACL; S-R; BAM); Desajuste psicol\u00f3gico (Prue ba de oraciones incompletas de Rotter) \nSpecify the numerical result being assessed. In case of  multiple alternative analyses being presented, speci fy the numeric result \n(e.g. RR = 1.52 (95% CI 0.83 to 2.77) and/or a refe rence (e.g. to a table, figure or paragraph) that u niquely defines the result \nbeing assessed. Tendencia al descenso de ansiedad en todos los grupos  (F=10.41, p<.001) pero no hubo \ndiferencias significativas en la escala Adjective Chec k List (ACL). no hubo diferencias entre los \ngrupos en la medida de ansiedad conductual (hetero-re portada). \n Is the review team\u2019s aim for this result\u2026?  \nx \nto assess the effect of assignment to intervention  (the \u2018intention -to -treat\u2019 effect)  \n to assess the e ffect of adhering to intervention  (the \u2018per -protocol\u2019 effect)  \n Which of the following sources were obtained to hel p inform the risk-of-bias assessment? (tick as many  as apply)  \n     x    Journal article(s) with results of the tria l \nDomain 1: Risk of bias arising from the randomization process  \nSignalling questions  Comments  Response options  \n1.1 Was the allocation sequence random?  Se comenta que hubo aleatorizaci\u00f3n pero no se describe el m\u00e9todo utilizado Yes / Probably yes / Probably No / No / No \ninformation \n1.2 Was the allocation sequence concealed until par ticipants were enrolled \nand assigned to interventions?  No se informa si la secuencia de aleatorizaci\u00f3n se mant uvo oculta Yes / Probably yes / Probably No / No / No \ninformation \n1.3 Did baseline differen ces between intervention groups suggest a problem No se comparan las caracter\u00edsticas en l\u00ednea base entre los grupos Yes / Probably yes / Probably No / No / No   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 297 with the randomization process?   information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low /High / Some concerns \nDomain 2: Risk of bias due to deviations from the i ntended interventions (effect of assignment to inte rvention)  \n2.1. Were participants aware of their assigned inte rvention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n se cree qu e es poco probable que los \nparticipantes estuvieran cegados a su condici\u00f3n. Yes / Probably yes / Probably no / No / No \ninformation \n2.2. Were carers and people delivering the interven tions aware of participants' \nassigned intervention during the trial?  Dadas las caracter\u00edsticas de la intervenci\u00f3n los instr uctores de la meditaci\u00f3n no \npudieron estar cegados a su condici\u00f3n. Yes / Probably yes / Probably no / No / No \ninformation \n2.3. If Y/PY/NI to 2.1 or 2.2 : Were there deviations from the intende d \nintervention that arose because of the experimental  context?  No se informa con suficiente detalle de si hubo cambio s en la intervenci\u00f3n prevista debidos \nal contexto experimental. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.4 . If Y/PY to 2.3 : Were these deviations from intended intervention \nbalanced between groups?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.5 If N/PN/NI to 2.4 : Were these deviations likely to have affected the  \noutcome?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \n2.6 Was an appropriate analysis used to estimate th e effect of assignment to \nintervention?  Los an\u00e1lisis se realizaron con todos los participante s elegibles despu\u00e9s de la \naleatorizaci\u00f3n. Yes / Probably yes / Probably no / No / No \ninformation \n2.7 If N/PN/NI to 2.6:  Was there potential for a substantial impact (on th e \nresult) of the failure to analyse participants in t he group to which they were \nrandomized?  No aplica. No applicable / Yes / Probably yes / Probably no / \nNo / No information \nRisk -of -bias judgement  Riesgo de sesgo incierto  Low / High / Some concerns \nDomain 3: Missing outcome data  \n3.1 Were data for this outcome available for all, o r nearly all, participants \nrandomized?  Medida hetero-reportada: Los datos estuvieron dispo nible para todos o pr\u00e1cticamente \ntodos los participantes (1.6% de p\u00e9rdidas) Medida auto-reportada: Los datos estuvieron disponi ble para todos o pr\u00e1cticamente todos \nlos participantes (1.6% de p\u00e9rdidas) Hetero-reportada: Yes / Probably yes / Probably No \n/ No / No Information \nAuto-reportada: Yes / Probably yes / Probably No / \nNo / No Information \n3.2 If N/PN/NI to 3.1: Is there evidence that the r esult was not biased by \nmissing outcome data?  Medida hetero-reportada: No aplica Medida auto-reportada: No aplica Hetero-reportada: No applicable / Yes / Probably \nyes / Probably no / No \nAuto-reportada:  No applicable / Yes / Probably yes \n/ Probably no / No \n3.3 If N/PN to 3.2: Could missingness in the outcom e depend on its true \nvalue?  Medida hetero-reportada: No aplica Medida auto-reportada: No aplica Hetero-reportada: No applicable / Yes / Probably \nyes / Probably no / No \nAuto-reportada:  No applicable / Yes / Probably yes \n/ Probably no / No \n3.4 If Y/PY/NI to 3.3: Is it likely that missingnes s in the outcome depended on \nits true value?  Medida hetero-reportada: No aplica Medida auto-reportada: No aplica Hetero-reportada: No applicable / Yes / Probably \nyes / Probably no / No \nAuto-reportada:  No applicable / Yes / Probably yes \n/ Probably no / No \nRisk-of-bias judgement  Medida hetero -reportada: Bajo riesgo de sesgo  \nMedida auto-reportada: Bajo riesgo de sesgo  Hetero-reportada: Low / High / Some concerns \nAuto-reportada:  Low / High / Some concerns \nDomain 4: Risk of bias  in measurement of the outcome  \n4.1 Was the method of measuring the outcome inappro priate?  Medida hetero-reportada: El m\u00e9todo para medir los r esultados parece haber sido el \napropiado. Medida auto-reportada: El m\u00e9todo para medir los res ultados parece haber sido el \napropiado. Hetero-reportada: Yes / Probably yes / Probably no \n/ No / No information \nAuto-reportada: Yes / Probably yes / Probably no / \nNo / No information \n4.2 Could measurement or ascertainment of the outco me have differed \nbetween intervention groups?  Medida hetero-reportada: El m\u00e9todo para medir los r esultados parece haber sido \ncomparable en todos los grupos Medida auto-reportada: El m\u00e9todo para medir los res ultados parece haber sido comparable \nen todos los grupos Hetero-reportada: Yes / Probably yes / Probably no \n/ No / No information \nAuto-reportada: Yes / Probably yes / Probably no / \nNo / No information \n4.3 If N/PN/NI to 4.1 and 4.2: Were outcome assesso rs aware of the \nintervention received by study participants?  Medida hetero-reportada: El evaluador estuvo cegado a la condici\u00f3n del participante \nMedida auto-reportada: La medida es auto-reportada y parece poco probable que los \nparticipantes est\u00e9n cegados a la asignaci\u00f3n. Hetero-reportada:No applicable / Yes / Probably \nyes / Probably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \n4.4 If Y/PY/NI to 4.3: Could assessment of the outc ome have been influenced \nby knowledge of intervention received?  Medida hetero-reportada: La medida es objetiva y par ece poco probable que los \nevaluadores puedan influir en los resultados  Medida auto-reportada: La medida es auto-reportada,  por lo que es posible que los Hetero-reportada: No applicable / Yes / Probably \nyes / Probably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  298 resultados se vean influidos por el conocimiento de la intervenci\u00f3n recibida / Probably no / No / No in formation  \n4.5 If Y/PY/NI to 4.4: Is it likely that assessment  of the outcome was influenced \nby knowledge of intervention received?  Medida hetero-reportada: El grupo comparador fue un control activo con protocolo similar \nal del grupo de intervenci\u00f3n, por lo que es probable  que las diferencias no se deban al \nconocimiento de la intervenci\u00f3n recibida Medida auto-reportada: El grupo comparador fue un con trol activo con protocolo similar al \ndel grupo de intervenci\u00f3n, por lo que es probable qu e las diferencias no se deban al \nconocimiento de la intervenci\u00f3n recibida Hetero-reportada: No applicable / Yes / Probably \nyes / Probably no / No / No information \nAuto-reportada: No applicable / Yes / Probably yes \n/ Probably no / No / No information \nRisk-of-bias judgement  Medida hetero -reportada: Riesgo de sesgo incierto  \nMedida auto-reportada: Riesgo de sesgo incierto Hetero-reportada: Low / High / Some concerns \nAuto-reportada: Low / High / Some concerns  \nDomain 5: Risk of bias in selection of the reported  result  \n5.1 Were the data that produced this result analyse d in accordance with a pre -\nspecified analysis plan that was finalized before un blinded outcome data were \navailable for analysis?  El protocolo del estudio no est\u00e1 disponible para cont rastar si se llevaron a cabo los an\u00e1lisis \nprevistos Yes / Probably yes / Probably no / No / No \ninformation \nIs the numerical result being a ssessed likely to have been selected, on the \nbasis of the results, from...    \n5.2. ... multiple outcome measurements (e.g. scales , definitions, time points) \nwithin the outcome domain?  Se realizaron an\u00e1lisis de comparaciones entre grupos co n los mismos instrumentos Yes / Probably yes / Probably no / No / No \ninformation \n5.3 ... multiple eligible analyses of the data?  El protocolo del estudio no est\u00e1 disponible, por tan to, no se puede comparar si los tipos de \nan\u00e1lisis que utilizaron fueron acordes con lo planeado  Yes / Probably yes / Probably no / No / No \ninformation \nRisk -of -bias judgement  Riesgo de sesgo incierto.  Low / High / Some concerns \nOverall risk of bias   \nRisk-of-bias judgement  Medida hetero -reportada: Alto riesgo de sesgo  \nMedida auto-reportada: Alto riesgo de sesgo Hetero-reportada: Low / High / Some concerns \nAuto-reportada: Low / High / Some concerns \n \n    \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 299 Anexo 7. Resultados de los estudios primarios Anexo 7. Resultados de los estudios primarios Anexo 7. Resultados de los estudios primarios Anexo 7. Resultados de los estudios primarios    \nTabla 8. Significaci\u00f3n estad\u00edstica de los resultado s de efectividad de los estudios primarios incluido s  \nAutor (a\u00f1o) Condici\u00f3n de salud \ny tama\u00f1o muestral S\u00edntomas y Calidad de \nVida espec\u00edfica Ansiedad Depresi\u00f3n Estr\u00e9s Insomni\no Psicopatolog\u00eda \ngeneral Calidad \nde Vida \ngeneral \nAlexander \n(1989)[61] Personas mayores en \nresidencia \n(n=77) \u2205 Funci\u00f3n cognitiva (DST) \u2205 (STAI) \u2205 (SDS) - - - - \nAnderson \n(1999)[62] Profesores \n(n=91) \u2295 Burnout (MBI) \n\u2295 Estr\u00e9s ocupacional (TSI) \u2295 (STAI) - - - - - \nBarnes \n(2012)[63] Estudiantes de instituto \n(n=156) \u2295 Masa del ventr\u00edculo izquierdo  \n\u2205 Presi\u00f3n sangu\u00ednea - - - - - - \nBasso \n(2019)[64] Adultos sanos \n(n=42) - \u2295 (STAI) - - \u2297 (PSQI) - - \nBeiranvand \n(2014)[65] Mujeres candidatas a \nces\u00e1rea \n(n=160) \u2295 Dolor (EVA) \n\u2295 N\u00e1useas y v\u00f3mitos \n\u2205 Presi\u00f3n sangu\u00ednea \n\u2205 Tasa cardiaca \n\u2205 Tasa respiratoria - - - - - - \nBokhari \n(2019)[66] Enfermedad coronaria \n(n=56) \u2295 Reserva de flujo mioc\u00e1rdico \n\u2205 Presi\u00f3n sangu\u00ednea - \u2205 (BDI-II) - - \u2205 (GHQ) - \nBormann \n(2006)[67] VIH \n(n=93) \u2205 Pensamientos intrusivos \nrelacionados con el VIH (IES-R)  \u2205 (STAI) \u2205 (CES-D) \u2205 (PSS) - - - \nBormann Veteranos de guerra con \u2205 S\u00edntomas TEPT (PTSD) - - - - \u2205 (BSI-18) -  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  300 Tabla 8. Significaci\u00f3n estad\u00edstica de los resultado s de efectividad de los estudios primarios incluido s  \nAutor (a\u00f1o) Condici\u00f3n de salud \ny tama\u00f1o muestral S\u00edntomas y Calidad de \nVida espec\u00edfica Ansiedad Depresi\u00f3n Estr\u00e9s Insomni\no Psicopatolog\u00eda \ngeneral Calidad \nde Vida \ngeneral \n(2008)[146] TEPT \n(n=29) \u2205 S\u00edntomas TEPT (CAPS) \nBormann \n(2013)[68] Veteranos de guerra con \nTEPT \n(n=146) \u2205 S\u00edntomas TEPT (PTSD) \n\u2205 S\u00edntomas TEPT (CAPS) \u2205 (BSI-18) \u2205 (BSI-18) - - - \u2295 (SF-12) \nBormann \n(2018)[69] Veteranos de guerra con \nTEPT  \n(n=173) \u2205 S\u00edntomas TEPT (CAPS) \n\u2205 S\u00edntomas TEPT (PCL) - \u2205 (PHQ-9) - \u2295 (ISI) - \u2205 (WHOQOL)  \nBoswell \n(1979)[70] Estudiantes \ncon ansiedad \n(n=80) - \u2205 (STAI) - - - - - \nBrito-Pons \n(2018)[71] Adultos sanos \n(n=50) - \u2295 (BAI) \u2295 (BDI) \u2295 (PSS) - - - \nBrooks \n(1985)[72] Veteranos de guerra con \nTEPT \n(n=18) \u2295 S\u00edntomas TEPT \u2295 (TMAS) \u2295 (BDI) - - - - \nCarson \n(2005)[73] Dolor cr\u00f3nico de espalda \n(n=61) \u2205 Dolor (MPQ; BPI) - - - - \u2205 (BSI-18) - \nCastillo-\nRichmond \n(2000)[74] Hipertensi\u00f3n \n(n=138) \u2205 Presi\u00f3n sangu\u00ednea \n\u2295 Medida de aterosclerosis - - - - -  \nChandler \n(2020)[75] Pre-hipertensi\u00f3n \n(n=39) \u2205 Presi\u00f3n sangu\u00ednea* - - \u2205 (PSS) - - -   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 301 Tabla 8. Significaci\u00f3n estad\u00edstica de los resultado s de efectividad de los estudios primarios incluido s  \nAutor (a\u00f1o) Condici\u00f3n de salud \ny tama\u00f1o muestral S\u00edntomas y Calidad de \nVida espec\u00edfica Ansiedad Depresi\u00f3n Estr\u00e9s Insomni\no Psicopatolog\u00eda \ngeneral Calidad \nde Vida \ngeneral \nChhatre \n(2013)[76] VIH \n(n=22) \u2295 (FAHI-total) - \u2205 (CES-D) \u2205 (PSS) - - \u2205 (SF-36) \nChirico \n(2020)[77] Profesores  \n(n=50)  \u2295 Burnout (MBI)  - - - - \u2295 (GHQ) - \nCole (2012)[78] Melanoma metast\u00e1sico \n(n=83) - - \u2205 (CES-D) \n - - - \u2205 (MQOL) \nCuriati \n(2005)[79] Insuficiencia card\u00edaca \ncongestiva \n(n=19) \u2295 Nivel de norepinefrina en \nsangre* \n\u2295 Cociente de ventilaci\u00f3n por \nminuto* - - - - - - \nDillbeck \n(1977)[80] Estudiantes universitarios \n(n=33) - \u2205 (STAI) - - - - - \nDion (2016)[81] C\u00e1ncer de mama \n(n=38) \u2205 Fatiga (EVA 0-10) \n\u2205 Dolor (EVA 0-10) - - \u2205 (PSS) - - - \nDunne \n(2019)[82] Trabajadores de \nemergencias \n(n=51) \u2295 Burnout (MBI)* \u2295 (DASS-21)* - - - - - \nDuraimani \n(2015)[83] Hipertensi\u00f3n \n(n=152) \u2205 Presi\u00f3n sangu\u00ednea - - - - - -  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  302 Tabla 8. Significaci\u00f3n estad\u00edstica de los resultado s de efectividad de los estudios primarios incluido s  \nAutor (a\u00f1o) Condici\u00f3n de salud \ny tama\u00f1o muestral S\u00edntomas y Calidad de \nVida espec\u00edfica Ansiedad Depresi\u00f3n Estr\u00e9s Insomni\no Psicopatolog\u00eda \ngeneral Calidad \nde Vida \ngeneral \nElder \n(2014)[84] Trabajadores residencia \nestudiantes con problemas \nde conducta \n(n=40)  \u2295 Burnout (MBI)  - \u2295 (MHI-5) \u2295 (PSS) - - - \nFatima \n(2014)[53] Poblaci\u00f3n general \n(n=65) \u2205 Presi\u00f3n sangu\u00ednea  - - - - - \u2295 (WHOQOL)  \nGagrani \n(2018)[85]  Glaucoma \n(n=60) \u2295 Presi\u00f3n intraocular - - - - - \u2295 (WHOQOL)  \nGalante \n(2016)[86] Poblaci\u00f3n general \n(n=809) - \u2205 (IDA) \u2205 (IDA) - - - - \nGaston \n(1988)[87] Psoriasis \n(n=18) \u2295 Severidad s\u00edntomas psoriasis  - - - - - -   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 303 Tabla 8. Significaci\u00f3n estad\u00edstica de los resultado s de efectividad de los estudios primarios incluido s  \nAutor (a\u00f1o) Condici\u00f3n de salud \ny tama\u00f1o muestral S\u00edntomas y Calidad de \nVida espec\u00edfica Ansiedad Depresi\u00f3n Estr\u00e9s Insomni\no Psicopatolog\u00eda \ngeneral Calidad \nde Vida \ngeneral \nHafner \n(1982)[88] Hipertensi\u00f3n \n(n=21) \u2205 Presi\u00f3n sangu\u00ednea - - - - - - \nHager \n(1978)[89] Presi\u00f3n arterial lim\u00edtrofe \n(n=30) \u2205 Presi\u00f3n sangu\u00ednea - - - - - - \nHeffner \n(2016)[147] Veteranos de guerra con \nTEPT \n(n=79) \u2295 S\u00edntomas TEPT (MT) \n\u2205 S\u00edntomas TEPT (OMBM) - - - - - - \nHeide \n(1980)[90] Estudiantes voluntarios \n(n=63) - \u2205 (STAI) - - - - - \nJanyacharoen \n(2018)[91] Personas mayores  (n=34) \u2205 6MWT  \n\u2205 FTSST  \n\u2295 TUGT  \n\u2295 FRT - - - - - \u2205 (WHOQOL)  \nJayadevappa \n(2007)[92] Insuficiencia card\u00edaca \ncongestiva \n(n=23) \u2295 6MWT \n\u2205 Hospitalizaciones \n\u2205 Eventos card\u00edacos - \u2295 (CES-D) \u2205 (PSS) - - \u2205 (SF-36) \nJazaieri \n(2013)[93] Adultos sanos \n(n=100) - \u2205 (PSWQ)  \u2205 (PSS) - - - \nJeitler \n(2015)[94] Dolor de cuello cr\u00f3nico \n(n=89) \u2295 Dolor en reposo (EVA 0-100) \n\u2205 Dolor en movimiento (EVA 0-\n100) \n\u2295 Molestia por el dolor (EVA 0-\n100) \u2205 (STAI) \u2205 (CES-D) \u2205 (PSS) - - \u2205 (SF-36)  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  304 Tabla 8. Significaci\u00f3n estad\u00edstica de los resultado s de efectividad de los estudios primarios incluido s  \nAutor (a\u00f1o) Condici\u00f3n de salud \ny tama\u00f1o muestral S\u00edntomas y Calidad de \nVida espec\u00edfica Ansiedad Depresi\u00f3n Estr\u00e9s Insomni\no Psicopatolog\u00eda \ngeneral Calidad \nde Vida \ngeneral \n\u2205 Funcionalidad (NPAD) \nJong (2019)[95] Ni\u00f1os con cefalea \n(n=131) \u2205 Frecuencia de la cefalea \u2205 (RCADS-25) \u2205 (RCADS-\n25) - - - - \nKeefer \n(2001)[96] S\u00edndrome de Intestino \nIrritable \n(n=16) \u2295 Severidad s\u00edntomas \ngastrointestinales (CPSR) - - - - - - \nKindlon \n(1983)[97] Estudiantes \n(n=35) - \u2205 (Attitude \nInventory)  - - - - - \nKirkland \n(1980)[148] Estudiantes \n(n=60) - \u2205 (CSAQ-C) - - - - - \nKirsch \n(1979)[98] Estudiantes con \nansiedad a hablar en \np\u00fablico \n(n=38) - \u2295 (PRCS) - - - - - \nKnabb \n(2020)[99] Estudiantes \n(n=101) - \u2205 (DASS-21) - - - - - \nLeach \n(2015)[100] Cuidadores de personas \ncon demencia \n(n=17) - \u2205 (WebNeuro) \u2205 (WebNeuro) \u2205 (WebNeuro) - - \u2205 (AqoL-\n8D) \nLee (2015)[101] Supervivientes trauma \ninterpersonal \n(n=63) \u2295 S\u00edntomas TEPT (PTSD) - - - - \u2205 (SDS) -   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 305 Tabla 8. Significaci\u00f3n estad\u00edstica de los resultado s de efectividad de los estudios primarios incluido s  \nAutor (a\u00f1o) Condici\u00f3n de salud \ny tama\u00f1o muestral S\u00edntomas y Calidad de \nVida espec\u00edfica Ansiedad Depresi\u00f3n Estr\u00e9s Insomni\no Psicopatolog\u00eda \ngeneral Calidad \nde Vida \ngeneral \nLehrer \n(1983)[102] Ansiedad \n(n=61) - \u2295 (STAI) \u2205 (SCL-90) \n(vs otro \ntratamiento \nactivo) \n\u2205 (SCL-90) \n(vs control) - - \u2205 (SCL-90)* - \nManocha \n(2011)[103] Trabajadores \n(n=180) - \u2205 (STAI) \u2295 (POMS) \u2295 (PSQ) - - - \nMenezes \n(2013)[104] Estudiantes universitarios \n(n=100) - \u2295 (STAI) - - - - - \nMenezes \n(2015)[105] Estudiantes universitarios \n(n=46) - \u2295 (STAI) - - - - - \nMichalsen \n(2016)[106] \n Dolor lumbar cr\u00f3nico \n(n=68) \u2205 Dolor en reposo (EVA 0-\n100) \n\u2205 Funcionalidad (RMDQ) \u2205 (HADS) \u2205 (HADS) \u2295 (PSS) - - \u2205 (SF-36) \nMilbury \n(2013)[107] C\u00e1ncer de mama \n(n=46) \u2205 Funcionamiento cognitivo \n(FACT-Cog) \n\u2205 Fatiga (BFI) - \u2205 (CES-D) - \u2205 (PSQI) - \u2205 (SF-36) \nMurphy \n(1986)[108] Consumo social de \nalcohol \n(n=60) \u2205 Consumo medio de alcohol - - - - - - \nNanthakwang \n(2020)[109] Mayores de 60 a\u00f1os con \ncalidad de sue\u00f1o pobre \n(n=51) - - - - \u2295 (PSQI) - \u2295 (PTQL)  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  306 Tabla 8. Significaci\u00f3n estad\u00edstica de los resultado s de efectividad de los estudios primarios incluido s  \nAutor (a\u00f1o) Condici\u00f3n de salud \ny tama\u00f1o muestral S\u00edntomas y Calidad de \nVida espec\u00edfica Ansiedad Depresi\u00f3n Estr\u00e9s Insomni\no Psicopatolog\u00eda \ngeneral Calidad \nde Vida \ngeneral \nNidich \n(2009a)[110] C\u00e1ncer de mama \n(n=130) \u2295 FACT-B - - - - - \u2295 Salud \nmental SF-\n36 \n\u2205 Vitalidad \nSF-36  \nNidich \n(2009b)[111] Estudiantes universitarios \n(n=298) \u2205 Presi\u00f3n sangu\u00ednea \u2295 (POMS)  \u2295 (POMS) \u2295 (POMS) - - - \nNidich \n(2016)[112] Internos de prisi\u00f3n con \nsintomatolog\u00eda TEPT \n(n=181) \u2295 S\u00edntomas TEPT (TSC-40) \u2295 (TSC-40) \u2295 (TSC-40) \u2295 (PSS) \u2295 (TSC-40)  - - \nNidich \n(2017)[113] Internas de prisi\u00f3n con \nsintomatolog\u00eda TEPT \n(n=22) \u2205 S\u00edntomas TEPT (PCL-C) - - - - - - \nNidich \n(2018)[114] Veteranos de guerra con \nTEPT \n(n=23) \u2295 S\u00edntomas TEPT (PCL-M) (vs \ncontrol) \n\u2205 S\u00edntomas TEPT (PCL-M) (vs \npsicoterapia) - \u2295 (PHQ-9) \n(vs control) \n\u2205 (PHQ-9) \n(vs \npsicoterapia) - - - \u2295 (Q-LES-\nQ) \nOman \n(2006)[115] Profesionales sanitarios \n(n=61) \u2205 Burnout (MBI) - - \u2295 (PSS) - - \u2205 (MOS) \nOttens \n(1975)[116] Estudiantes universitarios \n(n=54) \u2295 Consumo de tabaco (auto-\nregistro) d \n\u2205 Consumo de tabaco (auto-\nregistro) e - - - - - -   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 307 Tabla 8. Significaci\u00f3n estad\u00edstica de los resultado s de efectividad de los estudios primarios incluido s  \nAutor (a\u00f1o) Condici\u00f3n de salud \ny tama\u00f1o muestral S\u00edntomas y Calidad de \nVida espec\u00edfica Ansiedad Depresi\u00f3n Estr\u00e9s Insomni\no Psicopatolog\u00eda \ngeneral Calidad \nde Vida \ngeneral \nParker \n(1978)[117] Adultos con ansiedad y \nalcoholismo \n(n=30) \u2295 Presi\u00f3n sangu\u00ednea \u2205 (STAI) \n - - - - - \nPaul-Labrador \n(2006)[118] Enfermedad coronaria \n(n=103) \u2295 Presi\u00f3n sangu\u00ednea - - -  - - \nPuryear \n(1976)[119] Voluntarios \n(n=159) - \u2295 (IPAT) - - - - - \nRaskin \n(1980)[120] Estudiantes con \nansiedad \n(n=37) - \u2205 (TMAS) - - - - - \nRees \n(2013)[121] Refugiados de guerra \ncon TEPT \n(n=42) \u2295 (PCL-C) - - - - - - \nSchneider \n(1995)[122] & \nAlexander \n(1996)[123] Hipertensi\u00f3n \n(n=127) \u2205 Presi\u00f3n sangu\u00ednea - - - - - - \nSchneider \n(2005)[124] Hipertensi\u00f3n \n(n=197) \u2205 Presi\u00f3n sangu\u00ednea - - - - - - \nSchneider \n(2012)[125] Enfermedad coronaria \n(n=213) \u2295 Presi\u00f3n sangu\u00ednea \n\u2295 Riesgo de \nmortalidad/infarto/ictus* - \u2205 (CES-D) - - - - \nSeer Hipertensi\u00f3n \u2205 Presi\u00f3n sangu\u00ednea - - - - - -  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  308 Tabla 8. Significaci\u00f3n estad\u00edstica de los resultado s de efectividad de los estudios primarios incluido s  \nAutor (a\u00f1o) Condici\u00f3n de salud \ny tama\u00f1o muestral S\u00edntomas y Calidad de \nVida espec\u00edfica Ansiedad Depresi\u00f3n Estr\u00e9s Insomni\no Psicopatolog\u00eda \ngeneral Calidad \nde Vida \ngeneral \n(1980)[126] (n=41) \nSevertsen \n(1986)[127] Estudiantes de \nenfermer\u00eda voluntarias \n(n=10) - - - \u2205 (HRSRS) - - - \nShahar \n(2014)[128] Personas con altos \nniveles de autocr\u00edtica \n(n=38) - \u2205 (DASS-21) \u2295 (DASS-21) \u2205 (DASS-21) - - - \nSheppard \n(1997)[129] Trabajadores \n(n=44) \u2205 Presi\u00f3n sangu\u00ednea \u2205 (STAI) \u2205 (IPAT) - - - - \nSo (2001)[130] \nEstudio 1 Estudiantes de secundaria \n(n=154) - \u2295 (STAI) - - - - - \nSo (2001)[130] \nEstudio 2 Estudiantes de secundaria \n(n=118) - \u2295 (STAI) - - - - - \nSo (2001)[130] \nEstudio 3 Estudiantes de secundaria \n(n=99) - \u2295 (STAI) - - - - - \nTravis \n(2018)[132] Personal de la oficina  \n(n=96) - \u2295 (POMS) \u2295 (POMS) - - - - \nTuab (1994) Adultos con alcoholismo \n(n=118) \u2295 Consumo de alcohol (SHQ) a  \n\u2205 Consumo de alcohol (SHQ) b  \n\u2295 Consumo de alcohol (SHQ) c - - - - - - \nVaccarino S\u00edndrome metab\u00f3lico \u2205 Vasodilataci\u00f3n  \u2205 (STAI) \u2205 (BDI-II) \u2205 (PSS) - - -   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 309 Tabla 8. Significaci\u00f3n estad\u00edstica de los resultado s de efectividad de los estudios primarios incluido s  \nAutor (a\u00f1o) Condici\u00f3n de salud \ny tama\u00f1o muestral S\u00edntomas y Calidad de \nVida espec\u00edfica Ansiedad Depresi\u00f3n Estr\u00e9s Insomni\no Psicopatolog\u00eda \ngeneral Calidad \nde Vida \ngeneral \n(2013)[133] (n=68) \n \u2295 Factores de riesgo \n(puntuaci\u00f3n total) \n\u2205 Presi\u00f3n sangu\u00ednea \nVasudev (2016) \n[134]& Ionson \n(2019)[135] Personas mayores con \ndepresi\u00f3n mayor leve o \nmoderada \n(n=95) - \u2295 (GAI) \u2295 (HAM-D) - - - \u2205 (QOLSV) \nWachholtz \n(2005)[136] Estudiantes \n(n=68) - \u2295 (STAI) - - - - - \nWachholtz \n(2008)[137] Estudiantes con Migra\u00f1a \n(n=92) \u2295 Frecuencia del dolor \n\u2205 Severidad del dolor \u2205 (STAI) \u2205 (CES-D) - - - \u2205 (MSQoL) \nWeibel \n(2016)[138] Estudiantes \n(n=71) - \u2205 (STAI) - - - - - \nWilliams \n(2005)[139] VIH-SIDA \n(n=58) - - - - - - \u2205 (MVQOLI) \nWilson \n(1975)[140] Asma bronquial \n(n=25) \u2205 VEF1 \n\u2205 TFRM \n\u2205 Resistencia de las v\u00edas \nrespiratorias - - - - - - \nWolf \n(2003)[141] Poblaci\u00f3n general \n(n=93) - - \u2205 (GCS) \u2205 (ICS) - - - \nWren C\u00e1ncer de mama \u2295 Dolor corporal (BPI) \u2295 (STAI) - - - - -  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  310 Tabla 8. Significaci\u00f3n estad\u00edstica de los resultado s de efectividad de los estudios primarios incluido s  \nAutor (a\u00f1o) Condici\u00f3n de salud \ny tama\u00f1o muestral S\u00edntomas y Calidad de \nVida espec\u00edfica Ansiedad Depresi\u00f3n Estr\u00e9s Insomni\no Psicopatolog\u00eda \ngeneral Calidad \nde Vida \ngeneral \n(2019)[142] (n=138) \u2205 Dolor en la mama (BPI) \n\u2205 Fatiga (FACIT) \n\u2205 Presi\u00f3n sangu\u00ednea  \nWu (2019) \n[143] Adultos con angustia \nmoderada \n(n=122) - - - \u2295 (PSS) - \u2295 (GHQ) - \nYang \n(2009)[144] Estudiantes universitarios \n(n=242) - - - \u2295 (LAS) - - - \nZuroff \n(1978)[145] Estudiantes \n(n=60) - \u2205 (ACL) - - - - - \n\u2295 Efecto significativo favorable a la meditaci\u00f3n \n\u2297 Efecto significativo favorable al control \n\u2205 Sin diferencias significativas \n* No se reportan diferencias inter-grupo \n \na vs. neuroterapia \nb vs. biofeedback \nc vs. tratamiento habitual \nd vs. no tratamiento \ne vs. auto-control \n \n6MWT: six-minute walk distance test; ACL: Adjective Check  List scale of anxiety; AqoL-8D: Assessment of Quality of Li fe 8-dimension; BAI: Beck Anxiety Inventory; BDI-II: Bec k \nDepression Inventory-II; BFI: Brief Fatigue Inventory; BP I: Brief Pain Inventory; BSI-18: Brief Symptom Inventory -18; CAPS: Clinician-Administered PTSD Scale; CES-D: Ce nter for \nEpidemiologic Studies Depression Scale; CPSR: Composite  Primary IBS Symptom Reduction; CSAQ-C: Cognitive scale  of the Cognitive-Somatic Anxiety Questionnaire; DASS-2 1: \nDepression, Anxiety and Stress Scale; EVA: Escala Visual A nal\u00f3gica; FACIT: Fatigue scale; FACT-B: Functional Ass essment of Cancer Therapy\u2013Breast; FACT-Cog: Functional \nAssessment of Cancer Therapy; FAHI: Functional Assessment of  HIV Infection; FRT: Functional Reach Test; FTSST: F ive Times Sit to Stand Test; GAI: Geriatric Anxiety Inve ntory; \nGCS: Generalized Contentment Scale; GHQ: General He alth Questionnaire;  HADS: Hospital Anxiety Depression S cale; HRSRS: Holmes-Rahe Social Readjustment Scale; I CS: \nIndex of Clinical Stress; IDA: Irritability, Depression  and Anxiety scale; IES-R: Impact of Events Scale-Revised ; IPAT:  Institute of Personality and Ability Testing_De pression Scale; ISI: \nInsomnia Severity Index; LAS: Life Adaptation Scale; M HI-5: Mental Health Inventory-5; MBI: Maslach Burnout I nventory; MLWHFQ: Minnesota Living with Heart Failure \nQuestionnaire; MOS: Medical Outcomes Study; MPQ: McGil l Pain Questionnaire; MQOL: McGill quality of life sca le; MSQOL: Migraine Specific Quality of Life Scale; MT: Meditaci\u00f3n \nTrascendental; MVQOLI: Missoula-VITAS Quality of Life In dex; N: n\u00famero de participantes; NPAD: Neck Pain and  Disability Questionnaire; OMBM: Otras Meditaciones Basad as en   \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 311 Tabla 8. Significaci\u00f3n estad\u00edstica de los resultado s de efectividad de los estudios primarios incluido s  \nAutor (a\u00f1o) Condici\u00f3n de salud \ny tama\u00f1o muestral S\u00edntomas y Calidad de \nVida espec\u00edfica Ansiedad Depresi\u00f3n Estr\u00e9s Insomni\no Psicopatolog\u00eda \ngeneral Calidad \nde Vida \ngeneral \nMantras; PCL-C: PTSD Checklist-Civilian Version; PCL-M: PT SD Checklist\u2013Military Version; PHQ-9: Patient Health Qu estionarie-9; POMS: Profile of Mood States Total Mood \nDisturbance scale; PRCS: Personal Report of Confidenc e as a Speaker; PSQ: Psychological Strain Questionnaire ; PSQI: Pittsburgh Sleep Quality Index; PSS: Perceive d Stress \nScale; PSWQ: Penn State Worry Questionnaire; PTQL: Pic torial Thai Quality of Life; Q-LES-Q: Quality of Life E njoyment and Satisfaction Questionnaire; Q-LES-Q:SF: Qua lity of Life \nEnjoyment and Satisfaction Questionnaire-Short Form; QO LSV: Quality of Life Profile Seniors Version; RCADS-25:  Revised Children\u2019s Anxiety and Depression Scale-25; RMDQ:  \nRoland Morris Disability Index; SCL-90: Symptom Checklist -90; SDS: Symptom Distress Scale; SF-36: Short Form-36 He alth Survey; SHQ: Social History Questionnaire; STAI: \nState-Trait Anxiety Inventory; TEPT: Trastorno por estr\u00e9 s postraum\u00e1tico; TFRM:  Tasa de flujo respiratorio m\u00e1ximo; TMAS: Taylor Manif est Anxiety Scale; TSC-40: Trauma Symptom \nChecklist \u2013 40; TSI: Teacher's Stress Inventory; TUGT:  Timed up and go test; VEF1: Volumen espiratorio forz ado en 1 segundo; VIH: Virus de la inmunodeficiencia  humana; \nWHOQOL: World Health Organization Quality of Life bri ef form \n  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  312 Anexo Anexo Anexo Anexo 88 88. . . . Figuras Figuras Figuras Figuras    adicionales de adicionales de adicionales de adicionales de    ll llos os os os meta meta meta meta-- --\nan\u00e1lisis an\u00e1lisis an\u00e1lisis an\u00e1lisis    realizados realizados realizados realizados    \nMeditaci\u00f3n vs. control  \nAnsiedad \nA2. Efecto sobre la ansiedad seg\u00fan el tipo de grupo  control \n \n \n \n \n \n \n  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 313 A3. Efecto sobre la ansiedad seg\u00fan el tipo de pobla ci\u00f3n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  314 A4. Efecto sobre la ansiedad seg\u00fan la fecha de publ icaci\u00f3n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 315 A5. Efecto sobre la ansiedad seg\u00fan el tiempo de seg uimiento \n \n \n \n \n \n \n \n \n \n \n  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  316 Depresi\u00f3n \n \nD2. Efecto sobre la depresi\u00f3n seg\u00fan el tipo de punt uaciones (cambio desde \nl\u00ednea base o puntuaciones en el seguimiento) \n \n \n \n \n \n  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 317 D3. Efecto sobre la depresi\u00f3n seg\u00fan el tipo de grup o control \n \n \n \n \n \n \n \n \n \n \n  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  318 D4. Efecto sobre la depresi\u00f3n seg\u00fan el tipo de pobl aci\u00f3n \n \n \n \n \n \n \n \n \n  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 319 D5. Efecto sobre la depresi\u00f3n seg\u00fan el a\u00f1o de publi caci\u00f3n \n \n \n \n \n \n \n \n \n  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  320 D6. Efecto sobre la depresi\u00f3n seg\u00fan el tiempo de se guimiento \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 321 Estr\u00e9s \nE2. Efecto sobre el estr\u00e9s seg\u00fan el tipo de grupo c ontrol. \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  322  \nE3. Efecto sobre el estr\u00e9s seg\u00fan el tipo de poblaci \u00f3n \n \n \n \n \n \nE4. Efecto sobre el estr\u00e9s seg\u00fan el a\u00f1o de publicac i\u00f3n \n \n \n \n  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 323  \n \nE5. Efecto sobre el estr\u00e9s seg\u00fan el tiempo de segui miento \n \n \n \n  \nINFORMES, ESTUDIOS E INVESTIGACI\u00d3N  324 Calidad de vida \nCV2. Efecto sobre la calidad de vida: general o men tal  \n \n \n \nCV3. Efecto sobre la calidad de vida (general o men tal) seg\u00fan el tipo de grupo \ncontrol \n \n \n \n \n  \n \nEFECTIVIDAD Y SEGURIDAD DE LA MEDITACI\u00d3N 325 CV4. Efecto sobre la calidad de vida (general o men tal) seg\u00fan el tipo de \npoblaci\u00f3n \n \n \n \n \nCV5. Efecto sobre la calidad de vida (general o men tal) seg\u00fan el tiempo de \nseguimiento \n \n \n \n  \n  \n ", "language": "PDF", "image": "PDF", "pagetype": "PDF", "links": "PDF"}